Patent Publication Number: US-9428761-B2

Title: Plants having enhanced yield-related traits and a method for making the same

Description:
RELATED APPLICATIONS 
     This application is a divisional of U.S. application Ser. No. 12/519,787 filed Jul. 15, 2009, which is a national stage application (under 35 U.S.C. §371) of PCT/EP2007/064510, filed Dec. 21, 2007, which claims benefit of European application 06126950.2 filed Dec. 21, 2006, European application 06126891.8 filed Dec. 21, 2006, European application 06126852.0 filed Dec. 21, 2006, European application 06127112.8 filed Dec. 22, 2006, European application 06127101.1 filed Dec. 22, 2006, U.S. Provisional application 60/883,353 filed Jan. 4, 2007, U.S. Provisional application 60/883,355 filed Jan. 4, 2007, U.S. Provisional application 60/886,105 filed Jan. 23, 2007, U.S. Provisional application 60/886,104 filed Jan. 23, 2007, and U.S. Provisional application 60/886,106 filed Jan. 23, 2007, the entire contents of each of which are hereby incorporated by reference in this application. 
    
    
     SUBMISSION OF SEQUENCE LISTING 
     The Sequence Listing associated with this application is filed in electronic format via EFS-Web and hereby incorporated by reference into the specification in its entirety. The name of the text file containing the Sequence Listing is Sequence_Listing_17418_00118_US. The size of the text file is 857 KB, and the text file was created on Aug. 9, 2013. 
     The present invention relates generally to the field of molecular biology and concerns a method for enhancing various economically important yield-related traits in plants. More specifically, the present invention concerns a method for enhancing yield-related traits in plants by modulating expression in a plant of a nucleic acid encoding a Yield Enhancing Protein (YEP). The YEP is selected from a Vacuolar Processing Enzyme (VPE), a CCA1-like polypeptide, a SAP-like polypeptide, a Seed Yield Promoting Factor 1 (SYPF1) polypeptide and a Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) activase (RCA) polypeptide. The present invention also concerns plants having modulated expression of a nucleic acid encoding such a YEP, which plants have enhanced yield-related traits relative to control plants. The invention also provides hitherto unknown YEP-encoding nucleic acids, and constructs comprising the same, useful in performing the methods of the invention. 
     The ever-increasing world population and the dwindling supply of arable land available for agriculture fuels research towards increasing the efficiency of agriculture. Conventional means for crop and horticultural improvements utilise selective breeding techniques to identify plants having desirable characteristics. However, such selective breeding techniques have several drawbacks, namely that these techniques are typically labour intensive and result in plants that often contain heterogeneous genetic components that may not always result in the desirable trait being passed on from parent plants. Advances in molecular biology have allowed mankind to modify the germplasm of animals and plants. Genetic engineering of plants entails the isolation and manipulation of genetic material (typically in the form of DNA or RNA) and the subsequent introduction of that genetic material into a plant. Such technology has the capacity to deliver crops or plants having various improved economic, agronomic or horticultural traits. 
     A trait of particular economic interest is increased yield. Yield is normally defined as the measurable produce of economic value from a crop. This may be defined in terms of quantity and/or quality. Yield is directly dependent on several factors, for example, the number and size of the organs, plant architecture (for example, the number of branches), seed production, leaf senescence and more. Root development, nutrient uptake, stress tolerance and early vigour may also be important factors in determining yield. Optimizing the above-mentioned factors may therefore contribute to increasing crop yield. 
     Seed yield is a particularly important trait, since the seeds of many plants are important for human and animal nutrition. Crops such as, corn, rice, wheat, canola and soybean account for over half the total human caloric intake, whether through direct consumption of the seeds themselves or through consumption of meat products raised on processed seeds. They are also a source of sugars, oils and many kinds of metabolites used in industrial processes. Seeds contain an embryo (the source of new shoots and roots) and an endosperm (the source of nutrients for embryo growth during germination and during early growth of seedlings). The development of a seed involves many genes, and requires the transfer of metabolites from the roots, leaves and stems into the growing seed. The endosperm, in particular, assimilates the metabolic precursors of carbohydrates, oils and proteins and synthesizes them into storage macromolecules to fill out the grain. 
     Plant biomass is yield for forage crops like alfalfa, silage corn and hay. Many proxies for yield have been used in grain crops. Chief amongst these are estimates of plant size. Plant size can be measured in many ways depending on species and developmental stage, but include total plant dry weight, above-ground dry weight, above-ground fresh weight, leaf area, stem volume, plant height, rosette diameter, leaf length, root length, root mass, tiller number and leaf number. Many species maintain a conservative ratio between the size of different parts of the plant at a given developmental stage. These allometric relationships are used to extrapolate from one of these measures of size to another (e.g. Tittonell et al 2005 Agric Ecosys &amp; Environ 105: 213). Plant size at an early developmental stage will typically correlate with plant size later in development. A larger plant with a greater leaf area can typically absorb more light and carbon dioxide than a smaller plant and therefore will likely gain a greater weight during the same period (Fasoula &amp; Tollenaar 2005 Maydica 50:39). This is in addition to the potential continuation of the micro-environmental or genetic advantage that the plant had to achieve the larger size initially. There is a strong genetic component to plant size and growth rate (e.g. ter Steege et al 2005 Plant Physiology 139:1078), and so for a range of diverse genotypes plant size under one environmental condition is likely to correlate with size under another (Hittalmani et al 2003 Theoretical Applied Genetics 107:679). In this way a standard environment is used as a proxy for the diverse and dynamic environments encountered at different locations and times by crops in the field. 
     Harvest index, the ratio of seed yield to aboveground dry weight, is relatively stable under many environmental conditions and so a robust correlation between plant size and grain yield can often be obtained (e.g. Rebetzke et al 2002 Crop Science 42:739). These processes are intrinsically linked because the majority of grain biomass is dependent on current or stored photosynthetic productivity by the leaves and stem of the plant (Gardener et al 1985 Physiology of Crop Plants. Iowa State University Press, pp 68-73). Therefore, selecting for plant size, even at early stages of development, has been used as an indicator for future potential yield (e.g. Tittonell et al 2005 Agric Ecosys &amp; Environ 105: 213). When testing for the impact of genetic differences on stress tolerance, the ability to standardize soil properties, temperature, water and nutrient availability and light intensity is an intrinsic advantage of greenhouse or plant growth chamber environments compared to the field. However, artificial limitations on yield due to poor pollination due to the absence of wind or insects, or insufficient space for mature root or canopy growth, can restrict the use of these controlled environments for testing yield differences. Therefore, measurements of plant size in early development, under standardized conditions in a growth chamber or greenhouse, are standard practices to provide indication of potential genetic yield advantages. 
     A further trait of economic importance for many crops is early vigour. Improving early vigour is an important objective of modern rice breeding programs in both temperate and tropical rice cultivars. Long roots are important for proper soil anchorage in water-seeded rice. Where rice is sown directly into flooded fields, and where plants must emerge rapidly through water, longer shoots are associated with vigour. Where drill-seeding is practiced, longer mesocotyls and coleoptiles are important for good seedling emergence. Early vigour may also result from increased plant fitness due to, for example, the plants being better adapted to their environment (i.e. being more able to cope with various abiotic or biotic stress factors). Plants having early vigour also show better establishment of the crop (with the crop growing in a more uniform manner, i.e. with the majority of plants reaching the various stages of development at substantially the same time), and show better growth and often better yield. 
     The ability to engineer early vigour into plants would be of great importance in agriculture, as would the ability to increase plant seed yield, whether through seed number, seed biomass, seed development, seed filling, or any other seed-related trait. Aside form the many applications in agriculture (including in the production of ornamental plants, arboriculture, horticulture and forestry), enhancing yield-related traits would also have many non-agricultural uses, such as in the biotechnological production of substances such as pharmaceuticals, antibodies or vaccines. Increasing yield may also find use in the production of algae for use in bioreactors (for the biotechnological production of substances such as pharmaceuticals, antibodies or vaccines, or for the bioconversion of organic waste) and other such areas. 
     Surprisingly, it has now been found that modulating expression in a plant of a nucleic acid encoding a Yield Enhancing Polypeptide (YEP) selected from a Vacuolar Processing Enzyme (VPE), a CCA1-like polypeptide, a SAP-like polypeptide, a Seed Yield Promoting Factor 1 (SYPF1) polypeptide and a Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) activase (RCA) polypeptide gives plants having enhanced yield-related traits relative to control plants. 
     BACKGROUND 
     I. Vacuolar Processing Enzymes (VPEs) 
     Vacuolar Processing Enzymes (VPEs) are cysteine proteases that cleave a peptide bond at the C-terminal side of asparagine and aspartic acid. VPE was originally discovered as a novel cysteine proteinase responsible for the maturation of seed storage Proteins.  Arabidopsis  has four VPE genes (alpha VPE, beta VPE, gamma VPE and delta VPE). Hara-Nishimura et al., Current Opinion in Plant Biology 2005, 8:404-408. 
     In higher plants, proprotein precursors of various vacuolar proteins are converted post-translationally to their respective mature forms by the action of VPEs. The molecular structure of the enzyme was originally reported for castor bean VPE. VPE homologues have been found in plants (soybean, Jack bean,  Arabidopsis , vetch and citrus) and animals ( Schistosoma mansoni , human and mouse). A VPE precursor is composed of a signal peptide, an N-terminal propeptide, the mature VPE domain and a C-terminal propeptide. A yeast ( Saccharomyces cerevisiae ) transformant expressing a VPE precursor of castor bean accumulated the mature form in the vacuoles. The mature protein had a vacuolar processing activity; in contrast, the precursor had no activity. Analysis of mutants having no activity suggested that the conversion of the proprotein precursor of VPE into an active form might be mediated self-catalytically. (Hiraiwa et al. FEBS Letters 447, 1999, pp. 213-216). 
     Programmed cell death (PCD) occurs in animals and plants under various stresses and during development. VPE was identified as an executioner of plant PCD. VPE exhibits enzymatic properties similar to that of a caspase, which is a cysteine protease that mediates the PCD pathway in animals, although there is limited sequence identity between the two enzymes. VPE was reported to have caspase-1 activity (Hatsugai et al., SCIENCE VOL 305 6 Aug. 2004). VPE and caspase-1 share several structural properties: the catalytic dyads and three amino acids forming the substrate pockets (Asp pocket) are conserved between VPE and caspase-1. In contrast to such similarities, VPE is localized in the vacuoles, while caspases are localized in the cytosol. VPE functions as a key molecule of plant PCD through disrupting the vacuole in pathogenesis and development. Hatsugai et al., Apoptosis 2006; 11: 905-911. VPE gamma (VPEg), was reported to be induced during senescence, a form of PCD (see Rojo et al., 2004, Current Biology, Vol. 14, pp 1897-1906). 
     II. CCA1 
     MYB proteins are a superfamily of transcription factors that play regulatory roles in developmental processes and defence responses in plants. Expression analysis revealed that the expression for most of the  Arabidopsis  MYB genes were responsive to one or multiple types of hormone and stress treatments (Yanhui et al., Plant Mol. Biol. 60, 107-124, 2006). A phylogenetic comparison of the members of this superfamily in  Arabidopsis  and rice suggested that the  Arabidopsis  MYB superfamily underwent a rapid expansion after its divergence from monocots but before its divergence from other dicots (Yanhui et al., 2006). MYB proteins typically comprise a structurally conserved DNA-binding domain, the MYB domain. They are involved in the cell cycle, regulation of meristem formation, control of cellular differentiation and in the regulation of secondary metabolism. MYB domain transcription factors constitute one of the largest family of transcription factors in plants (at least 130 in  Arabidopsis thaliana ), but with little sequence conservation outside of the MYB domain. They have therefore been clustered into subgroups based on conserved motifs identified outside of the MYB coding region (Jiang et al. (2004) Genome Biology 5:R46). Different categories of MYB proteins can be identified depending on the number of imperfect repeats of the MYB domain they contain, grouped into 3 families: R2R3-MYB family, R1R2R3-MYB family and the MYB-related family. The R2R3-MYB family comprises the largest number of MYB proteins and is divided into five subfamilies (Yanhui et al. 2006): CCA1-like, CPC-like, TBP-like, 1-box-binding-like and R-R-type MYB proteins. Of these, the CCA1-like subfamily is the largest, and members of this subfamily contain the conserved motif SHAQK or MYADN in the MYB repeat. 
     The circadian clock controls various physiological and molecular processes in higher organisms. In plants, these processes include leaf movement, stomata opening, and expression of a large number of genes. In  Arabidopsis thaliana , a number of clock-associated protein components have been identified. Among them, CCA1 (CIRCADIAN CLOCK-ASSOCIATED 1)/LHY (LATE ELONGATED HYPOCOTYL) and TOC1 (TIMING OF CAB EXPRESSION 1) are believed to be the essential components of the central oscillator. CCA1 and LHY are homologous and partially redundant Myb-related DNA-binding proteins, whereas TOC1 is a member of a small family of proteins, designated as PSEUDO-RESPONSE REGULATOR. It is also believed that these two different types of clock components form an autoregulatory positive/negative feedback loop at the levels of transcription/translation that generates intrinsic rhythms (Nakamichi et al., Plant Cell Physiol. 46, 686-689, 2005). It was reported that constitutive expression of the CCA1 (CIRCADIAN CLOCK ASSOCIATED 1) gene in  Arabidopsis  plants (CCA1-ox) results in loss of circadian rhythmicity (Green et al., Plant Physiol. 129, 576-584, 2002). These CCA1-ox plants retain the ability to respond to diurnal changes in light. Thus, transcript levels of several circadian-regulated genes, as well as CCA1 itself and the closely related LHY, oscillate robustly if CCA1-ox plants are grown under diurnal conditions. However, in contrast with wild-type plants in which transcript levels change in anticipation of the dark/light transitions, the CCA1-ox plants have lost the ability to anticipate this daily change in their environment. CCA1-ox plants flowered later, especially under long-day conditions, and were less viable under very short-day conditions than their wild-type counterparts. In addition, it was demonstrated that two other circadian rhythm mutants, LHY-ox and elf3, have low-viability phenotypes. 
     WO2003013228 and US2004019927 describe that CCA1 overexpressing plants were late bolting, showed increased biomass (increased leaf number and size), and were darker green in vegetative and reproductive tissues. It was suggested that CCA1 could be useful in increasing chlorophyll content allowing more growth and productivity in conditions of low light. 
     Furthermore, it was stated that use of CCA1 to prevent flowering could help maximize vegetative yields and prevent escape of genetically modified organism (GMO) pollen (US2004045049). So far, there are no reports showing that increased CCA1 expression results increased seed yield, on the contrary, CCA1-overexpressors flowered later, especially under long-day conditions, and were less viable under very short-day conditions than their wild-type counterparts (Green et al., 2002). 
     III. SAP 
     The SAP domain (named after SAF-A/B, Acinus and PIAS) is a DNA binding domain that forms a helix-extended-helix structure. Proteins with a SAP domain (also named SAF box) have been identified in yeast, mammals and plants. The SAP domain is composed of 35 amino acids residues and comprises two amphipathic helices separated by a glycine-containing region. Some positions in this domain are enriched with positively charged amino acids (R, K) which are thought to contact the DNA backbone. The SAP domain reportedly forms a helix-extended-helix (HEH) structure and that some prokaryotic proteins, such as transcription terminator RHO protein, are also predicted to contain SAP domains. Chen et al., 2003 ( Plant Molecular Biology  52: 579-590) report that SAP domain-containing proteins have been implicated in various functions related to their interactions with DNA and/or RNA. SAP proteins have been implicated in nuclear architecture and/or RNA metabolism. For example, human scaffold attachment factor A (SAF-A) is an abundant component of the nuclear scaffold (nuclear matrix) and is also present in heterogeneous nuclear ribonucleoprotein complexes, which have been implicated in nuclear organization and RNA processing. Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Members of the PIAS proteins family combining SAP domains and MIZ Zn-finger motifs are the protein inhibitors of activated STATs (signal transducer and activator of transcription). Yeast Tho1p protein, another SAP-containing protein, plays a role in regulating elongation of transcription by RNA polymerase II. Chen et al., 2003, describe the cloning and characterization of a rice gene, OsBP-73, encoding a 375 amino acid protein with a SAP-like domain. The authors report that Northern blot analysis demonstrated that OsBP-73 is weakly expressed in root, leaf and immature seed. They also examined OsBP-73 gene expression by histochemical studies of transgenic rice plants carrying an OsBP-73 5_/GUS reporter gene. The reporter gene was found to be mainly expressed in the tissues with high cell division activities, such as root tip, stem node, panicle and immature seed. They further report that genetic interference of OsBP-73 gene expression by double-stranded RNA inhibits the whole plant growth but does not affect the passage from the juvenile to adult phase. They suggest that OsBP-73 may play an important role in the regulation of cell proliferation. 
     IV. SYPF1 
     SYPF1 is a novel transcription factor useful in enhancing yield-related traits in plants. 
     Transcription factors are usually defined as proteins that show sequence-specific DNA binding and that are capable of activating and/or repressing transcription. The  Arabidopsis  genome codes for at least 1533 transcriptional regulators, which account for ˜5.9% of its estimated total number of genes. About 45% of these transcription factors are reported to be from families specific to plants (Riechmann et al., 2000 (Science Vol. 290, 2105-2109)). 
     SYPF1, according to the PRODOM database, was found to share some similarity to tumor related At4g18650; TGA1 bzip activator coil coil. Miao et al., 1994 (Plant Mol. Biol. April 25(1): 1-11) report that TGA1a is a well-characterized transcription factor that may mediate the root-specific and auxin-responsive expression of some plant genes. 
     V. Ribulose-1,5-Bisphosphate Carboxylase/Oxygenase (RuBisCO) Activase (RCA) Polypeptide 
     Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCo, EC 4.1.1.39 [EC]) is the most abundant and one of the most important enzymes on earth. It catalyses the first and rate-limiting step in photosynthetic carbon fixation, the irreversible carboxylation of ribulose-1,5-bisphosphate and CO2 to form two 3-phosphoglyceric acid molecules. However, the rate of the reaction is extremely slow, and RuBisCo must be activated and carbamylated to become catalytically competent. Activation is achieved by RuBisCo activase (RCA), which can remove inhibitors from RuBisCo&#39;s catalytic sites, alter the conformation, and activate RuBisCo in vivo in an ATP-dependent manner (Andrews et al., 1995). 
     RCA is a nuclear-encoded chloroplast protein that is a member of the AAA+ family (ATPases associated with diverse cellular activities) based on sequence and structural homologies, whose members participate in macromolecular complexes that perform diverse chaperone-like functions. Consistent with the ATPase activity of RCA, a P loop (or Walker A; Walker et al., (1982) EMBO J. 1982; 1:945-951) triphosphate-binding loop consensus sequence GXXXGK(S/T), for nucleotide binding, is identified within the RCA polypeptide sequence. Several other critical amino acid residues necessary for RCA interaction with and activation of RuBisCo have also been identified (for review: Portis (2003) Photosynthesis Research 75: 11-27). 
     RCA consists in most plants of two isoforms, of 45-46 kDa (or alpha form) and of 41-43 kDa (or beta form), arising from a single gene via alternative splicing (for review, see Pots (2003) Photosynthesis Research 75: 11-27). The two forms differ only at the carboxy terminus, the longer form comprising two cysteine residues involved in light-dependent redox regulation (mediated by thioredoxin-f). In contrast with most plants, a single polypeptide (without the carboxy terminal extension) has been found in the green alga  Chlamydomonas reinhardtii , which also comprises a chloroplast transit peptide at the amino terminus of the polypeptide (Roesler &amp; Ogren (1990) Plant Physiol 94(4):1837-1841). 
     Mutant  Arabidopsis  plants lacking RCA activity (named rca-; Somerville et al. (1982) Plant Physiol 70: 381-387) or transgenic plants having a very low level of RCA activity cannot survive at atmospheric CO 2  levels ( Flaveria bidentis ; von Caemmerer et al. (2005) Plant Physiol 137(2):747-55), and those expressing reduced levels exhibit reduced rates of photosynthesis and growth (in  Arabidopsis , Eckhardt et al. (1997) Plant Physiol 113: 575-586; in tobacco, Mate et al. (1996) Planta 198: 604-613). However large reductions in RCA activity levels are required before steady-state photosynthesis is noticeably affected, at normal temperatures (for example,  Arabidopsis , rice (Jin et al. (2006) Ann Bot (Lond) 97(5):739-44), tobacco (He et al. (1997) Plant Physiol 115(4):1569-80; Hammond et al. (1998) Plant J 14: 101-110). 
       Arabidopsis  mutants lacking RCA (rca-) were transformed (complemented) with the alpha RCA isoform, a mutated alpha RCA isoform (the two Cys residues involved in redox regulation are mutated in Ala residues), the beta RCA isoform, or both RCA isoforms restored the ability of the plants to grow under normal levels of CO2 (Zhang et al. (2002) PNAS USA 99(5): 3330-3334). Plants expressing only the beta RCA isoform (and thus not light-dependent redox-regulated) or expressing only the mutated alpha RCA isoform (redox insensitive) were incapable of down-regulating RuBisCo under limiting light conditions. 
     Patent application US2006/0272044 relates to methods (by gene shuffling) for obtaining isolated polynucleotides sequences encoding RCA polypeptides having enhanced activity. 
     Surprisingly, it has now been found that modulating expression in a plant of a nucleic acid encoding a YEP selected from a Vacuolar Processing Enzyme (VPE), a CCA1-like polypeptide, a SAP-like polypeptide, a Seed Yield Promoting Factor 1 (SYPF1) polypeptide and a Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) activase (RCA) polypeptide gives plants having enhanced yield-related traits relative to control plants. 
     DEFINITIONS 
     Polypeptide(s)/Protein(s) 
     The terms “polypeptide” and “protein” are used interchangeably herein and refer to amino acids in a polymeric form of any length. 
     Polynucleotide(s)/Nucleic Acid(s)/Nucleic Acid Sequence(s)/Nucleotide Sequence(s) 
     The terms “polynucleotide(s)”, “nucleic acid sequence(s)”, “nucleotide sequence(s)” are used interchangeably herein and refer to nucleotides, either ribonucleotides or deoxyribonucleotides or a combination of both, in a polymeric form of any length. 
     Control Plant(s) 
     The choice of suitable control plants is a routine part of an experimental setup and may include corresponding wild type plants or corresponding plants without the gene of interest. The control plant is typically of the same plant species or even of the same variety as the plant to be assessed. The control plant may also be a nullizygote of the plant to be assessed. A “control plant” as used herein refers not only to whole plants, but also to plant parts, including seeds and seed parts. 
     Homologue(s) 
     “Homologues” of a protein encompass peptides, oligopeptides, polypeptides, proteins and enzymes having amino acid substitutions, deletions and/or insertions relative to the unmodified protein in question and having similar biological and functional activity as the unmodified protein from which they are derived. 
     A deletion refers to removal of one or more amino acids from a protein. 
     An insertion refers to one or more amino acid residues being introduced into a predetermined site in a protein. Insertions may comprise N-terminal and/or C-terminal fusions as well as intra-sequence insertions of single or multiple amino acids. Generally, insertions within the amino acid sequence will be smaller than N- or C-terminal fusions, of the order of about 1 to 10 residues. Examples of N- or C-terminal fusion proteins or peptides include the binding domain or activation domain of a transcriptional activator as used in the yeast two-hybrid system, phage coat proteins, (histidine)-6-tag, glutathione S-transferase-tag, protein A, maltose-binding protein, dihydrofolate reductase, Tag•100 epitope, c-myc epitope, FLAG®-epitope, lacZ, CMP (calmodulin-binding peptide), HA epitope, protein C epitope and VSV epitope. 
     A substitution refers to replacement of amino acids of the protein with other amino acids having similar properties (such as similar hydrophobicity, hydrophilicity, antigenicity, propensity to form or break α-helical structures or β-sheet structures). Amino acid substitutions are typically of single residues, but may be clustered depending upon functional constraints placed upon the polypeptide; insertions will usually be of the order of about 1 to 10 amino acid residues. The amino acid substitutions are preferably conservative amino acid substitutions. Conservative substitution tables are well known in the art (see for example Creighton (1984) Proteins. W.H. Freeman and Company and Table 1 below). 
     
       
         
           
               
             
               
                 TABLE 1 
               
             
            
               
                   
               
               
                 Examples of conserved amino acid substitutions 
               
            
           
           
               
               
               
            
               
                   
                 Residue 
                 Conservative Substitutions 
               
               
                   
                   
               
               
                   
                 Ala 
                 Ser 
               
               
                   
                 Arg 
                 Lys 
               
               
                   
                 Asn 
                 Gln; His 
               
               
                   
                 Asp 
                 Glu 
               
               
                   
                 Gln 
                 Asn 
               
               
                   
                 Cys 
                 Ser 
               
               
                   
                 Glu 
                 Asp 
               
               
                   
                 Gly 
                 Pro 
               
               
                   
                 His 
                 Asn; Gln 
               
               
                   
                 Ile 
                 Leu, Val 
               
               
                   
                 Leu 
                 Ile; Val 
               
               
                   
                 Lys 
                 Arg; Gln 
               
               
                   
                 Met 
                 Leu; Ile 
               
               
                   
                 Phe 
                 Met; Leu; Tyr 
               
               
                   
                 Ser 
                 Thr; Gly 
               
               
                   
                 Thr 
                 Ser; Val 
               
               
                   
                 Trp 
                 Tyr 
               
               
                   
                 Tyr 
                 Trp; Phe 
               
               
                   
                 Val 
                 Ile; Leu 
               
               
                   
                   
               
            
           
         
       
     
     Amino acid substitutions, deletions and/or insertions may readily be made using peptide synthetic techniques well known in the art, such as solid phase peptide synthesis and the like, or by recombinant DNA manipulation. Methods for the manipulation of DNA sequences to produce substitution, insertion or deletion variants of a protein are well known in the art. For example, techniques for making substitution mutations at predetermined sites in DNA are well known to those skilled in the art and include M13 mutagenesis, T7-Gen in vitro mutagenesis (USB, Cleveland, Ohio), QuickChange Site Directed mutagenesis (Stratagene, San Diego, Calif.), PCR-mediated site-directed mutagenesis or other site-directed mutagenesis protocols. 
     Derivatives 
     “Derivatives” include peptides, oligopeptides, polypeptides which may, compared to the amino acid sequence of the naturally-occurring form of the protein, such as the protein of interest, comprise substitutions of amino acids with non-naturally occurring amino acid residues, or additions of non-naturally occurring amino acid residues. “Derivatives” of a protein also encompass peptides, oligopeptides, polypeptides which comprise naturally occurring altered (glycosylated, acylated, prenylated, phosphorylated, myristoylated, sulphated etc.) or non-naturally altered amino acid residues compared to the amino acid sequence of a naturally-occurring form of the polypeptide. A derivative may also comprise one or more non-amino acid substituents or additions compared to the amino acid sequence from which it is derived, for example a reporter molecule or other ligand, covalently or non-covalently bound to the amino acid sequence, such as a reporter molecule which is bound to facilitate its detection, and non-naturally occurring amino acid residues relative to the amino acid sequence of a naturally-occurring protein. Furthermore, “derivatives” also include fusions of the naturally-occurring form of the protein with tagging peptides such as FLAG, HIS6 or thioredoxin (for a review of tagging peptides, see Terpe, Appl. Microbiol. Biotechnol. 60, 523-533, 2003). 
     Orthologue(s)/Paralogue(s) 
     Orthologues and paralogues encompass evolutionary concepts used to describe the ancestral relationships of genes. Paralogues are genes within the same species that have originated through duplication of an ancestral gene; orthologues are genes from different organisms that have originated through speciation, and are also derived from a common ancestral gene. 
     Domain 
     The term “domain” refers to a set of amino acids conserved at specific positions along an alignment of sequences of evolutionarily related proteins. While amino acids at other positions can vary between homologues, amino acids that are highly conserved at specific positions indicate amino acids that are likely essential in the structure, stability or activity of a protein. Identified by their high degree of conservation in aligned sequences of a family of protein homologues, they can be used as identifiers to determine if any polypeptide in question belongs to a previously identified polypeptide family. 
     Motif/Consensus Sequence/Signature 
     The term “motif” or “consensus sequence” or “signature” refers to a short conserved region in the sequence of evolutionarily related proteins. Motifs are frequently highly conserved parts of domains, but may also include only part of the domain, or be located outside of conserved domain (if all of the amino acids of the motif fall outside of a defined domain). 
     Hybridisation 
     The term “hybridisation” as defined herein is a process wherein substantially homologous complementary nucleotide sequences anneal to each other. The hybridisation process can occur entirely in solution, i.e. both complementary nucleic acids are in solution. The hybridisation process can also occur with one of the complementary nucleic acids immobilised to a matrix such as magnetic beads, Sepharose beads or any other resin. The hybridisation process can furthermore occur with one of the complementary nucleic acids immobilised to a solid support such as a nitro-cellulose or nylon membrane or immobilised by e.g. photolithography to, for example, a siliceous glass support (the latter known as nucleic acid arrays or microarrays or as nucleic acid chips). In order to allow hybridisation to occur, the nucleic acid molecules are generally thermally or chemically denatured to melt a double strand into two single strands and/or to remove hairpins or other secondary structures from single stranded nucleic acids. 
     The term “stringency” refers to the conditions under which a hybridisation takes place. The stringency of hybridisation is influenced by conditions such as temperature, salt concentration, ionic strength and hybridisation buffer composition. Generally, low stringency conditions are selected to be about 30° C. lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. Medium stringency conditions are when the temperature is 20° C. below Tm, and high stringency conditions are when the temperature is 10° C. below Tm. High stringency hybridisation conditions are typically used for isolating hybridising sequences that have high sequence similarity to the target nucleic acid sequence. However, nucleic acids may deviate in sequence and still encode a substantially identical polypeptide, due to the degeneracy of the genetic code. Therefore medium stringency hybridisation conditions may sometimes be needed to identify such nucleic acid molecules. 
     The Tm is the temperature under defined ionic strength and pH, at which 50% of the target sequence hybridises to a perfectly matched probe. The Tm is dependent upon the solution conditions and the base composition and length of the probe. For example, longer sequences hybridise specifically at higher temperatures. The maximum rate of hybridisation is obtained from about 16° C. up to 32° C. below Tm. The presence of monovalent cations in the hybridisation solution reduce the electrostatic repulsion between the two nucleic acid strands thereby promoting hybrid formation; this effect is visible for sodium concentrations of up to 0.4M (for higher concentrations, this effect may be ignored). Formamide reduces the melting temperature of DNA-DNA and DNA-RNA duplexes with 0.6 to 0.7° C. for each percent formamide, and addition of 50% formamide allows hybridisation to be performed at 30 to 45° C., though the rate of hybridisation will be lowered. Base pair mismatches reduce the hybridisation rate and the thermal stability of the duplexes. On average and for large probes, the Tm decreases about 1° C. per % base mismatch. The Tm may be calculated using the following equations, depending on the types of hybrids: 
     1) DNA-DNA hybrids (Meinkoth and Wahl, Anal. Biochem., 138: 267-284, 1984):
 
Tm=81.5° C.+16.6×log 10[Na+] a +0.41×%[ G/C   b ]−500 x[L   c ]−1−0.61 x  % formamide
 
     2) DNA-RNA or RNA-RNA hybrids:
 
Tm=79.8+18.5 (log 10[Na+] a )+0.58(%  G/C   b )+11.8(%  G/C   b )2−820 /L   c  
 
     3) oligo-DNA or oligo-RNA d  hybrids: 
     For &lt;20 nucleotides: Tm=2 (ln) 
     For 20-35 nucleotides: Tm=22+1.46 (ln)
           a  or for other monovalent cation, but only accurate in the 0.01-0.4 M range.     b  only accurate for % GC in the 30% to 75% range.     c  L=length of duplex in base pairs.     d  Oligo, oligonucleotide; ln, effective length of primer=2×(no. of G/C)+(no. of A/T).       

     Non-specific binding may be controlled using any one of a number of known techniques such as, for example, blocking the membrane with protein containing solutions, additions of heterologous RNA, DNA, and SDS to the hybridisation buffer, and treatment with Rnase. For non-homologous probes, a series of hybridizations may be performed by varying one of (i) progressively lowering the annealing temperature (for example from 68° C. to 42° C.) or (ii) progressively lowering the formamide concentration (for example from 50% to 0%). The skilled artisan is aware of various parameters which may be altered during hybridisation and which will either maintain or change the stringency conditions. 
     Besides the hybridisation conditions, specificity of hybridisation typically also depends on the function of post-hybridisation washes. To remove background resulting from non-specific hybridisation, samples are washed with dilute salt solutions. Critical factors of such washes include the ionic strength and temperature of the final wash solution: the lower the salt concentration and the higher the wash temperature, the higher the stringency of the wash. Wash conditions are typically performed at or below hybridisation stringency. A positive hybridisation gives a signal that is at least twice of that of the background. Generally, suitable stringent conditions for nucleic acid hybridisation assays or gene amplification detection procedures are as set forth above. More or less stringent conditions may also be selected. The skilled artisan is aware of various parameters which may be altered during washing and which will either maintain or change the stringency conditions. 
     For example, typical high stringency hybridisation conditions for DNA hybrids longer than 50 nucleotides encompass hybridisation at 65° C. in 1×SSC or at 42° C. in 1×SSC and 50% formamide, followed by washing at 65° C. in 0.3×SSC. Examples of medium stringency hybridisation conditions for DNA hybrids longer than 50 nucleotides encompass hybridisation at 50° C. in 4×SSC or at 40° C. in 6×SSC and 50% formamide, followed by washing at 50° C. in 2×SSC. The length of the hybrid is the anticipated length for the hybridising nucleic acid. When nucleic acids of known sequence are hybridised, the hybrid length may be determined by aligning the sequences and identifying the conserved regions described herein. 1×SSC is 0.15M NaCl and 15 mM sodium citrate; the hybridisation solution and wash solutions may additionally include 5×Denhardt&#39;s reagent, 0.5-1.0% SDS, 100 μg/ml denatured, fragmented salmon sperm DNA, 0.5% sodium pyrophosphate. 
     For the purposes of defining the level of stringency, reference can be made to Sambrook et al. (2001) Molecular Cloning: a laboratory manual, 3rd Edition Cold Spring Harbor Laboratory Press, CSH, New York or to Current Protocols in Molecular Biology, John Wiley &amp; Sons, N.Y. (1989 and yearly updates). 
     Splice Variant 
     The term “splice variant” as used herein encompasses variants of a nucleic acid sequence in which selected introns and/or exons have been excised, replaced, displaced or added, or in which introns have been shortened or lengthened. Such variants will be ones in which the biological activity of the protein is substantially retained; this may be achieved by selectively retaining functional segments of the protein. Such splice variants may be found in nature or may be manmade. Methods for predicting and isolating such splice variants are well known in the art (see for example Foissac and Schiex, BMC Bioinformatics. 2005; 6: 25). 
     Allelic Variant 
     Alleles or allelic variants are alternative forms of a given gene, located at the same chromosomal position. Allelic variants encompass Single Nucleotide Polymorphisms (SNPs), as well as Small Insertion/Deletion Polymorphisms (INDELs). The size of INDELs is usually less than 100 bp. SNPs and INDELs form the largest set of sequence variants in naturally occurring polymorphic strains of most organisms. 
     Gene Shuffling/Directed Evolution 
     Gene shuffling or directed evolution consists of iterations of DNA shuffling followed by appropriate screening and/or selection to generate variants of nucleic acids or portions thereof encoding proteins having a modified biological activity (Castle et al., (2004) Science 304(5674): 1151-4; U.S. Pat. Nos. 5,811,238 and 6,395,547). 
     Regulatory Element/Control Sequence/Promoter 
     The terms “regulatory element”, “control sequence” and “promoter” are all used interchangeably herein and are to be taken in a broad context to refer to regulatory nucleic acid sequences capable of effecting expression of the sequences to which they are ligated. The term “promoter” typically refers to a nucleic acid control sequence located upstream from the transcriptional start of a gene and which is involved in recognising and binding of RNA polymerase and other proteins, thereby directing transcription of an operably linked nucleic acid. Encompassed by the aforementioned terms are transcriptional regulatory sequences derived from a classical eukaryotic genomic gene (including the TATA box which is required for accurate transcription initiation, with or without a CCAAT box sequence) and additional regulatory elements (i.e. upstream activating sequences, enhancers and silencers) which alter gene expression in response to developmental and/or external stimuli, or in a tissue-specific manner. Also included within the term is a transcriptional regulatory sequence of a classical prokaryotic gene, in which case it may include a −35 box sequence and/or −10 box transcriptional regulatory sequences. The term “regulatory element” also encompasses a synthetic fusion molecule or derivative that confers, activates or enhances expression of a nucleic acid molecule in a cell, tissue or organ. 
     A “plant promoter” comprises regulatory elements, which mediate the expression of a coding sequence segment in plant cells. Accordingly, a plant promoter need not be of plant origin, but may originate from viruses or micro-organisms, for example from viruses which attack plant cells. The “plant promoter” can also originate from a plant cell, e.g. from the plant which is transformed with the nucleic acid sequence to be expressed in the inventive process and described herein. This also applies to other “plant” regulatory signals, such as “plant” terminators. The promoters upstream of the nucleotide sequences useful in the methods of the present invention can be modified by one or more nucleotide substitution(s), insertion(s) and/or deletion(s) without interfering with the functionality or activity of either the promoters, the open reading frame (ORF) or the 3′-regulatory region such as terminators or other 3′ regulatory regions which are located away from the ORF. It is furthermore possible that the activity of the promoters is increased by modification of their sequence, or that they are replaced completely by more active promoters, even promoters from heterologous organisms. For expression in plants, the nucleic acid molecule must, as described above, be linked operably to or comprise a suitable promoter which expresses the gene at the right point in time and with the required spatial expression pattern. 
     Operably Linked 
     The term “operably linked” as used herein refers to a functional linkage between the promoter sequence and the gene of interest, such that the promoter sequence is able to initiate transcription of the gene of interest. 
     Developmentally-Regulated Promoter 
     A developmentally-regulated promoter is active during certain developmental stages or in parts of the plant that undergo developmental changes. 
     Inducible Promoter 
     An inducible promoter has induced or increased transcription initiation in response to a chemical (for a review see Gatz 1997, Annu. Rev. Plant Physiol. Plant Mol. Biol., 48:89-108), environmental or physical stimulus, or may be “stress-inducible”, i.e. activated when a plant is exposed to various stress conditions, or a “pathogen-inducible” i.e. activated when a plant is exposed to exposure to various pathogens. 
     Organ-Specific/Tissue-Specific Promoter 
     An organ-specific or tissue-specific promoter is one that is capable of preferentially initiating transcription in certain organs or tissues, such as the leaves, roots, seed tissue etc. Promoters able to initiate transcription in certain cells only are referred to herein as “cell-specific”. 
     Organ-Specific/Tissue-Specific Promoter 
     An organ-specific or tissue-specific promoter is one that is capable of preferentially initiating transcription in certain organs or tissues, such as the leaves, roots, seed tissue etc. For example, a “root-specific promoter” is a promoter that is transcriptionally active predominantly in plant roots, substantially to the exclusion of any other parts of a plant, whilst still allowing for any leaky expression in these other plant parts. Promoters able to initiate transcription in certain cells only are referred to herein as “cell-specific”. 
     Examples of root-specific promoters are listed in the table below: 
     Examples of Root-Specific Promoters 
     
       
         
           
               
               
             
               
                   
               
               
                 Gene Source 
                 Reference 
               
               
                   
               
             
            
               
                 RCc3 
                 Plant Mol Biol. 1995 January; 27(2): 237-48 
               
               
                   Arabidopsis  PHT1 
                 Kovama et al., 2005; Mudge et al. (2002, Plant J. 31: 341) 
               
               
                   Medicago  phosphate transporter 
                 Xiao et al., 2006 
               
               
                   Arabidopsis  Pyk10 
                 Nitz et al. (2001) Plant Sci 161(2): 337-346 
               
               
                 root-expressible genes 
                 Tingey et al., EMBO J. 6: 1, 1987. 
               
               
                 tobacco auxin-inducible gene 
                 Van der Zaal et al., Plant Mol. Biol. 16, 983, 1991. 
               
               
                 β-tubulin 
                 Oppenheimer, et al., Gene 63: 87, 1988. 
               
               
                 tobacco root-specific genes 
                 Conkling, et al., Plant Physiol. 93: 1203, 1990. 
               
               
                   B. napus  G1-3b gene 
                 U.S. Pat. No. 5,401,836 
               
               
                 SbPRP1 
                 Suzuki et al., Plant Mol. Biol. 21: 109-119, 1993. 
               
               
                 LRX1 
                 Baumberger et al. 2001, Genes &amp; Dev. 15: 1128 
               
               
                 BTG-26  Brassica napus   
                 US 20050044585 
               
               
                 LeAMT1 (tomato) 
                 Lauter et al. (1996, PNAS 3: 8139) 
               
               
                 The LeNRT1-1 (tomato) 
                 Lauter et al. (1996, PNAS 3: 8139) 
               
               
                 class I patatin gene (potato)  
                 Liu et al., Plant Mol. Biol. 153: 386-395, 1991. 
               
               
                 KDC1 ( Daucus carota ) 
                 Downey et al. (2000, J. Biol. Chem. 275: 39420) 
               
               
                 TobRB7 gene 
                 W Song (1997) PhD Thesis, North Carolina State 
               
               
                   
                 University, Raleigh, NC USA 
               
               
                 OsRAB5a (rice) 
                 Wang et al. 2002, Plant Sci. 163: 273 
               
               
                 ALF5 ( Arabidopsis ) 
                 Diener et al. (2001, Plant Cell 13: 1625) 
               
               
                 NRT2; 1Np ( N. plumbaginifolia ) 
                 Quesada et al. (1997, Plant Mol. Biol. 34: 265) 
               
               
                   
               
            
           
         
       
     
     
       
         
           
               
             
               
                 TABLE 2 
               
             
            
               
                   
               
               
                 Examples of seed-specific promoters 
               
            
           
           
               
               
            
               
                 Gene source 
                 Reference 
               
               
                   
               
               
                 seed-specific genes 
                 Simon et al., Plant Mol. Biol. 5: 191, 1985; 
               
               
                   
                 Scofield et al., J. Biol. Chem. 262: 12202, 1987.; 
               
               
                   
                 Baszczynski et al., Plant Mol. Biol. 14: 633, 1990. 
               
               
                 Brazil Nut albumin 
                 Pearson et al., Plant Mol. Biol. 18: 235-245, 1992. 
               
               
                 Legumin 
                 Ellis et al., Plant Mol. Biol. 10: 203-214, 1988. 
               
               
                 glutelin (rice) 
                 Takaiwa et al., Mol. Gen. Genet. 208: 15-22, 1986; 
               
               
                   
                 Takaiwa et al., FEBS Letts. 221: 43-47, 1987. 
               
               
                 Zein 
                 Matzke et al Plant Mol Biol, 14(3): 323-32 1990 
               
               
                 napA 
                 Stalberg et al, Planta 199: 515-519, 1996. 
               
               
                 wheat LMW and HMW glutenin-1 
                 Mol Gen Genet 216: 81-90, 1989; NAR 17: 461-2, 1989 
               
               
                 wheat SPA 
                 Albani et al, Plant Cell, 9: 171-184, 1997 
               
               
                 wheat α, β, γ-gliadins 
                 EMBO J. 3: 1409-15, 1984 
               
               
                 barley ltr1 promoter 
                 Diaz et al. (1995) Mol Gen Genet 248(5): 592-8 
               
               
                 barley B1, C, D, hordein 
                 Theor Appl Gen 98: 1253-62, 1999; Plant J 4: 343-55, 
               
               
                   
                 1993; Mol Gen Genet 250: 750-60, 1996 
               
               
                 barley DOF 
                 Mena et al, The Plant Journal, 116(1): 53-62, 1998 
               
               
                 blz2 
                 EP99106056.7 
               
               
                 Synthetic promoter 
                 Vicente-Carbajosa et al., Plant J. 13: 629-640, 1998. 
               
               
                 rice prolamin NRP33 
                 Wu et al, Plant Cell Physiology 39(8) 885-889, 1998 
               
               
                 rice a-globulin Glb-1 
                 Wu et al, Plant Cell Physiology 39(8) 885-889, 1998 
               
               
                 rice OSH1 
                 Sato et al, Proc. Natl. Acad. Sci. USA, 93: 8117-22, 1996 
               
               
                 rice α-globulin REB/OHP-1 
                 Nakase et al. Plant Mol. Biol. 33: 513-522, 1997 
               
               
                 rice ADP-glucose 
                 Trans Res 6: 157-68, 1997 
               
               
                 pyrophosphorylase 
                   
               
               
                 maize ESR gene family 
                 Plant J 12: 235-46, 1997 
               
               
                   Sorghum  α-kafirin 
                 DeRose et al., Plant Mol. Biol 32: 1029-35, 1996 
               
               
                 KNOX 
                 Postma-Haarsma et al, Plant Mol. Biol. 39: 257-71, 1999 
               
               
                 rice oleosin 
                 Wu et al, J. Biochem. 123: 386, 1998 
               
               
                 sunflower oleosin 
                 Cummins et al., Plant Mol. Biol. 19: 873-876, 1992 
               
               
                 PRO0117, putative rice 40S 
                 WO 2004/070039 
               
               
                 ribosomal protein 
                   
               
               
                 PRO0136, rice alanine 
                 Unpublished 
               
               
                 aminotransferase 
                   
               
               
                 PRO0147, trypsin inhibitor ITR1  
                 Unpublished 
               
               
                 (barley) 
                   
               
               
                 PRO0151, rice WSI18 
                 WO 2004/070039 
               
               
                 PRO0175, rice RAB21 
                 WO 2004/070039 
               
               
                 PRO005 
                 WO 2004/070039 
               
               
                 PRO0095 
                 WO 2004/070039 
               
               
                 α-amylase (Amy32b) 
                 Lanahan et al, Plant Cell 4: 203-211, 1992; Skriver et al, 
               
               
                   
                 Proc Natl Acad Sci USA 88: 7266-7270, 1991 
               
               
                 cathepsin β-like gene 
                 Cejudo et al, Plant Mol Biol 20: 849-856, 1992 
               
               
                 Barley Ltp2 
                 Kalla et al., Plant J. 6: 849-60, 1994 
               
               
                 Chi26 
                 Leah et al., Plant J. 4: 579-89, 1994 
               
               
                 Maize B-Peru 
                 Selinger et al., Genetics 149; 1125-38, 1998 
               
               
                   
               
            
           
         
       
     
     
       
         
           
               
             
               
                 TABLE 3 
               
             
            
               
                   
               
               
                 Examples of embryo-specific promoters: 
               
            
           
           
               
               
            
               
                 Gene source 
                 Reference 
               
               
                   
               
               
                 rice OSH1 
                 Sato et al, Proc. Natl. Acad. Sci. USA, 93: 8117-8122, 1996 
               
               
                 KNOX 
                 Postma-Haarsma et al, Plant Mol. Biol. 39: 257-71, 1999 
               
               
                 PRO0151 
                 WO 2004/070039 
               
               
                 PRO0175 
                 WO 2004/070039 
               
               
                 PRO005 
                 WO 2004/070039 
               
               
                 PRO0095 
                 WO 2004/070039 
               
               
                   
               
            
           
         
       
     
     
       
         
           
               
             
               
                 TABLE 4 
               
             
            
               
                   
               
               
                 Examples of aleurone-specific promoters: 
               
            
           
           
               
               
            
               
                 Gene source 
                 Reference 
               
               
                   
               
               
                 α-amylase (Amy32b) 
                 Lanahan et al, Plant Cell 4: 203-211, 1992; Skriver  
               
               
                   
                 et al, Proc Natl Acad Sci USA 88: 7266-7270, 1991 
               
               
                 cathepsin β-like gene 
                 Cejudo et al, Plant Mol Biol 20: 849-856, 1992 
               
               
                 Barley Ltp2 
                 Kalla et al., Plant J. 6: 849-60, 1994 
               
               
                 Chi26 
                 Leah et al., Plant J. 4: 579-89, 1994 
               
               
                 Maize B-Peru 
                 Selinger et al., Genetics 149; 1125-38, 1998 
               
               
                   
               
            
           
         
       
     
     Constitutive Promoter 
     A “constitutive promoter” refers to a promoter that is transcriptionally active during most, but not necessarily all, phases of its growth and development and under most environmental conditions, in at least one cell, tissue or organ. 
     
       
         
           
               
             
               
                 TABLE 5 
               
             
            
               
                   
               
               
                 Examples of constitutive promoters 
               
            
           
           
               
               
            
               
                 Gene Source 
                 Reference 
               
               
                   
               
               
                 Actin 
                 McElroy et al, Plant Cell, 2: 163-171, 1990 
               
               
                 HMGP 
                 WO 2004/070039 
               
               
                 CAMV 35S 
                 Odell et al, Nature, 313: 810-812, 1985 
               
               
                 CaMV 19S 
                 Nilsson et al., Physiol. Plant. 100: 456-462, 1997 
               
               
                 GOS2 
                 de Pater et al, Plant J Nov; 2(6): 837-44, 1992,  
               
               
                   
                 WO 2004/065596 
               
               
                 Ubiquitin 
                 Christensen et al, Plant Mol. Biol. 18: 675-689, 1992 
               
               
                 Rice cyclophilin 
                 Buchholz et al, Plant Mol Biol. 25(5): 837-43, 1994 
               
               
                 Maize H3 histone 
                 Lepetit et al, Mol. Gen. Genet. 231: 276-285, 1992 
               
               
                 Alfalfa H3 histone 
                 Wu et al. Plant Mol. Biol. 11: 641-649, 1988 
               
               
                 Actin 2 
                 An et al, Plant J. 10(1); 107-121, 1996 
               
               
                 34S FMV 
                 Sanger et al., Plant. Mol. Biol., 14, 1990: 433-443 
               
               
                 Rubisco  
                 U.S. Pat. No. 4,962,028 
               
               
                 small subunit 
                   
               
               
                 OCS 
                 Leisner (1988) Proc Natl Acad Sci USA 85(5): 2553 
               
               
                 SAD1 
                 Jain et al., Crop Science, 39 (6), 1999: 1696 
               
               
                 SAD2 
                 Jain et al., Crop Science, 39 (6), 1999: 1696 
               
               
                 nos 
                 Shaw et al. (1984) Nucleic Acids Res. 12(20):  
               
               
                   
                 7831-7846 
               
               
                 V-ATPase 
                 WO 01/14572 
               
               
                 Super promoter 
                 WO 95/14098 
               
               
                 G-box proteins 
                 WO 94/12015 
               
               
                   
               
            
           
         
       
     
     Ubiquitous Promoter 
     A Ubiquitous promoter is active in substantially all tissues or cells of an organism. 
     Green Tissue-Specific Promoter 
     A green tissue-specific promoter as defined herein is a promoter that is transcriptionally active predominantly in green tissue, substantially to the exclusion of any other parts of a plant, whilst still allowing for any leaky expression in these other plant parts. 
     Examples of green tissue-specific promoters which may be used to perform the methods of the invention are shown in Table 6 below. 
     
       
         
           
               
             
               
                 TABLE 6 
               
             
            
               
                   
               
               
                 Examples of green tissue-specific promoters 
               
            
           
           
               
               
               
            
               
                 Gene 
                 Expression 
                 Reference 
               
               
                   
               
               
                 Maize Orthophosphate dikinase 
                 Leaf specific  
                 Fukavama et al., 2001 
               
               
                 Maize Phosphoenolpyruvate  
                 Leaf specific  
                 Kausch et al., 2001 
               
               
                 carboxylase 
                   
                   
               
               
                 Rice Phosphoenolpyruvate  
                 Leaf specific  
                 Liu et al., 2003 
               
               
                 carboxylase 
                   
                   
               
               
                 Rice small subunit Rubisco 
                 Leaf specific  
                 Nomura et al., 2000 
               
               
                 rice beta expansin EXBP9 
                 Shoot specific 
                 WO 2004/070039 
               
               
                 Pigeonpea small subunit Rubisco 
                 Leaf specific  
                 Panguluri et al., 2005 
               
               
                 Pea RBCS3A 
                 Leaf specific 
               
               
                   
               
            
           
         
       
     
     Another example of a tissue-specific promoter is a meristem-specific promoter, which is transcriptionally active predominantly in meristematic tissue, substantially to the exclusion of any other parts of a plant, whilst still allowing for any leaky expression in these other plant parts. Examples of green meristem-specific promoters which may be used to perform the methods of the invention are shown in Table 7 below. 
     
       
         
           
               
             
               
                 TABLE 7 
               
             
            
               
                   
               
               
                 Examples of meristem-specific promoters 
               
            
           
           
               
               
               
            
               
                 Gene source 
                 Expression pattern 
                 Reference 
               
               
                   
               
               
                 rice OSH1 
                 Shoot apical meristem,  
                 Sato et al. (1996) Proc.  
               
               
                   
                 from embryo globular stage 
                 Natl. Acad. Sci. USA,  
               
               
                   
                 to seedling stage 
                 93: 8117-8122 
               
               
                 Rice  
                 Meristem specific 
                 BAD87835.1 
               
               
                 metallothionein 
                   
                   
               
               
                 WAK1 &amp; WAK 2 
                 Shoot and root apical 
                 Wagner &amp; Kohorn  
               
               
                   
                 meristems, and in expanding  
                 (2001) Plant Cell 13(2):  
               
               
                   
                 leaves and sepals 
                 303-318 
               
               
                   
               
            
           
         
       
     
     Terminator 
     The term “terminator” encompasses a control sequence which is a DNA sequence at the end of a transcriptional unit which signals 3′ processing and polyadenylation of a primary transcript and termination of transcription. The terminator can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The terminator to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene. 
     Selectable Marker (Gene)/Reporter Gene 
     “Selectable marker”, “selectable marker gene” or “reporter gene” includes any gene that confers a phenotype on a cell in which it is expressed to facilitate the identification and/or selection of cells that are transfected or transformed with a nucleic acid construct of the invention. These marker genes enable the identification of a successful transfer of the nucleic acid molecules via a series of different principles. Suitable markers may be selected from markers that confer antibiotic or herbicide resistance, that introduce a new metabolic trait or that allow visual selection. Examples of selectable marker genes include genes conferring resistance to antibiotics (such as nptII that phosphorylates neomycin and kanamycin, or hpt, phosphorylating hygromycin, or genes conferring resistance to, for example, bleomycin, streptomycin, tetracyclin, chloramphenicol, ampicillin, gentamycin, geneticin (G418), spectinomycin or blasticidin), to herbicides (for example bar which provides resistance to Basta®; aroA or gox providing resistance against glyphosate, or the genes conferring resistance to, for example, imidazolinone, phosphinothricin or sulfonylurea), or genes that provide a metabolic trait (such as manA that allows plants to use mannose as sole carbon source or xylose isomerase for the utilisation of xylose, or antinutritive markers such as the resistance to 2-deoxyglucose). Expression of visual marker genes results in the formation of colour (for example β-glucuronidase, GUS or β-galactosidase with its coloured substrates, for example X-Gal), luminescence (such as the luciferin/luceferase system) or fluorescence (Green Fluorescent Protein, GFP, and derivatives thereof). This list represents only a small number of possible markers. The skilled worker is familiar with such markers. Different markers are preferred, depending on the organism and the selection method. 
     Transgenic/Transgene/Recombinant 
     For the purposes of the invention, “transgenic”, “transgene” or “recombinant” means with regard to, for example, a nucleic acid sequence, an expression cassette, gene construct or a vector comprising the nucleic acid sequence or an organism transformed with the nucleic acid sequences, expression cassettes or vectors according to the invention, all those constructions brought about by recombinant methods in which either
         (a) the nucleic acid sequences encoding proteins useful in the methods of the invention, or   (b) genetic control sequence(s) which is operably linked with the nucleic acid sequence according to the invention, for example a promoter, or   (c) a) and b)
 
are not located in their natural genetic environment or have been modified by recombinant methods, it being possible for the modification to take the form of, for example, a substitution, addition, deletion, inversion or insertion of one or more nucleotide residues. The natural genetic environment is understood as meaning the natural genomic or chromosomal locus in the original plant or the presence in a genomic library. In the case of a genomic library, the natural genetic environment of the nucleic acid sequence is preferably retained, at least in part. The environment flanks the nucleic acid sequence at least on one side and has a sequence length of at least 50 bp, preferably at least 500 bp, especially preferably at least 1000 bp, most preferably at least 5000 bp. A naturally occurring expression cassette—for example the naturally occurring combination of the natural promoter of the nucleic acid sequences with the corresponding nucleic acid sequence encoding a polypeptide useful in the methods of the present invention, as defined above—becomes a transgenic expression cassette when this expression cassette is modified by non-natural, synthetic (“artificial”) methods such as, for example, mutagenic treatment. Suitable methods are described, for example, in U.S. Pat. No. 5,565,350 or WO 00/15815.
       

     A transgenic plant for the purposes of the invention is thus understood as meaning, as above, that the nucleic acids used in the method of the invention are not at their natural locus in the genome of said plant, it being possible for the nucleic acids to be expressed homologously or heterologously. However, as mentioned, transgenic also means that, while the nucleic acids according to the invention or used in the inventive method are at their natural position in the genome of a plant, the sequence has been modified with regard to the natural sequence, and/or that the regulatory sequences of the natural sequences have been modified. Transgenic is preferably understood as meaning the expression of the nucleic acids according to the invention at an unnatural locus in the genome, i.e. homologous or, preferably, heterologous expression of the nucleic acids takes place. Preferred transgenic plants are mentioned herein. 
     Transformation 
     The term “introduction” or “transformation” as referred to herein encompasses the transfer of an exogenous polynucleotide into a host cell, irrespective of the method used for transfer. Plant tissue capable of subsequent clonal propagation, whether by organogenesis or embryogenesis, may be transformed with a genetic construct of the present invention and a whole plant regenerated there from. The particular tissue chosen will vary depending on the clonal propagation systems available for, and best suited to, the particular species being transformed. Exemplary tissue targets include leaf disks, pollen, embryos, cotyledons, hypocotyls, megagametophytes, callus tissue, existing meristematic tissue (e.g., apical meristem, axillary buds, and root meristems), and induced meristem tissue (e.g., cotyledon meristem and hypocotyl meristem). The polynucleotide may be transiently or stably introduced into a host cell and may be maintained non-integrated, for example, as a plasmid. Alternatively, it may be integrated into the host genome. The resulting transformed plant cell may then be used to regenerate a transformed plant in a manner known to persons skilled in the art. 
     The transfer of foreign genes into the genome of a plant is called transformation. Transformation of plant species is now a fairly routine technique. Advantageously, any of several transformation methods may be used to introduce the gene of interest into a suitable ancestor cell. The methods described for the transformation and regeneration of plants from plant tissues or plant cells may be utilized for transient or for stable transformation. Transformation methods include the use of liposomes, electroporation, chemicals that increase free DNA uptake, injection of the DNA directly into the plant, particle gun bombardment, transformation using viruses or pollen and microprojection. Methods may be selected from the calcium/polyethylene glycol method for protoplasts (Krens, F. A. et al., (1982) Nature 296, 72-74; Negrutiu I et al. (1987) Plant Mol Biol 8: 363-373); electroporation of protoplasts (Shillito R. D. et al. (1985) Bio/Technol 3, 1099-1102); microinjection into plant material (Crossway A et al., (1986) Mol. Gen. Genet. 202: 179-185); DNA or RNA-coated particle bombardment (Klein T M et al., (1987) Nature 327: 70) infection with (non-integrative) viruses and the like. 
     Transgenic plants, including transgenic crop plants, are preferably produced via  Agrobacterium -mediated transformation. An advantageous transformation method is the transformation in planta. To this end, it is possible, for example, to allow the  agrobacteria  to act on plant seeds or to inoculate the plant meristem with  agrobacteria . It has proved particularly expedient in accordance with the invention to allow a suspension of transformed  agrobacteria  to act on the intact plant or at least on the flower primordia. The plant is subsequently grown on until the seeds of the treated plant are obtained (Clough and Bent, Plant J. (1998) 16, 735-743). Methods for  Agrobacterium -mediated transformation of rice include well known methods for rice transformation, such as those described in any of the following: European patent application EP 1198985 A1, Aldemita and Hodges (Planta 199: 612-617, 1996); Chan et al. (Plant Mol Biol 22 (3): 491-506, 1993), Hiei et al. (Plant J 6 (2): 271-282, 1994), which disclosures are incorporated by reference herein as if fully set forth. In the case of corn transformation, the preferred method is as described in either Ishida et al. (Nat. Biotechnol 14(6): 745-50, 1996) or Frame et al. (Plant Physiol 129(1): 13-22, 2002), which disclosures are incorporated by reference herein as if fully set forth. Said methods are further described by way of example in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S. D. Kung and R. Wu, Academic Press (1993) 128-143 and in Potrykus Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991) 205-225). The nucleic acids or the construct to be expressed is preferably cloned into a vector, which is suitable for transforming  Agrobacterium tumefaciens , for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711).  Agrobacteria  transformed by such a vector can then be used in known manner for the transformation of plants, such as plants used as a model, like  Arabidopsis  ( Arabidopsis thaliana  is within the scope of the present invention not considered as a crop plant), or crop plants such as, by way of example, tobacco plants, for example by immersing bruised leaves or chopped leaves in an agrobacterial solution and then culturing them in suitable media. The transformation of plants by means of  Agrobacterium tumefaciens  is described, for example, by Höfgen and Willmitzer in Nucl. Acid Res. (1988) 16, 9877 or is known inter alia from F. F. White, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S. D. Kung and R. Wu, Academic Press, 1993, pp. 15-38. 
     In addition to the transformation of somatic cells, which then have to be regenerated into intact plants, it is also possible to transform the cells of plant meristems and in particular those cells which develop into gametes. In this case, the transformed gametes follow the natural plant development, giving rise to transgenic plants. Thus, for example, seeds of  Arabidopsis  are treated with  agrobacteria  and seeds are obtained from the developing plants of which a certain proportion is transformed and thus transgenic [Feldman, K A and Marks M D (1987). Mol Gen Genet. 208:274-289; Feldmann K (1992). In: C Koncz, N-H Chua and J Shell, eds, Methods in  Arabidopsis  Research. Word Scientific, Singapore, pp. 274-289]. Alternative methods are based on the repeated removal of the inflorescences and incubation of the excision site in the center of the rosette with transformed  agrobacteria , whereby transformed seeds can likewise be obtained at a later point in time (Chang (1994). Plant J. 5: 551-558; Katavic (1994). Mol Gen Genet, 245: 363-370). However, an especially effective method is the vacuum infiltration method with its modifications such as the “floral dip” method. In the case of vacuum infiltration of  Arabidopsis , intact plants under reduced pressure are treated with an agrobacterial suspension [Bechthold, N (1993). C R Acad Sci Paris Life Sci, 316: 1194-1199], while in the case of the“floral dip” method the developing floral tissue is incubated briefly with a surfactant-treated agrobacterial suspension [Clough, S J and Bent, A F (1998). The Plant J. 16, 735-743]. A certain proportion of transgenic seeds are harvested in both cases, and these seeds can be distinguished from non-transgenic seeds by growing under the above-described selective conditions. In addition the stable transformation of plastids is of advantages because plastids are inherited maternally is most crops reducing or eliminating the risk of transgene flow through pollen. The transformation of the chloroplast genome is generally achieved by a process which has been schematically displayed in Klaus et al., 2004 [Nature Biotechnology 22 (2), 225-229]. Briefly the sequences to be transformed are cloned together with a selectable marker gene between flanking sequences homologous to the chloroplast genome. These homologous flanking sequences direct site specific integration into the plastome. Plastidal transformation has been described for many different plant species and an overview is given in Bock (2001) Transgenic plastids in basic research and plant biotechnology. J Mol. Biol. 2001 Sep. 21; 312 (3):425-38 or Maliga, P (2003) Progress towards commercialization of plastid transformation technology. Trends Biotechnol. 21, 20-28. Further biotechnological progress has recently been reported in form of marker free plastid transformants, which can be produced by a transient co-integrated maker gene (Klaus et al., 2004, Nature Biotechnology 22(2), 225-229). 
     T-DNA Activation Taming 
     T-DNA activation tagging (Hayashi et al. Science (1992) 1350-1353), involves insertion of T-DNA, usually containing a promoter (may also be a translation enhancer or an intron), in the genomic region of the gene of interest or 10 kb up- or downstream of the coding region of a gene in a configuration such that the promoter directs expression of the targeted gene. Typically, regulation of expression of the targeted gene by its natural promoter is disrupted and the gene falls under the control of the newly introduced promoter. The promoter is typically embedded in a T-DNA. This T-DNA is randomly inserted into the plant genome, for example, through  Agrobacterium  infection and leads to modified expression of genes near the inserted T-DNA. The resulting transgenic plants show dominant phenotypes due to modified expression of genes close to the introduced promoter. 
     TILLING 
     TILLING (Targeted Induced Local Lesions In Genomes) is a mutagenesis technology useful to generate and/or identify nucleic acids encoding proteins with modified expression and/or activity. TILLING also allows selection of plants carrying such mutant variants. These mutant variants may exhibit modified expression, either in strength or in location or in timing (if the mutations affect the promoter for example). These mutant variants may exhibit higher activity than that exhibited by the gene in its natural form. TILLING combines high-density mutagenesis with high-throughput screening methods. The steps typically followed in TILLING are: (a) EMS mutagenesis (Redei G P and Koncz C (1992) In Methods in  Arabidopsis  Research, Koncz C, Chua N H, Schell J, eds. Singapore, World Scientific Publishing Co, pp. 16-82; Feldmann et al., (1994) In Meyerowitz E M, Somerville C R, eds,  Arabidopsis . Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., pp 137-172; Lightner J and Caspar T (1998) In J Martinez-Zapater, J Salinas, eds, Methods on Molecular Biology, Vol. 82. Humana Press, Totowa, N.J., pp 91-104); (b) DNA preparation and pooling of individuals; (c) PCR amplification of a region of interest; (d) denaturation and annealing to allow formation of heteroduplexes; (e) DHPLC, where the presence of a heteroduplex in a pool is detected as an extra peak in the chromatogram; (f) identification of the mutant individual; and (g) sequencing of the mutant PCR product. Methods for TILLING are well known in the art (McCallum et al., (2000) Nat Biotechnol 18: 455-457; reviewed by Stemple (2004) Nat Rev Genet. 5(2): 145-50). 
     Homologous Recombination 
     Homologous recombination allows introduction in a genome of a selected nucleic acid at a defined selected position. Homologous recombination is a standard technology used routinely in biological sciences for lower organisms such as yeast or the moss  Physcomitrella . Methods for performing homologous recombination in plants have been described not only for model plants (Offring a et al. (1990) EMBO J. 9(10): 3077-84) but also for crop plants, for example rice (Terada et al. (2002) Nat Biotech 20(10): 1030-4; Iida and Terada (2004) Curr Opin Biotech 15(2): 132-8). 
     Yield 
     The term “yield” in general means a measurable produce of economic value, necessarily related to a specified crop, to an area, and to a period of time. Individual plant parts directly contribute to yield based on their number, size and/or weight, or the actual yield is the yield per acre for a crop and year, which is determined by dividing total production (includes both harvested and appraised production) by planted acres. 
     Increase/Improve/Enhance 
     The terms “increase”, “improve” or “enhance” are interchangeable and shall mean in the sense of the application at least a 5%, 6%, 7%, 8%, 9% or 10%, preferably at least 15% or 20%, more preferably 25%, 30%, 35% or 40% more yield and/or growth in comparison to control plants as defined herein. 
     Seed Yield 
     Increased seed yield may manifest itself as one or more of the following: a) an increase in seed biomass (total seed weight) which may be on an individual seed basis and/or per plant and/or per hectare or acre; b) increased number of flowers per plant; c) increased number of (filled) seeds; d) increased seed filling rate (which is expressed as the ratio between the number of filled seeds divided by the total number of seeds); e) increased harvest index, which is expressed as a ratio of the yield of harvestable parts, such as seeds, divided by the total biomass; and f) increased thousand kernel weight (TKW), which is extrapolated from the number of filled seeds counted and their total weight. An increased TKW may result from an increased seed size and/or seed weight, and may also result from an increase in embryo and/or endosperm size. 
     An increase in seed yield may also be manifested as an increase in seed size and/or seed volume. Furthermore, an increase in seed yield may also manifest itself as an increase in seed area and/or seed length and/or seed width and/or seed perimeter. Increased yield may also result in modified architecture, or may occur because of modified architecture. 
     Plant 
     The term “plant” as used herein encompasses whole plants, ancestors and progeny of the plants and plant parts, including seeds, shoots, stems, leaves, roots (including tubers), flowers, and tissues and organs, wherein each of the aforementioned comprise the gene/nucleic acid of interest. The term “plant” also encompasses plant cells, suspension cultures, callus tissue, embryos, meristematic regions, gametophytes, sporophytes, pollen and microspores, again wherein each of the aforementioned comprises the gene/nucleic acid of interest. 
     Plants that are particularly useful in the methods of the invention include all plants which belong to the superfamily Viridiplantae, in particular monocotyledonous and dicotyledonous plants including fodder or forage legumes, ornamental plants, food crops, trees or shrubs selected from the list comprising  Acer  spp.,  Actinidia  spp.,  Abelmoschus  spp.,  Agave sisalana, Agropyron  spp.,  Agrostis stolonifera, Allium  spp.,  Amaranthus  spp.,  Ammophila arenaria, Ananas comosus, Annona  spp.,  Apium graveolens, Arachis  spp,  Artocarpus  spp.,  Asparagus officinalis, Avena  spp. (e.g.  Avena sativa, Avena fatua, Avena byzantina, Avena fatua  var.  sativa, Avena hybrida ),  Averrhoa carambola, Bambusa  sp.,  Benincasa hispida, Bertholletia excelsea, Beta vulgaris, Brassica  spp. (e.g.  Brassica napus, Brassica rapa  spp. [canola, oilseed rape, turnip rape]),  Cadaba farinosa, Camellia sinensis, Canna indica, Cannabis sativa, Capsicum  spp.,  Carex elata, Carica papaya, Carissa macrocarpa, Carya  spp.,  Carthamus tinctorius, Castanea  spp.,  Ceiba pentandra, Cichorium endivia, Cinnamomum  spp.,  Citrullus lanatus, Citrus  spp.,  Cocos  spp.,  Coffea  spp.,  Colocasia esculenta, Cola  spp.,  Corchorus  sp.,  Coriandrum sativum, Corylus  spp.,  Crataegus  spp.,  Crocus sativus, Cucurbita  spp.,  Cucumis  spp.,  Cynara  spp.,  Daucus carota, Desmodium  spp.,  Dimocarpus longan, Dioscorea  spp.,  Diospyros  spp.,  Echinochloa  spp.,  Elaeis  (e.g.  Elaeis guineensis, Elaeis oleifera ),  Eleusine coracana, Erianthus  sp.,  Eriobotrya japonica, Eucalyptus  sp.,  Eugenia uniflora, Fagopyrum  spp.,  Fagus  spp.,  Festuca arundinacea, Ficus carica, Fortunella  spp.,  Fragaria  spp.,  Ginkgo biloba, Glycine  spp. (e.g.  Glycine max, Soja hispida  or  Soja max ),  Gossypium hirsutum, Helianthus  spp. (e.g.  Helianthus annuus ),  Hemerocallis fulva, Hibiscus  spp.,  Hordeum  spp. (e.g.  Hordeum vulgare ),  Ipomoea batatas, Juglans  spp.,  Lactuca sativa, Lathyrus  spp.,  Lens culinaris, Linum usitatissimum, Litchi chinensis, Lotus  spp.,  Luffa acutangula, Lupinus  spp.,  Luzula sylvatica, Lycopersicon  spp. (e.g.  Lycopersicon esculentum, Lycopersicon lycopersicum, Lycopersicon pyriforme ),  Macrotyloma  spp.,  Malus  spp.,  Malpighia emarginata, Mammea americana, Mangifera indica, Manihot  spp.,  Manilkara zapota, Medicago sativa, Melilotus  spp.,  Mentha  spp.,  Miscanthus sinensis, Momordica  spp.,  Morus nigra, Musa  spp.,  Nicotiana  spp.,  Olea  spp.,  Opuntia  spp.,  Ornithopus  spp.,  Oryza  spp. (e.g.  Oryza sativa, Oryza latifolia ),  Panicum miliaceum, Panicum virgatum, Passiflora edulis, Pastinaca sativa, Pennisetum  sp.,  Persea  spp.,  Petroselinum crispum, Phalaris arundinacea, Phaseolus  spp.,  Phleum pratense, Phoenix  spp.,  Phragmites australis, Physalis  spp.,  Pinus  spp.,  Pistacia vera, Pisum  spp.,  Poa  spp.,  Populus  spp.,  Prosopis  spp.,  Prunus  spp.,  Psidium  spp.,  Punica granatum, Pyrus communis, Quercus  spp.,  Raphanus sativus, Rheum rhabarbarum, Ribes  spp.,  Ricinus communis, Rubus  spp.,  Saccharum  spp.,  Salix  sp.,  Sambucus  spp.,  Secale cereale, Sesamum  spp.,  Sinapis  sp.,  Solanum  spp. (e.g.  Solanum tuberosum, Solanum integrifolium  or  Solanum lycopersicum ),  Sorghum bicolor, Spinacia  spp.,  Syzygium  spp.,  Tagetes  spp.,  Tamarindus indica, Theobroma cacao, Trifolium  spp.,  Triticosecale rimpaui, Triticum  spp. (e.g.  Triticum aestivum, Triticum durum, Triticum turgidum, Triticum hybernum, Triticum macha, Triticum sativum  or  Triticum vulgare ),  Tropaeolum minus, Tropaeolum majus, Vaccinium  spp.,  Vicia  spp.,  Vigna  spp.,  Viola odorata, Vitis  spp.,  Zea mays, Zizania palustris, Ziziphus  spp., amongst others. 
     DETAILED DESCRIPTION OF THE INVENTION 
     (i) VPE 
     According to a first embodiment, the present invention provides a method for enhancing yield-related traits in plants relative to control plants, comprising modulating expression in a plant of a nucleic acid encoding a VPE. 
     The present invention also provides hitherto unknown VPE-encoding nucleic acids and VPEs. These sequences also being useful in performing the methods of the invention. 
     According to a further embodiment of the present invention, there is therefore provided an isolated nucleic acid molecule comprising:
         (i) a nucleic acid represented by SEQ ID NO: 151, SEQ ID NO: 153, SEQ ID NO: 155, SEQ ID NO: 157, SEQ ID NO: 159, SEQ ID NO: 161, SEQ ID NO: 163, SEQ ID NO: 165, SEQ ID NO: 167, SEQ ID NO: 169, SEQ ID NO: 171;   (ii) the complement of any one of the SEQ ID NOs given in (i);   (iii) a nucleic acid encoding a VPE having, in increasing order of preference, at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity to any one of the amino acid sequences given in SEQ ID NO: 152, SEQ ID NO: 154 and SEQ ID NO: 156, SEQ ID NO: 158, SEQ ID NO: 160, SEQ ID NO: 162, SEQ ID NO: 164, SEQ ID NO: 166, SEQ ID NO: 168, SEQ ID NO: 170, SEQ ID NO: 172;   (iv) a nucleic acid capable of hybridizing under stringent conditions to any one of the nucleic acids given in (i), (ii) or (iii) above.       

     According to a further embodiment of the present invention, there is also provided an isolated polypeptide comprising:
         (i) an amino acid sequence represented by any one of SEQ ID NO: 152, SEQ ID NO: 154 and SEQ ID NO: 156, SEQ ID NO: 158, SEQ ID NO: 160, SEQ ID NO: 162, SEQ ID NO: 164, SEQ ID NO: 166, SEQ ID NO: 168, SEQ ID NO: 170, SEQ ID NO: 172;   (ii) an amino acid sequence having, in increasing order of preference, at least at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity to any one of the amino acid sequences given in SEQ ID NO: 152, SEQ ID NO: 154 and SEQ ID NO: 156, SEQ ID NO: 158, SEQ ID NO: 160, SEQ ID NO: 162, SEQ ID NO: 164, SEQ ID NO: 166, SEQ ID NO: 168, SEQ ID NO: 170, SEQ ID NO: 172;   (iii) derivatives of any of the amino acid sequences given in (i) or (ii) above.       

     A preferred method for modulating (preferably, increasing) expression of a nucleic acid encoding a VPE is by introducing and expressing in a plant a nucleic acid encoding a VPE. 
     Any reference hereinafter to a “protein useful in the methods of the invention” is taken to mean a VPE as defined herein. Any reference hereinafter to a “nucleic acid useful in the methods of the invention” is taken to mean a nucleic acid capable of encoding such a VPE. The nucleic acid to be introduced into a plant (and therefore useful in performing the methods of the invention) is any nucleic acid encoding the type of protein which will now be described, hereafter also named “VPE nucleic acid” or “VPE gene”. 
     A “VPE” as defined herein refers to any vacuolar processing enzyme. VPE are cysteine proteases that cleave a peptide bond at the C-terminal end of asparagine and aspartic acid (Hiraiwa et al. FEBS Letters 447, 1999, pp. 213-216). 
     The proteins of the invention are identifiable by the presence of the conserved domains (see  FIGS. 5A and 5B  showing the domain structure of a gamma VPEs (VPEg)). VPEg comprise one or more of the following features:
         signal peptide for insertion into the endomembrane system;   an N-terminal inhibitory domain;   an active domain;   a C-terminal inhibitory domain; and   Conserved Histidine and Cysteine residues.       

     The term “domain” is defined in the “definitions section herein. Specialist databases exist for the identification of domains, for example, SMART (Schultz et al. (1998) Proc. Natl. Acad. Sci. USA 95, 5857-5864; Letunic et al. (2002) Nucleic Acids Res 30, 242-244, InterPro (Mulder et al., (2003) Nucl. Acids. Res. 31, 315-318, Prosite (Bucher and Bairoch (1994), A generalized profile syntax for biomolecular sequences motifs and its function in automatic sequence interpretation. (In) ISMB-94; Proceedings 2nd International Conference on Intelligent Systems for Molecular Biology. Altman R., Brutlag D., Karp P., Lathrop R., Searls D., Eds., pp 53-61, AAAIPress, Menlo Park; Hulo et al., Nucl. Acids. Res. 32:D134-D137, (2004), or Pfam (Bateman et al., Nucleic Acids Research 30(1): 276-280 (2002). A set of tools for in silico analysis of protein sequences is available on the ExPASY proteomics server (hosted by the Swiss Institute of Bioinformatics (Gasteiger et al., ExPASy: the proteomics server for in-depth protein knowledge and analysis, Nucleic Acids Res. 31:3784-3788 (2003)). Domains may also be identified using routine techniques, such as by sequence alignment. 
     Methods for the alignment of sequences for comparison are well known in the art, such methods include GAP, BESTFIT, BLAST, FASTA and TFASTA. GAP uses the algorithm of Needleman and Wunsch ((1970) J Mol Biol 48: 443-453) to find the global (i.e. spanning the complete sequences) alignment of two sequences that maximizes the number of matches and minimizes the number of gaps. The BLAST algorithm (Altschul et al. (1990) J Mol Biol 215: 403-10) calculates percent sequence identity and performs a statistical analysis of the similarity between the two sequences. The software for performing BLAST analysis is publicly available through the National Centre for Biotechnology Information (NCBI). Homologues may readily be identified using, for example, the ClustalW multiple sequence alignment algorithm (version 1.83), with the default pairwise alignment parameters, and a scoring method in percentage. Global percentages of similarity and identity may also be determined using one of the methods available in the MatGAT software package (Campanella et al., BMC Bioinformatics. 2003 Jul. 10; 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences.). Minor manual editing may be performed to optimise alignment between conserved motifs, as would be apparent to a person skilled in the art. Furthermore, instead of using full-length sequences for the identification of homologues, specific domains may also be used. The sequence identity values, which are indicated in the Example section herein as a percentage were determined over the entire nucleic acid or amino acid sequence, and/or over selected domains or conserved motif(s), using the programs mentioned above using the default parameters. 
     Furthermore, VPEs (at least in their native form) typically have the following activity. Further details are provided in the Examples section herein. 
     The VPE represented by SEQ ID NO: 150 is an enzyme with an Enzyme Commission (EC) number EC 3.4.22.34 for ebi.ac.uk/intenz/query?cmd=Search EC&amp;ec=3.4.22.34&amp;status=OK legumain (also called asparaginyl endopeptidase). Asparaginyl endopeptidases catalyse the hydrolysis of proteins and small molecule substrates at Asn Xaa- bonds. Peptidases in this class are not inhibited by compound E-64. VPEg (VPE gamma) has been shown to exhibit protease activity towards Asp residues and towards an Asp-Gln bond to remove the N-terminal propeptide (Haraiwa et al. 1999, FEBS 447: 213-216). Alternative methods to detect protease activity of VPE proteins have been reported (see for example Kuroyanagi, The Journal of Biological Chemistry Vol. 280, No. 38, pp. 32914-32920). 
     VPEs also typically exhibit CASPASE I activity (see Hatsugai et al., (Science VOL 305 6 Aug. 2004) and Rojo et al., 2004 (Current Biology, Vol. 14, pp 1897-1906)). The following active pentapetide site in caspases is reported: E(A/G)CES (SEQ ID NO: 209). 
     The present invention is illustrated by transforming plants with the nucleic acid sequence represented by SEQ ID NO: 149, encoding the polypeptide sequence of SEQ ID NO: 150. However, performance of the invention is not restricted to these sequences; the methods of the invention may advantageously be performed using any VPE-encoding nucleic acid or VPE as defined herein. 
     Examples of nucleic acids encoding VPEs are given in the Examples section herein. Such nucleic acids are useful in performing the methods of the invention. The amino acid sequences given in the Examples are example sequences of orthologues and paralogues of the VPE represented by SEQ ID NO: 150, the terms “orthologues” and “paralogues” being as defined herein. Further orthologues and paralogues may readily be identified by performing a so-called reciprocal blast search. Typically, this involves a first BLAST involving BLASTing a query sequence (for example using any of the sequences listed in the table in the Examples against any sequence database, such as the publicly available NCBI database. BLASTN or TBLASTX (using standard default values) are generally used when starting from a nucleotide sequence, and BLASTP or TBLASTN (using standard default values) when starting from a protein sequence. The BLAST results may optionally be filtered. The full-length sequences of either the filtered results or non-filtered results are then BLASTed back (second BLAST) against sequences from the organism from which the query sequence is derived (where the query sequence is SEQ ID NO: 149 or SEQ ID NO: 150, the second BLAST would therefore be against  Arabidopsis  sequences). The results of the first and second BLASTs are then compared. A paralogue is identified if a high-ranking hit from the first blast is from the same species as from which the query sequence is derived, a BLAST back then ideally results in the query sequence as highest hit; an orthologue is identified if a high-ranking hit in the first BLAST is not from the same species as from which the query sequence is derived, and preferably results upon BLAST back in the query sequence being among the highest hits. 
     High-ranking hits are those having a low E-value. The lower the E-value, the more significant the score (or in other words the lower the chance that the hit was found by chance). Computation of the E-value is well known in the art. In addition to E-values, comparisons are also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In the case of large families, ClustalW may be used, followed by a neighbour joining tree, to help visualize clustering of related genes and to identify orthologues and paralogues. 
     Nucleic acid variants may also be useful in practising the methods of the invention. Examples of such variants include nucleic acids encoding homologues and derivatives of any one of the amino acid sequences given in Table B1 of the Examples section, the terms “homologue” and “derivative” being as defined herein. Also useful in the methods of the invention are nucleic acids encoding homologues and derivatives of orthologues or paralogues of any one of the amino acid sequences given in Table B1 of the Examples section. Homologues and derivatives useful in the methods of the present invention have substantially the same biological and functional activity as the unmodified protein from which they are derived. 
     Further nucleic acid variants useful in practising the methods of the invention include portions of nucleic acids encoding VPEs, nucleic acids hybridising to nucleic acids encoding VPEs, splice variants of nucleic acids encoding VPEs, allelic variants of nucleic acids encoding VPEs and variants of nucleic acids encoding VPEs obtained by gene shuffling. The terms hybridising sequence, splice variant, allelic variant and gene shuffling are as described herein. 
     Nucleic acids encoding VPEs need not be full-length nucleic acids, since performance of the methods of the invention does not rely on the use of full-length nucleic acid sequences. According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a portion of any one of the nucleic acid sequences given in Table B1 in the Examples section, or a portion of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table B1. 
     A portion of a nucleic acid may be prepared, for example, by making one or more deletions to the nucleic acid. The portions may be used in isolated form or they may be fused to other coding (or non-coding) sequences in order to, for example, produce a protein that combines several activities. When fused to other coding sequences, the resultant polypeptide produced upon translation may be bigger than that predicted for the protein portion. 
     Portions useful in the methods of the invention, encode a VPE as defined herein, and have substantially the same biological activity as the amino acid sequences given in Table B1 in the Examples section. Preferably, the portion is a portion of any one of the nucleic acids given in Table B1 of the Examples section, or is a portion of a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table B1. The portion is typically at least 800 consecutive nucleotides in length, preferably at least 1,000 consecutive nucleotides in length, more preferably at least 1,200 consecutive nucleotides in length and most preferably at least 1,500 consecutive nucleotides in length, the consecutive nucleotides being of any one of the nucleic acid sequences given in Table B1 of the Examples, or of a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table B1. Most preferably the portion is a portion of the nucleic acid of SEQ ID NO: 149. Preferably, the portion encodes an amino acid sequence comprising (any one or more of the domains defined herein. Preferably, the portion encodes an amino acid sequence which when used in the construction of a VPE phylogenetic tree, such as the one depicted in  FIG. 6 , tends to cluster with the group of gamma VPEs comprising the amino acid sequence represented by SEQ ID NO: 150 rather than with any other group. 
     Another nucleic acid variant useful in the methods of the invention is a nucleic acid capable of hybridising, under reduced stringency conditions, preferably under stringent conditions, with a nucleic acid encoding a VPE as defined herein, or with a portion as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a nucleic acid capable of hybridizing to any one of the nucleic acids given in Table B1 of the Examples section, or comprising introducing and expressing in a plant a nucleic acid capable of hybridising to a nucleic acid encoding an orthologue, paralogue or homologue of any of the nucleic acid sequences given in Table B1 of the Examples. 
     Hybridising sequences useful in the methods of the invention encode a VPE as defined herein, and have substantially the same biological activity as the amino acid sequences given in Table B1 of the Examples. Preferably, the hybridising sequence is capable of hybridising to any one of the nucleic acids given in Table B1, or to a portion of any of these sequences, a portion being as defined above, or wherein the hybridising sequence is capable of hybridising to a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table B1. Most preferably, the hybridising sequence is capable of hybridising to a nucleic acid as represented by SEQ ID NO: 149 or to a portion thereof. Preferably, the hybridising sequence encodes an amino acid sequence comprising any one or more of the motifs or domains as defined herein. Preferably, the hybridising sequence encodes an amino acid sequence which when used in the construction of a VPE phylogenetic tree, such as the one depicted in  FIG. 6 , tends to cluster with the group of gamma VPEs comprising the amino acid sequence represented by SEQ ID NO: 150 rather than with any other group. 
     Another nucleic acid variant useful in the methods of the invention is a splice variant encoding a VPE as defined hereinabove, a splice variant being as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a splice variant of any one of the nucleic acid sequences given in Table B1 in the Examples, or a splice variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table B1. 
     Preferred splice variants are splice variants of a nucleic acid represented by SEQ ID NO: 149, or a splice variant of a nucleic acid encoding an orthologue or paralogue of SEQ ID NO: 150. Preferably, the amino acid sequence encoded by the splice variant comprises any one or more of the motifs or domains as defined herein. Preferably, the amino acid sequence encoded by the splice variant, when used in the construction of a VPE phylogenetic tree, such as the one depicted in  FIG. 6 , tends to cluster with the group of gamma VPEs comprising the amino acid sequence represented by SEQ ID NO: 150 rather than with any other group. 
     Another nucleic acid variant useful in performing the methods of the invention is an allelic variant of a nucleic acid encoding a VPE as defined hereinabove, an allelic variant being as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant an allelic variant of any one of the nucleic acids given in Table B1 of the Examples, or comprising introducing and expressing in a plant an allelic variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table B1. 
     The allelic variants useful in the methods of the present invention have substantially the same biological activity as the VPE of SEQ ID NO: 150 and any of the amino acids depicted in Table B1 of the Examples section. Allelic variants exist in nature, and encompassed within the methods of the present invention is the use of these natural alleles. Preferably, the allelic variant is an allelic variant of SEQ ID NO: 149 or an allelic variant of a nucleic acid encoding an orthologue or paralogue of SEQ ID NO: 150. Preferably, the amino acid encoded by the allelic variant comprises any one or more of the motifs or domains as defined herein. Preferably, the amino acid sequence encoded by the allelic variant, when used in the construction of a VPE phylogenetic tree, such as the one depicted in  FIG. 6 , tends to cluster with the group of gamma VPE proteins comprising the amino acid sequence represented by SEQ ID NO: 150 rather than with any other group. 
     Gene shuffling or directed evolution may also be used to generate variants of nucleic acids encoding VPEs as defined above; the term “gene shuffling” being as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a variant of any one of the nucleic acid sequences given in Table B1 of the Example, or comprising introducing and expressing in a plant a variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table B1 shown in the Examples section, which variant nucleic acid is obtained by gene shuffling. 
     Preferably, the variant nucleic acid obtained by gene shuffling encodes an amino acid sequence comprising any one or more of the motifs or domains as defined herein. Preferably, the amino acid sequence encoded by the variant nucleic acid obtained by gene shuffling, when used in the construction of a VPE phylogenetic tree such as the one depicted in  FIG. 6 , tends to cluster with the group of gamma VPEs comprising the amino acid sequence represented by SEQ ID NO: 150 rather than with any other group. 
     Furthermore, nucleic acid variants may also be obtained by site-directed mutagenesis. Several methods are available to achieve site-directed mutagenesis, the most common being PCR based methods (Current Protocols in Molecular Biology. Wiley Eds.). 
     Nucleic acids encoding VPEs proteins may be derived from any natural or artificial source. The nucleic acid may be modified from its native form in composition and/or genomic environment through deliberate human manipulation. Preferably the VPE-encoding nucleic acid is from a plant, further preferably from a dicotyledonous plant, more preferably from the brassica family, most preferably the nucleic acid is from  Arabidopsis thaliana.    
     Performance of the methods of the invention gives plants having enhanced yield-related traits. In particular performance of the methods of the invention gives plants having increased yield, especially increased seed yield relative to control plants. The terms “yield” and “seed yield” are described in more detail in the “definitions” section herein. 
     Reference herein to enhanced yield-related traits is taken to mean an increase in biomass (weight) of one or more parts of a plant, which may include aboveground (harvestable) parts and/or (harvestable) parts below ground. In particular, such harvestable parts are seeds, and performance of the methods of the invention results in plants having increased seed yield relative to the seed yield of suitable control plants. 
     Taking corn as an example, a yield increase may be manifested as one or more of the following: increase in the number of plants established per hectare or acre, an increase in the number of ears per plant, an increase in the number of rows, number of kernels per row, kernel weight, thousand kernel weight, ear length/diameter, increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), among others. Taking rice as an example, a yield increase may manifest itself as an increase in one or more of the following: number of plants per hectare or acre, number of panicles per plant, number of spikelets per panicle, number of flowers (florets) per panicle (which is expressed as a ratio of the number of filled seeds over the number of primary panicles), increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), increase in thousand kernel weight, among others. 
     The present invention provides a method for increasing yield, especially seed yield of plants, relative to control plants, which method comprises modulating expression, preferably increasing expression, in a plant of a nucleic acid encoding a VPE as defined herein. 
     Since the transgenic plants according to the present invention have increased yield, it is likely that these plants exhibit an increased growth rate (during at least part of their life cycle), relative to the growth rate of control plants at a corresponding stage in their life cycle. 
     The increased growth rate may be specific to one or more parts of a plant (including seeds), or may be throughout substantially the whole plant. Plants having an increased growth rate may have a shorter life cycle. The life cycle of a plant may be taken to mean the time needed to grow from a dry mature seed up to the stage where the plant has produced dry mature seeds, similar to the starting material. This life cycle may be influenced by factors such as early vigour, growth rate, greenness index, flowering time and speed of seed maturation. The increase in growth rate may take place at one or more stages in the life cycle of a plant or during substantially the whole plant life cycle. Increased growth rate during the early stages in the life cycle of a plant may reflect enhanced vigour. The increase in growth rate may alter the harvest cycle of a plant allowing plants to be sown later and/or harvested sooner than would otherwise be possible (a similar effect may be obtained with earlier flowering time). If the growth rate is sufficiently increased, it may allow for the further sowing of seeds of the same plant species (for example sowing and harvesting of rice plants followed by sowing and harvesting of further rice plants all within one conventional growing period). Similarly, if the growth rate is sufficiently increased, it may allow for the further sowing of seeds of different plants species (for example the sowing and harvesting of corn plants followed by, for example, the sowing and optional harvesting of soybean, potato or any other suitable plant). Harvesting additional times from the same rootstock in the case of some crop plants may also be possible. Altering the harvest cycle of a plant may lead to an increase in annual biomass production per acre (due to an increase in the number of times (say in a year) that any particular plant may be grown and harvested). An increase in growth rate may also allow for the cultivation of transgenic plants in a wider geographical area than their wild-type counterparts, since the territorial limitations for growing a crop are often determined by adverse environmental conditions either at the time of planting (early season) or at the time of harvesting (late season). Such adverse conditions may be avoided if the harvest cycle is shortened. The growth rate may be determined by deriving various parameters from growth curves, such parameters may be: T-Mid (the time taken for plants to reach 50% of their maximal size) and T-90 (time taken for plants to reach 90% of their maximal size), amongst others. 
     According to a preferred feature of the present invention, performance of the methods of the invention gives plants having an increased growth rate relative to control plants. Therefore, according to the present invention, there is provided a method for increasing the growth rate of plants, which method comprises modulating expression, preferably increasing expression, in a plant of a nucleic acid encoding a VPE as defined herein. 
     An increase in yield and/or growth rate occurs whether the plant is under non-stress conditions or whether the plant is exposed to various stresses compared to control plants. Plants typically respond to exposure to stress by growing more slowly. In conditions of severe stress, the plant may even stop growing altogether. Mild stress on the other hand is defined herein as being any stress to which a plant is exposed which does not result in the plant ceasing to grow altogether without the capacity to resume growth. Mild stress in the sense of the invention leads to a reduction in the growth of the stressed plants of less than 40%, 35% or 30%, preferably less than 25%, 20% or 15%, more preferably less than 14%, 13%, 12%, 11% or 10% or less in comparison to the control plant under non-stress conditions. Due to advances in agricultural practices (irrigation, fertilization, pesticide treatments) severe stresses are not often encountered in cultivated crop plants. As a consequence, the compromised growth induced by mild stress is often an undesirable feature for agriculture. Mild stresses are the everyday biotic and/or abiotic (environmental) stresses to which a plant is exposed. Abiotic stresses may be due to drought or excess water, anaerobic stress, salt stress, chemical toxicity, oxidative stress and hot, cold or freezing temperatures. The abiotic stress may be an osmotic stress caused by a water stress (particularly due to drought), salt stress, oxidative stress or an ionic stress. Biotic stresses are typically those stresses caused by pathogens, such as bacteria, viruses, fungi and insects. 
     In particular, the methods of the present invention may be performed under non-stress conditions or under conditions of mild drought to give plants having increased yield relative to control plants. As reported in Wang et al. (Planta (2003) 218: 1-14), abiotic stress leads to a series of morphological, physiological, biochemical and molecular changes that adversely affect plant growth and productivity. Drought, salinity, extreme temperatures and oxidative stress are known to be interconnected and may induce growth and cellular damage through similar mechanisms. Rabbani et al. (Plant Physiol (2003) 133: 1755-1767) describes a particularly high degree of “cross talk” between drought stress and high-salinity stress. For example, drought and/or salinisation are manifested primarily as osmotic stress, resulting in the disruption of homeostasis and ion distribution in the cell. Oxidative stress, which frequently accompanies high or low temperature, salinity or drought stress, may cause denaturing of functional and structural proteins. As a consequence, these diverse environmental stresses often activate similar cell signaling pathways and cellular responses, such as the production of stress proteins, up-regulation of anti-oxidants, accumulation of compatible solutes and growth arrest. The term “non-stress” conditions as used herein are those environmental conditions that allow optimal growth of plants. Persons skilled in the art are aware of normal soil conditions and climatic conditions for a given location. 
     Performance of the methods of the invention gives plants grown under non-stress conditions or under mild drought conditions increased yield relative to suitable control plants grown under comparable conditions. Therefore, according to the present invention, there is provided a method for increasing yield in plants grown under non-stress conditions or under mild drought conditions, which method comprises increasing expression in a plant of a nucleic acid encoding a VPE. 
     The present invention encompasses plants or parts thereof (including seeds) obtainable by the methods according to the present invention. The plants or parts thereof comprise a nucleic acid transgene encoding a VPE as defined above. 
     The invention also provides genetic constructs and vectors to facilitate introduction and/or expression in plants of nucleic acids encoding VPEs. The gene constructs may be inserted into vectors, which may be commercially available, suitable for transforming into plants and suitable for expression of the gene of interest in the transformed cells. The invention also provides use of a gene construct as defined herein in the methods of the invention. 
     More specifically, the present invention provides a construct comprising:
         (a) a nucleic acid encoding a VPE as defined above;   (b) one or more control sequences capable of driving expression of the nucleic acid sequence of (a); and optionally   (c) a transcription termination sequence.       

     The term “control sequence” and “termination sequence” are as defined herein. Plants are transformed with a vector comprising any of the nucleic acids described above. The skilled artisan is well aware of the genetic elements that must be present on the vector in order to successfully transform, select and propagate host cells containing the sequence of interest. The sequence of interest is operably linked to one or more control sequences (at least to a promoter). 
     Advantageously, any type of promoter may be used to drive expression of the nucleic acid sequence. A constitutive promoter is particularly useful as is a root-specific promoter. However, particularly preferred is a seed-specific promoter. A seed-specific promoter is transcriptionally active predominantly in seed tissue, but not necessarily exclusively in seed tissue (in cases of leaky expression). The seed-specific promoter may be active during seed development and/or during germination. Seed-specific promoters are well known in the art. It should be clear that the applicability of the present invention is not restricted to the VPE-encoding nucleic acid represented by SEQ ID NO: 149, nor is the applicability of the invention restricted to expression of a VPE-encoding nucleic acid when driven by a seed-specific promoter. Examples of other seed-specific promoters which may also be used to drive expression of a VPE-encoding nucleic acid are shown in the “Definitions” section herein. Further examples of seed-specific promoters are given in Qing Qu and Takaiwa (Plant Biotechnol. J. 2, 113-125, 2004), which disclosure is incorporated by reference herein as if fully set forth. 
     More preferably a promoter that is transcriptionally active in the embryo and/or alerone layers of a seed. Preferably, the seed-specific promoter is a Water-Stress Inducible (WSI) promoter or a functionally equivalent promoter. More preferably, the promoter sequence is as represented by SEQ ID NO: 205. Examples of other embryo-specific promoters which may also be used to drive expression of a VPE-encoding nucleic acid are shown in the “Definitions” section herein. Examples of other alerone-specific promoters which may also be used to drive expression of a VPE-encoding nucleic acid are also shown in the “Definitions” section herein. 
     For the identification of functionally equivalent promoters, the promoter strength and/or expression pattern of a candidate promoter may be analysed for example by operably linking the promoter to a reporter gene and assaying the expression level and pattern of the reporter gene in various tissues of the plant. Suitable well-known reporter genes include for example beta-glucuronidase or beta galactosidase. The promoter activity is assayed by measuring the enzymatic activity of the beta-glucuronidase or beta-galactosidase. The promoter strength and/or expression pattern may then be compared to that of a reference promoter (such as the one used in the methods of the present invention). Alternatively, promoter strength may be assayed by quantifying mRNA levels or by comparing mRNA levels of the nucleic acid used in the methods of the present invention, with mRNA levels of housekeeping genes such as 18S rRNA, using methods known in the art, such as Northern blotting with densitometric analysis of autoradiograms, quantitative real-time PCR or RT-PCR (Heid et al., 1996 Genome Methods 6: 986-994). Generally by “weak promoter” is intended a promoter that drives expression of a coding sequence at a low level. By “low level” is intended at levels of about 1/10,000 transcripts to about 1/100,000 transcripts, to about 1/500,0000 transcripts per cell. Conversely, a “strong promoter” drives expression of a coding sequence at high level, or at about 1/10 transcripts to about 1/100 transcripts to about 1/1,000 transcripts per cell. 
     Optionally, one or more terminator sequences may be used in the construct introduced into a plant. Additional regulatory elements may include transcriptional as well as translational enhancers. Those skilled in the art will be aware of terminator and enhancer sequences that may be suitable for use in performing the invention. Such sequences would be known or may readily be obtained by a person skilled in the art. 
     An intron sequence may also be added to the 5′ untranslated region (UTR) or in the coding sequence to increase the amount of the mature message that accumulates in the cytosol. Inclusion of a spliceable intron in the transcription unit in both plant and animal expression constructs has been shown to increase gene expression at both the mRNA and protein levels up to 1000-fold (Buchman and Berg, Mol. Cell. Biol. 8:4395-4405 (1988); Callis et al., Genes Dev. 1:1183-1200 (1987)). Such intron enhancement of gene expression is typically greatest when placed near the 5′ end of the transcription unit. Use of the maize introns Adh1-S intron 1, 2, and 6, the Bronze-1 intron are known in the art. For general information, see The Maize Handbook, Chapter 116, Freeling and Walbot, Eds., Springer, N.Y. (1994). 
     Other control sequences (besides promoter, enhancer, silencer, intron sequences, 3′UTR and/or 5′UTR regions) may be protein and/or RNA stabilizing elements. Such sequences would be known or may readily be obtained by a person skilled in the art. 
     The genetic constructs of the invention may further include an origin of replication sequence that is required for maintenance and/or replication in a specific cell type. One example is when a genetic construct is required to be maintained in a bacterial cell as an episomal genetic element (e.g. plasmid or cosmid molecule). Preferred origins of replication include, but are not limited to, the f1-otri and colE1. 
     For the detection of the successful transfer of the nucleic acid sequences as used in the methods of the invention and/or selection of transgenic plants comprising these nucleic acids, it is advantageous to use marker genes (or reporter genes). Therefore, the genetic construct may optionally comprise a selectable marker gene. Selectable markers are described in more detail in the “definitions” section herein. 
     It is known that upon stable or transient integration of nucleic acids into plant cells, only a minority of the cells takes up the foreign DNA and, if desired, integrates it into its genome, depending on the expression vector used and the transfection technique used. To identify and select these integrants, a gene coding for a selectable marker (such as the ones described above) is usually introduced into the host cells together with the gene of interest. These markers can for example be used in mutants in which these genes are not functional by, for example, deletion by conventional methods. Furthermore, nucleic acid molecules encoding a selectable marker can be introduced into a host cell on the same vector that comprises the sequence encoding the polypeptides of the invention or used in the methods of the invention, or else in a separate vector. Cells which have been stably transfected with the introduced nucleic acid can be identified for example by selection (for example, cells which have integrated the selectable marker survive whereas the other cells die). 
     Since the marker genes, particularly genes for resistance to antibiotics and herbicides, are no longer required or are undesired in the transgenic host cell once the nucleic acids have been introduced successfully, the process according to the invention for introducing the nucleic acids advantageously employs techniques which enable the removal or excision of these marker genes. One such a method is what is known as co-transformation. The co-transformation method employs two vectors simultaneously for the transformation, one vector bearing the nucleic acid according to the invention and a second bearing the marker gene(s). A large proportion of transformants receives or, in the case of plants, comprises (up to 40% or more of the transformants), both vectors. In case of transformation with  Agrobacteria , the transformants usually receive only a part of the vector, i.e. the sequence flanked by the T-DNA, which usually represents the expression cassette. The marker genes can subsequently be removed from the transformed plant by performing crosses. In another method, marker genes integrated into a transposon are used for the transformation together with desired nucleic acid (known as the Ac/Ds technology). The transformants can be crossed with a transposase source or the transformants are transformed with a nucleic acid construct conferring expression of a transposase, transiently or stable. In some cases (approx. 10%), the transposon jumps out of the genome of the host cell once transformation has taken place successfully and is lost. In a further number of cases, the transposon jumps to a different location. In these cases the marker gene must be eliminated by performing crosses. In microbiology, techniques were developed which make possible, or facilitate, the detection of such events. A further advantageous method relies on what is known as recombination systems; whose advantage is that elimination by crossing can be dispensed with. The best-known system of this type is what is known as the Cre/lox system. Cre1 is a recombinase that removes the sequences located between the loxP sequences. If the marker gene is integrated between the loxP sequences, it is removed once transformation has taken place successfully, by expression of the recombinase. Further recombination systems are the HIN/HIX, FLP/FRT and REP/STB system (Tribble et al., J. Biol. Chem., 275, 2000: 22255-22267; Velmurugan et al., J. Cell Biol., 149, 2000: 553-566). A site-specific integration into the plant genome of the nucleic acid sequences according to the invention is possible. Naturally, these methods can also be applied to microorganisms such as yeast, fungi or bacteria. 
     The invention also provides a method for the production of transgenic plants having enhanced yield-related traits relative to control plants, comprising introduction and expression in a plant of any nucleic acid encoding a VPE as defined hereinabove. 
     More specifically, the present invention provides a method for the production of transgenic plants having increased yield, which method comprises:
         (i) introducing and expressing in a plant or plant cell a VPE-encoding nucleic acid; and   (ii) cultivating the plant cell under conditions promoting plant growth and development.       

     The nucleic acid may be introduced directly into a plant cell or into the plant itself (including introduction into a tissue, organ or any other part of a plant). According to a preferred feature of the present invention, the nucleic acid is preferably introduced into a plant by transformation. The term “transformation” is described in more detail in the “definitions” section herein. 
     The genetically modified plant cells can be regenerated via all methods with which the skilled worker is familiar. Suitable methods can be found in the abovementioned publications by S. D. Kung and R. Wu, Potrykus or Höfgen and Willmitzer. 
     Generally after transformation, plant cells or cell groupings are selected for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the gene of interest, following which the transformed material is regenerated into a whole plant. To select transformed plants, the plant material obtained in the transformation is, as a rule, subjected to selective conditions so that transformed plants can be distinguished from untransformed plants. For example, the seeds obtained in the above-described manner can be planted and, after an initial growing period, subjected to a suitable selection by spraying. A further possibility consists in growing the seeds, if appropriate after sterilization, on agar plates using a suitable selection agent so that only the transformed seeds can grow into plants. Alternatively, the transformed plants are screened for the presence of a selectable marker such as the ones described above. 
     Following DNA transfer and regeneration, putatively transformed plants may also be evaluated, for instance using Southern analysis, for the presence of the gene of interest, copy number and/or genomic organisation. Alternatively or additionally, expression levels of the newly introduced DNA may be monitored using Northern and/or Western analysis, both techniques being well known to persons having ordinary skill in the art. 
     The generated transformed plants may be propagated by a variety of means, such as by clonal propagation or classical breeding techniques. For example, a first generation (or T1) transformed plant may be selfed and homozygous second-generation (or T2) transformants selected, and the T2 plants may then further be propagated through classical breeding techniques. 
     The generated transformed organisms may take a variety of forms. For example, they may be chimeras of transformed cells and non-transformed cells; clonal transformants (e.g., all cells transformed to contain the expression cassette); grafts of transformed and untransformed tissues (e.g., in plants, a transformed rootstock grafted to an untransformed scion). 
     The present invention clearly extends to any plant cell or plant produced by any of the methods described herein, and to all plant parts and propagules thereof. The present invention extends further to encompass the progeny of a primary transformed or transfected cell, tissue, organ or whole plant that has been produced by any of the aforementioned methods, the only requirement being that progeny exhibit the same genotypic and/or phenotypic characteristic(s) as those produced by the parent in the methods according to the invention. 
     The invention also includes host cells containing an isolated nucleic acid encoding a VPE as defined hereinabove. Preferred host cells according to the invention are plant cells. Host plants for the nucleic acids or the vector used in the method according to the invention, the expression cassette or construct or vector are, in principle, advantageously all plants, which are capable of synthesizing the polypeptides used in the inventive method. 
     The methods of the invention are advantageously applicable to any plant. 
     Plants that are particularly useful in the methods of the invention include all plants which belong to the superfamily Viridiplantae, in particular monocotyledonous and dicotyledonous plants including fodder or forage legumes, ornamental plants, food crops, trees or shrubs. According to a preferred embodiment of the present invention, the plant is a crop plant. Examples of crop plants include soybean, sunflower, canola, alfalfa, rapeseed, cotton, tomato, potato and tobacco. Further preferably, the plant is a monocotyledonous plant. Examples of monocotyledonous plants include sugarcane. More preferably the plant is a cereal. Examples of cereals include rice, maize, wheat, barley, millet, rye, sorghum and oats. 
     The invention also extends to harvestable parts of a plant such as, but not limited to seeds, leaves, fruits, flowers, stems, rhizomes, tubers and bulbs. The invention furthermore relates to products derived, preferably directly derived, from a harvestable part of such a plant, such as dry pellets or powders, oil, fat and fatty acids, starch or proteins. 
     According to a preferred feature of the invention, the modulated expression is increased expression. Methods for increasing expression of nucleic acids or genes, or gene products, are well documented in the art and include, for example, overexpression driven by appropriate promoters, the use of transcription enhancers or translation enhancers. Isolated nucleic acids which serve as promoter or enhancer elements may be introduced in an appropriate position (typically upstream) of a non-heterologous form of a polynucleotide so as to upregulate expression. For example, endogenous promoters may be altered in vivo by mutation, deletion, and/or substitution (see, Kmiec, U.S. Pat. No. 5,565,350; Zarling et al., PCT/US93/03868), or isolated promoters may be introduced into a plant cell in the proper orientation and distance from a gene of the present invention so as to control the expression of the gene. 
     If polypeptide expression is desired, it is generally desirable to include a polyadenylation region at the 3′-end of a polynucleotide coding region. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The 3′ end sequence to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene. 
     As mentioned above, a preferred method for modulating (preferably, increasing) expression of a nucleic acid encoding a VPE is by introducing and expressing in a plant a nucleic acid encoding a VPE; however the effects of performing the method, i.e. enhancing yield-related traits may also be achieved using other well known techniques. A description of some of these techniques will now follow. 
     One such technique is T-DNA activation tagging (Hayashi et al. Science (1992) 1350-1353), which involves insertion of T-DNA, usually containing a promoter (may also be a translation enhancer or an intron), in the genomic region of the gene of interest or 10 kb up- or downstream of the coding region of a gene in a configuration such that the promoter directs expression of the targeted gene. Typically, regulation of expression of the targeted gene by its natural promoter is disrupted and the gene falls under the control of the newly introduced promoter. The promoter is typically embedded in a T-DNA. This T-DNA is randomly inserted into the plant genome, for example, through  Agrobacterium  infection and leads to modified expression of genes near the inserted T-DNA. The resulting transgenic plants show dominant phenotypes due to modified expression of genes close to the introduced promoter. 
     The effects of the invention may also be reproduced using the technique of TILLING (Targeted Induced Local Lesions In Genomes); for a description of the same see the “definitions” section. 
     The effects of the invention may also be reproduced using homologous recombination; for a description of the same see the “definitions” section. 
     The present invention also encompasses use of nucleic acids encoding VPEs as described herein and use of these VPEs in enhancing any of the aforementioned yield-related traits in plants. 
     Nucleic acids encoding VPEs described herein, or the VPEs themselves, may find use in breeding programmes in which a DNA marker is identified which may be genetically linked to a VPE-encoding gene. The nucleic acids/genes, or the VPE proteins themselves may be used to define a molecular marker. This DNA or protein marker may then be used in breeding programmes to select plants having enhanced yield-related traits as defined hereinabove in the methods of the invention. 
     Allelic variants of a VPE protein-encoding nucleic acid/gene may also find use in marker-assisted breeding programmes. Such breeding programmes sometimes require introduction of allelic variation by mutagenic treatment of the plants, using for example EMS mutagenesis; alternatively, the programme may start with a collection of allelic variants of so called “natural” origin caused unintentionally. Identification of allelic variants then takes place, for example, by PCR. This is followed by a step for selection of superior allelic variants of the sequence in question and which give increased yield. Selection is typically carried out by monitoring growth performance of plants containing different allelic variants of the sequence in question. Growth performance may be monitored in a greenhouse or in the field. Further optional steps include crossing plants in which the superior allelic variant was identified with another plant. This could be used, for example, to make a combination of interesting phenotypic features. 
     Nucleic acids encoding VPEs may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes. Such use of VPE-encoding nucleic acids requires only a nucleic acid sequence of at least 15 nucleotides in length. The VPE-encoding nucleic acids may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (Sambrook J, Fritsch E F and Maniatis T (1989) Molecular Cloning, A Laboratory Manual) of restriction-digested plant genomic DNA may be probed with the VPE-encoding nucleic acids. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et al. (1987) Genomics 1: 174-181) in order to construct a genetic map. In addition, the nucleic acids may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the VPE-encoding nucleic acid in the genetic map previously obtained using this population (Botstein et al. (1980) Am. J. Hum. Genet. 32:314-331). 
     The production and use of plant gene-derived probes for use in genetic mapping is described in Bernatzky and Tanksley (1986) Plant Mol. Biol. Reporter 4: 37-41. Numerous publications describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art. 
     The nucleic acid probes may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel et al. In: Non-mammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein). 
     In another embodiment, the nucleic acid probes may be used in direct fluorescence in situ hybridisation (FISH) mapping (Trask (1991) Trends Genet. 7:149-154). Although current methods of FISH mapping favour use of large clones (several kb to several hundred kb; see Laan et al. (1995) Genome Res. 5:13-20), improvements in sensitivity may allow performance of FISH mapping using shorter probes. 
     A variety of nucleic acid amplification-based methods for genetic and physical mapping may be carried out using the nucleic acids. Examples include allele-specific amplification (Kazazian (1989) J. Lab. Clin. Med. 11:95-96), polymorphism of PCR-amplified fragments (CAPS; Sheffield et al. (1993) Genomics 16:325-332), allele-specific ligation (Landegren et al. (1988) Science 241:1077-1080), nucleotide extension reactions (Sokolov (1990) Nucleic Acid Res. 18:3671), Radiation Hybrid Mapping (Walter et al. (1997) Nat. Genet. 7:22-28) and Happy Mapping (Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807). For these methods, the sequence of a nucleic acid is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR-based genetic mapping, it may be necessary to identify DNA sequence differences between the parents of the mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, is generally not necessary for mapping methods. 
     The methods according to the present invention result in plants having enhanced yield-related traits, as described hereinbefore. These traits may also be combined with other economically advantageous traits, such as further yield-enhancing traits, tolerance to other abiotic and biotic stresses, traits modifying various architectural features and/or biochemical and/or physiological features. 
     (ii) CCA1 
     Surprisingly, it has now been found that modulating expression in a plant of a nucleic acid encoding a CCA1-like polypeptide gives plants having enhanced yield-related traits relative to control plants, in particular increased seed yield. The particular class of CCA1-like polypeptides suitable for enhancing yield-related traits in plants is described in detail below. 
     The present invention provides a method for enhancing yield-related traits, in particular seed yield, in plants relative to control plants, comprising modulating expression in a plant of a nucleic acid encoding a CCA1-like polypeptide. 
     Any reference hereinafter to a “protein useful in the methods of the invention” is taken to mean a CCA1-like polypeptide as defined herein. Any reference hereinafter to a “nucleic acid useful in the methods of the invention” is taken to mean a nucleic acid capable of encoding such a CCA1-like polypeptide. 
     The terms “polypeptide” and “protein” are as defined in the Definitions section herein. The terms “polynucleotide(s)”, “nucleic acid sequence(s)”, “nucleotide sequence(s)” are also as defined herein. The term “Control plant” is also defined hereinabove. 
     A preferred method for modulating (preferably, increasing) expression of a nucleic acid encoding a protein useful in the methods of the invention is by introducing and expressing in a plant a nucleic acid encoding a protein useful in the methods of the invention as defined below. 
     The nucleic acid to be introduced into a plant (and therefore useful in performing the methods of the invention) is any nucleic acid encoding the type of protein which will now be described, hereafter also named “CCA1-like nucleic acid” or “CCA1-like gene”. A “CCA1-like” polypeptide as defined herein refers to any MYB transcription factor of the SHAQKYF class. MYB transcription factors are well known in the art, a recent overview of MYB transcription factors in rice and  Arabidopsis thaliana  is given in Yanhui et al. (Plant Mol. Biol. 60, 107-124, 2006), which disclosure is incorporated herein by reference. Transcription factors regulate gene expression and comprise at least a DNA binding domain and an activation/repression domain. The MYB DNA binding domain is usually composed of one to three imperfect repeats, each with about 52 amino acids that adopt a helix-turn-helix conformation that intercalates in the major groove of the DNA. Each MYB repeat comprises three regularly spaced tryptophan residues that participate in a hydrophobic cluster and that are postulated to be involved in the specific recognition of DNA. 
     CCA1-like proteins as defined herein comprise a SANT domain (defined in SMART as SM00717, InterPro IPR001005, see  FIG. 1 ), which is involved in the recognition of a specific DNA motif, the YAAC(G/T)G sequence (wherein Y symbolises C or T). 
     The SANT domain preferably comprises motif 1 and/or motif 2: 
     
       
         
           
               
            
               
                 Motif 1, SEQ ID NO: 141: 
               
               
                 W(T/S)(E/D/A/P/T/R)(G/E/P/Q/D/A/N/Y)E(H/Q)(D/E/N/ 
               
               
                   
               
               
                 R/K/Q/A/S)(K/R/L/M/T/N/Q)F(L/I/V/M)(E/D/Q/I/L/V/M/ 
               
               
                   
               
               
                 T/A/R/H)(A/S/G)(L/I/M)(Q/H/I/K/R/S/E/D/N)(L/M/K/R/ 
               
               
                   
               
               
                 Q/V/T)(F/Y/H/V/L/F)(D/G)(R/K/E) 
               
            
           
         
       
     
     Preferably, motif 1 has the sequence 
     
       
         
           
               
            
               
                 W(T/S)(E/D/A)(G/E/P/Q/D/A)EH(D/E/N/R/K/Q/A)(K/R/ 
               
               
                   
               
               
                 L)F(L/I/V)(E/D/Q/I)(A/S)(L/I)(Q/H/I/K/R)(L/M/K) 
               
               
                   
               
               
                 (F/Y/H)(D/G)R 
               
            
           
         
       
     
     More preferably, motif 1 has the sequence 
     
       
         
           
               
               
            
               
                   
                 WT(E/D)(E/P/Q/D)EH(D/N/K/Q)(K/R)F(L/I)(E/D/Q) 
               
               
                   
               
               
                   
                 AL(Q/H/I/K/R)L(F/Y/H)(D/G)R 
               
            
           
         
       
     
     Most preferably motif 1 has the sequence 
     
       
         
           
               
               
            
               
                   
                 WTEEEHNRFIEALRLYGR 
               
            
           
         
       
     
     
       
         
           
               
            
               
                 Motif 2, SEQ ID NO: 142 
               
               
                 (F/H/Y/C/L)(V/I)(G/A/K/T/V/S/R)(S/T)(K/R)(T/N/S) 
               
               
                   
               
               
                 (V/T/A/P/S)(I/V/T/M/R/E/A)Q(I/V)(R/A/S)(S/M)(H/Y) 
               
               
                   
               
               
                 (A/Y)(Q/D)(K/Y/N)(Y/H/F)(F/K/C)(L/T/S/A/I/R/H) 
               
            
           
         
       
     
     Preferably, motif 2 has the sequence 
     
       
         
           
               
               
            
               
                   
                 (F/H/Y)(V/I)(G/A)(S/T)K(T/N/S)(V/T/A)(I/V) 
               
               
                   
               
               
                   
                 QIRSHAQK(Y/H/F)F(L/T/S/A) 
               
            
           
         
       
     
     Most preferably motif 2 has the sequence 
     
       
         
           
               
               
            
               
                   
                 HVATKTAVQIRSHAQKFFS 
               
            
           
         
       
     
     Preferably, the CCA1-lile protein useful in the methods of the present invention also comprises motif 3 and/or motif 4: 
     
       
         
           
               
               
            
               
                   
                 Motif 3, SEQ ID NO: 143: 
               
               
                   
                 PP(P/Q)(R/Y/L)(P/H)(K/R/P) 
               
               
                   
               
               
                   
                 Motif 4, SEQ ID NO: 144: 
               
               
                   
                 ATVAAA(S/T)AWWA 
               
            
           
         
       
     
     Further preferably, the CCA1-lile protein useful in the methods of the present invention also comprises motif 5, SEQ ID NO: 145: DRSS(C/S)GSNT 
     A person skilled in the art could readily determine whether an amino acid sequence in question falls within the definition of a “CCA1-like” polypeptide using known techniques and software for the making of a phylogenetic tree, such as a GCG, EBI or CLUSTAL package, using default parameters. A preferred method for constructing a phylogenetic tree is the method described by Yanhui et al. (2006). Any sequence clustering within the CCA1-like subfamily as defined by Yanhui et al. would be considered to fall within the aforementioned definition of a CCA1-like polypeptide, and would be considered suitable for use in the methods of the invention. 
     Examples of proteins useful in the methods of the invention and nucleic acids encoding the same are as given below in table A of Example 1. 
     Also useful in the methods of the invention are homologues of any one of the amino acid sequences given in table A of Example 1. “Homologues” are as defined in the Definitions section hereinabove. 
     Also useful in the methods of the invention are derivatives of any one of the polypeptides given in table A of Example 1 or orthologues or paralogues of any of the aforementioned SEQ ID NOs. The term “derivatives” being as defined herein. Particularly preferred are derivatives of SEQ ID NO: 2 or derivatives of the polypeptides given in table A of Example 1. Derivatives useful in the methods of the present invention preferably have similar biological and functional activity as the unmodified protein from which they are derived. 
     The invention is illustrated by transforming plants with the  Arabidopsis thaliana  nucleic acid sequence represented by SEQ ID NO: 1, encoding the polypeptide sequence of SEQ ID NO: 2, however performance of the invention is not restricted to these sequences. The methods of the invention may advantageously be performed using any nucleic acid encoding a protein useful in the methods of the invention as defined herein, including orthologues and paralogues, such as any of the nucleic acid sequences given in table A of Example 1. 
     The amino acid sequences given in table A of Example 1 may be considered to be orthologues and paralogues of the CCA1-like polypeptide represented by SEQ ID NO: 2, orthologues and paralogues being as defined herein. 
     Orthologues and paralogues may easily be found by performing a so-called reciprocal blast search. Typically, this involves a first BLAST involving BLASTing a query sequence (for example using any of the sequences listed in table A of Example 1) against any sequence database, such as the publicly available NCBI database. BLASTN or TBLASTX (using standard default values) are generally used when starting from a nucleotide sequence, and BLASTP or TBLASTN (using standard default values) when starting from a protein sequence. The BLAST results may optionally be filtered. The full-length sequences of either the filtered results or non-filtered results are then BLASTed back (second BLAST) against sequences from the organism from which the query sequence is derived (where the query sequence is SEQ ID NO: 1 or SEQ ID NO: 2, the second BLAST would therefore be against  Arabidopsis thaliana  sequences). The results of the first and second BLASTs are then compared. A paralogue is identified if a high-ranking hit from the first blast is from the same species as from which the query sequence is derived, a BLAST back then ideally results in the query sequence as highest hit; an orthologue is identified if a high-ranking hit in the first BLAST is not from the same species as from which the query sequence is derived, and preferably results upon BLAST back in the query sequence being among the highest hits. 
     High-ranking hits are those having a low E-value. The lower the E-value, the more significant the score (or in other words the lower the chance that the hit was found by chance). Computation of the E-value is well known in the art. In addition to E-values, comparisons are also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In the case of large families, ClustalW may be used, followed by a neighbour joining tree, to help visualize clustering of related genes and to identify orthologues and paralogues. 
     Table A of Example 1 gives examples of orthologues and paralogues of the CCA1-like protein represented by SEQ ID NO 2. Further orthologues and paralogues may readily be identified using the BLAST procedure described above. 
     The proteins of the invention are identifiable by the presence of the conserved SANT domain and one or more of the motifs 3 to 5 (shown in  FIG. 1 ). The term “domain” refers to a set of amino acids conserved at specific positions along an alignment of sequences of evolutionarily related proteins. While amino acids at other positions can vary between homologues, amino acids that are highly conserved at specific positions indicate amino acids that are essential in the structure, stability or activity of a protein. Identified by their high degree of conservation in aligned sequences of a family of protein homologues, they can be used as identifiers to determine if any polypeptide in question belongs to a previously identified polypeptide family (in this case, the proteins useful in the methods of the invention and nucleic acids encoding the same as defined herein). 
     The term “motif”, “consensus sequence” and “signature” are as defined herein. The term “domain” is also defined herein. 
     Specialist databases also exist for the identification of domains, for example, SMART (Schultz et al. (1998) Proc. Natl. Acad. Sci. USA 95, 5857-5864; Letunic et al. (2002) Nucleic Acids Res 30, 242-244, InterPro (Mulder et al., (2003) Nucl. Acids. Res. 31, 315-318, Prosite (Bucher and Bairoch (1994), A generalized profile syntax for biomolecular sequences motifs and its function in automatic sequence interpretation. (In) ISMB-94; Proceedings 2nd International Conference on Intelligent Systems for Molecular Biology. Altman R., Brutlag D., Karp P., Lathrop R., Searls D., Eds., pp 53-61, AAAIPress, Menlo Park; Hulo et al., Nucl. Acids. Res. 32:D134-D137, (2004), or Pfam (Bateman et al., Nucleic Acids Research 30(1): 276-280 (2002). A set of tools for in silico analysis of protein sequences is available on the ExPASY proteomics server (hosted by the Swiss Institute of Bioinformatics (Gasteiger et al., ExPASy: the proteomics server for in-depth protein knowledge and analysis, Nucleic Acids Res. 31:3784-3788 (2003)). 
     Domains may also be identified using routine techniques, such as by sequence alignment. Methods for the alignment of sequences for comparison are well known in the art, such methods include GAP, BESTFIT, BLAST, FASTA and TFASTA. GAP uses the algorithm of Needleman and Wunsch ((1970) J Mol Biol 48: 443-453) to find the global (i.e. spanning the complete sequences) alignment of two sequences that maximizes the number of matches and minimizes the number of gaps. The BLAST algorithm (Altschul et al. (1990) J Mol Biol 215: 403-10) calculates percent sequence identity and performs a statistical analysis of the similarity between the two sequences. The software for performing BLAST analysis is publicly available through the National Centre for Biotechnology Information (NCBI). Homologues may readily be identified using, for example, the ClustalW multiple sequence alignment algorithm (version 1.83), with the default pairwise alignment parameters, and a scoring method in percentage. Global percentages of similarity and identity may also be determined using one of the methods available in the MatGAT software package (Campanella et al., BMC Bioinformatics. 2003 Jul. 10; 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences.). Minor manual editing may be performed to optimise alignment between conserved motifs, as would be apparent to a person skilled in the art. Furthermore, instead of using full-length sequences for the identification of homologues, specific domains (such as the SANT domain, or one of the motifs defined above) may be used as well. The sequence identity values, which are indicated below in Example 3 as a percentage were determined over the entire nucleic acid or amino acid sequence, and/or over selected domains or conserved motif(s), using the programs mentioned above using the default parameters. 
     Furthermore, CCA1-like proteins (at least in their native form) typically have DNA binding activity. A person skilled in the art may easily determine the presence of DNA binding activity or transcriptional activation using routine tools and techniques. To determine the DNA binding activity of CCA1-like proteins, several assays are available (for example Current Protocols in Molecular Biology, Volumes 1 and 2, Ausubel et al. (1994), Current Protocols). In particular, a DNA binding assay for CCA1-like transcription factors using the A2 fragment of the Lhcb1*3 gene is described in Wang et al. (Plant Cell 9, 497-507, 1197). Further details are provided in Example 6. 
     Nucleic acids encoding proteins useful in the methods of the invention need not be full-length nucleic acids, since performance of the methods of the invention does not rely on the use of full-length nucleic acid sequences. Examples of nucleic acids suitable for use in performing the methods of the invention include the nucleic acid sequences given in table A of Example 1, but are not limited to those sequences. Nucleic acid variants may also be useful in practising the methods of the invention. Examples of such nucleic acid variants include portions of nucleic acids encoding a protein useful in the methods of the invention, nucleic acids hybridising to nucleic acids encoding a protein useful in the methods of the invention, splice variants of nucleic acids encoding a protein useful in the methods of the invention, allelic variants of nucleic acids encoding a protein useful in the methods of the invention and variants of nucleic acids encoding a protein useful in the methods of the invention that are obtained by gene shuffling. The terms portion, hybridising sequence, splice variant, allelic variant and gene shuffling will now be described. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a portion of any one of the nucleic acid sequences given in table A of Example 1, or a portion of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in table A of Example 1. 
     Portions useful in the methods of the invention, encode a polypeptide falling within the definition of a nucleic acid encoding a protein useful in the methods of the invention as defined herein and having substantially the same biological activity as the amino acid sequences given in table A of Example 1. Preferably, the portion is a portion of any one of the nucleic acids given in table A of Example 1. The portion is typically at least 1200 consecutive nucleotides in length, preferably at least 1400 consecutive nucleotides in length, more preferably at least 1600 consecutive nucleotides in length and most preferably at least 1800 consecutive nucleotides in length, the consecutive nucleotides being of any one of the nucleic acid sequences given in table A of Example 1. Most preferably the portion is a portion of the nucleic acid of SEQ ID NO: 1. Preferably, the portion encodes an amino acid sequence comprising a SANT domain as defined herein. 
     A portion of a nucleic acid encoding a CCA1-like protein as defined herein may be prepared, for example, by making one or more deletions to the nucleic acid. The portions may be used in isolated form or they may be fused to other coding (or non coding) sequences in order to, for example, produce a protein that combines several activities. When fused to other coding sequences, the resultant polypeptide produced upon translation may be bigger than that predicted for the CCA1-like protein portion. 
     Another nucleic acid variant useful in the methods of the invention is a nucleic acid capable of hybridising, under reduced stringency conditions, preferably under stringent conditions, with a nucleic acid encoding a CCA1-like protein as defined herein, or with a portion as defined herein. The term “hybridisation” is as defined hereinabove. 
     Hybridising sequences useful in the methods of the invention, encode a polypeptide having a SANT domain (see the alignment of  FIG. 2 ) and having substantially the same biological activity as the CCA1-like protein represented by any of the amino acid sequences given in table A of Example 1. The hybridising sequence is typically at least 1200 consecutive nucleotides in length, preferably at least 1400 consecutive nucleotides in length, more preferably at least 1600 consecutive nucleotides in length and most preferably at least 1800 consecutive nucleotides in length, the consecutive nucleotides being of any one of the nucleic acid sequences given in table A of Example 1. Preferably, the hybridising sequence is one that is capable of hybridising to any of the nucleic acids given in table A of Example 1, or to a portion of any of these sequences, a portion being as defined above. Most preferably, the hybridising sequence is capable of hybridising to a nucleic acid as represented by SEQ ID NO: 1 or to a portion thereof. Preferably, the hybridising sequence encodes an amino acid sequence comprising any one or more of the motifs or domains as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a nucleic acid capable of hybridizing to any one of the nucleic acids given in the table of Example 1, or comprising introducing and expressing in a plant a nucleic acid capable of hybridising to a nucleic acid encoding an orthologue, paralogue or homologue of any of the nucleic acid sequences given in the table of Example 1. 
     Another nucleic acid variant useful in the methods of the invention is a splice variant encoding a CCA1-like protein as defined hereinabove, the term “splice variant” being as defined herein 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a splice variant of any one of the nucleic acid sequences given in table A of Example 1, or a splice variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in table A of Example 1. 
     Preferred splice variants are splice variants of a nucleic acid represented by SEQ ID NO: 1 or a splice variant of a nucleic acid encoding an orthologue or paralogue of SEQ ID NO: 2. Preferably, the amino acid sequence encoded by the splice variant comprises any one or more of the motifs or domains as defined herein. 
     Another nucleic acid variant useful in performing the methods of the invention is an allelic variant of a nucleic acid encoding a CCA1-like protein as defined hereinabove, the term “alleic variant” being as defined herein. The allelic variants useful in the methods of the present invention have substantially the same biological activity as the CCA1-like protein of SEQ ID NO: 2. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant an allelic variant of any one of the nucleic acids given in table A of Example 1, or comprising introducing and expressing in a plant an allelic variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in table A of Example 1. 
     Preferably, the allelic variant is an allelic variant of SEQ ID NO: 1 or an allelic variant of a nucleic acid encoding an orthologue or paralogue of SEQ ID NO: 2. Preferably, the amino acid sequence encoded by the allelic variant comprises any one or more of the motifs or domains as defined herein. 
     A further nucleic acid variant useful in the methods of the invention is a nucleic acid variant encoding CCA1-like proteins as defined above, which variant is obtained by gene shuffling; “gene shuffling” or “directed evolution” are as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a variant of any one of the nucleic acid sequences given in table A of Example 1, or comprising introducing and expressing in a plant a variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in table A of Example 1, which variant nucleic acid is obtained by gene shuffling. Preferably, the variant nucleic acid obtained by gene shuffling encodes an amino acid sequence comprising any one or more of the motifs or domains as defined herein. 
     Furthermore, nucleic acid variants may also be obtained by site-directed mutagenesis. Several methods are available to achieve site-directed mutagenesis, the most common being PCR based methods (Current Protocols in Molecular Biology. Wiley Eds.). 
     Nucleic acids encoding CCA1-like proteins may be derived from any natural or artificial source. The nucleic acid may be modified from its native form in composition and/or genomic environment through deliberate human manipulation. Preferably the CCA1-like-encoding nucleic acid is from a plant, further preferably from a dicotyledonous plant, more preferably from the Brassicaceae family, most preferably the nucleic acid is from  Arabidopsis thaliana.    
     Any reference herein to a CCA1-like protein is therefore taken to mean a CCA1-like protein as defined above. Any nucleic acid encoding such a CCA1-like protein is suitable for use in performing the methods of the invention. 
     The present invention also encompasses plants or parts thereof (including seeds) obtainable by the methods according to the present invention. The plants or parts thereof comprise a nucleic acid transgene encoding a CCA1-like protein as defined above. 
     The invention also provides genetic constructs and vectors to facilitate introduction and/or expression of the nucleic acid sequences useful in the methods according to the invention, in a plant. The gene constructs may be inserted into vectors, which may be commercially available, suitable for transforming into plants and suitable for expression of the gene of interest in the transformed cells. The invention also provides use of a gene construct as defined herein in the methods of the invention. 
     More specifically, the present invention provides a construct comprising
         (a) nucleic acid encoding CCA1-like protein as defined above;   (b) one or more control sequences capable of driving expression of the nucleic acid sequence of (a); and optionally   (c) a transcription termination sequence.       

     Plants are transformed with a vector comprising the sequence of interest (i.e., a nucleic acid encoding a CCA1-like polypeptide as defined herein. The skilled artisan is well aware of the genetic elements that must be present on the vector in order to successfully transform, select and propagate host cells containing the sequence of interest. The sequence of interest is operably linked to one or more control sequences (at least to a promoter). The terms “regulatory element”, “control sequence” and “promoter” are as defined hereinabove. The term “operably linked” is also as defined herein. 
     Advantageously, any type of promoter may be used to drive expression of the nucleic acid sequence. 
     The promoter may be a constitutive promoter. The term “constitutive promoter” is as defined herein, and examples of constitutive promoters are also given in the Definitions section herein. Alternatively, the promoter may be an inducible promoter, as defined in the Definitions section herein. Additionally or alternatively, the promoter may be an organ-specific or tissue-specific promoter, also as defined herein. 
     Preferably, the CCA1-like nucleic acid or variant thereof is operably linked to a constitutive promoter. A preferred constitutive promoter is one that is also substantially ubiquitously expressed. Further preferably the promoter is derived from a plant, more preferably a monocotyledonous plant. Most preferred is use of a GOS2 promoter (preferably from rice) (SEQ ID NO: 146). It should be clear that the applicability of the present invention is not restricted to the CCA1-like nucleic acid represented by SEQ ID NO: 1, nor is the applicability of the invention restricted to expression of a CCA1-like nucleic acid when driven by a GOS2 promoter. Examples of other constitutive promoters which may also be used to drive expression of a CCA1-like nucleic acid are shown in the Definitions section herein. 
     It is envisaged that the increase in yield will also be obtained when the CCA1-like nucleic acid or variant thereof is operably linked to a green-tissue specific promoter. Examples of green tissue-specific promoters are provided in the Definitions section herein. 
     For the identification of functionally equivalent promoters, the promoter strength and/or expression pattern of a candidate promoter may be analysed for example by operably linking the promoter to a reporter gene and assay the expression level and pattern of the reporter gene in various tissues of the plant. Suitable well-known reporter genes include for example beta-glucuronidase or beta galactosidase. The promoter activity is assayed by measuring the enzymatic activity of the beta-glucuronidase or beta-galactosidase. The promoter strength and/or expression pattern may then be compared to that of a reference promoter (such as the one used in the methods of the present invention). Alternatively, promoter strength may be assayed by quantifying mRNA levels or by comparing mRNA levels of the nucleic acid used in the methods of the present invention, with mRNA levels of housekeeping genes such as 18S rRNA, using methods known in the art, such as Northern blotting with densitometric analysis of autoradiograms, quantitative real-time PCR or RT-PCR (Heid et al., 1996 Genome Methods 6: 986-994). Generally by “weak promoter” is intended a promoter that drives expression of a coding sequence at a low level. By “low level” is intended at levels of about 1/10,000 transcripts to about 1/100,000 transcripts, to about 1/500,0000 transcripts per cell. 
     Conversely, a “strong promoter” drives expression of a coding sequence at high level, or at about 1/10 transcripts to about 1/100 transcripts to about 1/1,000 transcripts per cell. 
     Optionally, one or more terminator sequences may be used in the construct introduced into a plant, the term “terminator” being as defined herein. Additional regulatory elements may include transcriptional as well as translational enhancers. Those skilled in the art will be aware of terminator and enhancer sequences that may be suitable for use in performing the invention. Such sequences would be known or may readily be obtained by a person skilled in the art. 
     An intron sequence may also be added to the 5′ untranslated region (UTR) or in the coding sequence to increase the amount of the mature message that accumulates in the cytosol. Inclusion of a spliceable intron in the transcription unit in both plant and animal expression constructs has been shown to increase gene expression at both the mRNA and protein levels up to 1000-fold (Buchman and Berg, Mol. Cell. Biol. 8:4395-4405 (1988); Callis et al., Genes Dev. 1:1183-1200 (1987)). Such intron enhancement of gene expression is typically greatest when placed near the 5′ end of the transcription unit. Use of the maize introns Adh1-S intron 1, 2, and 6, the Bronze-1 intron are known in the art. For general information, see The Maize Handbook, Chapter 116, Freeling and Walbot, Eds., Springer, N.Y. (1994). 
     Other control sequences (besides promoter, enhancer, silencer, intron sequences, 3′UTR and/or 5′UTR regions) may be protein and/or RNA stabilizing elements. Such sequences would be known or may readily be obtained by a person skilled in the art. 
     The genetic constructs of the invention may further include an origin of replication sequence that is required for maintenance and/or replication in a specific cell type. One example is when a genetic construct is required to be maintained in a bacterial cell as an episomal genetic element (e.g. plasmid or cosmid molecule). Preferred origins of replication include, but are not limited to, the f1-ori and colE1. 
     For the detection of the successful transfer of the nucleic acid sequences as used in the methods of the invention and/or selection of transgenic plants comprising these nucleic acids, it is advantageous to use marker genes (or reporter genes). Therefore, the genetic construct may optionally comprise a selectable marker gene. The terms “selectable marker”, “selectable marker gene” or “reporter gene” are as defined hereinabove. 
     It is known that upon stable or transient integration of nucleic acids into plant cells, only a minority of the cells takes up the foreign DNA and, if desired, integrates it into its genome, depending on the expression vector used and the transfection technique used. To identify and select these integrants, a gene coding for a selectable marker (such as the ones described above) is usually introduced into the host cells together with the gene of interest. These markers can for example be used in mutants in which these genes are not functional by, for example, deletion by conventional methods. Furthermore, nucleic acid molecules encoding a selectable marker can be introduced into a host cell on the same vector that comprises the sequence encoding the polypeptides of the invention or used in the methods of the invention, or else in a separate vector. Cells which have been stably transfected with the introduced nucleic acid can be identified for example by selection (for example, cells which have integrated the selectable marker survive whereas the other cells die). 
     Since the marker genes, particularly genes for resistance to antibiotics and herbicides, are no longer required or are undesired in the transgenic host cell once the nucleic acids have been introduced successfully, the process according to the invention for introducing the nucleic acids advantageously employs techniques which enable the removal or excision of these marker genes. One such a method is what is known as co-transformation. The co-transformation method employs two vectors simultaneously for the transformation, one vector bearing the nucleic acid according to the invention and a second bearing the marker gene(s). A large proportion of transformants receives or, in the case of plants, comprises (up to 40% or more of the transformants), both vectors. In case of transformation with  Agrobacteria , the transformants usually receive only a part of the vector, i.e. the sequence flanked by the T-DNA, which usually represents the expression cassette. The marker genes can subsequently be removed from the transformed plant by performing crosses. In another method, marker genes integrated into a transposon are used for the transformation together with desired nucleic acid (known as the Ac/Ds technology). The transformants can be crossed with a transposase source or the transformants are transformed with a nucleic acid construct conferring expression of a transposase, transiently or stable. In some cases (approx. 10%), the transposon jumps out of the genome of the host cell once transformation has taken place successfully and is lost. In a further number of cases, the transposon jumps to a different location. In these cases the marker gene must be eliminated by performing crosses. In microbiology, techniques were developed which make possible, or facilitate, the detection of such events. A further advantageous method relies on what is known as recombination systems; whose advantage is that elimination by crossing can be dispensed with. The best-known system of this type is what is known as the Cre/lox system. Cre1 is a recombinase that removes the sequences located between the loxP sequences. If the marker gene is integrated between the loxP sequences, it is removed once transformation has taken place successfully, by expression of the recombinase. Further recombination systems are the HIN/HIX, FLP/FRT and REP/STB system (Tribble et al., J. Biol. Chem., 275, 2000: 22255-22267; Velmurugan et al., J. Cell Biol., 149, 2000: 553-566). A site-specific integration into the plant genome of the nucleic acid sequences according to the invention is possible. Naturally, these methods can also be applied to microorganisms such as yeast, fungi or bacteria. 
     The invention also provides a method for the production of transgenic plants having enhanced yield-related traits relative to control plants, comprising introduction and expression in a plant of any nucleic acid encoding a CCA1-like protein as defined hereinabove. 
     For the purposes of the invention, “transgenic”, “transgene” or “recombinant” are as defined in the Definitions section herein. It is envisaged that the introduction of multiple copies of a naturally-occurring expression cassette as described above would also be useful in the methods of the present invention. 
     More specifically, the present invention provides a method for the production of transgenic plants having increased yield, which method comprises:
         (i) introducing and expressing in a plant or plant cell a CCA1-like nucleic acid or variant thereof; and   (ii) cultivating the plant cell under conditions promoting plant growth and development.       

     The nucleic acid may be introduced directly into a plant cell or into the plant itself (including introduction into a tissue, organ or any other part of a plant). According to a preferred feature of the present invention, the nucleic acid is preferably introduced into a plant by transformation. 
     The term “introduction” or “transformation” is defined in the Definitions section herein. The genetically modified plant cells can be regenerated via all methods with which the skilled worker is familiar. Suitable methods can be found in the abovementioned publications by S.D. Kung and R. Wu, Potrykus or Höfgen and Willmitzer. 
     Generally after transformation, plant cells or cell groupings are selected for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the gene of interest, following which the transformed material is regenerated into a whole plant. To select transformed plants, the plant material obtained in the transformation is, as a rule, subjected to selective conditions so that transformed plants can be distinguished from untransformed plants. For example, the seeds obtained in the above-described manner can be planted and, after an initial growing period, subjected to a suitable selection by spraying. A further possibility consists in growing the seeds, if appropriate after sterilization, on agar plates using a suitable selection agent so that only the transformed seeds can grow into plants. Alternatively, the transformed plants are screened for the presence of a selectable marker such as the ones described above. 
     Following DNA transfer and regeneration, putatively transformed plants may also be evaluated, for instance using Southern analysis, for the presence of the gene of interest, copy number and/or genomic organisation. Alternatively or additionally, expression levels of the newly introduced DNA may be monitored using Northern and/or Western analysis, both techniques being well known to persons having ordinary skill in the art. 
     The generated transformed plants may be propagated by a variety of means, such as by clonal propagation or classical breeding techniques. For example, a first generation (or T1) transformed plant may be selfed and homozygous second-generation (or T2) transformants selected, and the T2 plants may then further be propagated through classical breeding techniques. 
     The generated transformed organisms may take a variety of forms. For example, they may be chimeras of transformed cells and non-transformed cells; clonal transformants (e.g., all cells transformed to contain the expression cassette); grafts of transformed and untransformed tissues (e.g., in plants, a transformed rootstock grafted to an untransformed scion). 
     The present invention clearly extends to any plant cell or plant produced by any of the methods described herein, and to all plant parts and propagules thereof. The present invention extends further to encompass the progeny of a primary transformed or transfected cell, tissue, organ or whole plant that has been produced by any of the aforementioned methods, the only requirement being that progeny exhibit the same genotypic and/or phenotypic characteristic(s) as those produced by the parent in the methods according to the invention. 
     The invention also includes host cells containing an isolated nucleic acid encoding a CCA1-like protein as defined hereinabove. Preferred host cells according to the invention are plant cells. 
     Host plants for the nucleic acids or the vector used in the method according to the invention, the expression cassette or construct or vector are, in principle, advantageously all plants, which are capable of synthesizing the polypeptides used in the inventive method. 
     A transgenic plant for the purposes of the invention is thus understood as meaning, as above, that the nucleic acids used in the method of the invention are not at their natural locus in the genome of said plant, it being possible for the nucleic acids to be expressed homologously or heterologously. However, as mentioned, transgenic also means that, while the nucleic acids according to the invention or used in the inventive method are at their natural position in the genome of a plant, the sequence has been modified with regard to the natural sequence, and/or that the regulatory sequences of the natural sequences have been modified. Transgenic is preferably understood as meaning the expression of the nucleic acids according to the invention at an unnatural locus in the genome, i.e. homologous or, preferably, heterologous expression of the nucleic acids takes place. Preferred transgenic plants are mentioned herein. 
     The invention also extends to harvestable parts of a plant such as, but not limited to seeds, leaves, fruits, flowers, stems, rhizomes, tubers and bulbs. The invention furthermore relates to products derived, preferably directly derived, from a harvestable part of such a plant, such as dry pellets or powders, oil, fat and fatty acids, starch or proteins. 
     According to a preferred feature of the invention, the modulated expression is increased expression. Methods for increasing expression of nucleic acids or genes, or gene products, are well documented in the art and include, for example, overexpression driven by appropriate promoters, the use of transcription enhancers or translation enhancers. Isolated nucleic acids which serve as promoter or enhancer elements may be introduced in an appropriate position (typically upstream) of a non-heterologous form of a polynucleotide so as to upregulate expression. For example, endogenous promoters may be altered in vivo by mutation, deletion, and/or substitution (see, Kmiec, U.S. Pat. No. 5,565,350; Zarling et al., PCT/US93/03868), or isolated promoters may be introduced into a plant cell in the proper orientation and distance from a gene of the present invention so as to control the expression of the gene. 
     If polypeptide expression is desired, it is generally desirable to include a polyadenylation region at the 3′-end of a polynucleotide coding region. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The 3′ end sequence to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene. 
     An intron sequence may also be added as described above. 
     Other control sequences (besides promoter, enhancer, silencer, intron sequences, 3′UTR and/or 5′UTR regions) may be protein and/or RNA stabilizing elements. 
     As mentioned above, a preferred method for modulating (preferably, increasing) expression of a nucleic acid encoding a CCA1-like protein is by introducing and expressing in a plant a nucleic acid encoding a CCA1-like protein; however the effects of performing the method, i.e. enhancing yield-related traits may also be achieved using other well known techniques. A description of some of these techniques will now follow. 
     One such technique is T-DNA activation tagging as defined herein. The effects of the invention may also be reproduced using the technique of TILLING (Targeted Induced Local Lesions In Genomes), which technique is defined in the Definitions section herein. The effects of the invention may also be reproduced using homologous recombination, which technique is as defined herein. 
     Reference herein to enhanced yield-related traits is taken to mean an increase in biomass (weight) of one or more parts of a plant, which may include aboveground (harvestable) parts and/or (harvestable) parts below ground. 
     In particular, such harvestable parts are seeds, and performance of the methods of the invention results in plants having increased seed yield relative to the seed yield of suitable control plants. 
     The term “yield” and “seed yield” are as defined herein, and the terms “increase”, “improving” or “improve” are also as defined herein. 
     Taking corn as an example, a yield increase may be manifested as one or more of the following: increase in the number of plants established per hectare or acre, an increase in the number of ears per plant, an increase in the number of rows, number of kernels per row, kernel weight, thousand kernel weight, ear length/diameter, increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), among others. Taking rice as an example, a yield increase may manifest itself as an increase in one or more of the following: number of plants per hectare or acre, number of panicles per plant, number of spikelets per panicle, number of flowers (florets) per panicle (which is expressed as a ratio of the number of filled seeds over the number of primary panicles), increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), increase in thousand kernel weight, among others. 
     Since the transgenic plants according to the present invention have increased yield, it is likely that these plants exhibit an increased growth rate (during at least part of their life cycle), relative to the growth rate of control plants at a corresponding stage in their life cycle. The increased growth rate may be specific to one or more parts of a plant (including seeds), or may be throughout substantially the whole plant. Plants having an increased growth rate may have a shorter life cycle. The life cycle of a plant may be taken to mean the time needed to grow from a dry mature seed up to the stage where the plant has produced dry mature seeds, similar to the starting material. This life cycle may be influenced by factors such as early vigour, growth rate, greenness index, flowering time and speed of seed maturation. The increase in growth rate may take place at one or more stages in the life cycle of a plant or during substantially the whole plant life cycle. Increased growth rate during the early stages in the life cycle of a plant may reflect enhanced vigour. The increase in growth rate may alter the harvest cycle of a plant allowing plants to be sown later and/or harvested sooner than would otherwise be possible (a similar effect may be obtained with earlier flowering time). If the growth rate is sufficiently increased, it may allow for the further sowing of seeds of the same plant species (for example sowing and harvesting of rice plants followed by sowing and harvesting of further rice plants all within one conventional growing period). Similarly, if the growth rate is sufficiently increased, it may allow for the further sowing of seeds of different plants species (for example the sowing and harvesting of corn plants followed by, for example, the sowing and optional harvesting of soy bean, potato or any other suitable plant). Harvesting additional times from the same rootstock in the case of some crop plants may also be possible. Altering the harvest cycle of a plant may lead to an increase in annual biomass production per acre (due to an increase in the number of times (say in a year) that any particular plant may be grown and harvested). An increase in growth rate may also allow for the cultivation of transgenic plants in a wider geographical area than their wild-type counterparts, since the territorial limitations for growing a crop are often determined by adverse environmental conditions either at the time of planting (early season) or at the time of harvesting (late season). Such adverse conditions may be avoided if the harvest cycle is shortened. The growth rate may be determined by deriving various parameters from growth curves, such parameters may be: T-Mid (the time taken for plants to reach 50% of their maximal size) and T-90 (time taken for plants to reach 90% of their maximal size), amongst others. 
     According to a preferred feature of the present invention, performance of the methods of the invention gives plants having an increased growth rate relative to control plants. Therefore, according to the present invention, there is provided a method for increasing the growth rate of plants, which method comprises modulating expression, preferably increasing expression, in a plant of a nucleic acid encoding a CCA1-like protein as defined herein. 
     An increase in yield and/or growth rate occurs whether the plant is under non-stress conditions or whether the plant is exposed to various stresses compared to control plants. Plants typically respond to exposure to stress by growing more slowly. In conditions of severe stress, the plant may even stop growing altogether. Mild stress on the other hand is defined herein as being any stress to which a plant is exposed which does not result in the plant ceasing to grow altogether without the capacity to resume growth. Mild stress in the sense of the invention leads to a reduction in the growth of the stressed plants of less than 40%, 35% or 30%, preferably less than 25%, 20% or 15%, more preferably less than 14%, 13%, 12%, 11% or 10% or less in comparison to the control plant under non-stress conditions. Due to advances in agricultural practices (irrigation, fertilization, pesticide treatments) severe stresses are not often encountered in cultivated crop plants. As a consequence, the compromised growth induced by mild stress is often an undesirable feature for agriculture. Mild stresses are the everyday biotic and/or abiotic (environmental) stresses to which a plant is exposed. Abiotic stresses may be due to drought or excess water, anaerobic stress, salt stress, chemical toxicity, oxidative stress and hot, cold or freezing temperatures. The abiotic stress may be an osmotic stress caused by a water stress (particularly due to drought), salt stress, oxidative stress or an ionic stress. Biotic stresses are typically those stresses caused by pathogens, such as bacteria, viruses, fungi and insects. 
     In particular, the methods of the present invention may be performed under non-stress conditions or under conditions of mild drought to give plants having increased yield relative to control plants. As reported in Wang et al. (Planta (2003) 218: 1-14), abiotic stress leads to a series of morphological, physiological, biochemical and molecular changes that adversely affect plant growth and productivity. Drought, salinity, extreme temperatures and oxidative stress are known to be interconnected and may induce growth and cellular damage through similar mechanisms. Rabbani et al. (Plant Physiol (2003) 133: 1755-1767) describes a particularly high degree of “cross talk” between drought stress and high-salinity stress. For example, drought and/or salinisation are manifested primarily as osmotic stress, resulting in the disruption of homeostasis and ion distribution in the cell. Oxidative stress, which frequently accompanies high or low temperature, salinity or drought stress, may cause denaturing of functional and structural proteins. As a consequence, these diverse environmental stresses often activate similar cell signalling pathways and cellular responses, such as the production of stress proteins, up-regulation of anti-oxidants, accumulation of compatible solutes and growth arrest. The term “non-stress” conditions as used herein are those environmental conditions that allow optimal growth of plants. Persons skilled in the art are aware of normal soil conditions and climatic conditions for a given location. 
     Performance of the methods of the invention gives plants grown under non-stress conditions or under mild drought conditions increased yield relative to suitable control plants grown under comparable conditions. Therefore, according to the present invention, there is provided a method for increasing yield in plants grown under non-stress conditions or under mild drought conditions, which method comprises increasing expression in a plant of a nucleic acid encoding a CCA1-like polypeptide. 
     In a preferred embodiment of the invention, the increase in yield and/or growth rate occurs according to the methods of the present invention under non-stress conditions. 
     The methods of the invention are advantageously applicable to any plant, the term “plant” being as defined herein. 
     According to a preferred embodiment of the present invention, the plant is a crop plant. Examples of crop plants include soybean, sunflower, canola, alfalfa, rapeseed, cotton, tomato, potato and tobacco. Further preferably, the plant is a monocotyledonous plant. Examples of monocotyledonous plants include sugarcane. More preferably the plant is a cereal. Examples of cereals include rice, maize, wheat, barley, millet, rye, sorghum and oats. 
     The present invention also encompasses use of nucleic acids encoding the CCA1-like protein described herein and use of these CCA1-like proteins in enhancing yield-related traits in plants. 
     Nucleic acids encoding the CCA1-like protein described herein, or the CCA1-like proteins themselves, may find use in breeding programmes in which a DNA marker is identified which may be genetically linked to a CCA1-like-encoding gene. The nucleic acids/genes, or the CCA1-like proteins themselves may be used to define a molecular marker. This DNA or protein marker may then be used in breeding programmes to select plants having enhanced yield-related traits as defined hereinabove in the methods of the invention. 
     Allelic variants of a CCA1-like protein-encoding nucleic acid/gene may also find use in marker-assisted breeding programmes. Such breeding programmes sometimes require introduction of allelic variation by mutagenic treatment of the plants, using for example EMS mutagenesis; alternatively, the programme may start with a collection of allelic variants of so called “natural” origin caused unintentionally. Identification of allelic variants then takes place, for example, by PCR. This is followed by a step for selection of superior allelic variants of the sequence in question and which give increased yield. Selection is typically carried out by monitoring growth performance of plants containing different allelic variants of the sequence in question. Growth performance may be monitored in a greenhouse or in the field. Further optional steps include crossing plants in which the superior allelic variant was identified with another plant. This could be used, for example, to make a combination of interesting phenotypic features. 
     Nucleic acids encoding CCA1-like proteins may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes. Such use of CCA1-like protein-encoding nucleic acids requires only a nucleic acid sequence of at least 15 nucleotides in length. The CCA1-like protein-encoding nucleic acids may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (Sambrook J, Fritsch E F and Maniatis T (1989) Molecular Cloning, A Laboratory Manual) of restriction-digested plant genomic DNA may be probed with the CCA1-like protein-encoding nucleic acids. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et al. (1987) Genomics 1: 174-181) in order to construct a genetic map. In addition, the nucleic acids may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the CCA1-like protein-encoding nucleic acid in the genetic map previously obtained using this population (Botstein et al. (1980) Am. J. Hum. Genet. 32:314-331). 
     The production and use of plant gene-derived probes for use in genetic mapping is described in Bernatzky and Tanksley (1986) Plant Mol. Biol. Reporter 4: 37-41. Numerous publications describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art. 
     The nucleic acid probes may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel et al. In: Non-mammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein). 
     In another embodiment, the nucleic acid probes may be used in direct fluorescence in situ hybridisation (FISH) mapping (Trask (1991) Trends Genet. 7:149-154). Although current methods of FISH mapping favour use of large clones (several kb to several hundred kb; see Laan et al. (1995) Genome Res. 5:13-20), improvements in sensitivity may allow performance of FISH mapping using shorter probes. 
     A variety of nucleic acid amplification-based methods for genetic and physical mapping may be carried out using the nucleic acids. Examples include allele-specific amplification (Kazazian (1989) J. Lab. Clin. Med. 11:95-96), polymorphism of PCR-amplified fragments (CAPS; Sheffield et al. (1993) Genomics 16:325-332), allele-specific ligation (Landegren et al. (1988) Science 241:1077-1080), nucleotide extension reactions (Sokolov (1990) Nucleic Acid Res. 18:3671), Radiation Hybrid Mapping (Walter et al. (1997) Nat. Genet. 7:22-28) and Happy Mapping (Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807). For these methods, the sequence of a nucleic acid is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR-based genetic mapping, it may be necessary to identify DNA sequence differences between the parents of the mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, is generally not necessary for mapping methods. 
     The methods according to the present invention result in plants having enhanced yield-related traits, as described hereinbefore. These traits may also be combined with other economically advantageous traits, such as further yield-enhancing traits, tolerance to other abiotic and biotic stresses, traits modifying various architectural features and/or biochemical and/or physiological features. 
     (iii) SAP 
     Surprisingly, it has now been found that modulating expression in a plant of a nucleic acid encoding a SAP-like polypeptide gives plants having enhanced yield-related traits relative to control plants. 
     According to a first embodiment, the present invention provides a method for enhancing yield-related traits in plants relative to control plants, comprising modulating expression in a plant of a nucleic acid encoding a SAP-like polypeptide. 
     The present invention also provides hitherto unknown SAP-like-encoding nucleic acids and SAP-like polypeptides. These sequences also being useful in performing the methods of the invention. 
     According to a further embodiment of the present invention, there is therefore provided an isolated nucleic acid molecule comprising:
         (i) a nucleic acid represented by SEQ ID NO: 212, SEQ ID NO: 214, SEQ ID NO: 216, SEQ ID NO: 218, SEQ ID NO: 220, SEQ ID NO: 222, SEQ ID NO: 224 and SEQ ID NO: 226;   (ii) the complement of any one of the SEQ ID NOs given in (i);   (iii) a nucleic acid encoding a SAP-like polypeptide having, in increasing order of preference, at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity to any one of the amino acid sequences given in SEQ ID NO: 213, SEQ ID NO: 215 and SEQ ID NO: 217, SEQ ID NO: 219, SEQ ID NO: 221, SEQ ID NO: 223, SEQ ID NO: 225 and SEQ ID NO: 227;   (iv) a nucleic acid capable of hybridizing under stringent conditions to any one of the nucleic acids given in (i), (ii) or (iii) above.       

     According to a further embodiment of the present invention, there is also provided an isolated polypeptide comprising:
         (i) an amino acid sequence represented by any one of SEQ ID NO: 213, SEQ ID NO: 215 and SEQ ID NO: 217, SEQ ID NO: 219, SEQ ID NO: 221, SEQ ID NO: 223, SEQ ID NO: 225 and SEQ ID NO: 227;   (ii) an amino acid sequence having, in increasing order of preference, at least at least 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity to any one of the amino acid sequences given in SEQ ID NO: 213, SEQ ID NO: 215 and SEQ ID NO: 217, SEQ ID NO: 219, SEQ ID NO: 221, SEQ ID NO: 223, SEQ ID NO: 225 and SEQ ID NO: 227;   (iii) derivatives of any of the amino acid sequences given in (i) or (ii) above.       

     A preferred method for modulating (preferably, increasing) expression of a nucleic acid encoding a SAP-like polypeptide is by introducing and expressing in a plant a nucleic acid encoding a SAP-like polypeptide. 
     Any reference hereinafter to a “protein useful in the methods of the invention” is taken to mean a SAP-like polypeptide as defined herein. Any reference hereinafter to a “nucleic acid useful in the methods of the invention” is taken to mean a nucleic acid capable of encoding such a SAP-like polypeptide. The nucleic acid to be introduced into a plant (and therefore useful in performing the methods of the invention) is any nucleic acid encoding the type of protein which will now be described, hereafter also named “SAP-like nucleic acid” or “SAP-like gene”. 
     A “SAP-like polypeptide” as defined herein refers to any polypeptide comprising the following SAP domain:
         (i) Motif 1 (SEQ ID NO: 240): XLSSLKVXELRELAKSRGIKGYSKMKKXELVELLS, where X is any amino acid; or   (ii) a motif having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95% or more sequence identity to Motif 1; or   (iii) A motif having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 100% sequence identity to Motif 1 as it appears in SEQ ID NO: 211: DLSTLKVTELRELAKSRGIKGYSKMKKNDLVELLS (SEQ ID NO: 243).       

     Additionally, a SAP-like polypeptide may comprise:
         (i) Motif 2 (SEQ ID NO: 241): EKxEIVELFKKVQxxLRxRAxxKxExKxxxExAKAQxxxExxTVDSLLxLLRKHSxDQxKK, where X is any amino acid; or   (ii) a motif having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95% or more sequence identity to Motif 2; or   (iii) A motif having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 100% sequence identity to Motif 2 as it appears in SEQ ID NO: 211: EKEIVELFKRVQAQLRARGKGKEEKKPEQAKAQGERGSVDSLLNLLRKHSVDQR RK (SEQ ID NO: 244); and/or   (iv) Motif 3(SEQ ID NO: 242): RPxSxFxRRSPVP, where X is any amino acid; or   (v) a motif having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or more sequence identity to Motif 3;   (vi) A motif having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 100% sequence identity to Motif 3 as it appears in SEQ ID NO: 211: RPASNFRRRSPVP (SEQ ID NO: 245).       

     The term “domain” and “motif” is defined in the “definitions” section herein. Specialist databases exist for the identification of domains, for example, SMART (Schultz et al. (1998) Proc. Natl. Acad. Sci. USA 95, 5857-5864; Letunic et al. (2002) Nucleic Acids Res 30, 242-244, InterPro (Mulder et al., (2003) Nucl. Acids. Res. 31, 315-318, Prosite (Bucher and Bairoch (1994), A generalized profile syntax for biomolecular sequences motifs and its function in automatic sequence interpretation. (In) ISMB-94; Proceedings 2nd International Conference on Intelligent Systems for Molecular Biology. Altman R., Brutlag D., Karp P., Lathrop R., Searls D., Eds., pp 53-61, AAAIPress, Menlo Park; Hulo et al., Nucl. Acids. Res. 32:D134-D137, (2004), or Pfam (Bateman et al., Nucleic Acids Research 30(1): 276-280 (2002). A set of tools for in silico analysis of protein sequences is available on the ExPASY proteomics server (hosted by the Swiss Institute of Bioinformatics (Gasteiger et al., ExPASy: the proteomics server for in-depth protein knowledge and analysis, Nucleic Acids Res. 31:3784-3788 (2003)). Domains may also be identified using routine techniques, such as by sequence alignment. 
     Methods for the alignment of sequences for comparison are well known in the art, such methods include GAP, BESTFIT, BLAST, FASTA and TFASTA. GAP uses the algorithm of Needleman and Wunsch ((1970) J Mol Biol 48: 443-453) to find the global (i.e. spanning the complete sequences) alignment of two sequences that maximizes the number of matches and minimizes the number of gaps. The BLAST algorithm (Altschul et al. (1990) J Mol Biol 215: 403-10) calculates percent sequence identity and performs a statistical analysis of the similarity between the two sequences. The software for performing BLAST analysis is publicly available through the National Centre for Biotechnology Information (NCBI). Homologues may readily be identified using, for example, the ClustalW multiple sequence alignment algorithm (version 1.83), with the default pairwise alignment parameters, and a scoring method in percentage. Global percentages of similarity and identity may also be determined using one of the methods available in the MatGAT software package (Campanella et al., BMC Bioinformatics. 2003 Jul. 10; 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences.). Minor manual editing may be performed to optimise alignment between conserved motifs, as would be apparent to a person skilled in the art. Furthermore, instead of using full-length sequences for the identification of homologues, specific domains may also be used. The sequence identity values, which are indicated below in the Example section as a percentage were determined over the entire nucleic acid or amino acid sequence, and/or over selected domains or conserved motif(s), using the programs mentioned above using the default parameters. 
     Furthermore, SAP-like polypeptides (at least in their native form) typically have DNA-binding activity. Tools and techniques for measuring DNA-binding activity are well known in the art; one such example is given in the Examples section herein. 
     The present invention is illustrated by transforming plants with the nucleic acid sequence represented by SEQ ID NO: 210, encoding the polypeptide sequence of SEQ ID NO: 211. However, performance of the invention is not restricted to these sequences; the methods of the invention may advantageously be performed using any SAP-like-encoding nucleic acid or SAP-like polypeptide as defined herein. 
     Examples of nucleic acids encoding SAP-like polypeptides are given in Table C1 herein. Such nucleic acids are useful in performing the methods of the invention. The amino acid sequences given in Table C1 are example sequences of orthologues and paralogues of the SAP-like polypeptide represented by SEQ ID NO: 211, the terms “orthologues” and “paralogues” being as defined herein. Further orthologues and paralogues may readily be identified by performing a so-called reciprocal blast search. Typically, this involves a first BLAST involving BLASTing a query sequence (for example using any of the sequences listed in Table C1) against any sequence database, such as the publicly available NCBI database. BLASTN or TBLASTX (using standard default values) are generally used when starting from a nucleotide sequence, and BLASTP or TBLASTN (using standard default values) when starting from a protein sequence. The BLAST results may optionally be filtered. The full-length sequences of either the filtered results or non-filtered results are then BLASTed back (second BLAST) against sequences from the organism from which the query sequence is derived (where the query sequence is SEQ ID NO: 210 or SEQ ID NO: 211, the second BLAST would therefore be against rice sequences). The results of the first and second BLASTs are then compared. A paralogue is identified if a high-ranking hit from the first blast is from the same species as from which the query sequence is derived, a BLAST back then ideally results in the query sequence amongst the highest hits; an orthologue is identified if a high-ranking hit in the first BLAST is not from the same species as from which the query sequence is derived, and preferably results upon BLAST back in the query sequence being among the highest hits. 
     High-ranking hits are those having a low E-value. The lower the E-value, the more significant the score (or in other words the lower the chance that the hit was found by chance). Computation of the E-value is well known in the art. In addition to E-values, comparisons are also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In the case of large families, ClustalW may be used, followed by a neighbour joining tree, to help visualize clustering of related genes and to identify orthologues and paralogues. 
     Nucleic acid variants may also be useful in practising the methods of the invention. Examples of such variants include nucleic acids encoding homologues and derivatives of any one of the amino acid sequences given in Table C1, the terms “homologue” and “derivative” being as defined herein. Also useful in the methods of the invention are nucleic acids encoding homologues and derivatives of orthologues or paralogues of any one of the amino acid sequences given in Table C1. Homologues and derivatives useful in the methods of the present invention have substantially the same biological and functional activity as the unmodified protein from which they are derived. 
     Further nucleic acid variants useful in practising the methods of the invention include portions of nucleic acids encoding SAP-like polypeptides, nucleic acids hybridising to nucleic acids encoding SAP-like polypeptides, splice variants of nucleic acids encoding SAP-like polypeptides, allelic variants of nucleic acids encoding SAP-like polypeptides and variants of nucleic acids encoding SAP-like polypeptides obtained by gene shuffling. The terms hybridising sequence, splice variant, allelic variant and gene shuffling are as described herein. 
     Nucleic acids encoding SAP-like polypeptides need not be full-length nucleic acids, since performance of the methods of the invention does not rely on the use of full-length nucleic acid sequences. According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a portion of any one of the nucleic acid sequences given in Table C1 in the Examples section herein, or a portion of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table C1. 
     A portion of a nucleic acid may be prepared, for example, by making one or more deletions to the nucleic acid. The portions may be used in isolated form or they may be fused to other coding (or non-coding) sequences in order to, for example, produce a protein that combines several activities. When fused to other coding sequences, the resultant polypeptide produced upon translation may be bigger than that predicted for the protein portion. 
     Portions useful in the methods of the invention, encode a SAP-like polypeptides as defined herein, and have substantially the same biological activity as the amino acid sequences given in Table C1. Preferably, the portion is a portion of any one of the nucleic acids given in Table C1, or is a portion of a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table C1. In order to perform the methods of the invention, the portion need only encode a SAP domain as defined herein, i.e. encode:
         (a) Motif 1 (SEQ ID NO: 240): XLSSLKVXELRELAKSRGIKGYSKMKKXELVELLS, where X is any amino acid; or   (b) a motif having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95% or more sequence identity to Motif 1; or   (c) A motif having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 100% sequence identity to Motif 1 as it appears in SEQ ID NO: 211: DLSTLKVTELRELAKSRGIKGYSKMKKNDLVELLS (SEQ ID NO: 243).       

     The portion therefore need only be around 100 consecutive nucleotides in length, so long as those 100 consecutive nucleotides encode a SAP domain as defined herein. Preferably, the portion encodes a polypeptide comprising the SAP domain as defined herein and Motifs 2 and Motifs 3 as defined herein. Preferably the portion is, in increasing order of preference at least 200, 300, 400, 500, 600, 700, 800, 900, 1,000, 1,100 consecutive nucleotides in length, the consecutive nucleotides being of any one of the nucleic acid sequences given in Table C1, or of a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table C1. Most preferably the portion is a portion of the nucleic acid of SEQ ID NO: 210. Preferably, the portion encodes an amino acid sequence comprising (any one or more of the domains defined herein). Preferably, the portion encodes an amino acid sequence which when used in the construction of a phylogenetic tree, such as the one depicted in  FIG. 10 , tends to cluster with the group of SAP-like polypeptides comprising the amino acid sequence represented by SEQ ID NO: 211 rather than with any other group. 
     Another nucleic acid variant useful in the methods of the invention is a nucleic acid capable of hybridising, under reduced stringency conditions, preferably under stringent conditions, with a nucleic acid encoding a SAP-like polypeptide as defined herein, or with a portion as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a nucleic acid capable of hybridizing to any one of the nucleic acids given in Table C1, or comprising introducing and expressing in a plant a nucleic acid capable of hybridising to a nucleic acid encoding an orthologue, paralogue or homologue of any of the nucleic acid sequences given in Table C1. 
     Hybridising sequences useful in the methods of the invention encode a SAP-like polypeptide as defined herein, and have substantially the same biological activity as the amino acid sequences given in Table C1. Preferably, the hybridising sequence is capable of hybridising to any one of the nucleic acids given in Table C1, or to a portion of any of these sequences, a portion being as defined above, or wherein the hybridising sequence is capable of hybridising to a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table C1. Most preferably, the hybridising sequence is capable of hybridising to a nucleic acid as represented by SEQ ID NO: 210 or to a portion thereof. Preferably, the hybridising sequence encodes an amino acid sequence comprising any one or more of the motifs or domains as defined herein. In order to perform the methods of the invention, the hybridising sequence need only encode a SAP domain as defined herein, i.e. encode:
         (a) Motif 1 (SEQ ID NO: 240): XLSSLKVXELRELAKSRGIKGYSKMKKXELVELLS, where X is any amino acid; or   (b) a motif having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95% or more sequence identity to Motif 1; or   (c) A motif having in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 100% sequence identity to Motif 1 as it appears in SEQ ID NO: 211: DLSTLKVTELRELAKSRGIKGYSKMKKNDLVELLS (SEQ ID NO: 243).       

     Preferably, the hybridising sequence encodes an amino acid sequence which when used in the construction of a phylogenetic tree, such as the one depicted in  FIG. 10 , tends to cluster with the group of SAP-like polypeptides comprising the amino acid sequence represented by SEQ ID NO: 211 rather than with any other group. 
     Another nucleic acid variant useful in the methods of the invention is a splice variant encoding a SAP-like polypeptide as defined hereinabove, a splice variant being as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a splice variant of any one of the nucleic acid sequences given in Table C1, or a splice variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table C1. 
     Preferred splice variants are splice variants of a nucleic acid represented by SEQ ID NO: 210, or a splice variant of a nucleic acid encoding an orthologue or paralogue of SEQ ID NO: 211. Preferably, the amino acid sequence encoded by the splice variant comprises any one or more of the motifs or domains as defined herein. In order to perform the methods of the invention, the splice variant need only encode a SAP domain as defined herein. Preferably, the amino acid sequence encoded by the splice variant, when used in the construction of a phylogenetic tree, such as the one depicted in  FIG. 10 , tends to cluster with the group of SAP-like polypeptides comprising the amino acid sequence represented by SEQ ID NO: 211 rather than with any other group. 
     Another nucleic acid variant useful in performing the methods of the invention is an allelic variant of a nucleic acid encoding a SAP-like polypeptide as defined hereinabove, an allelic variant being as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant an allelic variant of any one of the nucleic acids given in Table C1, or comprising introducing and expressing in a plant an allelic variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table C1. 
     The allelic variants useful in the methods of the present invention have substantially the same biological activity as the SAP-like polypeptide of SEQ ID NO: 211 and any of the amino acids depicted in Table C1. Allelic variants exist in nature, and encompassed within the methods of the present invention is the use of these natural alleles. Preferably, the allelic variant is an allelic variant of SEQ ID NO: 210 or an allelic variant of a nucleic acid encoding an orthologue or paralogue of SEQ ID NO: 211. Preferably, the amino acid encoded by the allelic variant comprises any one or more of the motifs or domains as defined herein. In order to perform the methods of the invention, the allelic variant need only encode a SAP domain as defined herein. Preferably, the amino acid sequence encoded by the allelic variant, when used in the construction of a phylogenetic tree, such as the one depicted in  FIG. 10 , tends to cluster with the group of SAP-like polypeptides comprising the amino acid sequence represented by SEQ ID NO: 211 rather than with any other group. 
     Gene shuffling or directed evolution may also be used to generate variants of nucleic acids encoding SAP-like polypeptides as defined above; the term “gene shuffling” being as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a variant of any one of the nucleic acid sequences given in Table C1, or comprising introducing and expressing in a plant a variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table C1, which variant nucleic acid is obtained by gene shuffling. 
     Preferably, the variant nucleic acid obtained by gene shuffling encodes an amino acid sequence comprising any one or more of the motifs or domains as defined herein. In order to perform the methods of the invention, the variant nucleic acid need only encode a SAP domain as defined herein. Preferably, the amino acid sequence encoded by the variant nucleic acid obtained by gene shuffling, when used in the construction of a phylogenetic tree such as the one depicted in  FIG. 10 , tends to cluster with the group of SAP-like polypeptides comprising the amino acid sequence represented by SEQ ID NO: 211 rather than with any other group. 
     Furthermore, nucleic acid variants may also be obtained by site-directed mutagenesis. Several methods are available to achieve site-directed mutagenesis, the most common being PCR based methods (Current Protocols in Molecular Biology. Wiley Eds.). 
     Nucleic acids encoding SAP-like polypeptides may be derived from any natural or artificial source. The nucleic acid may be modified from its native form in composition and/or genomic environment through deliberate human manipulation. Preferably the SAP-like polypeptide-encoding nucleic acid is from a plant, further preferably from a monocotyledonous plant, more preferably from the family poaceae, most preferably the nucleic acid is from  Oryza sativa.    
     Performance of the methods of the invention gives plants having enhanced yield-related traits. In particular performance of the methods of the invention gives plants having increased yield, especially increased seed yield relative to control plants. The terms “yield” and “seed yield” are described in more detail in the “definitions” section herein. 
     Reference herein to enhanced yield-related traits is taken to mean an increase in biomass (weight) of one or more parts of a plant, which may include aboveground (harvestable) parts and/or (harvestable) parts below ground. In particular, such harvestable parts are seeds, and performance of the methods of the invention results in plants having increased seed yield relative to the seed yield of suitable control plants. 
     Taking corn as an example, a yield increase may be manifested as one or more of the following: increase in the number of plants established per hectare or acre, an increase in the number of ears per plant, an increase in the number of rows, number of kernels per row, kernel weight, thousand kernel weight, ear length/diameter, increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), among others. Taking rice as an example, a yield increase may manifest itself as an increase in one or more of the following: number of plants per hectare or acre, number of panicles per plant, number of spikelets per panicle, number of flowers (florets) per panicle (which is expressed as a ratio of the number of filled seeds over the number of primary panicles), increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), increase in thousand kernel weight, among others. 
     The present invention provides a method for increasing yield, especially seed yield of plants, relative to control plants, which method comprises modulating expression, preferably increasing expression, in a plant of a nucleic acid encoding a SAP-like polypeptide as defined herein. 
     Since the transgenic plants according to the present invention have increased yield, it is likely that these plants exhibit an increased growth rate (during at least part of their life cycle), relative to the growth rate of control plants at a corresponding stage in their life cycle. 
     The increased growth rate may be specific to one or more parts of a plant (including seeds), or may be throughout substantially the whole plant. Plants having an increased growth rate may have a shorter life cycle. The life cycle of a plant may be taken to mean the time needed to grow from a dry mature seed up to the stage where the plant has produced dry mature seeds, similar to the starting material. This life cycle may be influenced by factors such as early vigour, growth rate, greenness index, flowering time and speed of seed maturation. The increase in growth rate may take place at one or more stages in the life cycle of a plant or during substantially the whole plant life cycle. Increased growth rate during the early stages in the life cycle of a plant may reflect enhanced vigour. The increase in growth rate may alter the harvest cycle of a plant allowing plants to be sown later and/or harvested sooner than would otherwise be possible (a similar effect may be obtained with earlier flowering time). If the growth rate is sufficiently increased, it may allow for the further sowing of seeds of the same plant species (for example sowing and harvesting of rice plants followed by sowing and harvesting of further rice plants all within one conventional growing period). Similarly, if the growth rate is sufficiently increased, it may allow for the further sowing of seeds of different plants species (for example the sowing and harvesting of corn plants followed by, for example, the sowing and optional harvesting of soybean, potato or any other suitable plant). Harvesting additional times from the same rootstock in the case of some crop plants may also be possible. Altering the harvest cycle of a plant may lead to an increase in annual biomass production per acre (due to an increase in the number of times (say in a year) that any particular plant may be grown and harvested). An increase in growth rate may also allow for the cultivation of transgenic plants in a wider geographical area than their wild-type counterparts, since the territorial limitations for growing a crop are often determined by adverse environmental conditions either at the time of planting (early season) or at the time of harvesting (late season). Such adverse conditions may be avoided if the harvest cycle is shortened. The growth rate may be determined by deriving various parameters from growth curves, such parameters may be: T-Mid (the time taken for plants to reach 50% of their maximal size) and T-90 (time taken for plants to reach 90% of their maximal size), amongst others. 
     According to a preferred feature of the present invention, performance of the methods of the invention gives plants having an increased growth rate relative to control plants. Therefore, according to the present invention, there is provided a method for increasing the growth rate of plants, which method comprises modulating expression, preferably increasing expression, in a plant of a nucleic acid encoding a SAP-like polypeptide as defined herein. 
     An increase in yield and/or growth rate occurs whether the plant is under non-stress conditions or whether the plant is exposed to various stresses compared to control plants. Plants typically respond to exposure to stress by growing more slowly. In conditions of severe stress, the plant may even stop growing altogether. Mild stress on the other hand is defined herein as being any stress to which a plant is exposed which does not result in the plant ceasing to grow altogether without the capacity to resume growth. Mild stress in the sense of the invention leads to a reduction in the growth of the stressed plants of less than 40%, 35% or 30%, preferably less than 25%, 20% or 15%, more preferably less than 14%, 13%, 12%, 11% or 10% or less in comparison to the control plant under non-stress conditions. Due to advances in agricultural practices (irrigation, fertilization, pesticide treatments) severe stresses are not often encountered in cultivated crop plants. As a consequence, the compromised growth induced by mild stress is often an undesirable feature for agriculture. Mild stresses are the everyday biotic and/or abiotic (environmental) stresses to which a plant is exposed. Abiotic stresses may be due to drought or excess water, anaerobic stress, salt stress, chemical toxicity, oxidative stress and hot, cold or freezing temperatures. The abiotic stress may be an osmotic stress caused by a water stress (particularly due to drought), salt stress, oxidative stress or an ionic stress. Biotic stresses are typically those stresses caused by pathogens, such as bacteria, viruses, fungi and insects. 
     In particular, the methods of the present invention may be performed under non-stress conditions or under conditions of mild drought to give plants having increased yield relative to control plants. As reported in Wang et al. (Planta (2003) 218: 1-14), abiotic stress leads to a series of morphological, physiological, biochemical and molecular changes that adversely affect plant growth and productivity. Drought, salinity, extreme temperatures and oxidative stress are known to be interconnected and may induce growth and cellular damage through similar mechanisms. Rabbani et al. (Plant Physiol (2003) 133: 1755-1767) describes a particularly high degree of “cross talk” between drought stress and high-salinity stress. For example, drought and/or salinisation are manifested primarily as osmotic stress, resulting in the disruption of homeostasis and ion distribution in the cell. Oxidative stress, which frequently accompanies high or low temperature, salinity or drought stress, may cause denaturing of functional and structural proteins. As a consequence, these diverse environmental stresses often activate similar cell signaling pathways and cellular responses, such as the production of stress proteins, up-regulation of anti-oxidants, accumulation of compatible solutes and growth arrest. The term “non-stress” conditions as used herein are those environmental conditions that allow optimal growth of plants. Persons skilled in the art are aware of normal soil conditions and climatic conditions for a given location. 
     Performance of the methods of the invention gives plants grown under non-stress conditions or under mild drought conditions increased yield relative to suitable control plants grown under comparable conditions. Therefore, according to the present invention, there is provided a method for increasing yield in plants grown under non-stress conditions or under mild drought conditions, which method comprises increasing expression in a plant of a nucleic acid encoding a SAP-like polypeptide. 
     The present invention encompasses plants or parts thereof (including seeds) obtainable by the methods according to the present invention. The plants or parts thereof comprise a nucleic acid transgene encoding a SAP-like polypeptide as defined above. 
     The invention also provides genetic constructs and vectors to facilitate introduction and/or expression in plants of nucleic acids encoding SAP-like polypeptides. The gene constructs may be inserted into vectors, which may be commercially available, suitable for transforming into plants and suitable for expression of the gene of interest in the transformed cells. The invention also provides use of a gene construct as defined herein in the methods of the invention. 
     More specifically, the present invention provides a construct comprising:
         (a) a nucleic acid encoding a SAP-like polypeptide as defined above;   (b) one or more control sequences capable of driving expression of the nucleic acid sequence of (a); and optionally   (c) a transcription termination sequence.       

     The term “control sequence” and “termination sequence” are as defined herein. Plants are transformed with a vector comprising any of the nucleic acids described above. The skilled artisan is well aware of the genetic elements that must be present on the vector in order to successfully transform, select and propagate host cells containing the sequence of interest. The sequence of interest is operably linked to one or more control sequences (at least to a promoter). 
     Advantageously, any type of promoter may be used to drive expression of the nucleic acid sequence. A constitutive promoter is particularly useful in the methods, as is a tissue-specific promoter. In particular, the tissue-specific promoter is a root-specific promoter or a young green tissue-specific promoter. See the “Definitions” section herein for definitions of the various promoter types. It should be clear that the applicability of the present invention is not restricted to the SAP-like polypeptide-encoding nucleic acid represented by SEQ ID NO: 210, nor is the applicability of the invention restricted to expression of a SAP-like polypeptide-encoding nucleic acid when driven by a constitutive promoter, a root-specific promoter or a young green tissue-specific promoter. 
     The young green tissue-specific promoter is preferably a protochlorophyllide reductase (PcR) promoter. Examples of other young green tissue-specific promoters which may also be used to drive expression of a SAP-like-encoding nucleic acid are shown in Table 6 in the “Definitions” section herein. The constitutive promoter is preferably a GOS2 promoter, preferably a GOS2 promoter from rice. See Table 6 in the “Definitions” section herein for further examples of constitutive promoters. The root-specific promoter is preferably an RCC3 promoter, preferably an RCC3 promoter (Plant Mol. Biol. 1995 January; 27(2):237-48), more preferably an RCC3 promoter from rice, further preferably as represented by a nucleic acid sequence substantially similar to SEQ ID NO: 246, most preferably the promoter is as represented by SEQ ID NO: 246. See the “Definitions” section for further examples of root-specific promoters. 
     For the identification of functionally equivalent promoters, the promoter strength and/or expression pattern of a candidate promoter may be analysed for example by operably linking the promoter to a reporter gene and assaying the expression level and pattern of the reporter gene in various tissues of the plant. Suitable well-known reporter genes include for example beta-glucuronidase or beta galactosidase. The promoter activity is assayed by measuring the enzymatic activity of the beta-glucuronidase or beta-galactosidase. The promoter strength and/or expression pattern may then be compared to that of a reference promoter (such as the one used in the methods of the present invention). Alternatively, promoter strength may be assayed by quantifying mRNA levels or by comparing mRNA levels of the nucleic acid used in the methods of the present invention, with mRNA levels of housekeeping genes such as 18S rRNA, using methods known in the art, such as Northern blotting with densitometric analysis of autoradiograms, quantitative real-time PCR or RT-PCR (Heid et al., 1996 Genome Methods 6: 986-994). Generally by “weak promoter” is intended a promoter that drives expression of a coding sequence at a low level. By “low level” is intended at levels of about 1/10,000 transcripts to about 1/100,000 transcripts, to about 1/500,0000 transcripts per cell. Conversely, a “strong promoter” drives expression of a coding sequence at high level, or at about 1/10 transcripts to about 1/100 transcripts to about 1/1,000 transcripts per cell. 
     Optionally, one or more terminator sequences may be used in the construct introduced into a plant. Additional regulatory elements may include transcriptional as well as translational enhancers. Those skilled in the art will be aware of terminator and enhancer sequences that may be suitable for use in performing the invention. Such sequences would be known or may readily be obtained by a person skilled in the art. 
     An intron sequence may also be added to the 5′ untranslated region (UTR) or in the coding sequence to increase the amount of the mature message that accumulates in the cytosol. Inclusion of a spliceable intron in the transcription unit in both plant and animal expression constructs has been shown to increase gene expression at both the mRNA and protein levels up to 1000-fold (Buchman and Berg, Mol. Cell. Biol. 8:4395-4405 (1988); Callis et al., Genes Dev. 1:1183-1200 (1987)). Such intron enhancement of gene expression is typically greatest when placed near the 5′ end of the transcription unit. Use of the maize introns Adh1-S intron 1, 2, and 6, the Bronze-1 intron are known in the art. For general information, see The Maize Handbook, Chapter 116, Freeling and Walbot, Eds., Springer, N.Y. (1994). 
     Other control sequences (besides promoter, enhancer, silencer, intron sequences, 3′UTR and/or 5′UTR regions) may be protein and/or RNA stabilizing elements. Such sequences would be known or may readily be obtained by a person skilled in the art. 
     The genetic constructs of the invention may further include an origin of replication sequence that is required for maintenance and/or replication in a specific cell type. One example is when a genetic construct is required to be maintained in a bacterial cell as an episomal genetic element (e.g. plasmid or cosmid molecule). Preferred origins of replication include, but are not limited to, the f1-ori and colE1. 
     For the detection of the successful transfer of the nucleic acid sequences as used in the methods of the invention and/or selection of transgenic plants comprising these nucleic acids, it is advantageous to use marker genes (or reporter genes). Therefore, the genetic construct may optionally comprise a selectable marker gene. Selectable markers are described in more detail in the “definitions” section herein. 
     It is known that upon stable or transient integration of nucleic acids into plant cells, only a minority of the cells takes up the foreign DNA and, if desired, integrates it into its genome, depending on the expression vector used and the transfection technique used. To identify and select these integrants, a gene coding for a selectable marker (such as the ones described above) is usually introduced into the host cells together with the gene of interest. These markers can for example be used in mutants in which these genes are not functional by, for example, deletion by conventional methods. Furthermore, nucleic acid molecules encoding a selectable marker can be introduced into a host cell on the same vector that comprises the sequence encoding the polypeptides of the invention or used in the methods of the invention, or else in a separate vector. Cells which have been stably transfected with the introduced nucleic acid can be identified for example by selection (for example, cells which have integrated the selectable marker survive whereas the other cells die). 
     Since the marker genes, particularly genes for resistance to antibiotics and herbicides, are no longer required or are undesired in the transgenic host cell once the nucleic acids have been introduced successfully, the process according to the invention for introducing the nucleic acids advantageously employs techniques which enable the removal or excision of these marker genes. One such a method is what is known as co-transformation. The co-transformation method employs two vectors simultaneously for the transformation, one vector bearing the nucleic acid according to the invention and a second bearing the marker gene(s). A large proportion of transformants receives or, in the case of plants, comprises (up to 40% or more of the transformants), both vectors. In case of transformation with  Agrobacteria , the transformants usually receive only a part of the vector, i.e. the sequence flanked by the T-DNA, which usually represents the expression cassette. The marker genes can subsequently be removed from the transformed plant by performing crosses. In another method, marker genes integrated into a transposon are used for the transformation together with desired nucleic acid (known as the Ac/Ds technology). The transformants can be crossed with a transposase source or the transformants are transformed with a nucleic acid construct conferring expression of a transposase, transiently or stable. In some cases (approx. 10%), the transposon jumps out of the genome of the host cell once transformation has taken place successfully and is lost. In a further number of cases, the transposon jumps to a different location. In these cases the marker gene must be eliminated by performing crosses. In microbiology, techniques were developed which make possible, or facilitate, the detection of such events. A further advantageous method relies on what is known as recombination systems; whose advantage is that elimination by crossing can be dispensed with. The best-known system of this type is what is known as the Cre/lox system. Cre1 is a recombinase that removes the sequences located between the loxP sequences. If the marker gene is integrated between the loxP sequences, it is removed once transformation has taken place successfully, by expression of the recombinase. Further recombination systems are the HIN/HIX, FLP/FRT and REP/STB system (Tribble et al., J. Biol. Chem., 275, 2000: 22255-22267; Velmurugan et al., J. Cell Biol., 149, 2000: 553-566). A site-specific integration into the plant genome of the nucleic acid sequences according to the invention is possible. Naturally, these methods can also be applied to microorganisms such as yeast, fungi or bacteria. 
     The invention also provides a method for the production of transgenic plants having enhanced yield-related traits relative to control plants, comprising introduction and expression in a plant of any nucleic acid encoding a SAP-like polypeptide as defined hereinabove. 
     More specifically, the present invention provides a method for the production of transgenic plants having increased yield, which method comprises:
         (i) introducing and expressing in a plant or plant cell a SAP-like polypeptide-encoding nucleic acid; and   (ii) cultivating the plant cell under conditions promoting plant growth and development.       

     The nucleic acid may be introduced directly into a plant cell or into the plant itself (including introduction into a tissue, organ or any other part of a plant). According to a preferred feature of the present invention, the nucleic acid is preferably introduced into a plant by transformation. The term “transformation” is described in more detail in the “definitions” section herein. 
     The genetically modified plant cells can be regenerated via all methods with which the skilled worker is familiar. Suitable methods can be found in the abovementioned publications by S.D. Kung and R. Wu, Potrykus or Höfgen and Willmitzer. 
     Generally after transformation, plant cells or cell groupings are selected for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the gene of interest, following which the transformed material is regenerated into a whole plant. To select transformed plants, the plant material obtained in the transformation is, as a rule, subjected to selective conditions so that transformed plants can be distinguished from untransformed plants. For example, the seeds obtained in the above-described manner can be planted and, after an initial growing period, subjected to a suitable selection by spraying. A further possibility consists in growing the seeds, if appropriate after sterilization, on agar plates using a suitable selection agent so that only the transformed seeds can grow into plants. Alternatively, the transformed plants are screened for the presence of a selectable marker such as the ones described above. 
     Following DNA transfer and regeneration, putatively transformed plants may also be evaluated, for instance using Southern analysis, for the presence of the gene of interest, copy number and/or genomic organisation. Alternatively or additionally, expression levels of the newly introduced DNA may be monitored using Northern and/or Western analysis, both techniques being well known to persons having ordinary skill in the art. 
     The generated transformed plants may be propagated by a variety of means, such as by clonal propagation or classical breeding techniques. For example, a first generation (or T1) transformed plant may be selfed and homozygous second-generation (or T2) transformants selected, and the T2 plants may then further be propagated through classical breeding techniques. 
     The generated transformed organisms may take a variety of forms. For example, they may be chimeras of transformed cells and non-transformed cells; clonal transformants (e.g., all cells transformed to contain the expression cassette); grafts of transformed and untransformed tissues (e.g., in plants, a transformed rootstock grafted to an untransformed scion). 
     The present invention clearly extends to any plant cell or plant produced by any of the methods described herein, and to all plant parts and propagules thereof. The present invention extends further to encompass the progeny of a primary transformed or transfected cell, tissue, organ or whole plant that has been produced by any of the aforementioned methods, the only requirement being that progeny exhibit the same genotypic and/or phenotypic characteristic(s) as those produced by the parent in the methods according to the invention. 
     The invention also includes host cells containing an isolated nucleic acid encoding a SAP-like polypeptide as defined hereinabove. Preferred host cells according to the invention are plant cells. Host plants for the nucleic acids or the vector used in the method according to the invention, the expression cassette or construct or vector are, in principle, advantageously all plants, which are capable of synthesizing the polypeptides used in the inventive method. 
     The methods of the invention are advantageously applicable to any plant. Plants that are particularly useful in the methods of the invention include all plants which belong to the superfamily Viridiplantae, in particular monocotyledonous and dicotyledonous plants including fodder or forage legumes, ornamental plants, food crops, trees or shrubs. According to a preferred embodiment of the present invention, the plant is a crop plant. Examples of crop plants include soybean, sunflower, canola, alfalfa, rapeseed, cotton, tomato, potato and tobacco. Further preferably, the plant is a monocotyledonous plant. Examples of monocotyledonous plants include sugarcane. More preferably the plant is a cereal. Examples of cereals include rice, maize, wheat, barley, millet, rye, sorghum and oats. 
     The invention also extends to harvestable parts of a plant such as, but not limited to seeds, leaves, fruits, flowers, stems, rhizomes, tubers and bulbs. The invention furthermore relates to products derived, preferably directly derived, from a harvestable part of such a plant, such as dry pellets or powders, oil, fat and fatty acids, starch or proteins. 
     According to a preferred feature of the invention, the modulated expression is increased expression. Methods for increasing expression of nucleic acids or genes, or gene products, are well documented in the art and include, for example, overexpression driven by appropriate promoters, the use of transcription enhancers or translation enhancers. Isolated nucleic acids which serve as promoter or enhancer elements may be introduced in an appropriate position (typically upstream) of a non-heterologous form of a polynucleotide so as to upregulate expression. For example, endogenous promoters may be altered in vivo by mutation, deletion, and/or substitution (see, Kmiec, U.S. Pat. No. 5,565,350; Zarling et al., PCT/US93/03868), or isolated promoters may be introduced into a plant cell in the proper orientation and distance from a gene of the present invention so as to control the expression of the gene. 
     If polypeptide expression is desired, it is generally desirable to include a polyadenylation region at the 3′-end of a polynucleotide coding region. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The 3′ end sequence to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene. 
     As mentioned above, a preferred method for modulating (preferably, increasing) expression of a nucleic acid encoding a SAP-like polypeptide is by introducing and expressing in a plant a nucleic acid encoding a SAP-like polypeptide; however the effects of performing the method, i.e. enhancing yield-related traits may also be achieved using other well known techniques. A description of some of these techniques will now follow. 
     One such technique is T-DNA activation tagging (Hayashi et al. Science (1992) 1350-1353), which involves insertion of T-DNA, usually containing a promoter (may also be a translation enhancer or an intron), in the genomic region of the gene of interest or 10 kb up- or downstream of the coding region of a gene in a configuration such that the promoter directs expression of the targeted gene. Typically, regulation of expression of the targeted gene by its natural promoter is disrupted and the gene falls under the control of the newly introduced promoter. The promoter is typically embedded in a T-DNA. This T-DNA is randomly inserted into the plant genome, for example, through  Agrobacterium  infection and leads to modified expression of genes near the inserted T-DNA. The resulting transgenic plants show dominant phenotypes due to modified expression of genes close to the introduced promoter. 
     The effects of the invention may also be reproduced using the technique of TILLING (Targeted Induced Local Lesions In Genomes); for a description of the same see the “definitions” section. 
     The effects of the invention may also be reproduced using homologous recombination; for a description of the same see the “definitions” section. 
     The present invention also encompasses use of nucleic acids encoding SAP-like polypeptides as described herein and use of these SAP-like polypeptide in enhancing any of the aforementioned yield-related traits in plants. 
     Nucleic acids encoding SAP-like polypeptide described herein, or the SAP-like polypeptides themselves, may find use in breeding programmes in which a DNA marker is identified which may be genetically linked to a SAP-like polypeptide-encoding gene. The nucleic acids/genes, or the SAP-like polypeptides themselves may be used to define a molecular marker. This DNA or protein marker may then be used in breeding programmes to select plants having enhanced yield-related traits as defined hereinabove in the methods of the invention. 
     Allelic variants of a SAP-like polypeptide-encoding nucleic acid/gene may also find use in marker-assisted breeding programmes. Such breeding programmes sometimes require introduction of allelic variation by mutagenic treatment of the plants, using for example EMS mutagenesis; alternatively, the programme may start with a collection of allelic variants of so called “natural” origin caused unintentionally. Identification of allelic variants then takes place, for example, by PCR. This is followed by a step for selection of superior allelic variants of the sequence in question and which give increased yield. Selection is typically carried out by monitoring growth performance of plants containing different allelic variants of the sequence in question. Growth performance may be monitored in a greenhouse or in the field. Further optional steps include crossing plants in which the superior allelic variant was identified with another plant. This could be used, for example, to make a combination of interesting phenotypic features. 
     Nucleic acids encoding SAP-like polypeptides may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes. Such use of SAP-like polypeptide-encoding nucleic acids requires only a nucleic acid sequence of at least 15 nucleotides in length. The SAP-like polypeptide-encoding nucleic acids may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (Sambrook J, Fritsch E F and Maniatis T (1989) Molecular Cloning, A Laboratory Manual) of restriction-digested plant genomic DNA may be probed with the SAP-like-encoding nucleic acids. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et al. (1987) Genomics 1: 174-181) in order to construct a genetic map. In addition, the nucleic acids may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the SAP-like polypeptide-encoding nucleic acid in the genetic map previously obtained using this population (Botstein et al. (1980) Am. J. Hum. Genet. 32:314-331). 
     The production and use of plant gene-derived probes for use in genetic mapping is described in Bernatzky and Tanksley (1986) Plant Mol. Biol. Reporter 4: 37-41. Numerous publications describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art. 
     The nucleic acid probes may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel et al. In: Non-mammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein). 
     In another embodiment, the nucleic acid probes may be used in direct fluorescence in situ hybridisation (FISH) mapping (Trask (1991) Trends Genet. 7:149-154). Although current methods of FISH mapping favour use of large clones (several kb to several hundred kb; see Laan et al. (1995) Genome Res. 5:13-20), improvements in sensitivity may allow performance of FISH mapping using shorter probes. 
     A variety of nucleic acid amplification-based methods for genetic and physical mapping may be carried out using the nucleic acids. Examples include allele-specific amplification (Kazazian (1989) J. Lab. Clin. Med. 11:95-96), polymorphism of PCR-amplified fragments (CAPS; Sheffield et al. (1993) Genomics 16:325-332), allele-specific ligation (Landegren et al. (1988) Science 241:1077-1080), nucleotide extension reactions (Sokolov (1990) Nucleic Acid Res. 18:3671), Radiation Hybrid Mapping (Walter et al. (1997) Nat. Genet. 7:22-28) and Happy Mapping (Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807). For these methods, the sequence of a nucleic acid is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR-based genetic mapping, it may be necessary to identify DNA sequence differences between the parents of the mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, is generally not necessary for mapping methods. 
     The methods according to the present invention result in plants having enhanced yield-related traits, as described hereinbefore. These traits may also be combined with other economically advantageous traits, such as further yield-enhancing traits, tolerance to other abiotic and biotic stresses, traits modifying various architectural features and/or biochemical and/or physiological features. 
     (iv) SYPF1 
     Surprisingly, it has now been found that modulating expression in a plant of a nucleic acid encoding a SYPF1 polypeptide gives plants having enhanced yield-related traits relative to control plants. 
     According to a first embodiment, the present invention provides a method for enhancing yield-related traits in plants relative to control plants, comprising modulating expression in a plant of a nucleic acid encoding a SYPF1 polypeptide. 
     A preferred method for modulating (preferably, increasing) expression of a nucleic acid encoding a SYPF1 polypeptide is by introducing and expressing in a plant a nucleic acid encoding a SYPF1 polypeptide. 
     Any reference hereinafter to a “protein useful in the methods of the invention” is taken to mean a SYPF1 polypeptide as defined herein. Any reference hereinafter to a “nucleic acid useful in the methods of the invention” is taken to mean a nucleic acid capable of encoding such a SYPF1 polypeptide. The nucleic acid to be introduced into a plant (and therefore useful in performing the methods of the invention) is any nucleic acid encoding the type of protein which will now be described, hereafter also named “SYPF1 nucleic acid” or “SYPF1 gene”. 
     A “SYPF1 polypeptide” as defined herein refers to any polypeptide having, in increasing order of preference, at least 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or more sequence identity to any one, preferably to any two, most preferably to all three of Motifs I, II and III as shown in the alignment of  FIG. 19 . The boxed regions represent conserved regions or motifs found in SYPF1 polypeptides. 
     A SYPF1 polypeptide may comprise any one, preferably any two, most preferably all three of Motifs I, II and III as shown in the alignment of  FIG. 19 , which Motifs comprise any conservative amino acid change at any position. 
     A SYPF1 polypeptide may comprise any one, preferably any two, most preferably all three of Motifs I, II and III as shown in the alignment of  FIG. 19 . 
     The Motifs are preferably as found in the sequence of SEQ ID NO: 322 or in the corresponding rice orthologue (SEQ ID NO: 336), i.e. 
     
       
         
           
               
               
            
               
                   
                 Motif 1: 
               
               
                   
                 (as found in SEQ ID NO: 322) 
               
               
                   
                 SLVSNFLSHYLQYYEEKS 
               
               
                   
               
               
                   
                 (as found in SEQ ID NO: 336) 
               
               
                   
                 RLVNRVLGHYEHYYRTK 
               
            
           
         
       
         
         
           
             The Motifs may comprise any conservative amino acid change at any position. 
             The Motifs may comprise between one and nine non-conservative amino acid changes at any position. 
           
         
       
    
     
       
         
           
               
               
            
               
                   
                 Motif 2: 
               
               
                   
                 (as found in SEQ ID NO: 322) 
               
               
                   
                 PPWLSSYEKLILWIGGFKP 
               
               
                   
               
               
                   
                 (as found in SEQ ID NO: 336) 
               
               
                   
                 PSWTSTTENLYLWCGGWRP 
               
            
           
         
       
         
         
           
             The Motifs may comprise any conservative amino acid change at any position. 
             The Motifs may comprise between one and ten non-conservative amino acid changes at any position. 
           
         
       
    
     
       
         
           
               
               
            
               
                   
                 Motif 3: 
               
               
                   
                 (as found in SEQ ID NO: 322) 
               
               
                   
                 NADQLRCVTVGKVVEVLNPRQSIKLLRA 
               
               
                   
               
               
                   
                 (as found in SEQ ID NO: 336) 
               
               
                   
                 MADGLRLETMREVVALLRPSQAVHFLIA 
               
            
           
         
       
         
         
           
             The Motifs may comprise any conservative amino acid change at any position. 
             The Motifs may comprise between one and fourteen non-conservative amino acid changes at any position. 
           
         
       
    
     Additionally or alternatively, the “SYPF1 polypeptide” as defined herein comprises in increasing order of preference at least 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or more sequence identity to the SYPF1 polypeptide represented by SEQ ID NO: 322 or to any of the amino acid sequences given in Table E1 herein. 
     Furthermore, SYPF1 polypeptides (at least in their native form) may have DNA-binding activity. Tools and techniques for measuring DNA-binding activity are well known in the art. 
     The terms “domain” and “motif” are defined in the “definitions” section herein. Specialist databases exist for the identification of domains, for example, SMART (Schultz et al. (1998) Proc. Natl. Acad. Sci. USA 95, 5857-5864; Letunic et al. (2002) Nucleic Acids Res 30, 242-244, InterPro (Mulder et al., (2003) Nucl. Acids. Res. 31, 315-318, Prosite (Bucher and Bairoch (1994), A generalized profile syntax for biomolecular sequences motifs and its function in automatic sequence interpretation. (In) ISMB-94; Proceedings 2nd International Conference on Intelligent Systems for Molecular Biology. Altman R., Brutlag D., Karp P., Lathrop R., Searls D., Eds., pp 53-61, AAAIPress, Menlo Park; Hulo et al., Nucl. Acids. Res. 32:D134-D137, (2004), or Pfam (Bateman et al., Nucleic Acids Research 30(1): 276-280 (2002). A set of tools for in silico analysis of protein sequences is available on the ExPASY proteomics server (hosted by the Swiss Institute of Bioinformatics (Gasteiger et al., ExPASy: the proteomics server for in-depth protein knowledge and analysis, Nucleic Acids Res. 31:3784-3788 (2003)). Domains may also be identified using routine techniques, such as by sequence alignment. 
     Analysis of the polypeptide sequence of SEQ ID NO: 322 in the SMART database, revealed there to be four domains of so-called intrinsic disorder (See  FIG. 18 ). These domains are R-, K-, S-rich and may point to a role in protein-protein interactions. The four domains are: 
     
       
         
           
               
               
            
               
                   
                 1 st  Domain of intrinsic disorder: 
               
               
                   
                 MPNTSSSQSF 
               
               
                   
               
               
                   
                 2 nd  Domain of intrinsic disorder: 
               
               
                   
                 VSVADLTRHQKDRISSLKSETRRKEREV 
               
               
                   
               
               
                   
                 3 rd  Domain of intrinsic disorder: 
               
               
                   
                 LVQQSVADPPVM 
               
               
                   
               
               
                   
                 4 th  Domain of intrinsic disorder: 
               
               
                   
                 HLRLRDRDQERA 
               
            
           
         
       
     
     Such domains of intrinsic disorder may also be found in the corresponding rice orthologue of SEQ ID NO: 336 (NP_909348) 
     
       
         
           
               
               
            
               
                   
                 1 st  Domain of intrinsic disorder: 
               
               
                   
                 PPPSPHPPH 
               
               
                   
               
               
                   
                 2 nd  Domain of intrinsic disorder: 
               
               
                   
                 SRDLAALRSAASAATNPAAPPDDA 
               
               
                   
               
               
                   
                 3 rd  Domain of intrinsic disorder: 
               
               
                   
                 LAGGGLGAGDLGDL 
               
               
                   
               
               
                   
                 4 th  Domain of intrinsic disorder: 
               
               
                   
                 ELAGGGGMDAEGMEMEM 
               
            
           
         
       
     
     Furthermore, analysis of the polypeptide sequence of SEQ ID NO: 322 in the PRODOM database revealed there to be similarity to: tumour related At4g18650; TGA1 bzip activator coil coil. 
     Furthermore, SYPF1 polypeptides comprise F-rich (phenylalanine-rich) and C-rich (cysteine-rich) regions. These regions are highlighted in  FIG. 18  showing the sequence of SEQ ID NO: 322. 
     Methods for the alignment of sequences for comparison are well known in the art, such methods include GAP, BESTFIT, BLAST, FASTA and TFASTA. GAP uses the algorithm of Needleman and Wunsch ((1970) J Mol Biol 48: 443-453) to find the global (i.e. spanning the complete sequences) alignment of two sequences that maximizes the number of matches and minimizes the number of gaps. The BLAST algorithm (Altschul et al. (1990) J Mol Biol 215: 403-10) calculates percent sequence identity and performs a statistical analysis of the similarity between the two sequences. The software for performing BLAST analysis is publicly available through the National Centre for Biotechnology Information (NCBI). Homologues may readily be identified using, for example, the ClustalW multiple sequence alignment algorithm (version 1.83), with the default pairwise alignment parameters, and a scoring method in percentage. Global percentages of similarity and identity may also be determined using one of the methods available in the MatGAT software package (Campanella et al., BMC Bioinformatics. 2003 Jul. 10; 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences.). Minor manual editing may be performed to optimise alignment between conserved motifs, as would be apparent to a person skilled in the art. Furthermore, instead of using full-length sequences for the identification of homologues, specific domains may also be used. The sequence identity values, which are indicated below in the Examples section herein as a percentage were determined over the entire nucleic acid or amino acid sequence, and/or over selected domains or conserved motif(s), using the programs mentioned above using the default parameters. 
     The present invention is illustrated by transforming plants with the nucleic acid sequence represented by SEQ ID NO: 321, encoding the polypeptide sequence of SEQ ID NO: 322. However, performance of the invention is not restricted to these sequences; the methods of the invention may advantageously be performed using any SYPF1-encoding nucleic acid or SYPF1 polypeptides as defined herein. 
     Examples of nucleic acids encoding SYPF1 polypeptides are given in Table E1 herein. Such nucleic acids are useful in performing the methods of the invention. The amino acid sequences given in Table E1 are example sequences of orthologues and paralogues of the SYPF1 polypeptides represented by SEQ ID NO: 322, the terms “orthologues” and “paralogues” being as defined herein. Further orthologues and paralogues may readily be identified by performing a so-called reciprocal blast search. Typically, this involves a first BLAST involving BLASTing a query sequence (for example using any of the sequences listed in Table E1) against any sequence database, such as the publicly available NCBI database. BLASTN or TBLASTX (using standard default values) are generally used when starting from a nucleotide sequence, and BLASTP or TBLASTN (using standard default values) when starting from a protein sequence. The BLAST results may optionally be filtered. The full-length sequences of either the filtered results or non-filtered results are then BLASTed back (second BLAST) against sequences from the organism from which the query sequence is derived (where the query sequence is SEQ ID NO: 321 or SEQ ID NO: 322, the second BLAST would therefore be against  Arabidopsis  sequences). The results of the first and second BLASTs are then compared. A paralogue is identified if a high-ranking hit from the first blast is from the same species as from which the query sequence is derived, a BLAST back then ideally results in the query sequence amongst the highest hits; an orthologue is identified if a high-ranking hit in the first BLAST is not from the same species as from which the query sequence is derived, and preferably results upon BLAST back in the query sequence being among the highest hits. 
     High-ranking hits are those having a low E-value. The lower the E-value, the more significant the score (or in other words the lower the chance that the hit was found by chance). Computation of the E-value is well known in the art. In addition to E-values, comparisons are also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In the case of large families, ClustalW may be used, followed by a neighbour joining tree, to help visualize clustering of related genes and to identify orthologues and paralogues. 
     Nucleic acid variants may also be useful in practising the methods of the invention. Examples of such variants include nucleic acids encoding homologues and derivatives of any one of the amino acid sequences given in Table E1, the terms “homologue” and “derivative” being as defined herein. Also useful in the methods of the invention are nucleic acids encoding homologues and derivatives of orthologues or paralogues of any one of the amino acid sequences given in Table E1. Homologues and derivatives useful in the methods of the present invention have substantially the same biological and functional activity as the unmodified protein from which they are derived. 
     Further nucleic acid variants useful in practising the methods of the invention include portions of nucleic acids encoding SYPF1 polypeptides, nucleic acids hybridising to nucleic acids encoding SYPF1 polypeptides, splice variants of nucleic acids encoding SYPF1 polypeptides, allelic variants of nucleic acids encoding SYPF1 polypeptides and variants of nucleic acids encoding SYPF1 polypeptides obtained by gene shuffling. The terms hybridising sequence, splice variant, allelic variant and gene shuffling are as described herein. 
     Nucleic acids encoding SYPF1 polypeptides need not be full-length nucleic acids, since performance of the methods of the invention does not rely on the use of full-length nucleic acid sequences. According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a portion of any one of the nucleic acid sequences given in Table E1, or a portion of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table E1. 
     A portion of a nucleic acid may be prepared, for example, by making one or more deletions to the nucleic acid. The portions may be used in isolated form or they may be fused to other coding (or non-coding) sequences in order to, for example, produce a protein that combines several activities. When fused to other coding sequences, the resultant polypeptide produced upon translation may be bigger than that predicted for the protein portion. 
     Portions useful in the methods of the invention, encode a SYPF1 polypeptides as defined herein, and have substantially the same biological activity as the amino acid sequences given in Table E1. Preferably, the portion is a portion of any one of the nucleic acids given in Table E1, or is a portion of a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table E1. Preferably the portion is, in increasing order of preference at least 300, 400, 500 or 600 consecutive nucleotides in length, the consecutive nucleotides being of any one of the nucleic acid sequences given in Table E1, or of a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table E1. Most preferably the portion is a portion of the nucleic acid of SEQ ID NO: 321. Preferably, the portion encodes an amino acid sequence comprising (any one or more of the domains or motifs defined herein). Preferably, the portion encodes an amino acid sequence which when used in the construction of a phylogenetic tree, such as the one depicted in  FIG. 20 , tends to cluster with the group of SYPF1 polypeptides comprising the amino acid sequence represented by SEQ ID NO: 322 rather than with any other group. 
     Another nucleic acid variant useful in the methods of the invention is a nucleic acid capable of hybridising, under reduced stringency conditions, preferably under stringent conditions, with a nucleic acid encoding a SYPF1 polypeptide as defined herein, or with a portion as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a nucleic acid capable of hybridizing to any one of the nucleic acids given in Table E1, or comprising introducing and expressing in a plant a nucleic acid capable of hybridising to a nucleic acid encoding an orthologue, paralogue or homologue of any of the nucleic acid sequences given in Table E1. 
     Hybridising sequences useful in the methods of the invention encode a SYPF1 polypeptide as defined herein, and have substantially the same biological activity as the amino acid sequences given in Table E1. Preferably, the hybridising sequence is capable of hybridising to any one of the nucleic acids given in Table E1, or to a portion of any of these sequences, a portion being as defined above, or wherein the hybridising sequence is capable of hybridising to a nucleic acid encoding an orthologue or paralogue of any one of the amino acid sequences given in Table E1. Most preferably, the hybridising sequence is capable of hybridising to a nucleic acid as represented by SEQ ID NO: 321 or to a portion thereof. Preferably, the hybridising sequence encodes an amino acid sequence comprising any one or more of the motifs or domains as defined herein. Preferably, the hybridising sequence encodes an amino acid sequence which when used in the construction of a phylogenetic tree, such as the one depicted in  FIG. 20 , tends to cluster with the group of SYPF1 polypeptides comprising the amino acid sequence represented by SEQ ID NO: 322 rather than with any other group. 
     Another nucleic acid variant useful in the methods of the invention is a splice variant encoding a SYPF1 polypeptide as defined hereinabove, a splice variant being as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a splice variant of any one of the nucleic acid sequences given in Table E1, or a splice variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table E1. 
     Preferred splice variants are splice variants of a nucleic acid represented by SEQ ID NO: 321, or a splice variant of a nucleic acid encoding an orthologue or paralogue of SEQ ID NO: 322. Preferably, the amino acid sequence encoded by the splice variant comprises any one or more of the motifs or domains as defined herein. Preferably, the amino acid sequence encoded by the splice variant, when used in the construction of a phylogenetic tree, such as the one depicted in  FIG. 20 , tends to cluster with the group of SYPF1 polypeptides comprising the amino acid sequence represented by SEQ ID NO: 322 rather than with any other group. 
     Another nucleic acid variant useful in performing the methods of the invention is an allelic variant of a nucleic acid encoding a SYPF1 polypeptide as defined hereinabove, an allelic variant being as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant an allelic variant of any one of the nucleic acids given in Table E1, or comprising introducing and expressing in a plant an allelic variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table E1. 
     The allelic variants useful in the methods of the present invention have substantially the same biological activity as the SYPF1 polypeptide of SEQ ID NO: 322 and any of the amino acids depicted in Table D1. Allelic variants exist in nature, and encompassed within the methods of the present invention is the use of these natural alleles. Preferably, the allelic variant is an allelic variant of SEQ ID NO: 321 or an allelic variant of a nucleic acid encoding an orthologue or paralogue of SEQ ID NO: 322. Preferably, the amino acid encoded by the allelic variant comprises any one or more of the motifs or domains as defined herein. Preferably, the amino acid sequence encoded by the allelic variant, when used in the construction of a phylogenetic tree, such as the one depicted in  FIG. 20 , tends to cluster with the group of SYPF1 polypeptides comprising the amino acid sequence represented by SEQ ID NO: 322 rather than with any other group. 
     Gene shuffling or directed evolution may also be used to generate variants of nucleic acids encoding SYPF1 polypeptides as defined above; the term “gene shuffling” being as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a variant of any one of the nucleic acid sequences given in Table E1, or comprising introducing and expressing in a plant a variant of a nucleic acid encoding an orthologue, paralogue or homologue of any of the amino acid sequences given in Table E1, which variant nucleic acid is obtained by gene shuffling. 
     Preferably, the variant nucleic acid obtained by gene shuffling encodes an amino acid sequence comprising any one or more of the motifs or domains as defined herein. Preferably, the amino acid sequence encoded by the variant nucleic acid obtained by gene shuffling, when used in the construction of a phylogenetic tree such as the one depicted in  FIG. 20 , tends to cluster with the group of SYPF1 polypeptides comprising the amino acid sequence represented by SEQ ID NO: 322 rather than with any other group. 
     Furthermore, nucleic acid variants may also be obtained by site-directed mutagenesis. Several methods are available to achieve site-directed mutagenesis, the most common being PCR based methods (Current Protocols in Molecular Biology. Wiley Eds.). 
     Nucleic acids encoding SYPF1 polypeptides may be derived from any natural or artificial source. The nucleic acid may be modified from its native form in composition and/or genomic environment through deliberate human manipulation. Preferably the SYPF1 polypeptide-encoding nucleic acid is from a plant, further preferably from a dicotyledonous plant, more preferably from the family Brassicaceae, more preferably from the genus  Arabidopsis , most preferably from  Arabidopsis thaliana.    
     Performance of the methods of the invention gives plants having enhanced yield-related traits. In particular, performance of the methods of the invention gives plants having increased yield, especially increased seed yield relative to control plants. The terms “yield” and “seed yield” are described in more detail in the “definitions” section herein. 
     Reference herein to enhanced yield-related traits is taken to mean an increase in biomass (weight) of one or more parts of a plant, which may include aboveground (harvestable) parts and/or (harvestable) parts below ground. In particular, such harvestable parts are seeds, and performance of the methods of the invention results in plants having increased seed yield relative to the seed yield of suitable control plants. 
     Taking corn as an example, a yield increase may be manifested as one or more of the following: increase in the number of plants established per hectare or acre, an increase in the number of ears per plant, an increase in the number of rows, number of kernels per row, kernel weight, thousand kernel weight, ear length/diameter, increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), among others. Taking rice as an example, a yield increase may manifest itself as an increase in one or more of the following: number of plants per hectare or acre, number of panicles per plant, number of spikelets per panicle, number of flowers (florets) per panicle (which is expressed as a ratio of the number of filled seeds over the number of primary panicles), increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), increase in thousand kernel weight, among others. 
     The present invention provides a method for increasing yield, especially seed yield of plants, relative to control plants, which method comprises modulating expression, preferably increasing expression, in a plant of a nucleic acid encoding a SYPF1 polypeptide as defined herein. 
     Since the transgenic plants according to the present invention have increased yield, it is likely that these plants exhibit an increased growth rate (during at least part of their life cycle), relative to the growth rate of control plants at a corresponding stage in their life cycle. 
     The increased growth rate may be specific to one or more parts of a plant (including seeds), or may be throughout substantially the whole plant. Plants having an increased growth rate may have a shorter life cycle. The life cycle of a plant may be taken to mean the time needed to grow from a dry mature seed up to the stage where the plant has produced dry mature seeds, similar to the starting material. This life cycle may be influenced by factors such as early vigour, growth rate, greenness index, flowering time and speed of seed maturation. The increase in growth rate may take place at one or more stages in the life cycle of a plant or during substantially the whole plant life cycle. Increased growth rate during the early stages in the life cycle of a plant may reflect enhanced vigour. The increase in growth rate may alter the harvest cycle of a plant allowing plants to be sown later and/or harvested sooner than would otherwise be possible (a similar effect may be obtained with earlier flowering time). If the growth rate is sufficiently increased, it may allow for the further sowing of seeds of the same plant species (for example sowing and harvesting of rice plants followed by sowing and harvesting of further rice plants all within one conventional growing period). Similarly, if the growth rate is sufficiently increased, it may allow for the further sowing of seeds of different plants species (for example the sowing and harvesting of corn plants followed by, for example, the sowing and optional harvesting of soybean, potato or any other suitable plant). Harvesting additional times from the same rootstock in the case of some crop plants may also be possible. Altering the harvest cycle of a plant may lead to an increase in annual biomass production per acre (due to an increase in the number of times (say in a year) that any particular plant may be grown and harvested). An increase in growth rate may also allow for the cultivation of transgenic plants in a wider geographical area than their wild-type counterparts, since the territorial limitations for growing a crop are often determined by adverse environmental conditions either at the time of planting (early season) or at the time of harvesting (late season). Such adverse conditions may be avoided if the harvest cycle is shortened. The growth rate may be determined by deriving various parameters from growth curves, such parameters may be: T-Mid (the time taken for plants to reach 50% of their maximal size) and T-90 (time taken for plants to reach 90% of their maximal size), amongst others. 
     According to a preferred feature of the present invention, performance of the methods of the invention gives plants having an increased growth rate relative to control plants. Therefore, according to the present invention, there is provided a method for increasing the growth rate of plants, which method comprises modulating expression, preferably increasing expression, in a plant of a nucleic acid encoding a SYPF1 polypeptide as defined herein. 
     An increase in yield and/or growth rate occurs whether the plant is under non-stress conditions or whether the plant is exposed to various stresses compared to control plants. Plants typically respond to exposure to stress by growing more slowly. In conditions of severe stress, the plant may even stop growing altogether. Mild stress on the other hand is defined herein as being any stress to which a plant is exposed which does not result in the plant ceasing to grow altogether without the capacity to resume growth. Mild stress in the sense of the invention leads to a reduction in the growth of the stressed plants of less than 40%, 35% or 30%, preferably less than 25%, 20% or 15%, more preferably less than 14%, 13%, 12%, 11% or 10% or less in comparison to the control plant under non-stress conditions. Due to advances in agricultural practices (irrigation, fertilization, pesticide treatments) severe stresses are not often encountered in cultivated crop plants. As a consequence, the compromised growth induced by mild stress is often an undesirable feature for agriculture. Mild stresses are the everyday biotic and/or abiotic (environmental) stresses to which a plant is exposed. Abiotic stresses may be due to drought or excess water, anaerobic stress, salt stress, chemical toxicity, oxidative stress and hot, cold or freezing temperatures. The abiotic stress may be an osmotic stress caused by a water stress (particularly due to drought), salt stress, oxidative stress or an ionic stress. Biotic stresses are typically those stresses caused by pathogens, such as bacteria, viruses, fungi and insects. 
     In particular, the methods of the present invention may be performed under non-stress conditions or under conditions of mild drought to give plants having increased yield relative to control plants. As reported in Wang et al. (Planta (2003) 218: 1-14), abiotic stress leads to a series of morphological, physiological, biochemical and molecular changes that adversely affect plant growth and productivity. Drought, salinity, extreme temperatures and oxidative stress are known to be interconnected and may induce growth and cellular damage through similar mechanisms. Rabbani et al. (Plant Physiol (2003) 133: 1755-1767) describes a particularly high degree of “cross talk” between drought stress and high-salinity stress. For example, drought and/or salinisation are manifested primarily as osmotic stress, resulting in the disruption of homeostasis and ion distribution in the cell. Oxidative stress, which frequently accompanies high or low temperature, salinity or drought stress, may cause denaturing of functional and structural proteins. As a consequence, these diverse environmental stresses often activate similar cell signaling pathways and cellular responses, such as the production of stress proteins, up-regulation of anti-oxidants, accumulation of compatible solutes and growth arrest. The term “non-stress” conditions as used herein are those environmental conditions that allow optimal growth of plants. Persons skilled in the art are aware of normal soil conditions and climatic conditions for a given location. 
     Performance of the methods of the invention gives plants grown under non-stress conditions or under mild drought conditions increased yield relative to suitable control plants grown under comparable conditions. Therefore, according to the present invention, there is provided a method for increasing yield in plants grown under non-stress conditions or under mild drought conditions, which method comprises increasing expression in a plant of a nucleic acid encoding a SYPF1 polypeptide. 
     The present invention encompasses plants or parts thereof (including seeds) obtainable by the methods according to the present invention. The plants or parts thereof comprise a nucleic acid transgene encoding a SYPF1 polypeptide as defined above. 
     The invention also provides genetic constructs and vectors to facilitate introduction and/or expression in plants of nucleic acids encoding SYPF1 polypeptides. The gene constructs may be inserted into vectors, which may be commercially available, suitable for transforming into plants and suitable for expression of the gene of interest in the transformed cells. The invention also provides use of a gene construct as defined herein in the methods of the invention. 
     More specifically, the present invention provides a construct comprising:
         (a) a nucleic acid encoding a SYPF1 polypeptide as defined above;   (b) one or more control sequences capable of driving expression of the nucleic acid sequence of (a); and optionally   (c) a transcription termination sequence.       

     The term “control sequence” and “termination sequence” are as defined herein. 
     Plants are transformed with a vector comprising any of the nucleic acids described above. The skilled artisan is well aware of the genetic elements that must be present on the vector in order to successfully transform, select and propagate host cells containing the sequence of interest. The sequence of interest is operably linked to one or more control sequences (at least to a promoter). 
     Advantageously, any type of promoter may be used to drive expression of the nucleic acid sequence. A constitutive promoter is particularly useful in the methods of the invention, particularly medium-strength constitutive promoters. It should be clear that the applicability of the present invention is not restricted to the SYPF1 polypeptide-encoding nucleic acid represented by SEQ ID NO: 321, nor is the applicability of the invention restricted to expression of a SYPF1 polypeptide-encoding nucleic acid when driven by a constitutive promoter. 
     The constitutive promoter is preferably an HMG (High Mobility Group) promoter. See the “Definitions” section herein for further examples of constitutive promoters. 
     For the identification of functionally equivalent promoters, the promoter strength and/or expression pattern of a candidate promoter may be analysed for example by operably linking the promoter to a reporter gene and assaying the expression level and pattern of the reporter gene in various tissues of the plant. Suitable well-known reporter genes include for example beta-glucuronidase or beta galactosidase. The promoter activity is assayed by measuring the enzymatic activity of the beta-glucuronidase or beta-galactosidase. The promoter strength and/or expression pattern may then be compared to that of a reference promoter (such as the one used in the methods of the present invention). Alternatively, promoter strength may be assayed by quantifying mRNA levels or by comparing mRNA levels of the nucleic acid used in the methods of the present invention, with mRNA levels of housekeeping genes such as 18S rRNA, using methods known in the art, such as Northern blotting with densitometric analysis of autoradiograms, quantitative real-time PCR or RT-PCR (Heid et al., 1996 Genome Methods 6: 986-994). Generally by “weak promoter” is intended a promoter that drives expression of a coding sequence at a low level. By “low level” is intended at levels of about 1/10,000 transcripts to about 1/100,000 transcripts, to about 1/500,0000 transcripts per cell. Conversely, a “strong promoter” drives expression of a coding sequence at high level, or at about 1/10 transcripts to about 1/100 transcripts to about 1/1,000 transcripts per cell. 
     Optionally, one or more terminator sequences may be used in the construct introduced into a plant. Additional regulatory elements may include transcriptional as well as translational enhancers. Those skilled in the art will be aware of terminator and enhancer sequences that may be suitable for use in performing the invention. Such sequences would be known or may readily be obtained by a person skilled in the art. 
     An intron sequence may also be added to the 5′ untranslated region (UTR) or in the coding sequence to increase the amount of the mature message that accumulates in the cytosol. Inclusion of a spliceable intron in the transcription unit in both plant and animal expression constructs has been shown to increase gene expression at both the mRNA and protein levels up to 1000-fold (Buchman and Berg, Mol. Cell. Biol. 8:4395-4405 (1988); Callis et al., Genes Dev. 1:1183-1200 (1987)). Such intron enhancement of gene expression is typically greatest when placed near the 5′ end of the transcription unit. Use of the maize introns Adh1-S intron 1, 2, and 6, the Bronze-1 intron are known in the art. For general information, see The Maize Handbook, Chapter 116, Freeling and Walbot, Eds., Springer, N.Y. (1994). 
     Other control sequences (besides promoter, enhancer, silencer, intron sequences, 3′UTR and/or 5′UTR regions) may be protein and/or RNA stabilizing elements. Such sequences would be known or may readily be obtained by a person skilled in the art. 
     The genetic constructs of the invention may further include an origin of replication sequence that is required for maintenance and/or replication in a specific cell type. One example is when a genetic construct is required to be maintained in a bacterial cell as an episomal genetic element (e.g. plasmid or cosmid molecule). Preferred origins of replication include, but are not limited to, the f1-ori and colE1. 
     For the detection of the successful transfer of the nucleic acid sequences as used in the methods of the invention and/or selection of transgenic plants comprising these nucleic acids, it is advantageous to use marker genes (or reporter genes). Therefore, the genetic construct may optionally comprise a selectable marker gene. Selectable markers are described in more detail in the “definitions” section herein. 
     It is known that upon stable or transient integration of nucleic acids into plant cells, only a minority of the cells takes up the foreign DNA and, if desired, integrates it into its genome, depending on the expression vector used and the transfection technique used. To identify and select these integrants, a gene coding for a selectable marker (such as the ones described above) is usually introduced into the host cells together with the gene of interest. These markers can for example be used in mutants in which these genes are not functional by, for example, deletion by conventional methods. Furthermore, nucleic acid molecules encoding a selectable marker can be introduced into a host cell on the same vector that comprises the sequence encoding the polypeptides of the invention or used in the methods of the invention, or else in a separate vector. Cells which have been stably transfected with the introduced nucleic acid can be identified for example by selection (for example, cells which have integrated the selectable marker survive whereas the other cells die). 
     Since the marker genes, particularly genes for resistance to antibiotics and herbicides, are no longer required or are undesired in the transgenic host cell once the nucleic acids have been introduced successfully, the process according to the invention for introducing the nucleic acids advantageously employs techniques which enable the removal or excision of these marker genes. One such a method is what is known as co-transformation. The co-transformation method employs two vectors simultaneously for the transformation, one vector bearing the nucleic acid according to the invention and a second bearing the marker gene(s). A large proportion of transformants receives or, in the case of plants, comprises (up to 40% or more of the transformants), both vectors. In case of transformation with  Agrobacteria , the transformants usually receive only a part of the vector, i.e. the sequence flanked by the T-DNA, which usually represents the expression cassette. The marker genes can subsequently be removed from the transformed plant by performing crosses. In another method, marker genes integrated into a transposon are used for the transformation together with desired nucleic acid (known as the Ac/Ds technology). The transformants can be crossed with a transposase source or the transformants are transformed with a nucleic acid construct conferring expression of a transposase, transiently or stable. In some cases (approx. 10%), the transposon jumps out of the genome of the host cell once transformation has taken place successfully and is lost. In a further number of cases, the transposon jumps to a different location. In these cases the marker gene must be eliminated by performing crosses. In microbiology, techniques were developed which make possible, or facilitate, the detection of such events. A further advantageous method relies on what is known as recombination systems; whose advantage is that elimination by crossing can be dispensed with. The best-known system of this type is what is known as the Cre/lox system. Cre1 is a recombinase that removes the sequences located between the loxP sequences. If the marker gene is integrated between the loxP sequences, it is removed once transformation has taken place successfully, by expression of the recombinase. Further recombination systems are the HIN/HIX, FLP/FRT and REP/STB system (Tribble et al., J. Biol. Chem., 275, 2000: 22255-22267; Velmurugan et al., J. Cell Biol., 149, 2000: 553-566). A site-specific integration into the plant genome of the nucleic acid sequences according to the invention is possible. Naturally, these methods can also be applied to microorganisms such as yeast, fungi or bacteria. 
     The invention also provides a method for the production of transgenic plants having enhanced yield-related traits relative to control plants, comprising introduction and expression in a plant of any nucleic acid encoding a SYPF1 polypeptide as defined hereinabove. 
     More specifically, the present invention provides a method for the production of transgenic plants having increased yield, which method comprises:
         (i) introducing and expressing in a plant or plant cell a SYPF1 polypeptide-encoding nucleic acid; and   (ii) cultivating the plant cell under conditions promoting plant growth and development.       

     The nucleic acid may be introduced directly into a plant cell or into the plant itself (including introduction into a tissue, organ or any other part of a plant). According to a preferred feature of the present invention, the nucleic acid is preferably introduced into a plant by transformation. The term “transformation” is described in more detail in the “definitions” section herein. 
     The genetically modified plant cells can be regenerated via all methods with which the skilled worker is familiar. Suitable methods can be found in the abovementioned publications by S.D. Kung and R. Wu, Potrykus or Höfgen and Willmitzer. 
     Generally after transformation, plant cells or cell groupings are selected for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the gene of interest, following which the transformed material is regenerated into a whole plant. To select transformed plants, the plant material obtained in the transformation is, as a rule, subjected to selective conditions so that transformed plants can be distinguished from untransformed plants. For example, the seeds obtained in the above-described manner can be planted and, after an initial growing period, subjected to a suitable selection by spraying. A further possibility consists in growing the seeds, if appropriate after sterilization, on agar plates using a suitable selection agent so that only the transformed seeds can grow into plants. Alternatively, the transformed plants are screened for the presence of a selectable marker such as the ones described above. 
     Following DNA transfer and regeneration, putatively transformed plants may also be evaluated, for instance using Southern analysis, for the presence of the gene of interest, copy number and/or genomic organisation. Alternatively or additionally, expression levels of the newly introduced DNA may be monitored using Northern and/or Western analysis, both techniques being well known to persons having ordinary skill in the art. 
     The generated transformed plants may be propagated by a variety of means, such as by clonal propagation or classical breeding techniques. For example, a first generation (or T1) transformed plant may be selfed and homozygous second-generation (or T2) transformants selected, and the T2 plants may then further be propagated through classical breeding techniques. 
     The generated transformed organisms may take a variety of forms. For example, they may be chimeras of transformed cells and non-transformed cells; clonal transformants (e.g., all cells transformed to contain the expression cassette); grafts of transformed and untransformed tissues (e.g., in plants, a transformed rootstock grafted to an untransformed scion). 
     The present invention clearly extends to any plant cell or plant produced by any of the methods described herein, and to all plant parts and propagules thereof. The present invention extends further to encompass the progeny of a primary transformed or transfected cell, tissue, organ or whole plant that has been produced by any of the aforementioned methods, the only requirement being that progeny exhibit the same genotypic and/or phenotypic characteristic(s) as those produced by the parent in the methods according to the invention. 
     The invention also includes host cells containing an isolated nucleic acid encoding a SYPF1 polypeptide as defined hereinabove. Preferred host cells according to the invention are plant cells. Host plants for the nucleic acids or the vector used in the method according to the invention, the expression cassette or construct or vector are, in principle, advantageously all plants, which are capable of synthesizing the polypeptides used in the inventive method. 
     The methods of the invention are advantageously applicable to any plant. 
     Plants that are particularly useful in the methods of the invention include all plants which belong to the superfamily Viridiplantae, in particular monocotyledonous and dicotyledonous plants including fodder or forage legumes, ornamental plants, food crops, trees or shrubs. According to a preferred embodiment of the present invention, the plant is a crop plant. Examples of crop plants include soybean, sunflower, canola, alfalfa, rapeseed, cotton, tomato, potato and tobacco. Further preferably, the plant is a monocotyledonous plant. Examples of monocotyledonous plants include sugarcane. More preferably the plant is a cereal. Examples of cereals include rice, maize, wheat, barley, millet, rye, sorghum and oats. 
     The invention also extends to harvestable parts of a plant such as, but not limited to seeds, leaves, fruits, flowers, stems, rhizomes, tubers and bulbs. The invention furthermore relates to products derived, preferably directly derived, from a harvestable part of such a plant, such as dry pellets or powders, oil, fat and fatty acids, starch or proteins. 
     According to a preferred feature of the invention, the modulated expression is increased expression. Methods for increasing expression of nucleic acids or genes, or gene products, are well documented in the art and include, for example, overexpression driven by appropriate promoters, the use of transcription enhancers or translation enhancers. Isolated nucleic acids which serve as promoter or enhancer elements may be introduced in an appropriate position (typically upstream) of a non-heterologous form of a polynucleotide so as to upregulate expression. For example, endogenous promoters may be altered in vivo by mutation, deletion, and/or substitution (see, Kmiec, U.S. Pat. No. 5,565,350; Zarling et al., PCT/US93/03868), or isolated promoters may be introduced into a plant cell in the proper orientation and distance from a gene of the present invention so as to control the expression of the gene. 
     If polypeptide expression is desired, it is generally desirable to include a polyadenylation region at the 3′-end of a polynucleotide coding region. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The 3′ end sequence to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene. 
     As mentioned above, a preferred method for modulating (preferably, increasing) expression of a nucleic acid encoding a SYPF1 polypeptide is by introducing and expressing in a plant a nucleic acid encoding a SYPF1 polypeptide; however the effects of performing the method, i.e. enhancing yield-related traits may also be achieved using other well known techniques. A description of some of these techniques will now follow. 
     One such technique is T-DNA activation tagging (Hayashi et al. Science (1992) 1350-1353), which involves insertion of T-DNA, usually containing a promoter (may also be a translation enhancer or an intron), in the genomic region of the gene of interest or 10 kb up- or downstream of the coding region of a gene in a configuration such that the promoter directs expression of the targeted gene. Typically, regulation of expression of the targeted gene by its natural promoter is disrupted and the gene falls under the control of the newly introduced promoter. The promoter is typically embedded in a T-DNA. This T-DNA is randomly inserted into the plant genome, for example, through  Agrobacterium  infection and leads to modified expression of genes near the inserted T-DNA. The resulting transgenic plants show dominant phenotypes due to modified expression of genes close to the introduced promoter. 
     The effects of the invention may also be reproduced using the technique of TILLING (Targeted Induced Local Lesions In Genomes); for a description of the same see the “definitions” section. 
     The effects of the invention may also be reproduced using homologous recombination; for a description of the same see the “definitions” section. 
     The present invention also encompasses use of nucleic acids encoding SYPF1 polypeptides as described herein and use of these SYPF1 polypeptide in enhancing any of the aforementioned yield-related traits in plants. 
     Nucleic acids encoding SYPF1 polypeptide described herein, or the SYPF1 polypeptides themselves, may find use in breeding programmes in which a DNA marker is identified which may be genetically linked to a SYPF1 polypeptide-encoding gene. The nucleic acids/genes, or the SYPF1 polypeptides themselves may be used to define a molecular marker. This DNA or protein marker may then be used in breeding programmes to select plants having enhanced yield-related traits as defined hereinabove in the methods of the invention. 
     Allelic variants of a SYPF1 polypeptide-encoding nucleic acid/gene may also find use in marker-assisted breeding programmes. Such breeding programmes sometimes require introduction of allelic variation by mutagenic treatment of the plants, using for example EMS mutagenesis; alternatively, the programme may start with a collection of allelic variants of so called “natural” origin caused unintentionally. Identification of allelic variants then takes place, for example, by PCR. This is followed by a step for selection of superior allelic variants of the sequence in question and which give increased yield. Selection is typically carried out by monitoring growth performance of plants containing different allelic variants of the sequence in question. Growth performance may be monitored in a greenhouse or in the field. Further optional steps include crossing plants in which the superior allelic variant was identified with another plant. This could be used, for example, to make a combination of interesting phenotypic features. 
     Nucleic acids encoding SYPF1 polypeptides may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes. Such use of SYPF1 polypeptide-encoding nucleic acids requires only a nucleic acid sequence of at least 15 nucleotides in length. The SYPF1 polypeptide-encoding nucleic acids may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (Sambrook J, Fritsch E F and Maniatis T (1989) Molecular Cloning, A Laboratory Manual) of restriction-digested plant genomic DNA may be probed with the SYPF1-encoding nucleic acids. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et al. (1987) Genomics 1: 174-181) in order to construct a genetic map. In addition, the nucleic acids may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the SYPF1 polypeptide-encoding nucleic acid in the genetic map previously obtained using this population (Botstein et al. (1980) Am. J. Hum. Genet. 32:314-331). 
     The production and use of plant gene-derived probes for use in genetic mapping is described in Bernatzky and Tanksley (1986) Plant Mol. Biol. Reporter 4: 37-41. Numerous publications describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art. 
     The nucleic acid probes may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel et al. In: Non-mammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein). 
     In another embodiment, the nucleic acid probes may be used in direct fluorescence in situ hybridisation (FISH) mapping (Trask (1991) Trends Genet. 7:149-154). Although current methods of FISH mapping favour use of large clones (several kb to several hundred kb; see Laan et al. (1995) Genome Res. 5:13-20), improvements in sensitivity may allow performance of FISH mapping using shorter probes. 
     A variety of nucleic acid amplification-based methods for genetic and physical mapping may be carried out using the nucleic acids. Examples include allele-specific amplification (Kazazian (1989) J. Lab. Clin. Med. 11:95-96), polymorphism of PCR-amplified fragments (CAPS; Sheffield et al. (1993) Genomics 16:325-332), allele-specific ligation (Landegren et al. (1988) Science 241:1077-1080), nucleotide extension reactions (Sokolov (1990) Nucleic Acid Res. 18:3671), Radiation Hybrid Mapping (Walter et al. (1997) Nat. Genet. 7:22-28) and Happy Mapping (Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807). For these methods, the sequence of a nucleic acid is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR-based genetic mapping, it may be necessary to identify DNA sequence differences between the parents of the mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, is generally not necessary for mapping methods. 
     The methods according to the present invention result in plants having enhanced yield-related traits, as described hereinbefore. These traits may also be combined with other economically advantageous traits, such as further yield-enhancing traits, tolerance to other abiotic and biotic stresses, traits modifying various architectural features and/or biochemical and/or physiological features. 
     (v) RCA 
     Surprisingly, it has now been found that increasing expression in a plant of a nucleic acid sequence encoding a Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) activase (RCA) polypeptide gives plants having enhanced yield-related traits relative to control plants. The particular class of RCA polypeptides suitable for enhancing yield-related traits in plants is described in detail below. 
     The present invention provides a method for enhancing yield-related traits in plants relative to control plants, comprising increasing expression in a plant of a nucleic acid sequence encoding an RCA polypeptide. 
     Any reference hereinafter to a “polypeptide useful in the methods of the invention” is taken to mean an RCA polypeptide as defined herein. Any reference hereinafter to a “nucleic acid sequence useful in the methods of the invention” is taken to mean a nucleic acid sequence capable of encoding such an RCA polypeptide. The terms “polypeptide” and “protein” are as defined herein. The terms “polynucleotide(s)”, “nucleic acid sequence(s)”, “nucleotide sequence(s)” are also defined herein. The term “control plant” is also as defined herein. 
     A preferred method for increasing expression of a nucleic acid sequence encoding a polypeptide useful in the methods of the invention is by introducing and expressing in a plant a nucleic acid sequence encoding a polypeptide useful in the methods of the invention as defined below. 
     The nucleic acid sequence to be introduced into a plant (and therefore useful in performing the methods of the invention) is any nucleic acid sequence encoding the type of polypeptide which will now be described, hereafter also named “RCA nucleic acid sequence” or “RCA gene”. An “RCA” polypeptide as defined herein refers to any polypeptide sequence that is not redox-regulated and comprising from N-terminus to C-terminus: (i) a plastidic transit peptide; (ii) in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 98% sequence identity to the AAA domain as represented by SEQ ID NO: 311. 
     Additionally, an RCA polypeptide may comprise within the AAA domain a Motif 1 G(G/R)KG(Q/E)GK(S/T) as represented by SEQ ID NO: 312. Within this motif, is allowed one or more conservative change at any position, and/or one or two non-conservative change(s) at any position. 
     Alternatively, an “RCA” polypeptide as defined herein refers to any polypeptide sequence that is not redox-regulated with in increasing order of preference at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 98% sequence identity to the RCA polypeptide as represented by SEQ ID NO: 251. 
     An RCA polypeptide that is not redox-regulated is herein taken to mean an RCA polypeptide that is not regulated by light via the ferredoxin/thioredoxin system. Examples of such RCA polypeptides are the naturally occurring beta (short form, or SF) RCA polypeptides, or alpha (long form, or LF)) RCA polypeptides that have been truncated or mutated in the C-terminal extension to prevent redox regulation. 
     Examples of polypeptides useful in the methods of the invention and nucleic acid sequences encoding the same are as given below in table D1 of the Examples section. Such RCA polypeptides are the naturally occurring beta (short form, or SF) RCA polypeptides, or alpha (long form, or LF)) RCA polypeptides that are truncated or mutated in the C-terminal extension to prevent redox regulation. 
     Also useful in the methods of the invention are homologues of any one of the polypeptide sequences given in table D1 in the Examples section. “Homologues” are defined in the Definitions section herein. 
     Also useful in the methods of the invention are derivatives of any one of the polypeptides given in table D1 or orthologues or paralogues of any of the aforementioned SEQ ID NOs. “Derivatives” are as defined in the Definitions section herein. Derivatives of SEQ ID NO: 251 or of any of the polypeptides given in table D1 are preferred. 
     The invention is illustrated by transforming plants with the  Chlamydomonas reinhardtii  nucleic acid sequence represented by SEQ ID NO: 250, encoding the polypeptide sequence of SEQ ID NO: 251, however performance of the invention is not restricted to these sequences. The methods of the invention may advantageously be performed using any nucleic acid sequence encoding a polypeptide useful in the methods of the invention as defined herein, including orthologues and paralogues, such as any of the nucleic acid sequences given in table D1. Such RCA polypeptides are the naturally occurring beta (short form, or SF) RCA polypeptides, or alpha (long form, or LF)) RCA polypeptides that are truncated or mutated in the C-terminal extension to prevent redox regulation. 
     The polypeptide sequences given in table D1 may be considered to be orthologues and paralogues of the RCA polypeptide represented by SEQ ID NO: 251, the terms “orthologues” and “paralogues” being as defined herein. 
     Orthologues and paralogues may easily be found by performing a so-called reciprocal blast search. Typically, this involves a first BLAST involving BLASTing a query sequence (for example using any of the sequences listed in table D1) against any sequence database, such as the publicly available NCBI database. BLASTN or TBLASTX (using standard default values) are generally used when starting from a nucleotide sequence, and BLASTP or TBLASTN (using standard default values) when starting from a polypeptide sequence. The BLAST results may optionally be filtered. The full-length sequences of either the filtered results or non-filtered results are then BLASTed back (second BLAST) against sequences from the organism from which the query sequence is derived (where the query sequence is SEQ ID NO: 250 or SEQ ID NO: 251, the second BLAST would therefore be against  Chlamydomonas reinhardtii  sequences). The results of the first and second BLASTs are then compared. A paralogue is identified if a high-ranking hit from the first blast is from the same species as from which the query sequence is derived, a BLAST back then ideally results in the query sequence as highest hit; an orthologue is identified if a high-ranking hit in the first BLAST is not from the same species as from which the query sequence is derived, and preferably results upon BLAST back in the query sequence being among the highest hits. 
     High-ranking hits are those having a low E-value. The lower the E-value, the more significant the score (or in other words the lower the chance that the hit was found by chance). Computation of the E-value is well known in the art. In addition to E-values, comparisons are also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In the case of large families, ClustalW may be used, followed by a neighbour joining tree, to help visualize clustering of related genes and to identify orthologues and paralogues. 
     Table D1 gives examples of orthologues and paralogues of the RCA polypeptide represented by SEQ ID NO 251. Further orthologues and paralogues may readily be identified using the BLAST procedure described above. Such RCA polypeptides are the naturally occurring beta (short form, or SF) RCA polypeptides, or alpha (long form, or LF)) RCA polypeptides that are truncated or mutated in the C-terminal extension to prevent redox regulation. 
     The polypeptides of the invention are identifiable by the presence of the conserved AAA domain (shown in  FIG. 14 ), the term “domain” being as defined herein. The term “motif”, “consensus sequence” and “signature” are also defined herein. 
     The term “extension” as defined herein, refers to the additional amino acid residues of polypeptides extending beyond the last amino acid of the shortest polypeptide in a multiple sequence alignment. The amino acid residues may be naturally occurring, or modified by human intervention. 
     Specialist databases also exist for the identification of domains, for example, SMART (Schultz et al. (1998) Proc. Natl. Acad. Sci. USA 95, 5857-5864; Letunic et al. (2002) Nucleic Acids Res 30, 242-244, InterPro (Mulder et al., (2003) Nucl. Acids. Res. 31, 315-318, Prosite (Bucher and Bairoch (1994), A generalized profile syntax for biomolecular sequences motifs and its function in automatic sequence interpretation. (In) ISMB-94; Proceedings 2nd International Conference on Intelligent Systems for Molecular Biology. Altman R., Brutlag D., Karp P., Lathrop R., Searls D., Eds., pp 53-61, AAAIPress, Menlo Park; Hulo et al., Nucl. Acids. Res. 32:D134-D137, (2004), or Pfam (Bateman et al., Nucleic Acids Research 30(1): 276-280 (2002). A set of tools for in silico analysis of polypeptide sequences is available on the ExPASY proteomics server (hosted by the Swiss Institute of Bioinformatics (Gasteiger et al., ExPASy: the proteomics server for in-depth protein knowledge and analysis, Nucleic Acids Res. 31:3784-3788 (2003)). For example, the AAA domain of SEQ ID NO: 251 is represented in the InterPro database by accession number IPR003959. 
     Domains may also be identified using routine techniques, such as by sequence alignment. Methods for the alignment of sequences for comparison are well known in the art, such methods include GAP, BESTFIT, BLAST, FASTA and TFASTA. GAP uses the algorithm of Needleman and Wunsch ((1970) J Mol Biol 48: 443-453) to find the global (i.e. spanning the complete sequences) alignment of two sequences that maximizes the number of matches and minimizes the number of gaps. The BLAST algorithm (Altschul et al. (1990) J Mol Biol 215: 403-10) calculates percent sequence identity and performs a statistical analysis of the similarity between the two sequences. The software for performing BLAST analysis is publicly available through the National Centre for Biotechnology Information (NCBI). Homologues may readily be identified using, for example, the ClustalW multiple sequence alignment algorithm (version 1.83), with the default pairwise alignment parameters, and a scoring method in percentage. Global percentages of similarity and identity may also be determined using one of the methods available in the MatGAT software package (Campanella et al., BMC Bioinformatics. 2003 Jul. 10; 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences.). Minor manual editing may be performed to optimise alignment between conserved motifs, as would be apparent to a person skilled in the art. Furthermore, instead of using full-length sequences for the identification of homologues, specific domains (such as the AAA domain, or Motif1 defined above) may be used as well. The sequence identity values, which are indicated below in Example 3 as a percentage were determined over the entire nucleic acid or polypeptide sequence, and/or over selected domains or conserved motif(s), using the programs mentioned above using the default parameters. 
     The task of protein subcellular localisation prediction is important and well studied. Knowing a protein&#39;s localisation helps elucidate its function. Experimental methods for protein localization range from immunolocalization to tagging of proteins using green fluorescent protein (GFP). Such methods are accurate although labor-intensive compared with computational methods. Recently much progress has been made in computational prediction of protein localisation from sequence data. Among algorithms well known to a person skilled in the art are available at the ExPASy Proteomics tools hosted by the Swiss Institute for Bioinformatics, for example, PSort, TargetP, ChloroP, Predotar, LipoP, MITOPROT, PATS, PTS1, SignalP and others. The identification of subcellular localisation of the polypeptide of the invention is described in the Examples section herein. In particular SEQ ID NO: 251 of the present invention is assigned to the plastidic (chloroplastic) compartment of photosynthetic (autotrophic) cells. 
     Methods for targeting to plastids are well known in the art and include the use of transit peptides. The table below shows examples of transit peptides which can be used to target any RCA polypeptide to a plastid, which RCA polypeptide is not, in its natural form, normally targeted to a plastid, or which RCA polypeptide in its natural form is targeted to a plastid by virtue of a different transit peptide (for example, its natural transit peptide). For example, a nucleic acid sequence encoding a cyanobacterial RCA polypeptide (from Anabaena, described by Li et al., (1993) Plant Molec Biol 21(5): 753-764; SEQ ID NO: 301) may also be suitable for use in the methods of the invention so long as the RCA polypeptide is targeted to a plastid, preferably to a chloroplast, and that it is not redox-regulated. 
     Examples of transit peptide sequences useful in targeting polypeptides to plastids 
     
       
         
           
               
               
               
               
             
               
                   
               
               
                 NCBI Accession 
                   
                   
                   
               
               
                 Number/SEQ ID 
                   
                   
                   
               
               
                 NO 
                 Source Organism 
                 Protein Function 
                 Transit Peptide Sequence 
               
               
                   
               
             
            
               
                 SEQ ID NO: 
                 
                   Chlamydomonas 
                 
                 Ferredoxin 
                 MAMAMRSTFAARVGAKPAVRGARPASRMSCMA 
               
               
                 P07839 
                   
                   
                   
               
               
                   
               
               
                 SEQ ID NO: 
                 
                   
                     Chlamydomonas 
                   
                 
                 Rubisco activase 
                 MQVTMKSSAVSGQRVGGARVATRSVRRAQLQV 
               
               
                 AAR23425 
                   
                   
                   
               
               
                   
               
               
                 SEQ ID NO: 
                 
                   Arabidopsis 
                 
                 Aspartate amino  
                 MASLMLSLGSTSLLPREINKDKLKLGTSASNPFLK 
               
               
                 CAA56932 
                 
                   thaliana 
                 
                 transferase 
                 AKSFSRVTMTVAVKPSR 
               
               
                   
               
               
                 SEQ ID NO: 
                 
                   Arabidopsis 
                 
                 Acyl carrier protein1 
                 MATQFSASVSLQTSCLATTRISFQKPALISNHGKT 
               
               
                 CAA31991 
                 
                   thaliana 
                 
                   
                 NLSFNLRRSIPSRRLSVSC 
               
               
                   
               
               
                 SEQ ID NO: 
                 
                   Arabidopsis 
                 
                 Acyl carrier protein2 
                 MASIAASASISLQARPRQLAIAASQVKSFSNGRRS 
               
               
                 CAB63798 
                 
                   thaliana 
                 
                   
                 SLSFNLRQLPTRLTVSCAAKPETVDKVCAVVRKQL 
               
               
                   
               
               
                 SEQ ID NO: 
                 
                   Arabidopsis 
                 
                 Acyl carrier protein3 
                 MASIATSASTSLQARPRQLVIGAKQVKSFSYGSRS 
               
               
                 CAB63799 
                 
                   thaliana 
                 
                   
                 NLSFNLRQLPTRLTVYCAAKPETVDKVCAVVRKQ 
               
               
                   
                   
                   
                 LSLKE 
               
               
                   
               
            
           
         
       
     
     The RCA polypeptide is targeted and active in the chloroplast, i.e., the RCA polypeptide is capable of performing a dual activity: (re)-activation of RuBisCo, and ATP hydrolysis, in the chloroplast. Assays for testing these activities are well known in the art. Further details are provided in the Examples section herein. 
     Nucleic acid sequences encoding polypeptides useful in the methods of the invention need not be full-length nucleic acid sequences, since performance of the methods of the invention does not rely on the use of full-length nucleic acid sequences. Examples of nucleic acid sequences suitable for use in performing the methods of the invention include the nucleic acid sequences given in table D1, but are not limited to those sequences. Nucleic acid variants may also be useful in practising the methods of the invention. Examples of such nucleic acid variants include portions of nucleic acid sequences encoding a polypeptide useful in the methods of the invention, nucleic acid sequences hybridising to nucleic acid sequences encoding a polypeptide useful in the methods of the invention, splice variants of nucleic acid sequences encoding a polypeptide useful in the methods of the invention, allelic variants of nucleic acid sequences encoding a polypeptide useful in the methods of the invention and variants of nucleic acid sequences encoding a polypeptide useful in the methods of the invention that are obtained by site-directed mutagenesis. The terms portion, hybridising sequence, splice variant, allelic variant and site-directed mutagenesis will now be described. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a portion of any one of the nucleic acid sequences given in table D1, or a portion of a nucleic acid sequence encoding an orthologue, paralogue or homologue of any of the polypeptide sequences given in table D1. Such portions of RCA polypeptides are from naturally occurring beta (short form, or SF) RCA polypeptides, or from alpha (long form, or LF)) RCA polypeptides that are truncated or mutated in the C-terminal extension to prevent redox regulation. 
     Portions useful in the methods of the invention, encode a polypeptide falling within the definition of a nucleic acid sequence encoding a polypeptide useful in the methods of the invention as defined herein and having substantially the same biological activity as the polypeptide sequences given in table D1. Preferably, the portion is a portion of any one of the nucleic acid sequences given in table D1. The portion is typically at least 900 consecutive nucleotides in length, preferably at least 1000 consecutive nucleotides in length, more preferably at least 1100 consecutive nucleotides in length and most preferably at least 1227 consecutive nucleotides in length, the consecutive nucleotides being of any one of the nucleic acid sequences given in table D1. Preferably, the portion encodes a polypeptide sequence that is not redox-regulated and comprising from N-terminus to C-terminus: (i) a plastidic transit peptide; (ii) in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 98% sequence identity to the AAA domain as represented by SEQ ID NO: 311; and which may additionally comprise within the AAA domain a Motif 1 G(G/R)KG(Q/E)GK(S/T) as represented by SEQ ID NO: 312. Most preferably the portion is a portion of the nucleic acid sequence of SEQ ID NO: 250. 
     A portion of a nucleic acid sequence encoding an RCA polypeptide as defined herein may be prepared, for example, by making one or more deletions to the nucleic acid sequence. The portions may be used in isolated form or they may be fused to other coding (or non coding) sequences in order to, for example, produce a polypeptide that combines several activities, or to produce a polypeptide targeted to another subcellular compartment than its natural compartment. When fused to other coding sequences, the resultant polypeptide produced upon translation may be bigger than that predicted for the RCA polypeptide portion. 
     Another nucleic acid variant useful in the methods of the invention is a nucleic acid sequence capable of hybridising, under reduced stringency conditions, preferably under stringent conditions, with a nucleic acid sequence encoding an RCA polypeptide as defined herein, or with a portion as defined herein. 
     Hybridising sequences useful in the methods of the invention encode a polypeptide sequence comprising from N-terminus to C-terminus: (i) a plastidic transit peptide; (ii) in increasing order of preference at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 98% sequence identity to the AAA domain as represented by SEQ ID NO: 311; and which may additionally comprise within the AAA domain a Motif 1 G(G/R)KG(Q/E)GK(S/T) as represented by SEQ ID NO: 312. The hybridising sequence is typically at least 900 consecutive nucleotides in length, preferably at least 1000 consecutive nucleotides in length, more preferably at least 1100 consecutive nucleotides in length and most preferably at least 1200 consecutive nucleotides in length, the consecutive nucleotides being of any one of the nucleic acid sequences given in table D1. Preferably, the hybridising sequence is one that is capable of hybridising to any of the nucleic acid sequences given in table D1, or to a portion of any of these sequences, a portion being as defined above. Most preferably, the hybridising sequence is capable of hybridising to a nucleic acid sequence as represented by SEQ ID NO: 250 or to a portion thereof. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a nucleic acid sequence capable of hybridizing to any one of the nucleic acid sequences given in table D1, or comprising introducing and expressing in a plant a nucleic acid sequence capable of hybridising to a nucleic acid sequence encoding an orthologue, paralogue or homologue of any of the nucleic acid sequences given in the table D1. Such hybridising sequences encode naturally occurring beta (short form, or SF) RCA polypeptides, or encode alpha (long form, or LF)) RCA polypeptides that are truncated or mutated in the C-terminal extension to prevent redox regulation. The term “hybridisation” is as defined herein. 
     Another nucleic acid variant useful in the methods of the invention is a splice variant encoding an RCA polypeptide as defined hereinabove, the term “splice variant” being as defined herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits i n plants, comprising introducing and expressing in a plant a splice variant of any one of the nucleic acid sequences given in table D1, or a splice variant of a nucleic acid sequence encoding an orthologue, paralogue or homologue of any of the polypeptide sequences given in table D1. Such splice variants of nucleic acid sequences encode naturally occurring beta (short form, or SF) RCA polypeptides, or from alpha (long form, or LF)) RCA polypeptides that are truncated or mutated in the C-terminal extension to prevent redox regulation. 
     Preferred splice variants are splice variants of a nucleic acid sequence represented by SEQ ID NO: 250 or a splice variant of a nucleic acid sequence encoding an orthologue or paralogue of SEQ ID NO: 251. Preferably, the polypeptide sequence encoded by the splice variant comprises any one or more of the motifs or domains as defined herein. 
     Another nucleic acid variant useful in performing the methods of the invention is an allelic variant of a nucleic acid sequence encoding an RCA polypeptide as defined hereinabove. Alleles or allelic variants are alternative forms of a given gene, located at the same chromosomal position. Allelic variants exist in nature, and encompassed within the methods of the present invention is the use of these natural alleles. Allelic variants encompass Single Nucleotide Polymorphisms (SNPs), as well as Small Insertion/Deletion Polymorphisms (INDELs). The size of INDELs is usually less than 100 bp. SNPs and INDELs form the largest set of sequence variants in naturally occurring polymorphic strains of most organisms. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant an allelic variant of any one of the nucleic acid sequences given in table D1, or comprising introducing and expressing in a plant an allelic variant of a nucleic acid sequence encoding an orthologue, paralogue or homologue of any of the polypeptide sequences given in table D1. Such allelic variants of nucleic acid sequences encode naturally occurring beta (short form, or SF) RCA polypeptides, or encode alpha (long form, or LF)) RCA polypeptides that are truncated or mutated in the C-terminal extension to prevent redox regulation. 
     Preferably, the allelic variant is an allelic variant of SEQ ID NO: 250 or an allelic variant of a nucleic acid sequence encoding an orthologue or paralogue of SEQ ID NO: 251. Preferably, the polypeptide sequence encoded by the allelic variant comprises any one or more of the motifs or domains as defined herein. 
     A further nucleic acid variant useful in the methods of the invention is a nucleic acid variant obtained by site-directed mutagenesis, which is defined in the Definitions section herein. 
     According to the present invention, there is provided a method for enhancing yield-related traits in plants, comprising introducing and expressing in a plant a variant of any one of the nucleic acid sequences given in table D1, or comprising introducing and expressing in a plant a variant of a nucleic acid sequence encoding an orthologue, paralogue or homologue of any of the polypeptide sequences given in table D1, which variant nucleic acid sequence is obtained by site-directed mutagenesis. Such nucleic acid variants obtained by site directed mutagenesis encode beta (short form, or SF) RCA polypeptides, or encode alpha (long form, or LF)) RCA polypeptides that are truncated or mutated in the C-terminal extension to prevent redox regulation. 
     Preferably, the variant nucleic acid sequence obtained by site-directed mutagenesis encodes a polypeptide sequence comprising any one or more of the motifs or domains as defined herein. 
     The following nucleic acid variants encoding RCA polypeptides are examples of variants suitable in practising the methods of the invention:
         (i) a portion of a nucleic acid sequence encoding an RCA polypeptide;   (ii) a nucleic acid sequence capable of hybridising with a nucleic acid sequence encoding an RCA polypeptide;   (iii) a splice variant of a nucleic acid sequence encoding an RCA polypeptide;   (iv) an allelic variant of a nucleic acid sequence encoding an RCA polypeptide;   (v) a nucleic acid sequence encoding an RCA polypeptide obtained by site-directed mutagenesis;
 
which RCA polypeptide is not redox-regulated.
       

     Nucleic acid sequences encoding RCA polypeptides may be derived from any natural or artificial source. The nucleic acid sequence may be modified from its native form in composition and/or genomic environment through deliberate human manipulation. Preferably the nucleic acid sequence encoding an RCA polypeptide originates from a photosynthetic cell (Plantae kingdom). Further preferably the nucleic acid sequence encoding an RCA polypeptide originates from a plant cell. More preferably, the nucleic acid sequence encoding an RCA polypeptide originates from a diatom cell. Most preferably the nucleic acid sequence encoding an RCA polypeptide originates from an algal (red, brown or green) cell. The nucleic acid sequence may be isolated from green algae belonging Chlorophyta or Charophyta, or from land plants, non-vascular or vascular. Most preferably the nucleic acid sequence encoding an RCA polypeptide is from  Chlamydomonas reinhardtii.    
     Any reference herein to an RCA polypeptide is therefore taken to mean an RCA polypeptide as defined above. Any nucleic acid sequence encoding such an RCA polypeptide is suitable for use in performing the methods of the invention. 
     The present invention also encompasses plants or parts thereof (including seeds) obtainable by the methods according to the present invention. The plants or parts thereof comprise a nucleic acid transgene encoding an RCA polypeptide as defined above. 
     The invention also provides genetic constructs and vectors to facilitate introduction and/or expression of the nucleic acid sequences useful in the methods according to the invention, in a plant. The gene constructs may be inserted into vectors, which may be commercially available, suitable for transforming into plants and suitable for expression of the gene of interest in the transformed cells. The invention also provides use of a gene construct as defined herein in the methods of the invention. 
     More specifically, the present invention provides a construct comprising
         (a) nucleic acid sequence encoding an RCA polypeptide, as defined above;   (b) one or more control sequences capable of driving expression of the nucleic acid sequence of (a); and optionally   (c) a transcription termination sequence.       

     A preferred construct is one in which the control sequence is a strong constitutive promoter, more preferably a GOS2 promoter, further preferably the rice GOS2 promoter, most preferably the rice GOS2 promoter as represented by SEQ ID NO: 306. 
     Alternatively, a preferred construct is one in which the control sequence is a constitutive promoter of medium strength, more preferably an HMGB promoter, further preferably the rice HMGB promoter as represented by SEQ ID NO: 307. 
     Alternatively, a preferred construct is one in which the control sequence is a green tissue-specific promoter, more preferably a protochlorophyllide reductase promoter, further preferably the rice protochlorophyllide reductase promoter as represented by SEQ ID NO: 308. 
     Plants are transformed with a vector comprising the sequence of interest (i.e., a nucleic acid sequence encoding an RCA polypeptide as defined herein. The skilled artisan is well aware of the genetic elements that must be present on the vector in order to successfully transform, select and propagate host cells containing the sequence of interest. The sequence of interest is operably linked to one or more control sequences (at least to a promoter). The terms “regulatory element”, “control sequence” and “promoter” are as defined herein. The term “operably linked” is also as defined herein. 
     Advantageously, any type of promoter may be used to drive expression of the nucleic acid sequence. The term “promoter” refers to a nucleic acid control sequence located upstream from the transcriptional start of a gene and which is involved in recognising and binding of RNA polymerase and other proteins, thereby directing transcription of an operably linked nucleic acid sequence. A “plant” promoter comprises regulatory elements, which mediate the expression of a coding sequence segment in plant cells. Accordingly, a plant promoter need not be of plant origin, but may originate from viruses or micro-organisms, for example from viruses which attack plant cells. The “plant promoter” can also originate from a plant cell, e.g. from the plant which is transformed with the nucleic acid sequence to be expressed in the inventive process and described herein. This also applies to other “plant” regulatory signals, such as “plant” terminators. The promoters upstream of the nucleotide sequences useful in the methods of the present invention can be modified by one or more nucleotide substitution(s), insertion(s) and/or deletion(s) without interfering with the functionality or activity of either the promoters, the open reading frame (ORF) or the 3′-regulatory region such as terminators or other 3′ regulatory regions which are located away from the ORF. It is furthermore possible that the activity of the promoters is increased by modification of their sequence, or that they are replaced completely by more active promoters, even promoters from heterologous organisms. For expression in plants, the nucleic acid molecule must, as described above, be linked operably to or comprise a suitable promoter which expresses the gene at the right point in time and with the required spatial expression pattern. 
     The promoter may be a constitutive promoter or an inducible promoter, for example a stress-inducible promoter. Alternatively, the promoter may be an organ-specific or tissue-specific promoter (see definitions section herein for definitions and examples of various promoter types). 
     In one embodiment, the nucleic acid sequence is operably linked to a strong constitutive promoter. Preferably the promoter is derived from a plant, more preferably the promoter is from a monocotyledonous plant if a monocotyledonous plant is to be transformed. 
     In a preferred embodiment, the constitutive promoter is a GOS2 promoter, further preferably a rice GOS2 promoter. Most preferably, the GOS2 promoter is as represented by SEQ ID NO: 306. It should be clear that the applicability of the present invention is not restricted to the nucleic acid sequence encoding an RCA polypeptide as represented by SEQ ID NO: 250, nor is the applicability of the invention restricted to expression of a nucleic acid sequence encoding an RCA polypeptide when driven by a GOS2 promoter. 
     Alternatively, the nucleic acid sequence is operably linked to a constitutive promoter, preferably an HMGB promoter, further preferably a rice HMGB promoter. Most preferably, the HMGB promoter is as represented by SEQ ID NO: 307. It should be clear that the applicability of the present invention is not restricted to the nucleic acid sequence encoding an RCA polypeptide as represented by SEQ ID NO: 250, nor is the applicability of the invention restricted to expression of a nucleic acid sequence encoding an RCA polypeptide when driven by an HMGB promoter. 
     According to another preferred embodiment, the nucleic acid encoding an RCA polypeptide is operably linked to a green tissue-specific promoter, preferably a protochlorophyllide reductase promoter, further preferably a rice protochlorophyllide reductase promoter. Most preferably, the green tissue-specific promoter is as represented by SEQ ID NO: 308. It should be clear that the applicability of the present invention is not restricted to the nucleic acid sequence encoding an RCA polypeptide as represented by SEQ ID NO: 250, nor is the applicability of the invention restricted to expression of a nucleic acid sequence encoding an RCA polypeptide when driven by a protochlorophyllide reductase promoter. Other green-tissue specific promoters which are available for the expression of genes in plants are described in DE-A 19644478. 
     For the identification of functionally equivalent promoters, the promoter strength and/or expression pattern of a candidate promoter may be analysed for example by operably linking the promoter to a reporter gene and assay the expression level and pattern of the reporter gene in various tissues of the plant. Suitable well-known reporter genes include for example beta-glucuronidase or beta galactosidase. The promoter activity is assayed by measuring the enzymatic activity of the beta-glucuronidase or beta-galactosidase. The promoter strength and/or expression pattern may then be compared to that of a reference promoter (such as the one used in the methods of the present invention). Alternatively, promoter strength may be assayed by quantifying mRNA levels or by comparing mRNA levels of the nucleic acid sequence used in the methods of the present invention, with mRNA levels of housekeeping genes such as 18S rRNA, using methods known in the art, such as Northern blotting with densitometric analysis of autoradiograms, quantitative real-time PCR or RT-PCR (Heid et al., 1996 Genome Methods 6: 986-994). Generally by “weak promoter” is intended a promoter that drives expression of a coding sequence at a low level. By “low level” is intended at levels of about 1/10,000 transcripts to about 1/100,000 transcripts, to about 1/500,0000 transcripts per cell. Conversely, a “strong promoter” drives expression of a coding sequence at high level, or at about 1/10 transcripts to about 1/100 transcripts to about 1/1,000 transcripts per cell. 
     Optionally, one or more terminator sequences may be used in the construct introduced into a plant; the term “terminator” being as defined herein. Additional regulatory elements may include transcriptional as well as translational enhancers. Those skilled in the art will be aware of terminator and enhancer sequences that may be suitable for use in performing the invention. Such sequences would be known or may readily be obtained by a person skilled in the art. 
     An intron sequence may also be added to the 5′ untranslated region (UTR) or in the coding sequence to increase the amount of the mature message that accumulates in the cytosol. Inclusion of a spliceable intron in the transcription unit in both plant and animal expression constructs has been shown to increase gene expression at both the mRNA and protein levels up to 1000-fold (Buchman and Berg, Mol. Cell. Biol. 8:4395-4405 (1988); Callis et al., Genes Dev. 1:1183-1200 (1987)). Such intron enhancement of gene expression is typically greatest when placed near the 5′ end of the transcription unit. Use of the maize introns Adh1-S intron 1, 2, and 6, the Bronze-1 intron are known in the art. For general information, see The Maize Handbook, Chapter 116, Freeling and Walbot, Eds., Springer, N.Y. (1994). 
     Other control sequences (besides promoter, enhancer, silencer, intron sequences, 3′UTR and/or 5′UTR regions) may be protein and/or RNA stabilizing elements. Such sequences would be known or may readily be obtained by a person skilled in the art. 
     The genetic constructs of the invention may further include an origin of replication sequence that is required for maintenance and/or replication in a specific cell type. One example is when a genetic construct is required to be maintained in a bacterial cell as an episomal genetic element (e.g. plasmid or cosmid molecule). Preferred origins of replication include, but are not limited to, the f1-ori and colE1. 
     For the detection of the successful transfer of the nucleic acid sequences as used in the methods of the invention and/or selection of transgenic plants comprising these nucleic acid sequences, it is advantageous to use marker genes (or reporter genes). Therefore, the genetic construct may optionally comprise a selectable marker gene. As used herein, the term “selectable marker”, “selectable marker gene” or “reporter gene” includes any gene that confers a phenotype on a cell in which it is expressed to facilitate the identification and/or selection of cells that are transfected or transformed with a nucleic acid construct of the invention. These marker genes enable the identification of a successful transfer of the nucleic acid molecules via a series of different principles. Suitable markers may be selected from markers that confer antibiotic or herbicide resistance, that introduce a new metabolic trait or that allow visual selection. Examples of selectable marker genes include genes conferring resistance to antibiotics (such as nptII that phosphorylates neomycin and kanamycin, or hpt, phosphorylating hygromycin, or genes conferring resistance to, for example, bleomycin, streptomycin, tetracyclin, chloramphenicol, ampicillin, gentamycin, geneticin (G418), spectinomycin or blasticidin), to herbicides (for example bar which provides resistance to Basta®; aroA or gox providing resistance against glyphosate, or the genes conferring resistance to, for example, imidazolinone, phosphinothricin or sulfonylurea), or genes that provide a metabolic trait (such as manA that allows plants to use mannose as sole carbon source or xlose isomerase for the utilisation of xylose, or antinutritive markers such as the resistance to 2-deoxyglucose). Expression of visual marker genes results in the formation of colour (for example β-glucuronidase, GUS or β-galactosidase with its coloured substrates, for example X-Gal), luminescence (such as the luciferin/luceferase system) or fluorescence (Green Fluorescent Protein, GFP, and derivatives thereof). This list represents only a small number of possible markers. The skilled worker is familiar with such markers. Different markers are preferred, depending on the organism and the selection method. 
     It is known that upon stable or transient integration of nucleic acid sequences into plant cells, only a minority of the cells takes up the foreign DNA and, if desired, integrates it into its genome, depending on the expression vector used and the transfection technique used. To identify and select these integrants, a gene coding for a selectable marker (such as the ones described above) is usually introduced into the host cells together with the gene of interest. These markers can for example be used in mutants in which these genes are not functional by, for example, deletion by conventional methods. Furthermore, nucleic acid molecules encoding a selectable marker can be introduced into a host cell on the same vector that comprises the sequence encoding the polypeptides of the invention or used in the methods of the invention, or else in a separate vector. Cells which have been stably transfected with the introduced nucleic acid sequence can be identified for example by selection (for example, cells which have integrated the selectable marker survive whereas the other cells die). 
     Since the marker genes, particularly genes for resistance to antibiotics and herbicides, are no longer required or are undesired in the transgenic host cell once the nucleic acid sequence have been introduced successfully, the process according to the invention for introducing the nucleic acid sequences advantageously employs techniques which enable the removal or excision of these marker genes. One such a method is what is known as co-transformation. The co-transformation method employs two vectors simultaneously for the transformation, one vector bearing the nucleic acid sequence according to the invention and a second bearing the marker gene(s). A large proportion of transformants receives or, in the case of plants, comprises (up to 40% or more of the transformants), both vectors. In case of transformation with  Agrobacteria , the transformants usually receive only a part of the vector, i.e. the sequence flanked by the T-DNA, which usually represents the expression cassette. The marker genes can subsequently be removed from the transformed plant by performing crosses. In another method, marker genes integrated into a transposon are used for the transformation together with desired nucleic acid sequence (known as the Ac/Ds technology). The transformants can be crossed with a transposase source or the transformants are transformed with a nucleic acid construct conferring expression of a transposase, transiently or stable. In some cases (approx. 10%), the transposon jumps out of the genome of the host cell once transformation has taken place successfully and is lost. In a further number of cases, the transposon jumps to a different location. In these cases the marker gene must be eliminated by performing crosses. In microbiology, techniques were developed which make possible, or facilitate, the detection of such events. A further advantageous method relies on what is known as recombination systems; whose advantage is that elimination by crossing can be dispensed with. The best-known system of this type is what is known as the Cre/lox system. Cre1 is a recombinase that removes the sequences located between the loxP sequences. If the marker gene is integrated between the loxP sequences, it is removed once transformation has taken place successfully, by expression of the recombinase. Further recombination systems are the HIN/HIX, FLP/FRT and REP/STB system (Tribble et al., J. Biol. Chem., 275, 2000: 22255-22267; Velmurugan et al., J. Cell Biol., 149, 2000: 553-566). A site-specific integration into the plant genome of the nucleic acid sequences according to the invention is possible. Naturally, these methods can also be applied to microorganisms such as yeast, fungi or bacteria. 
     The invention also provides a method for the production of transgenic plants having enhanced yield-related traits relative to control plants, comprising introduction and expression in a plant of any nucleic acid sequence encoding an RCA polypeptide as defined hereinabove. The terms “transgenic”, “transgene” or “recombinant” are as defined herein. 
     More specifically, the present invention provides a method for the production of transgenic plants having enhanced yield-related traits relative to control plants, which method comprises:
         (i) introducing and expressing in a plant or plant cell a nucleic acid sequence encoding an RCA polypeptide; and   (ii) cultivating the plant cell under conditions promoting plant growth and development.       

     The nucleic acid sequence may be introduced directly into a plant cell or into the plant itself (including introduction into a tissue, organ or any other part of a plant). According to a preferred feature of the present invention, the nucleic acid sequence is preferably introduced into a plant by transformation, the term “introduction” or “transformation” being as defined herein. 
     In addition to the transformation of somatic cells, which then have to be regenerated into intact plants, it is also possible to transform the cells of plant meristems and in particular those cells which develop into gametes. In this case, the transformed gametes follow the natural plant development, giving rise to transgenic plants. Thus, for example, seeds of  Arabidopsis  are treated with  agrobacteria  and seeds are obtained from the developing plants of which a certain proportion is transformed and thus transgenic [Feldman, K A and Marks M D (1987). Mol Gen Genet. 208:274-289; Feldmann K (1992). In: C Koncz, N-H Chua and J Shell, eds, Methods in  Arabidopsis  Research. Word Scientific, Singapore, pp. 274-289]. Alternative methods are based on the repeated removal of the inflorescences and incubation of the excision site in the center of the rosette with transformed  agrobacteria , whereby transformed seeds can likewise be obtained at a later point in time (Chang (1994). Plant J. 5: 551-558; Katavic (1994). Mol Gen Genet, 245: 363-370). However, an especially effective method is the vacuum infiltration method with its modifications such as the “floral dip” method. In the case of vacuum infiltration of  Arabidopsis , intact plants under reduced pressure are treated with an agrobacterial suspension [Bechthold, N (1993). C R Acad Sci Paris Life Sci, 316: 1194-1199], while in the case of the“floral dip” method the developing floral tissue is incubated briefly with a surfactant-treated agrobacterial suspension [Clough, S J and Bent, A F (1998). The Plant J. 16, 735-743]. A certain proportion of transgenic seeds are harvested in both cases, and these seeds can be distinguished from non-transgenic seeds by growing under the above-described selective conditions. In addition the stable transformation of plastids is of advantages because plastids are inherited maternally is most crops reducing or eliminating the risk of transgene flow through pollen. The transformation of the chloroplast genome is generally achieved by a process which has been schematically displayed in Klaus et al., 2004 [Nature Biotechnology 22 (2), 225-229]. Briefly the sequences to be transformed are cloned together with a selectable marker gene between flanking sequences homologous to the chloroplast genome. These homologous flanking sequences direct site specific integration into the plastome. Plastidal transformation has been described for many different plant species and an overview is given in Bock (2001) Transgenic plastids in basic research and plant biotechnology. J Mol. Biol. 2001 Sep. 21; 312 (3):425-38 or Maliga, P (2003) Progress towards commercialization of plastid transformation technology. Trends Biotechnol. 21, 20-28. Further biotechnological progress has recently been reported in form of marker free plastid transformants, which can be produced by a transient co-integrated maker gene (Klaus et al., 2004, Nature Biotechnology 22(2), 225-229). 
     The genetically modified plant cells can be regenerated via any methods with which the skilled worker is familiar. Suitable methods can be found in the abovementioned publications by S. D. Kung and R. Wu, Potrykus or Höfgen and Willmitzer. 
     Generally after transformation, plant cells or cell groupings are selected for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the gene of interest, following which the transformed material is regenerated into a whole plant. To select transformed plants, the plant material obtained in the transformation is, as a rule, subjected to selective conditions so that transformed plants can be distinguished from untransformed plants. For example, the seeds obtained in the above-described manner can be planted and, after an initial growing period, subjected to a suitable selection by spraying. A further possibility consists in growing the seeds, if appropriate after sterilization, on agar plates using a suitable selection agent so that only the transformed seeds can grow into plants. Alternatively, the transformed plants are screened for the presence of a selectable marker such as the ones described above. 
     Following DNA transfer and regeneration, putatively transformed plants may also be evaluated, for instance using Southern analysis, for the presence of the gene of interest, copy number and/or genomic organisation. Alternatively or additionally, expression levels of the newly introduced DNA may be monitored using Northern and/or Western analysis, both techniques being well known to persons having ordinary skill in the art. 
     The generated transformed plants may be propagated by a variety of means, such as by clonal propagation or classical breeding techniques. For example, a first generation (or T1) transformed plant may be selfed and homozygous second-generation (or T2) transformants selected, and the T2 plants may then further be propagated through classical breeding techniques. 
     The generated transformed organisms may take a variety of forms. For example, they may be chimeras of transformed cells and non-transformed cells; clonal transformants (e.g., all cells transformed to contain the expression cassette); grafts of transformed and untransformed tissues (e.g., in plants, a transformed rootstock grafted to an untransformed scion). 
     The present invention clearly extends to any plant cell or plant produced by any of the methods described herein, and to all plant parts and propagules thereof. The present invention extends further to encompass the progeny of a primary transformed or transfected cell, tissue, organ or whole plant that has been produced by any of the aforementioned methods, the only requirement being that progeny exhibit the same genotypic and/or phenotypic characteristic(s) as those produced by the parent in the methods according to the invention. 
     The invention also includes host cells containing an isolated nucleic acid sequence encoding an RCA polypeptide as defined hereinabove. Preferred host cells according to the invention are plant cells. 
     Host plants for the nucleic acid sequences or the vector used in the method according to the invention, the expression cassette or construct or vector are, in principle, advantageously all plants, which are capable of synthesizing the polypeptides used in the inventive method. 
     A transgenic plant for the purposes of the invention is thus understood as meaning, as above, that the nucleic acid sequences used in the method of the invention are not at their natural locus in the genome of said plant, it being possible for the nucleic acid sequences to be expressed homologously or heterologously. However, as mentioned, transgenic also means that, while the nucleic acid sequences according to the invention or used in the inventive method are at their natural position in the genome of a plant, the sequence has been modified with regard to the natural sequence, and/or that the regulatory sequences of the natural sequences have been modified. Transgenic is preferably understood as meaning the expression of the nucleic acid sequences according to the invention at an unnatural locus in the genome, i.e. homologous or, preferably, heterologous expression of the nucleic acid sequences takes place. Preferred transgenic plants are mentioned herein. 
     The invention also extends to harvestable parts of a plant such as, but not limited to seeds, leaves, fruits, flowers, stems, rhizomes, tubers and bulbs. The invention furthermore relates to products derived, preferably directly derived, from a harvestable part of such a plant, such as dry pellets or powders, oil, fat and fatty acids, starch or proteins. 
     Methods for increasing expression of nucleic acid sequences or genes, or gene products, are well documented in the art and include, for example, overexpression driven by appropriate promoters, the use of transcription enhancers or translation enhancers. Isolated nucleic acid sequences which serve as promoter or enhancer elements may be introduced in an appropriate position (typically upstream) of a non-heterologous form of a polynucleotide so as to upregulate expression. For example, endogenous promoters may be altered in vivo by mutation, deletion, and/or substitution (see, Kmiec, U.S. Pat. No. 5,565,350; Zarling et al., PCT/US93/03868), or isolated promoters may be introduced into a plant cell in the proper orientation and distance from a gene of the present invention so as to control the expression of the gene. 
     The term “expression” or “gene expression” means the transcription of a specific gene or specific genes or specific genetic construct. The term “expression” or “gene expression” in particular means the transcription of a gene or genes or genetic construct into structural RNA (rRNA, tRNA) or mRNA with or without subsequent translation of the latter into a protein. The process includes transcription of DNA and processing of the resulting mRNA product. 
     The term “increasing expression” shall mean an increase of the expression of the nucleic acid sequence encoding an RCA polypeptide, which increase in expression leads to enhanced yield-related traits of the plants relative to control plants. Preferably, the increase in expression of the nucleic acid is 1.25, 1.5, 1.75, 2, 5, 7.5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100 or more fold the expression of the endogenous plant RCA polypeptide. 
     By increasing the expression (in a plastid) of a nucleic acid sequence encoding an RCA polypeptide, an increase in the amount of RCA polypeptide is obtained. This increase in amount of RCA polypeptide (in a plastid) leads to an increase in RCA activity. Alternatively, activity may also be increased when there is no change in the amount of an RCA polypeptide, or even when there is a reduction in the amount of an RCA polypeptide. This may occur when the intrinsic properties of the polypeptide are altered, for example, by making mutant versions that are more active than the naturally-occurring polypeptide. 
     The expression of a nucleic acid sequence encoding an RCA polypeptide is increased in a plastid using techniques well known in the art, such as by targeting an RCA polypeptide to the plastid using transit peptide sequences or by direct transformation of an RCA polypeptide without transit peptide sequences, into a plastid. Expression may be increased in any plastid, however, preferred is preferentially increasing expression in a chloroplast. 
     If polypeptide expression is desired, it is generally desirable to include a polyadenylation region at the 3′-end of a polynucleotide coding region. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The 3′ end sequence to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene. 
     An intron sequence may also be added as described above. 
     Other control sequences (besides promoter, enhancer, silencer, intron sequences, 3′UTR and/or 5′UTR regions) may be protein and/or RNA stabilizing elements. 
     As mentioned above, a preferred method for increasing expression of a nucleic acid sequence encoding an RCA polypeptide is by introducing and expressing in a plant a nucleic acid sequence encoding an RCA polypeptide; however the effects of performing the method, i.e. enhancing yield-related traits may also be achieved using other well known techniques. A description of some of these techniques will now follow. 
     One such technique is T-DNA activation tagging (Hayashi et al. Science (1992) 1350-1353), which involves insertion of T-DNA, usually containing a promoter (may also be a translation enhancer or an intron), in the genomic region of the gene of interest or 10 kb up- or downstream of the coding region of a gene in a configuration such that the promoter directs expression of the targeted gene. Typically, regulation of expression of the targeted gene by its natural promoter is disrupted and the gene falls under the control of the newly introduced promoter. The promoter is typically embedded in a T-DNA. This T-DNA is randomly inserted into the plant genome, for example, through  Agrobacterium  infection and leads to modified expression of genes near the inserted T-DNA. The resulting transgenic plants show dominant phenotypes due to modified expression of genes close to the introduced promoter. 
     The effects of the invention may also be reproduced using the technique of TILLING (Targeted Induced Local Lesions In Genomes). This is a mutagenesis technology useful to generate and/or identify a nucleic acid sequence encoding an RCA polypeptide with modified expression and/or activity. TILLING also allows selection of plants carrying such mutant variants. These mutant variants may exhibit modified expression, either in strength or in location or in timing (if the mutations affect the promoter for example). These mutant variants may exhibit higher RCA polypeptide activity than that exhibited by the gene in its natural form. TILLING combines high-density mutagenesis with high-throughput screening methods. The steps typically followed in TILLING are: (a) EMS mutagenesis (Redei GP and Koncz C (1992) In Methods in  Arabidopsis  Research, Koncz C, Chua N H, Schell J, eds. Singapore, World Scientific Publishing Co, pp. 16-82; Feldmann et al., (1994) In Meyerowitz E M, Somerville C R, eds,  Arabidopsis . Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., pp 137-172; Lightner J and Caspar T (1998) In J Martinez-Zapater, J Salinas, eds, Methods on Molecular Biology, Vol. 82. Humana Press, Totowa, N.J., pp 91-104); (b) DNA preparation and pooling of individuals; (c) PCR amplification of a region of interest; (d) denaturation and annealing to allow formation of heteroduplexes; (e) DHPLC, where the presence of a heteroduplex in a pool is detected as an extra peak in the chromatogram; (f) identification of the mutant individual; and (g) sequencing of the mutant PCR product. Methods for TILLING are well known in the art (McCallum et al., (2000) Nat Biotechnol 18: 455-457; reviewed by Stemple (2004) Nat Rev Genet. 5(2): 145-50). 
     The effects of the invention may also be reproduced using homologous recombination, which allows introduction in a genome of a selected nucleic acid sequence at a defined selected position. Homologous recombination is a standard technology used routinely in biological sciences for lower organisms such as yeast or the moss  Physcomitrella . Methods for performing homologous recombination in plants have been described not only for model plants (Offring a et al. (1990) EMBO J. 9(10): 3077-84) but also for crop plants, for example rice (Terada et al. (2002) Nat Biotech 20(10): 1030-4; Iida and Terada (2004) Curr Opin Biotech 15(2): 132-8). 
     Reference herein to enhanced yield-related traits is taken to mean an increase in biomass (weight) of one or more parts of a plant, which may include aboveground (harvestable) parts and/or (harvestable) parts below ground. In particular, such harvestable parts are seeds, and performance of the methods of the invention results in plants having increased seed yield relative to the seed yield of control plants. The term “yield” and “seed yield” is as defined herein. The terms “increased”, “improved”, “enhanced” are as defined herein. 
     In particular, the enhanced yield-related trait is selected from one or more of the following: (i) increased early vigour; (ii) increased aboveground biomass; (iii) earlier time to flower; (iv) increased number of (filled) seeds; and (v) increased TKW. 
     Taking corn as an example, a yield increase may be manifested as one or more of the following: increase in the number of plants established per hectare or acre, an increase in the number of ears per plant, an increase in the number of rows, number of kernels per row, kernel weight, thousand kernel weight, ear length/diameter, increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), among others. Taking rice as an example, a yield increase may manifest itself as an increase in one or more of the following: number of plants per hectare or acre, number of panicles per plant, number of spikelets per panicle, number of flowers (florets) per panicle (which is expressed as a ratio of the number of filled seeds over the number of primary panicles), increase in the seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), increase in thousand kernel weight, among others. 
     Enhanced yield-related traits may also result in modified architecture, or may occur because of modified architecture. 
     Since the transgenic plants according to the present invention have enhanced yield-related traits, it is likely that these plants exhibit an increased growth rate (during at least part of their life cycle), relative to the growth rate of control plants at a corresponding stage in their life cycle. The increased growth rate may be specific to one or more parts of a plant (including seeds), or may be throughout substantially the whole plant. Plants having an increased growth rate may have a shorter life cycle. The life cycle of a plant may be taken to mean the time needed to grow from a dry mature seed up to the stage where the plant has produced dry mature seeds, similar to the starting material. This life cycle may be influenced by factors such as early vigour, growth rate, greenness index, flowering time and speed of seed maturation. The increase in growth rate may take place at one or more stages in the life cycle of a plant or during substantially the whole plant life cycle. Increased growth rate during the early stages in the life cycle of a plant may reflect enhanced vigour. The increase in growth rate may alter the harvest cycle of a plant allowing plants to be sown later and/or harvested sooner than would otherwise be possible (a similar effect may be obtained with earlier flowering time). If the growth rate is sufficiently increased, it may allow for the further sowing of seeds of the same plant species (for example sowing and harvesting of rice plants followed by sowing and harvesting of further rice plants all within one conventional growing period). Similarly, if the growth rate is sufficiently increased, it may allow for the further sowing of seeds of different plants species (for example the sowing and harvesting of corn plants followed by, for example, the sowing and optional harvesting of soy bean, potato or any other suitable plant). Harvesting additional times from the same rootstock in the case of some crop plants may also be possible. Altering the harvest cycle of a plant may lead to an increase in annual biomass production per acre (due to an increase in the number of times (say in a year) that any particular plant may be grown and harvested). An increase in growth rate may also allow for the cultivation of transgenic plants in a wider geographical area than their wild-type counterparts, since the territorial limitations for growing a crop are often determined by adverse environmental conditions either at the time of planting (early season) or at the time of harvesting (late season). Such adverse conditions may be avoided if the harvest cycle is shortened. The growth rate may be determined by deriving various parameters from growth curves, such parameters may be: T-Mid (the time taken for plants to reach 50% of their maximal size) and T-90 (time taken for plants to reach 90% of their maximal size), amongst others. 
     According to a preferred feature of the present invention, performance of the methods of the invention gives plants having an increased growth rate relative to control plants. Therefore, according to the present invention, there is provided a method for increasing the growth rate of plants, which method comprises increasing expression in a plant of a nucleic acid sequence encoding an RCA polypeptide as defined herein. 
     Enhanced yield-related traits and/or increased growth rate occurs whether the plant is under non-stress conditions or whether the plant is exposed to various stresses compared to control plants. Plants typically respond to exposure to stress by growing more slowly. In conditions of severe stress, the plant may even stop growing altogether. Mild stress on the other hand is defined herein as being any stress to which a plant is exposed which does not result in the plant ceasing to grow altogether without the capacity to resume growth. Mild stress in the sense of the invention leads to a reduction in the growth of the stressed plants of less than 40%, 35% or 30%, preferably less than 25%, 20% or 15%, more preferably less than 14%, 13%, 12%, 11% or 10% or less in comparison to the control plant under non-stress conditions. Due to advances in agricultural practices (irrigation, fertilization, pesticide treatments) severe stresses are not often encountered in cultivated crop plants. As a consequence, the compromised growth induced by mild stress is often an undesirable feature for agriculture. Mild stresses are the everyday biotic and/or abiotic (environmental) stresses to which a plant is exposed. Abiotic stresses may be due to drought or excess water, anaerobic stress, salt stress, chemical toxicity, oxidative stress and hot, cold or freezing temperatures. The abiotic stress may be an osmotic stress caused by a water stress (particularly due to drought), salt stress, oxidative stress or an ionic stress. Biotic stresses are typically those stresses caused by pathogens, such as bacteria, viruses, fungi and insects. 
     In particular, the methods of the present invention may be performed under non-stress conditions or under conditions of mild drought to give plants having enhanced yield-related traits relative to control plants. As reported in Wang et al. (Planta (2003) 218: 1-14), abiotic stress leads to a series of morphological, physiological, biochemical and molecular changes that adversely affect plant growth and productivity. Drought, salinity, extreme light conditions (low or high or of varaibale wavelength) extreme temperatures (high or low) and oxidative stress are known to be interconnected and may induce growth and cellular damage through similar mechanisms. Rabbani et al. (Plant Physiol (2003) 133: 1755-1767) describes a particularly high degree of “cross talk” between drought stress and high-salinity stress. For example, drought and/or salinisation are manifested primarily as osmotic stress, resulting in the disruption of homeostasis and ion distribution in the cell. Oxidative stress, which frequently accompanies high or low temperature, salinity or drought stress, may cause denaturing of functional and structural proteins. As a consequence, these diverse environmental stresses often activate similar cell signaling pathways and cellular responses, such as the production of stress proteins, up-regulation of anti-oxidants, accumulation of compatible solutes and growth arrest. The term “non-stress” conditions as used herein are those environmental conditions that allow optimal growth of plants. Persons skilled in the art are aware of normal soil conditions and climatic conditions for a given location. 
     Performance of the methods of the invention gives plants grown under non-stress conditions or under mild drought conditions enhanced yield-related traits relative to suitable control plants grown under comparable conditions. Therefore, according to the present invention, there is provided a method for enhancing yield-related traits in plants grown under non-stress conditions or under mild drought conditions, which method comprises increasing expression in a plant of a nucleic acid sequence encoding an RCA polypeptide. 
     In a preferred embodiment of the invention, the enhancement of yield-related traits and/or increase in growth rate occurs according to the methods of the present invention under non-stress conditions. 
     Performance of the methods according to the present invention results in plants grown under abiotic stress conditions having increased yield-related traits relative to control plants grown under comparable stress conditions. As reported in Wang et al. (Planta (2003) 218: 1-14), abiotic stress leads to a series of morphological, physiological, biochemical and molecular changes that adversely affect plant growth and productivity. Drought, salinity, extreme temperatures and oxidative stress are known to be interconnected and may induce growth and cellular damage through similar mechanisms. Rabbani et al. (Plant Physiol (2003) 133: 1755-1767) describes a particularly high degree of “cross talk” between drought stress and high-salinity stress. For example, drought and/or salinisation are manifested primarily as osmotic stress, resulting in the disruption of homeostasis and ion distribution in the cell. Oxidative stress, which frequently accompanies high or low temperature, salinity or drought stress, may cause denaturing of functional and structural proteins. As a consequence, these diverse environmental stresses often activate similar cell signalling pathways and cellular responses, such as the production of stress proteins, up-regulation of anti-oxidants, accumulation of compatible solutes and growth arrest. Since diverse environmental stresses activate similar pathways, the exemplification of the present invention with drought stress should not be seen as a limitation to drought stress, but more as a screen to indicate the involvement of RCA polypeptides as defined above, in increasing yield-related traits relative to control plants grown in comparable stress conditions, in abiotic stresses in general. 
     The term “abiotic stress” as defined herein is taken to mean any one or more of: water stress (due to drought or excess water), anaerobic stress, salt stress, temperature stress (due to hot, cold or freezing temperatures), chemical toxicity stress and oxidative stress. According to one aspect of the invention, the abiotic stress is an osmotic stress, selected from water stress, salt stress, oxidative stress and ionic stress. Preferably, the water stress is drought stress. The term salt stress is not restricted to common salt (NaCl), but may be any stress caused by one or more of: NaCl, KCl, LiCl, MgCl 2 , CaCl 2 , amongst others. 
     Performance of the methods of the invention gives plants having increased yield-related traits, under abiotic stress conditions relative to control plants grown in comparable stress conditions. Therefore, according to the present invention, there is provided a method for increasing yield-related traits, in plants grown under abiotic stress conditions, which method comprises increasing expression in a plant of a nucleic acid sequence encoding an RCA polypeptide. According to one aspect of the invention, the abiotic stress is an osmotic stress, selected from one or more of the following: water stress, salt stress, oxidative stress and ionic stress. 
     Another example of abiotic environmental stress is the reduced availability of one or more nutrients that need to be assimilated by the plants for growth and development. Because of the strong influence of nutrition utilization efficiency on plant yield and product quality, a huge amount of fertilizer is poured onto fields to optimize plant growth and quality. Productivity of plants ordinarily is limited by three primary nutrients, phosphorous, potassium and nitrogen, which is usually the rate-limiting element in plant growth of these three. Therefore the major nutritional element required for plant growth is nitrogen (N). It is a constituent of numerous important compounds found in living cells, including amino acids, proteins (enzymes), nucleic acids, and chlorophyll. 1.5% to 2% of plant dry matter is nitrogen and approximately 16% of total plant protein. Thus, nitrogen availability is a major limiting factor for crop plant growth and production (Frink et al. (1999) Proc Natl Acad Sci USA 96(4): 1175-1180), and has as well a major impact on protein accumulation and amino acid composition. Therefore, of great interest are crop plants with increased yield-related traits, when grown under nitrogen-limiting conditions. 
     Performance of the methods of the invention gives plants grown under conditions of reduced nutrient availability, particularly under conditions of reduced nitrogen availability, having increased yield-related traits relative to control plants grown under comparable conditions. Therefore, according to the present invention, there is provided a method for increasing yield-related traits in plants grown under conditions of reduced nutrient availability, preferably reduced nitrogen availability, which method comprises increasing expression in a plant of a nucleic acid sequence encoding an RCA polypeptide. Reduced nutrient availability may result from a deficiency or excess of nutrients such as nitrogen, phosphates and other phosphorous-containing compounds, potassium, calcium, cadmium, magnesium, manganese, iron and boron, amongst others. Preferably, reduced nutrient availability is reduced nitrogen availability. 
     The methods of the invention are advantageously applicable to any plant, the term “plant” being as defined herein. 
     According to a preferred embodiment of the present invention, the plant is a crop plant. Examples of crop plants include soybean, sunflower, canola, alfalfa, rapeseed, cotton, tomato, potato and tobacco. Further preferably, the plant is a monocotyledonous plant. Examples of monocotyledonous plants include sugarcane. More preferably the plant is a cereal. Examples of cereals include rice, maize, wheat, barley, millet, rye, sorghum and oats. 
     The present invention also encompasses use of nucleic acid sequences encoding an RCA polypeptide described herein and use of these RCA polypeptides in enhancing yield-related traits in plants. 
     Nucleic acid sequences encoding an RCA polypeptide as described herein, or the RCA polypeptides themselves, may find use in breeding programmes in which a DNA marker is identified which may be genetically linked to a gene encoding an RCA polypeptide. The genes/nucleic acid sequences, or the RCA polypeptides themselves may be used to define a molecular marker. This DNA or polypeptide marker may then be used in breeding programmes to select plants having enhanced yield-related traits as defined hereinabove in the methods of the invention. 
     Allelic variants of a gene/nucleic acid sequence encoding an RCA polypeptide may also find use in marker-assisted breeding programmes. Such breeding programmes sometimes require introduction of allelic variation by mutagenic treatment of the plants, using for example EMS mutagenesis; alternatively, the programme may start with a collection of allelic variants of so called “natural” origin caused unintentionally. Identification of allelic variants then takes place, for example, by PCR. This is followed by a step for selection of superior allelic variants of the sequence in question, and which give enhanced yield-related traits. Selection is typically carried out by monitoring growth performance of plants containing different allelic variants of the sequence in question. Growth performance may be monitored in a greenhouse or in the field. Further optional steps include crossing plants in which the superior allelic variant was identified with another plant. This could be used, for example, to make a combination of interesting phenotypic features. 
     Nucleic acid sequences encoding an RCA polypeptide may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes. Such use of nucleic acid sequences encoding an RCA polypeptide requires only a nucleic acid sequence of at least 15 nucleotides in length. The nucleic acid sequences encoding an RCA polypeptide may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (Sambrook J, Fritsch E F and Maniatis T (1989) Molecular Cloning, A Laboratory Manual) of restriction-digested plant genomic DNA may be probed with the nucleic acid sequences encoding an RCA polypeptide. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et al. (1987) Genomics 1: 174-181) in order to construct a genetic map. In addition, the nucleic acid sequences may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the nucleic acid sequence encoding an RCA polypeptide in the genetic map previously obtained using this population (Botstein et al. (1980) Am. J. Hum. Genet. 32:314-331). 
     The production and use of plant gene-derived probes for use in genetic mapping is described in Bernatzky and Tanksley (1986) Plant Mol. Biol. Reporter 4: 37-41. Numerous publications describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art. 
     The nucleic acid probes may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel et al. In: Non-mammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein). 
     In another embodiment, the nucleic acid probes may be used in direct fluorescence in situ hybridisation (FISH) mapping (Trask (1991) Trends Genet. 7:149-154). Although current methods of FISH mapping favour use of large clones (several kb to several hundred kb; see Laan et al. (1995) Genome Res. 5:13-20), improvements in sensitivity may allow performance of FISH mapping using shorter probes. 
     A variety of nucleic acid amplification-based methods for genetic and physical mapping may be carried out using the nucleic acid sequences. Examples include allele-specific amplification (Kazazian (1989) J. Lab. Clin. Med. 11:95-96), polymorphism of PCR-amplified fragments (CAPS; Sheffield et al. (1993) Genomics 16:325-332), allele-specific ligation (Landegren et al. (1988) Science 241:1077-1080), nucleotide extension reactions (Sokolov (1990) Nucleic Acid Res. 18:3671), Radiation Hybrid Mapping (Walter et al. (1997) Nat. Genet. 7:22-28) and Happy Mapping (Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807). For these methods, the sequence of a nucleic acid is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR-based genetic mapping, it may be necessary to identify DNA sequence differences between the parents of the mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, is generally not necessary for mapping methods. 
     The methods according to the present invention result in plants having enhanced yield-related traits, as described hereinbefore. These traits may also be combined with other economically advantageous traits, such as further yield-enhancing traits, tolerance to other abiotic and biotic stresses, traits modifying various architectural features and/or biochemical and/or physiological features. 
    
    
     
       DESCRIPTION OF FIGURES 
       The present invention will now be described with reference to the following figures in which: 
         FIG. 1  shows the domain structure of the CCA1 protein represented by SEQ ID NO: 2. The SANT domain is given in bold underlined. Motifs 1 and 2 in the SANT domain are indicated in bold italics and underlined. Motifs 3, 4 and 5 are indicated in italics and underlined. 
         FIG. 2A  shows a phylogenetic tree of CCA1 proteins.  FIG. 2B  shows a multiple alignment of CCA1 proteins. The motifs indicated in  FIG. 1  can easily be recognised, and new motifs may be defined using this alignment. 
         FIG. 3  shows the binary vector for increased expression in  Oryza sativa  of an  Arabidopsis thaliana  CCA1-like protein-encoding nucleic acid under the control of a GOS2 promoter. 
         FIG. 4  details examples of CCA1 sequences useful in performing the methods according to the present invention. 
         FIGS. 5A and 5B  shows the domain structure of a gamma VPE.  FIG. 5A  is a schematic representation in which (from left to right) the diagonally stripped box represents a signal peptide for insertion into the endomembrane system; the white box represents an N-terminal inhibitory domain; the dotted box represents an active domain; and the grey shaded box represents the carboxy inhibitory domain. The positions of the Hystidine-Cystein catalytic dyad is marked “H” and “C”.  FIG. 5B  shows the position of the domains over a sequence alignment between a castor bean VPE (SEQ ID NO: 356) and SEQ ID NO: 150. The double line represents the signal peptide, the solid black line represents the active peptide; the black arrows indicate the putative aspartic residues at which autocatalytic processing occurs to produce the mature active peptide and the conserved Hys and Cys residues are boxed. Underlined with dots is the conserved active pentapeptide in caspases. The consensus sequence in  FIG. 5B  corresponds to SEQ ID NO: 359. 
         FIG. 6A  shows a phylogenetic tree of polypeptides of the peptidase superfamily. VPE peptidases cluster apart of peptidases in clans CA, CF or CE. VPE polypeptides cluster in four subclases, alpha, beta, gamma and delta, with alpha and gamma being the closest related;  FIG. 6B  is an alignment of VPEs; the highest sequence conservation is found in the peptidase domain. 
         FIG. 7  shows the binary vector for increased expression in  Oryza sativa  of an  Arabidopsis thaliana  VPE-encoding nucleic acid under the control of the rice-WSI18 gene promoter. 
         FIG. 8  shows VPE sequences useful in the methods of the invention. 
         FIG. 9  shows the domain structure and their respective positions in a SAP-like polypeptide, with Motif 1 being the SAP-like domain. 
         FIG. 10A  shows a phylogenetic tree and sequence alignment of SAP and SAP-like polypeptides. The clade with SAP polypeptides is boxed in a single line; the double line boxes the clades with SAP-like polypeptides.  FIG. 10B  shows an alignment of SAP-like polypeptides. The consensus sequence shown in  FIG. 10B  corresponds to SEQ ID NO: 361. 
         FIG. 11  shows the binary vector for increased expression in  Oryza sativa  of an  Oryza sativa  SAP-like protein-encoding nucleic acid under the control of the rice RCC3 promoter (pRCC3). 
         FIG. 12  details examples of SAP sequences useful in performing the methods according to the present invention. 
         FIG. 13  shows a model for RCA activation of RuBisCO. The sugar phosphate inhibitors bind to the active site of the RuBisCo large subunits, thereby closing them. RCA via ATP hydrolysis will oligomerise and bind to Rubisco to form a supercomplex consisting of the large and small RuBisCo subunits encircled by the 16 RCA subunits. This binding is responsible for conformational changes that will lead to a release of the individual RCA subunits, a release of the inhibitors, and an opening of the RuBisCo active sites (for more detailed explanations, see in Portis (2003) Photosynthesis Research 75:11-27). 
         FIG. 14  represents a drawing of the important features comprised in an RCA polypeptide, i.e., a transit peptide for plastidic targeting, an AAA domain, and a P loop triphosphate-binding loop consensus sequence G(G/R)KG(Q/E)GK(S/T), for nucleotide binding, corresponding to Motif1 as represented by SEQ ID NO: 312. 
         FIG. 15  shows an alignment of RCA polypeptides. The sequences were aligned using AlignX program from Vector NTI suite (InforMax, Bethesda, Md.). Multiple alignment was done with a gap opening penalty of 10 and a gap extension of 0.01. The beginning of sequence conservation between eukaryotic RCA polypeptides is delineated with a bracket (the amino acid sequence N-terminal upstream of this bracket is considered as comprising the transit peptide for plastidic subcellular targeting), as are the beginning and the end of the AAA domain. The P loop is boxed, and corresponds to Motif 1 as represented by SEQ ID NO: 312. The beginning of the C-terminal extension is also marked with a bracket. The sequences shown are: Chlre_RCA (SEQ ID NO: 251), Chlli_RCA (SEQ ID NO: 253), Ostta_RCA (SEQ ID NO: 255), Glyma_RCA LF (SEQ ID NO: 271), Aceru_RCA LF (SEQ ID NO: 263), Aceru_RCA SF (SEQ ID NO: 261), Arath_RCA SF (SEQ ID NO: 257), Chequ_RCA SF (SEQ ID NO: 265), Desan_RCA SF (SEQ ID NO: 267), Desan_RCA LF (SEQ ID NO: 269), Goshi_RCA SF (SEQ ID NO: 273), Horvu_RCA LF (SEQ ID NO: 275), Lartr_RCA SF (SEQ ID NO: 279), Lycpe_RCA LF (SEQ ID NO: 281), Nicta_RCA SF (SEQ ID NO: 285), Orysa_RCA LF (SEQ ID NO: 287), Orysa_RCA SF (SEQ ID NO: 289), Phavu_RCA SF (SEQ ID NO: 291), Triae_RCA SF (SEQ ID NO: 293), Zanae_RCA SF partial (SEQ ID NO: 299), Zeama_RCA SF (SEQ ID NO: 295), Horvu_RCA SF II (SEQ ID NO: 277), Arath_RCA LF (SEQ ID NO: 259), Maldo_RCA SF (SEQ ID NO: 283), Anasp_RCA (SEQ ID NO: 301), Nossp_RCA (SEQ ID NO: 303), Synco_RCA (SEQ ID NO: 305), consensus (SEQ ID NO: 362). 
         FIG. 16  shows the binary vector for increased expression in  Oryza sativa  of a nucleic acid sequence encoding a  Chlamydomonas reinhardtii  RCA polypeptide under the control of a constitutive promoter, or under the control of a green tissue-specific promoter. 
         FIG. 17  details examples of RCA sequences useful in performing the methods according to the present invention. 
         FIG. 18  shows the sequence of SEQ ID NO: 322 with underlined F-rich (phenylalanine-rich) and C-rich (cysteine-rich) regions. Within the boxes are the four regions of so-called intrinsic disorder. 
         FIG. 19  shows a CLUSTAL W multiple sequence alignment of SYPF1 polypeptides from various species. Conserved regions, shown as Motifs I, II and III are boxed. The sequences shown are: arabidopsisABF19046.1″ (SEQ ID NO: 346), ZW2″AT1G58330″NP_564730.1″ (SEQ ID NO: 346), SEQ ID NO: 02 (SEQ ID NO: 357), AT4G18690″(SEQ ID NO: 343), At4g18690″ (SEQ ID NO: 324), AT4G18680″NP_193603.1″ (SEQ ID NO: 326),  Nicotiana  (SEQ ID NO: 340), Os01g0159000″NP_001042081.1″ (SEQ ID NO: 336), AT4G18650(SEQ ID NO: 328), OBF4″“CAA49524.1” (SEQ ID NO: 358), At5g10030″bZip (SEQ ID NO: 332), HBP-1b″=“CAA40102.1”(SEQ ID NO: 334). 
         FIG. 20  shows a phylogenetic tree comprising SYP1 polypeptide sequences. Sequences clustering with the sequence of SEQ ID NO: 322 may be useful in performing the methods of the invention. 
         FIG. 21  shows the binary vector for increased expression in  Oryza sativa  of an  Arabidopsis thaliana  SYPF1 protein-encoding nucleic acid under the control of a HMG promoter. 
         FIG. 22  details examples of SYPF1 sequences useful in performing the methods according to the present invention. 
     
    
    
     EXAMPLES 
     The present invention will now be described with reference to the following examples, which are by way of illustration alone. The following examples are not intended to completely define or to otherwise limit the scope of the invention. 
     Part I. CCA1 
     Example 1 
     Identification of Sequences Related to the CCA1 of SEQ ID NO: 1 and SEQ ID NO: 2 
     Sequences (full length cDNA, ESTs or genomic) related to SEQ ID NO: 1 and/or protein sequences related to SEQ ID NO: 2 were identified amongst those maintained in the Entrez Nucleotides database at the National Center for Biotechnology Information (NCBI) using database sequence search tools, such as the Basic Local Alignment Tool (BLAST) (Altschul et al. (1990) J. Mol. Biol. 215:403-410; and Altschul et al. (1997) Nucleic Acids Res. 25:3389-3402). The program was used to find regions of local similarity between sequences by comparing nucleic acid or polypeptide sequences to sequence databases and by calculating the statistical significance of matches. The polypeptide encoded by SEQ ID NO: 1 was used for the TBLASTN algorithm, with default settings and the filter to ignore low complexity sequences set off. The output of the analysis was viewed by pairwise comparison, and ranked according to the probability score (E-value), where the score reflects the probability that a particular alignment occurs by chance (the lower the E-value, the more significant the hit). In addition to E-values, comparisons were also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In some instances, the default parameters may be adjusted to modify the stringency of the search. 
     Table A provides a list of nucleic acid and protein sequences related to the nucleic acid sequence as represented by SEQ ID NO: 1 and the protein sequence represented by SEQ ID NO: 2. 
     
       
         
           
               
             
               
                 TABLE A 
               
             
            
               
                   
               
               
                 Nucleic acid sequences related to the nucleic acid sequence (SEQ ID NO: 1) useful 
               
               
                 in the methods of the present invention, and the corresponding deduced polypeptides. 
               
            
           
           
               
               
               
               
               
               
            
               
                   
                   
                   
                   
                 Database 
                   
               
               
                   
                   
                 Nucleic acid  
                 Polypeptide 
                 accession 
                   
               
               
                 Name 
                 Source organism 
                 SEQ ID NO: 
                 SEQ ID NO: 
                 number 
                 Status 
               
               
                   
               
            
           
           
               
               
               
               
               
               
            
               
                 CCA1-like 
                 
                   Arabidopsis 
                   thaliana 
                 
                 1 
                 2 
                 / 
                 Full length 
               
               
                 MYB TF At1g01060 
                 
                   Arabidopsis 
                   thaliana 
                 
                 3 
                 4 
                 AY519507 
                 Full length 
               
               
                 lcl1 
                 
                   Arabidopsis 
                   thaliana 
                 
                 5 
                 6 
                 AJ937209 
                 Full length 
               
               
                 lcl2 
                 
                   Arabidopsis 
                   thaliana 
                 
                 7 
                 8 
                 AJ937210 
                 Full length 
               
               
                 lcl3 
                 
                   Arabidopsis 
                   thaliana 
                 
                 9 
                 10 
                 AJ937211 
                 Full length 
               
               
                 lcl4 
                 
                   Arabidopsis 
                   thaliana 
                 
                 11 
                 12 
                 AJ937212 
                 Full length 
               
               
                 lcl5 
                 
                   Arabidopsis 
                   thaliana 
                 
                 13 
                 14 
                 AJ937213 
                 Full length 
               
               
                 MYB TF At1g18330 
                 
                   Arabidopsis 
                   thaliana 
                 
                 15 
                 16 
                 AY550299 
                 Full length 
               
               
                 Myb-TF At1g19000 
                 
                   Arabidopsis 
                   thaliana 
                 
                 17 
                 18 
                 AY079415 
                 Full length 
               
               
                 MYB TF At1g70000 
                 
                   Arabidopsis 
                   thaliana 
                 
                 19 
                 20 
                 AY519509 
                 Full length 
               
               
                 MYB TF At1g74840 
                 
                   Arabidopsis 
                   thaliana 
                 
                 21 
                 22 
                 AY519510 
                 Full length 
               
               
                 MYB TF AT3G10113 
                 
                   Arabidopsis 
                   thaliana 
                 
                 23 
                 24 
                 NM_148701 
                 Full length 
               
               
                 MYB TF AT3G10580 
                 
                   Arabidopsis 
                   thaliana 
                 
                 25 
                 26 
                 NM_111894 
                 Full length 
               
               
                 MYB TF At3g10590 
                 
                   Arabidopsis 
                   thaliana 
                 
                 27 
                 28 
                 AY550300 
                 Full length 
               
               
                 MYB TF At3g16350 
                 
                   Arabidopsis 
                   thaliana 
                 
                 29 
                 30 
                 AY519512 
                 Full length 
               
               
                 MYB TF At4g09450 
                 
                   Arabidopsis 
                   thaliana 
                 
                 31 
                 32 
                 AY122911 
                 Full length 
               
               
                 MYB TF At5g37260 
                 
                   Arabidopsis 
                   thaliana 
                 
                 33 
                 34 
                 AY519515 
                 Full length 
               
               
                 MYB TF At5g47390 
                 
                   Arabidopsis 
                   thaliana 
                 
                 35 
                 36 
                 AY519516 
                 Full length 
               
               
                 MYB TF At5g56840 
                 
                   Arabidopsis 
                   thaliana 
                 
                 37 
                 38 
                 AY519517 
                 Full length 
               
               
                 MYB TF AT5G61620 
                 
                   Arabidopsis 
                   thaliana 
                 
                 39 
                 40 
                 NM_125556 
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 41 
                 42 
                 LOC_Os01g06320  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 43 
                 44 
                 LOC_Os01g09280  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 45 
                 46 
                 LOC_Os01g09640  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 47 
                 48 
                 LOC_Os01g41900  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 49 
                 50 
                 LOC_Os02g30700  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 51 
                 52 
                 LOC_Os05g07010  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 53 
                 54 
                 LOC_Os05g10690  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 55 
                 56 
                 LOC_Os05g51160  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 57 
                 58 
                 LOC_Os06g07640  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 59 
                 60 
                 LOC_Os06g07650  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 61 
                 62 
                 LOC_Os06g07700  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 63 
                 64 
                 LOC_Os06g07740  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 65 
                 66 
                 LOC_Os06g45840  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 67 
                 68 
                 LOC_Os08g04840  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 69 
                 70 
                 LOC_Os08g05510  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 71 
                 72 
                 LOC_Os08g06110  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 73 
                 74 
                 LOC_Os10g41200  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 75 
                 76 
                 LOC_Os10g41260  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 77 
                 78 
                 LOC_Os02g46030  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 79 
                 80 
                 LOC_Os04g49450  
                 Full length 
               
               
                 MYB TF 
                 
                   Oryza 
                   sativa 
                 
                 81 
                 82 
                 LOC_Os06g51260  
                 Full length 
               
               
                 LpLHY H1 
                 
                   Lemna 
                   paucicostata 
                 
                 83 
                 84 
                 AB210845 
                 Full length 
               
               
                 LgLHY H1 
                 
                   Lemna 
                   gibba 
                 
                 85 
                 86 
                 AB210849 
                 Full length 
               
               
                 MYB TF 
                 
                   Castanea 
                   sativa 
                 
                 87 
                 88 
                 AY611029 
                 Full length 
               
               
                 MYB TF 
                 
                   Phaseolus 
                   vulgaris 
                 
                 89 
                 90 
                 AJ420902 
                 Full length 
               
               
                 MYB114 
                 
                   Glycine 
                   max 
                 
                 91 
                 92 
                 DQ822977 
                 partial 
               
               
                 CCA1-like 
                 
                   Mesembryanthemum 
                 
                 93 
                 94 
                 AY371287 
                 Full length 
               
               
                   
                 
                   crystallinum 
                 
                   
                   
                   
                   
               
               
                 MYB clone 114030R 
                 
                   Lycopersicon 
                   esculentum 
                 
                 95 
                 96 
                 BT012912 
                 Full length 
               
               
                 MYB186 
                 
                   Glycine 
                   max 
                 
                 97 
                 98 
                 DQ822982 
                 partial 
               
               
                 LgLHY H2 
                 
                   Lemna 
                   gibba 
                 
                 99 
                 100 
                 AB210850 
                 Full length 
               
               
                 MYB PCO118792 
                 
                   Zea 
                   mays 
                 
                 101 
                 102 
                 AY103618 
                 Full length 
               
               
                 LpLHY H2 
                 
                   Lemna 
                   paucicostata 
                 
                 103 
                 104 
                 AB210846 
                 Full length 
               
               
                 MYB177 
                 
                   Glycine 
                   max 
                 
                 105 
                 106 
                 DQ822925 
                 Full length 
               
               
                 MYB clone 
                 
                   Triticum 
                   aestivum 
                 
                 107 
                 108 
                 BT009406 
                 Full length 
               
               
                 wlm96.pk054.b21:fis 
                   
                   
                   
                   
                   
               
               
                 MYB173 
                 
                   Glycine 
                   max 
                 
                 109 
                 110 
                 DQ822922 
                 Full length 
               
               
                 MYB140 
                 
                   Glycine 
                   max 
                 
                 111 
                 112 
                 DQ822986 
                 partial 
               
               
                 MYB131 
                 
                   Glycine 
                   max 
                 
                 113 
                 114 
                 DQ822983 
                 partial 
               
               
                 MYB144 
                 
                   Glycine 
                   max 
                 
                 115 
                 116 
                 DQ822987 
                 partial 
               
               
                 MYB174 
                 
                   Glycine 
                   max 
                 
                 117 
                 118 
                 DQ822939 
                 partial 
               
               
                 LHY-like 
                 
                   Ostreococcus 
                   tauri 
                 
                 119 
                 120 
                 AY740076 
                 partial 
               
               
                 MYB, clone mth2- 
                 
                   Medicago 
                   truncatula 
                 
                 121 
                 122 
                 AC150443 
                 partial 
               
               
                 71o19 
                   
                   
                   
                   
                   
               
               
                 MYBR5 
                 
                   Malus 
                   x 
                   domestica 
                 
                 123 
                 124 
                 DQ074476 
                 Full length 
               
               
                 MYB, clone 
                 
                   Triticum 
                   aestivum 
                 
                 125 
                 126 
                 BT008954 
                 Full length 
               
               
                 wdk1c.pk011.f12:fis, 
                   
                   
                   
                   
                   
               
               
                 MYB148 
                 
                   Glycine 
                   max 
                 
                 127 
                 128 
                 DQ822956 
                 partial 
               
               
                 MYB135 
                 
                   Glycine 
                   max 
                 
                 129 
                 130 
                 DQ822955  
                 partial 
               
               
                 Myb2 
                 
                   Pisum 
                   sativum 
                 
                 131 
                 132 
                 AY826731  
                 partial 
               
               
                 MYB133 
                 
                   Glycine 
                   max 
                 
                 133 
                 134 
                 DQ822916  
                 Full length 
               
               
                 MYB146 
                 
                   Glycine 
                   max 
                 
                 135 
                 136 
                 DQ822984  
                 partial 
               
               
                 MYB155 
                 
                   Glycine 
                   max 
                 
                 137 
                 138 
                 DQ822940  
                 partial 
               
               
                 MYB118 
                 
                   Glycine 
                   max 
                 
                 139 
                 140 
                 DQ822912  
                 Full length 
               
               
                   
               
            
           
         
       
     
     Example 2 
     Alignment of Relevant Polypeptide Sequences 
     AlignX from the Vector NTI (Invitrogen) is based on the Clustal algorithm of progressive alignment (Thompson et al. (1997) Nucleic Acids Res 25:4876-4882; Chema et al. (2003). Nucleic Acids Res 31:3497-3500). A phylogenetic tree can be constructed using a neighbour-joining clustering algorithm. Default values are for the gap open penalty of 10, for the gap extension penalty of 0.1 and the selected weight matrix is Blosum 62 (if polypeptides are aligned). 
     The result of the multiple sequence alignment using polypeptides relevant in identifying the ones useful in performing the methods of the invention is shown in  FIG. 2 . A selection of the sequences used for the multiple alignment was used as input data for calculating the phylogenetic tree. Although there is little overall sequence conservation (see example 3), regions of high conservation can be discriminated, such as the motifs of SEQ ID NO: 141 to 145, but additional motifs may be derived from the alignment. 
     Example 3 
     Calculation of Global Percentage Identity Between Polypeptide Sequences Useful in Performing the Methods of the Invention 
     Global percentages of similarity and identity between full length polypeptide sequences useful in performing the methods of the invention were determined using one of the methods available in the art, the MatGAT (Matrix Global Alignment Tool) software (BMC Bioinformatics. 2003 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences. Campanella J J, Bitincka L, Smalley J; software hosted by Ledion Bitincka). MatGAT software generates similarity/identity matrices for DNA or protein sequences without needing pre-alignment of the data. The program performs a series of pair-wise alignments using the Myers and Miller global alignment algorithm (with a gap opening penalty of 12, and a gap extension penalty of 2), calculates similarity and identity using for example Blosum 62 (for polypeptides), and then places the results in a distance matrix. Sequence similarity is shown in the bottom half of the dividing line and sequence identity is shown in the top half of the diagonal dividing line. 
     Parameters used in the comparison were: 
     
         
         
           
             Scoring matrix: Blosum62 
             First Gap: 12 
             Extending gap: 2 
           
         
       
    
     Results of the software analysis are shown in Table A1 for the global similarity and identity over the full length of the polypeptide sequences (excluding the partial polypeptide sequences). Percentage identity is given above the diagonal in bold and percentage similarity is given below the diagonal (normal face). 
     The percentage identity between the polypeptide sequences useful in performing the methods of the invention can be as low as 9% amino acid identity compared to SEQ ID NO: 2. 
     
       
         
           
               
             
               
                 TABLE A1 
               
               
                   
               
               
                 MatGAT results for global similarity and identity over the full length of the polypeptide sequences. 
               
               
                   
               
             
            
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
            
               
                   
                   
                 1 
                 2 
                 3 
                 4 
                 5 
                 6 
                 7 
                 8 
                 9 
                 10 
                 11 
                 12 
                 13 
               
               
                   
               
               
                 1. 
                 SEQID2 
                   
                 
                   42.4 
                 
                 
                   17.2 
                 
                 
                   16.3 
                 
                 
                   16.9 
                 
                 
                   17.4 
                 
                 
                   18.8 
                 
                 
                   21.6 
                 
                 
                   12.5 
                 
                 
                   11.9 
                 
                 
                   11.3 
                 
                 
                   19.4 
                 
                 
                   13 
                 
               
               
                 2. 
                 SEQID4 
                 57.8 
                   
                 
                   16.4 
                 
                 
                   15.3 
                 
                 
                   15.1 
                 
                 
                   14.9 
                 
                 
                   16.4 
                 
                 
                   21.5 
                 
                 
                   12.1 
                 
                 
                   11 
                 
                 
                   11.3 
                 
                 
                   18.8 
                 
                 
                   11.9 
                 
               
               
                 3. 
                 SEQID6 
                 25.5 
                 25.4 
                   
                 
                   44.2 
                 
                 
                   47.4 
                 
                 
                   43.8 
                 
                 
                   69.8 
                 
                 
                   25.3 
                 
                 
                   17.5 
                 
                 
                   14.4 
                 
                 
                   14.3 
                 
                 
                   25.9 
                 
                 
                   21.3 
                 
               
               
                 4. 
                 SEQID8 
                 25.7 
                 24.5 
                 57.6 
                   
                 
                   44.9 
                 
                 
                   46.6 
                 
                 
                   47.6 
                 
                 
                   25.9 
                 
                 
                   18.8 
                 
                 
                   18.8 
                 
                 
                   19.2 
                 
                 
                   27.5 
                 
                 
                   19.7 
                 
               
               
                 5. 
                 SEQID10 
                 25 
                 24.7 
                 61.1 
                 61.8 
                   
                 
                   58.8 
                 
                 
                   47.5 
                 
                 
                   27 
                 
                 
                   17 
                 
                 
                   18.6 
                 
                 
                   19.1 
                 
                 
                   26.3 
                 
                 
                   19.2 
                 
               
               
                 6. 
                 SEQID12 
                 25.5 
                 24.5 
                 57.6 
                 60.9 
                 73.2 
                   
                 
                   44.8 
                 
                 
                   26.2 
                 
                 
                   15.8 
                 
                 
                   16.7 
                 
                 
                   17.6 
                 
                 
                   26.8 
                 
                 
                   19.8 
                 
               
               
                 7. 
                 SEQID14 
                 26.3 
                 24.7 
                 78.5 
                 57 
                 59.6 
                 56.6 
                   
                 
                   26.9 
                 
                 
                   15.2 
                 
                 
                   16.6 
                 
                 
                   14.6 
                 
                 
                   26.5 
                 
                 
                   20.6 
                 
               
               
                 8. 
                 SEQID16 
                 32.6 
                 31.3 
                 41.6 
                 42.5 
                 42.5 
                 44.8 
                 43.1 
                   
                 
                   16.8 
                 
                 
                   17 
                 
                 
                   15.2 
                 
                 
                   88.1 
                 
                 
                   15.5 
                 
               
               
                 9. 
                 SEQID18 
                 22.2 
                 20.5 
                 29.4 
                 30.9 
                 35.9 
                 29.1 
                 29.8 
                 29.5 
                   
                 
                   39 
                 
                 
                   55.9 
                 
                 
                   16.1 
                 
                 
                   25.9 
                 
               
               
                 10. 
                 SEQID20 
                 19.4 
                 18 
                 29 
                 30.9 
                 36.2 
                 32.5 
                 31.2 
                 27.7 
                 51.2 
                   
                 
                   40.6 
                 
                 
                   17.7 
                 
                 
                   24.9 
                 
               
               
                 11. 
                 SEQID22 
                 20.1 
                 19.1 
                 33.1 
                 33.3 
                 34.1 
                 33.1 
                 34.4 
                 31.5 
                 69.8 
                 54 
                   
                 
                   15.2 
                 
                 
                   28 
                 
               
               
                 12. 
                 SEQID24 
                 30.8 
                 28.7 
                 43.5 
                 44 
                 41.7 
                 42.6 
                 42.6 
                 92.2 
                 29.8 
                 30.7 
                 31.8 
                   
                 
                   18.2 
                 
               
               
                 13. 
                 SEQID26 
                 20.1 
                 20.5 
                 38.2 
                 32.1 
                 36.6 
                 35.8 
                 36.9 
                 31.8 
                 41.8 
                 41.1 
                 42.5 
                 32.7 
                   
               
               
                 14. 
                 SEQID28 
                 16.4 
                 17.8 
                 29.7 
                 27 
                 30 
                 27.8 
                 33 
                 23.7 
                 35.8 
                 37.2 
                 37.4 
                 23.5 
                 40.4 
               
               
                 15. 
                 SEQID30 
                 25.2 
                 22.2 
                 30.5 
                 35.1 
                 27.6 
                 29.7 
                 26.6 
                 29.2 
                 44.7 
                 42.1 
                 42.1 
                 30.2 
                 32.8 
               
               
                 16. 
                 SEQID32 
                 15.6 
                 16.3 
                 29.4 
                 24.8 
                 26.5 
                 27.8 
                 28 
                 27.5 
                 37.5 
                 33 
                 38.1 
                 28 
                 54.7 
               
               
                 17. 
                 SEQID34 
                 28.5 
                 28.4 
                 46.1 
                 42.4 
                 46.7 
                 43 
                 46.3 
                 51.7 
                 30 
                 30 
                 28.9 
                 49.1 
                 29.3 
               
               
                 18. 
                 SEQID36 
                 23.2 
                 23.6 
                 33.7 
                 34 
                 33.2 
                 35.3 
                 34 
                 38.4 
                 43.6 
                 45.2 
                 41.6 
                 33.2 
                 32.6 
               
               
                 19. 
                 SEQID38 
                 18.8 
                 17.1 
                 27.3 
                 30.3 
                 27.5 
                 34.1 
                 35.1 
                 27.7 
                 44.2 
                 47.9 
                 48.3 
                 26.8 
                 36.2 
               
               
                 20. 
                 SEQID40 
                 23.2 
                 21.4 
                 30.9 
                 35.8 
                 32.5 
                 37.2 
                 29.3 
                 28.9 
                 43.8 
                 45.7 
                 44.5 
                 36 
                 39.4 
               
               
                 21. 
                 SEQID42 
                 28.9 
                 25.7 
                 52.3 
                 50.9 
                 52.6 
                 52.6 
                 51.3 
                 41.3 
                 28.8 
                 30.1 
                 28.4 
                 40.5 
                 28.4 
               
               
                 22. 
                 SEQID44 
                 22.5 
                 23.3 
                 33.3 
                 30.6 
                 31.1 
                 32.5 
                 32.2 
                 33.6 
                 42.9 
                 44.3 
                 41 
                 32 
                 34.7 
               
               
                 23. 
                 SEQID46 
                 20.9 
                 20.9 
                 35.5 
                 37.3 
                 39 
                 36.5 
                 30.6 
                 30.3 
                 46.5 
                 46.8 
                 47.1 
                 30.7 
                 36.8 
               
               
                 24. 
                 SEQID48 
                 20.9 
                 19.5 
                 24.6 
                 27.3 
                 25.6 
                 23.8 
                 27.9 
                 27.7 
                 42.5 
                 49.2 
                 43.5 
                 26.5 
                 37.2 
               
               
                 25. 
                 SEQID50 
                 20.2 
                 20 
                 28 
                 28.5 
                 31.4 
                 29.1 
                 34 
                 30.9 
                 38.6 
                 31.9 
                 29.7 
                 29.8 
                 38.3 
               
               
                 26. 
                 SEQID52 
                 22.9 
                 22 
                 45.4 
                 41.2 
                 42.5 
                 46 
                 46.1 
                 38.2 
                 29.8 
                 29.5 
                 29.4 
                 37.2 
                 34.1 
               
               
                 27. 
                 SEQID54 
                 20.2 
                 19.1 
                 30 
                 29.7 
                 30.3 
                 29.8 
                 31.4 
                 30.9 
                 47.4 
                 53 
                 51.2 
                 29.5 
                 40.8 
               
               
                 28. 
                 SEQID56 
                 21.4 
                 18.4 
                 27 
                 28.8 
                 30.3 
                 28.5 
                 28.7 
                 26 
                 45.3 
                 48.5 
                 48.5 
                 28.9 
                 37.3 
               
               
                 29. 
                 SEQID58 
                 21.9 
                 20.5 
                 26.5 
                 28.5 
                 30.2 
                 26.2 
                 25.5 
                 25.7 
                 38 
                 38.9 
                 37.4 
                 31.3 
                 35.5 
               
               
                 30. 
                 SEQID60 
                 24.3 
                 22.5 
                 27.7 
                 27.9 
                 25.6 
                 29.7 
                 25.6 
                 30.7 
                 32.7 
                 29.4 
                 33.5 
                 31.7 
                 32.7 
               
               
                 31. 
                 SEQID62 
                 20.7 
                 20.8 
                 29.5 
                 30 
                 26.5 
                 27.2 
                 25.8 
                 30.1 
                 36.2 
                 32.6 
                 35.6 
                 30.1 
                 36.9 
               
               
                 32. 
                 SEQID64 
                 22.7 
                 21.4 
                 29.6 
                 29.6 
                 28.5 
                 28.5 
                 29.8 
                 33.4 
                 29.3 
                 28.5 
                 32.3 
                 30.9 
                 32.9 
               
               
                 33. 
                 SEQID66 
                 13.7 
                 14 
                 30.4 
                 29.1 
                 31.4 
                 33.8 
                 31.6 
                 22 
                 21.8 
                 30.7 
                 28.3 
                 23.5 
                 22.6 
               
               
                 34. 
                 SEQID68 
                 24.2 
                 24 
                 30.3 
                 32.1 
                 29.2 
                 31.9 
                 32.1 
                 31.3 
                 38.4 
                 39.7 
                 36 
                 32.4 
                 32.6 
               
               
                 35. 
                 SEQID70 
                 25.2 
                 23.4 
                 33.6 
                 37.2 
                 32.7 
                 37.5 
                 33 
                 34.1 
                 42.2 
                 37.8 
                 41.9 
                 35.4 
                 34.5 
               
               
                 36. 
                 SEQID72 
                 52.3 
                 54.2 
                 22.5 
                 24.2 
                 21.1 
                 23.1 
                 23.5 
                 27.1 
                 18.2 
                 17.9 
                 17.2 
                 25.9 
                 18.5 
               
               
                 37. 
                 SEQID74 
                 21.2 
                 21.4 
                 40.6 
                 36.7 
                 30.8 
                 38.7 
                 38.1 
                 33.8 
                 46.5 
                 48.1 
                 47.2 
                 37.8 
                 34 
               
               
                 38. 
                 SEQID76 
                 21.7 
                 18.1 
                 37.5 
                 34.2 
                 38.3 
                 36.1 
                 37.2 
                 28 
                 43.9 
                 45.7 
                 47.5 
                 33.6 
                 41.5 
               
               
                 39. 
                 SEQID78 
                 36.8 
                 34.4 
                 30.8 
                 32 
                 31.8 
                 33 
                 31 
                 40.1 
                 24.4 
                 23 
                 22.6 
                 38.3 
                 22.2 
               
               
                 40. 
                 SEQID80 
                 39.6 
                 36.3 
                 32.8 
                 34.3 
                 29.6 
                 31.7 
                 32.2 
                 41.5 
                 25.7 
                 24.6 
                 21.8 
                 40 
                 24.2 
               
               
                 41. 
                 SEQID82 
                 37.5 
                 34.4 
                 35.3 
                 37.3 
                 34.4 
                 35.7 
                 35 
                 43.9 
                 27.7 
                 26.6 
                 24.8 
                 42.6 
                 29.5 
               
               
                 42. 
                 SEQID84 
                 52.6 
                 50.1 
                 28.7 
                 29.4 
                 27.3 
                 28.3 
                 27.2 
                 35.2 
                 21.2 
                 21.3 
                 22.1 
                 33 
                 24.2 
               
               
                 43. 
                 SEQID86 
                 52 
                 53.3 
                 27.4 
                 26.7 
                 25.6 
                 27.2 
                 27.2 
                 33.9 
                 20.5 
                 20 
                 20.1 
                 30.6 
                 20.1 
               
               
                 44. 
                 SEQID88 
                 54 
                 58.9 
                 22.3 
                 22.1 
                 19.5 
                 20.2 
                 20.2 
                 25.3 
                 16.8 
                 17.4 
                 18.5 
                 25.4 
                 18.4 
               
               
                 45. 
                 SEQID90 
                 53.1 
                 61 
                 23.4 
                 22.7 
                 21.3 
                 22.4 
                 21.3 
                 27.7 
                 18.4 
                 16.9 
                 16.2 
                 26.4 
                 18.7 
               
               
                 46. 
                 SEQID94 
                 52.4 
                 58.1 
                 22.6 
                 23.3 
                 20.4 
                 22.1 
                 20.3 
                 27.2 
                 18.1 
                 18.4 
                 16.9 
                 25.4 
                 16.6 
               
               
                 47. 
                 SEQID96 
                 50.7 
                 55.1 
                 21.8 
                 22.7 
                 21.3 
                 22.4 
                 20.7 
                 26 
                 19.2 
                 16.7 
                 17.3 
                 24.9 
                 16.9 
               
               
                 48. 
                 SEQID100 
                 50 
                 47.9 
                 33.6 
                 34.9 
                 32.4 
                 31.3 
                 32.9 
                 40.5 
                 26.6 
                 25 
                 24.1 
                 38.3 
                 27 
               
               
                 49. 
                 SEQID102 
                 30.3 
                 30.4 
                 44.7 
                 44.8 
                 46.3 
                 41.4 
                 48.6 
                 43.6 
                 29.8 
                 36.1 
                 31.8 
                 42.6 
                 30.3 
               
               
                 50. 
                 SEQID104 
                 48.5 
                 47.1 
                 31.4 
                 31.6 
                 31.8 
                 33.6 
                 34.3 
                 41.3 
                 26 
                 23.9 
                 21.7 
                 39.3 
                 25.5 
               
               
                 51. 
                 SEQID106 
                 35.7 
                 33.6 
                 36.5 
                 38.5 
                 35.1 
                 36.2 
                 33.7 
                 46.6 
                 26.4 
                 24.1 
                 24.1 
                 45.2 
                 27.5 
               
               
                 52. 
                 SEQID108 
                 36.5 
                 35.7 
                 32.3 
                 34.7 
                 31.2 
                 32.7 
                 34.1 
                 43.4 
                 25.4 
                 26.9 
                 26.3 
                 42.3 
                 25.2 
               
               
                 53. 
                 SEQID110 
                 28.3 
                 25.4 
                 44.7 
                 42.7 
                 44.9 
                 42.1 
                 46 
                 49.4 
                 38.3 
                 37.3 
                 32.1 
                 47.3 
                 39 
               
               
                 54. 
                 SEQID124 
                 27.6 
                 25.6 
                 61.6 
                 72.7 
                 60.7 
                 61.9 
                 58.5 
                 47.4 
                 30.3 
                 28.5 
                 32.8 
                 46.1 
                 33.4 
               
               
                 55. 
                 SEQID126 
                 26.8 
                 25.1 
                 64.5 
                 62.1 
                 66.2 
                 63.9 
                 65.7 
                 43.4 
                 32.2 
                 32.5 
                 31.8 
                 42.3 
                 31.4 
               
               
                 56. 
                 SEQID134 
                 27.1 
                 28.2 
                 55.9 
                 68.6 
                 63.1 
                 63.7 
                 59.8 
                 46.2 
                 32 
                 27.2 
                 34.7 
                 45.2 
                 33.5 
               
               
                 57. 
                 SEQID140 
                 24.8 
                 23.3 
                 70.6 
                 55.2 
                 58.2 
                 57 
                 78 
                 40.8 
                 34 
                 29.3 
                 37.6 
                 40.8 
                 39 
               
               
                   
               
               
                   
                   
                 14 
                 15 
                 16 
                 17 
                 18 
                 19 
                 20 
                 21 
                 22 
                 23 
                 24 
                 25 
                 26 
               
               
                   
               
               
                 1. 
                 SEQID2 
                 
                   10 
                 
                 
                   14.1 
                 
                 
                   9 
                 
                 
                   20.2 
                 
                 
                   12.2 
                 
                 
                   12.5 
                 
                 
                   12.5 
                 
                 
                   19.9 
                 
                 
                   13.3 
                 
                 
                   13.7 
                 
                 
                   13.5 
                 
                 
                   12 
                 
                 
                   16.6 
                 
               
               
                 2. 
                 SEQID4 
                 
                   9.9 
                 
                 
                   11.7 
                 
                 
                   10.5 
                 
                 
                   21 
                 
                 
                   13.3 
                 
                 
                   10.5 
                 
                 
                   13 
                 
                 
                   18.1 
                 
                 
                   12.7 
                 
                 
                   12.4 
                 
                 
                   10.2 
                 
                 
                   11.9 
                 
                 
                   14.9 
                 
               
               
                 3. 
                 SEQID6 
                 
                   14.7 
                 
                 
                   16.5 
                 
                 
                   15 
                 
                 
                   27.1 
                 
                 
                   19.8 
                 
                 
                   14 
                 
                 
                   16.7 
                 
                 
                   35.3 
                 
                 
                   18.3 
                 
                 
                   16.2 
                 
                 
                   11.6 
                 
                 
                   17.5 
                 
                 
                   29 
                 
               
               
                 4. 
                 SEQID8 
                 
                   15.1 
                 
                 
                   22 
                 
                 
                   15.4 
                 
                 
                   25.5 
                 
                 
                   20 
                 
                 
                   19.1 
                 
                 
                   17.2 
                 
                 
                   34.3 
                 
                 
                   18.9 
                 
                 
                   20.5 
                 
                 
                   13.3 
                 
                 
                   15 
                 
                 
                   28.1 
                 
               
               
                 5. 
                 SEQID10 
                 
                   15.3 
                 
                 
                   17.2 
                 
                 
                   12.9 
                 
                 
                   28.9 
                 
                 
                   18.9 
                 
                 
                   14.6 
                 
                 
                   18.3 
                 
                 
                   32.6 
                 
                 
                   20.1 
                 
                 
                   18.8 
                 
                 
                   13.5 
                 
                 
                   14.7 
                 
                 
                   27.9 
                 
               
               
                 6. 
                 SEQID12 
                 
                   13.7 
                 
                 
                   17 
                 
                 
                   13.5 
                 
                 
                   27.3 
                 
                 
                   19 
                 
                 
                   17.9 
                 
                 
                   19 
                 
                 
                   34.6 
                 
                 
                   19.3 
                 
                 
                   18.6 
                 
                 
                   11.4 
                 
                 
                   14.5 
                 
                 
                   29 
                 
               
               
                 7. 
                 SEQID14 
                 
                   18.5 
                 
                 
                   17.6 
                 
                 
                   14.1 
                 
                 
                   29.2 
                 
                 
                   19.7 
                 
                 
                   19.9 
                 
                 
                   15.9 
                 
                 
                   34.4 
                 
                 
                   19.3 
                 
                 
                   15.8 
                 
                 
                   13.3 
                 
                 
                   14.9 
                 
                 
                   31.4 
                 
               
               
                 8. 
                 SEQID16 
                 
                   12.7 
                 
                 
                   14.2 
                 
                 
                   14.4 
                 
                 
                   35.1 
                 
                 
                   18.7 
                 
                 
                   17.7 
                 
                 
                   15.3 
                 
                 
                   22.7 
                 
                 
                   16 
                 
                 
                   14.8 
                 
                 
                   13.9 
                 
                 
                   15.9 
                 
                 
                   23.4 
                 
               
               
                 9. 
                 SEQID18 
                 
                   23.6 
                 
                 
                   30.8 
                 
                 
                   26 
                 
                 
                   12.7 
                 
                 
                   33.3 
                 
                 
                   30.9 
                 
                 
                   29.5 
                 
                 
                   14.1 
                 
                 
                   31.7 
                 
                 
                   31.1 
                 
                 
                   26.8 
                 
                 
                   19.3 
                 
                 
                   19.1 
                 
               
               
                 10. 
                 SEQID20 
                 
                   23 
                 
                 
                   34.2 
                 
                 
                   23 
                 
                 
                   15.9 
                 
                 
                   32.6 
                 
                 
                   36.1 
                 
                 
                   31.1 
                 
                 
                   14 
                 
                 
                   32.2 
                 
                 
                   34.1 
                 
                 
                   34.5 
                 
                 
                   16.4 
                 
                 
                   16.5 
                 
               
               
                 11. 
                 SEQID22 
                 
                   20.7 
                 
                 
                   28.9 
                 
                 
                   28 
                 
                 
                   13.4 
                 
                 
                   31.6 
                 
                 
                   30.4 
                 
                 
                   27.6 
                 
                 
                   14.1 
                 
                 
                   29.9 
                 
                 
                   30 
                 
                 
                   28.4 
                 
                 
                   13.9 
                 
                 
                   12.4 
                 
               
               
                 12. 
                 SEQID24 
                 
                   13.6 
                 
                 
                   14.4 
                 
                 
                   13.4 
                 
                 
                   33.3 
                 
                 
                   18.9 
                 
                 
                   16.8 
                 
                 
                   17.4 
                 
                 
                   22.2 
                 
                 
                   15.7 
                 
                 
                   14.3 
                 
                 
                   13.6 
                 
                 
                   14.7 
                 
                 
                   23.1 
                 
               
               
                 13. 
                 SEQID26 
                 
                   28.4 
                 
                 
                   20.7 
                 
                 
                   48.8 
                 
                 
                   12 
                 
                 
                   19.9 
                 
                 
                   23.9 
                 
                 
                   25.9 
                 
                 
                   14.8 
                 
                 
                   23.5 
                 
                 
                   23.7 
                 
                 
                   23.6 
                 
                 
                   20.5 
                 
                 
                   18.8 
                 
               
               
                 14. 
                 SEQID28 
                   
                 
                   14.5 
                 
                 
                   38 
                 
                 
                   17.4 
                 
                 
                   16.2 
                 
                 
                   24.8 
                 
                 
                   17.1 
                 
                 
                   15.9 
                 
                 
                   15.1 
                 
                 
                   22 
                 
                 
                   22.1 
                 
                 
                   20.7 
                 
                 
                   16 
                 
               
               
                 15. 
                 SEQID30 
                 24.5 
                   
                 
                   19.1 
                 
                 
                   13.1 
                 
                 
                   41.4 
                 
                 
                   27.6 
                 
                 
                   29.1 
                 
                 
                   16.7 
                 
                 
                   46.6 
                 
                 
                   33.8 
                 
                 
                   35.8 
                 
                 
                   15.9 
                 
                 
                   15.4 
                 
               
               
                 16. 
                 SEQID32 
                 56.8 
                 27.9 
                   
                 
                   15.2 
                 
                 
                   19 
                 
                 
                   23.3 
                 
                 
                   21.8 
                 
                 
                   12.3 
                 
                 
                   19.3 
                 
                 
                   22.3 
                 
                 
                   23.5 
                 
                 
                   23.2 
                 
                 
                   14.1 
                 
               
               
                 17. 
                 SEQID34 
                 33.4 
                 26.6 
                 25.8 
                   
                 
                   17.3 
                 
                 
                   15.3 
                 
                 
                   14.8 
                 
                 
                   26.7 
                 
                 
                   15.6 
                 
                 
                   16.3 
                 
                 
                   12.4 
                 
                 
                   16.2 
                 
                 
                   26 
                 
               
               
                 18. 
                 SEQID36 
                 26 
                 57.4 
                 27.1 
                 31.8 
                   
                 
                   29.3 
                 
                 
                   32 
                 
                 
                   19.2 
                 
                 
                   44.4 
                 
                 
                   32 
                 
                 
                   28.6 
                 
                 
                   13.2 
                 
                 
                   15.1 
                 
               
               
                 19. 
                 SEQID38 
                 39.9 
                 37.7 
                 32.6 
                 29.3 
                 37.5 
                   
                 
                   32.6 
                 
                 
                   11.4 
                 
                 
                   29.6 
                 
                 
                   38.9 
                 
                 
                   37 
                 
                 
                   19 
                 
                 
                   12.6 
                 
               
               
                 20. 
                 SEQID40 
                 29.7 
                 42.9 
                 31.2 
                 26.8 
                 46 
                 44.8 
                   
                 
                   15.7 
                 
                 
                   32.7 
                 
                 
                   32.1 
                 
                 
                   26.4 
                 
                 
                   13 
                 
                 
                   16.1 
                 
               
               
                 21. 
                 SEQID42 
                 28.4 
                 28.9 
                 24.5 
                 44.4 
                 33.7 
                 28.1 
                 31.2 
                   
                 
                   17.3 
                 
                 
                   16.2 
                 
                 
                   12.5 
                 
                 
                   15.6 
                 
                 
                   39.9 
                 
               
               
                 22. 
                 SEQID44 
                 24.9 
                 59.7 
                 24.9 
                 27.9 
                 60.1 
                 41.3 
                 47 
                 31.7 
                   
                 
                   31.1 
                 
                 
                   32.4 
                 
                 
                   15.2 
                 
                 
                   16.9 
                 
               
               
                 23. 
                 SEQID46 
                 32.9 
                 49.9 
                 31.3 
                 29 
                 47.7 
                 50 
                 47.3 
                 32.6 
                 47.5 
                   
                 
                   46.3 
                 
                 
                   19.1 
                 
                 
                   17.5 
                 
               
               
                 24. 
                 SEQID48 
                 32.6 
                 45.7 
                 30.9 
                 30.2 
                 45.5 
                 49.8 
                 46.1 
                 23.2 
                 47.3 
                 58.7 
                   
                 
                   17.8 
                 
                 
                   14.4 
                 
               
               
                 25. 
                 SEQID50 
                 33 
                 26.4 
                 34.4 
                 32.1 
                 24.9 
                 35.9 
                 24.3 
                 30.1 
                 24.6 
                 37.4 
                 33.9 
                   
                 
                   18.4 
                 
               
               
                 26. 
                 SEQID52 
                 31.7 
                 24.3 
                 25.6 
                 42.2 
                 26.8 
                 26.8 
                 27.4 
                 52.3 
                 27 
                 30 
                 26.2 
                 30.1 
                   
               
               
                 27. 
                 SEQID54 
                 34.5 
                 44.7 
                 35.5 
                 30.7 
                 43.3 
                 49.8 
                 46.7 
                 30.4 
                 42.3 
                 72.3 
                 58.8 
                 35.5 
                 25.8 
               
               
                 28. 
                 SEQID56 
                 36.3 
                 44.2 
                 35.9 
                 31.7 
                 40.8 
                 48.5 
                 45.1 
                 24.5 
                 41.5 
                 54.2 
                 64.5 
                 39.5 
                 28.9 
               
               
                 29. 
                 SEQID58 
                 32.1 
                 35.1 
                 32.1 
                 29.3 
                 25.5 
                 33 
                 42.7 
                 24.9 
                 29 
                 41.1 
                 38.9 
                 34 
                 24.6 
               
               
                 30. 
                 SEQID60 
                 26.6 
                 34.8 
                 27.4 
                 29.7 
                 35 
                 28.2 
                 29.9 
                 27.4 
                 36.8 
                 31.2 
                 34.3 
                 27.4 
                 26.1 
               
               
                 31. 
                 SEQID62 
                 26.5 
                 31 
                 31.2 
                 28.9 
                 34.8 
                 34.9 
                 36.3 
                 29.1 
                 29.5 
                 38.4 
                 37.9 
                 32.6 
                 26.8 
               
               
                 32. 
                 SEQID64 
                 24.6 
                 32.3 
                 26.5 
                 28.2 
                 29.3 
                 29.3 
                 35.6 
                 26.5 
                 32 
                 35.4 
                 31.8 
                 27.9 
                 24 
               
               
                 33. 
                 SEQID66 
                 26.2 
                 19.6 
                 27.5 
                 24 
                 20 
                 33 
                 22.1 
                 29.4 
                 20.8 
                 19.4 
                 23.9 
                 23.6 
                 25.2 
               
               
                 34. 
                 SEQID68 
                 23.5 
                 50.1 
                 23.2 
                 29.2 
                 53.3 
                 35 
                 47 
                 31.9 
                 50.4 
                 43.1 
                 39.9 
                 25.1 
                 26.4 
               
               
                 35. 
                 SEQID70 
                 27.1 
                 41.1 
                 27.7 
                 33 
                 43.8 
                 43.4 
                 44.5 
                 36.9 
                 43.7 
                 50.1 
                 41.3 
                 26.5 
                 30.7 
               
               
                 36. 
                 SEQID72 
                 15.4 
                 23.1 
                 12.9 
                 25.2 
                 23.2 
                 16.4 
                 19.2 
                 22.8 
                 21.6 
                 20.3 
                 19.1 
                 18.4 
                 19.5 
               
               
                 37. 
                 SEQID74 
                 29.9 
                 56.6 
                 30.5 
                 32.7 
                 65.2 
                 43.7 
                 48.7 
                 32.4 
                 57.1 
                 53.8 
                 51.3 
                 29.9 
                 29.9 
               
               
                 38. 
                 SEQID76 
                 38.9 
                 39.3 
                 35.8 
                 29.3 
                 38.4 
                 43 
                 43.2 
                 31.7 
                 38.5 
                 43.2 
                 45.2 
                 35.9 
                 38.1 
               
               
                 39. 
                 SEQID78 
                 17.9 
                 28.7 
                 16.7 
                 38.5 
                 33.4 
                 20 
                 26.5 
                 31.2 
                 27.9 
                 24 
                 22.6 
                 25.3 
                 26.9 
               
               
                 40. 
                 SEQID80 
                 23.1 
                 27.6 
                 19.9 
                 40.4 
                 31.1 
                 22.9 
                 24.2 
                 33.7 
                 28.5 
                 25.9 
                 24.2 
                 24 
                 26.6 
               
               
                 41. 
                 SEQID82 
                 20.6 
                 27.9 
                 21.7 
                 40.1 
                 33.3 
                 23.5 
                 27.9 
                 36.6 
                 27.7 
                 28.2 
                 25.1 
                 29.5 
                 30.4 
               
               
                 42. 
                 SEQID84 
                 18.7 
                 27.3 
                 16.7 
                 31.8 
                 27.2 
                 17.8 
                 24.2 
                 30.1 
                 28.3 
                 23 
                 20.6 
                 22.8 
                 25.1 
               
               
                 43. 
                 SEQID86 
                 17 
                 23.9 
                 15.7 
                 31.2 
                 23.6 
                 17.9 
                 22.2 
                 27.7 
                 23.6 
                 22.9 
                 20 
                 22.2 
                 23.6 
               
               
                 44. 
                 SEQID88 
                 14.5 
                 22 
                 13 
                 22.9 
                 22.5 
                 15.2 
                 19.4 
                 22.1 
                 20.2 
                 17.1 
                 17.1 
                 17.3 
                 18.6 
               
               
                 45. 
                 SEQID90 
                 16.3 
                 23.1 
                 14.2 
                 23.9 
                 21.3 
                 15.5 
                 18.9 
                 23.4 
                 21.2 
                 20.7 
                 19.2 
                 17.4 
                 19.4 
               
               
                 46. 
                 SEQID94 
                 13.9 
                 22.9 
                 14.6 
                 22.6 
                 21 
                 16.5 
                 18.9 
                 24.5 
                 19.8 
                 18.7 
                 18.9 
                 17.1 
                 19.4 
               
               
                 47. 
                 SEQID96 
                 14.2 
                 22.6 
                 13 
                 23.8 
                 22.6 
                 15.7 
                 16.4 
                 23.6 
                 20.7 
                 19.7 
                 19.2 
                 15.6 
                 18.8 
               
               
                 48. 
                 SEQID100 
                 19.8 
                 28.4 
                 20.7 
                 38.1 
                 27.9 
                 21.4 
                 25 
                 35.4 
                 27.3 
                 26.1 
                 23.6 
                 26.8 
                 29.7 
               
               
                 49. 
                 SEQID102 
                 29.3 
                 30.5 
                 26.4 
                 53.7 
                 27.9 
                 29.6 
                 29.3 
                 43.8 
                 29.2 
                 31.6 
                 33.6 
                 29.3 
                 44.3 
               
               
                 50. 
                 SEQID104 
                 21.4 
                 28.2 
                 19.9 
                 37 
                 29.6 
                 22.1 
                 27.1 
                 34.5 
                 29.6 
                 26.4 
                 24.2 
                 24.6 
                 29.3 
               
               
                 51. 
                 SEQID106 
                 23.4 
                 31.2 
                 21.3 
                 43.6 
                 36 
                 24.1 
                 25.5 
                 34.4 
                 26.4 
                 24.5 
                 25 
                 22.7 
                 27.5 
               
               
                 52. 
                 SEQID108 
                 21.4 
                 29.8 
                 20.7 
                 40.5 
                 29.8 
                 21.6 
                 26.5 
                 34.7 
                 25.8 
                 23.4 
                 23.6 
                 25.6 
                 27.8 
               
               
                 53. 
                 SEQID110 
                 27.5 
                 30.7 
                 27.2 
                 56.8 
                 33.2 
                 33.8 
                 32.2 
                 36.6 
                 33.3 
                 38.1 
                 32.6 
                 27.9 
                 38 
               
               
                 54. 
                 SEQID124 
                 26.3 
                 29.2 
                 25.1 
                 44.6 
                 34.5 
                 30.7 
                 37.2 
                 52.3 
                 31.1 
                 38.1 
                 23.5 
                 29.4 
                 42.4 
               
               
                 55. 
                 SEQID126 
                 28.3 
                 30.2 
                 26.6 
                 46.3 
                 33.2 
                 30.1 
                 30.6 
                 52 
                 28.7 
                 36.1 
                 25.9 
                 30.8 
                 46.9 
               
               
                 56. 
                 SEQID134 
                 24.8 
                 32.8 
                 23.6 
                 42.9 
                 35.3 
                 29.6 
                 36.6 
                 49.5 
                 32.5 
                 37.5 
                 24.2 
                 29.9 
                 40.5 
               
               
                 57. 
                 SEQID140 
                 28.6 
                 28.7 
                 28.2 
                 46.7 
                 33.7 
                 30.8 
                 29.7 
                 50 
                 29 
                 27.1 
                 30.9 
                 29.3 
                 53.8 
               
               
                   
               
               
                   
                   
                 27 
                 28 
                 29 
                 30 
                 31 
                 32 
                 33 
                 34 
                 35 
                 36 
                 37 
                 38 
                 39 
               
               
                   
               
               
                 1. 
                 SEQID2 
                 
                   13.3 
                 
                 
                   12.3 
                 
                 
                   13.2 
                 
                 
                   12.6 
                 
                 
                   12.3 
                 
                 
                   13.1 
                 
                 
                   8.6 
                 
                 
                   13.3 
                 
                 
                   13.8 
                 
                 
                   36.1 
                 
                 
                   13.3 
                 
                 
                   12.7 
                 
                 
                   25.6 
                 
               
               
                 2. 
                 SEQID4 
                 
                   11.6 
                 
                 
                   11.5 
                 
                 
                   11.9 
                 
                 
                   13.2 
                 
                 
                   12.1 
                 
                 
                   12.4 
                 
                 
                   9 
                 
                 
                   13.9 
                 
                 
                   13.2 
                 
                 
                   39.1 
                 
                 
                   12.6 
                 
                 
                   10.9 
                 
                 
                   21.4 
                 
               
               
                 3. 
                 SEQID6 
                 
                   13.4 
                 
                 
                   13.2 
                 
                 
                   15.1 
                 
                 
                   14.7 
                 
                 
                   13.2 
                 
                 
                   14.2 
                 
                 
                   19 
                 
                 
                   17.7 
                 
                 
                   17.5 
                 
                 
                   15.7 
                 
                 
                   23.1 
                 
                 
                   19.1 
                 
                 
                   21.4 
                 
               
               
                 4. 
                 SEQID8 
                 
                   16.6 
                 
                 
                   15.9 
                 
                 
                   13.9 
                 
                 
                   13 
                 
                 
                   14.2 
                 
                 
                   14.7 
                 
                 
                   23.1 
                 
                 
                   18.4 
                 
                 
                   20.6 
                 
                 
                   15.6 
                 
                 
                   20.6 
                 
                 
                   20.6 
                 
                 
                   22 
                 
               
               
                 5. 
                 SEQID10 
                 
                   12.5 
                 
                 
                   12.9 
                 
                 
                   15.4 
                 
                 
                   13.9 
                 
                 
                   13.2 
                 
                 
                   13.8 
                 
                 
                   19.4 
                 
                 
                   16.7 
                 
                 
                   19.4 
                 
                 
                   14.8 
                 
                 
                   16.7 
                 
                 
                   21 
                 
                 
                   20.2 
                 
               
               
                 6. 
                 SEQID12 
                 
                   13.5 
                 
                 
                   13.3 
                 
                 
                   11.3 
                 
                 
                   14.7 
                 
                 
                   14.2 
                 
                 
                   11.8 
                 
                 
                   21.8 
                 
                 
                   19 
                 
                 
                   20.6 
                 
                 
                   14.5 
                 
                 
                   22.7 
                 
                 
                   18.4 
                 
                 
                   22.6 
                 
               
               
                 7. 
                 SEQID14 
                 
                   17.5 
                 
                 
                   14 
                 
                 
                   14 
                 
                 
                   14 
                 
                 
                   14.6 
                 
                 
                   13.7 
                 
                 
                   21.2 
                 
                 
                   17.8 
                 
                 
                   19.6 
                 
                 
                   15.4 
                 
                 
                   21.1 
                 
                 
                   18.5 
                 
                 
                   20.5 
                 
               
               
                 8. 
                 SEQID16 
                 
                   15.1 
                 
                 
                   13 
                 
                 
                   13.4 
                 
                 
                   14.7 
                 
                 
                   14.2 
                 
                 
                   14.1 
                 
                 
                   11 
                 
                 
                   17.1 
                 
                 
                   17.7 
                 
                 
                   19.9 
                 
                 
                   18.9 
                 
                 
                   18.8 
                 
                 
                   28.7 
                 
               
               
                 9. 
                 SEQID18 
                 
                   29.6 
                 
                 
                   26.1 
                 
                 
                   19.5 
                 
                 
                   20.3 
                 
                 
                   20.5 
                 
                 
                   18.1 
                 
                 
                   12.6 
                 
                 
                   25.9 
                 
                 
                   28.1 
                 
                 
                   11.8 
                 
                 
                   32.4 
                 
                 
                   29.1 
                 
                 
                   14.9 
                 
               
               
                 10. 
                 SEQID20 
                 
                   36.8 
                 
                 
                   32.8 
                 
                 
                   22 
                 
                 
                   19.5 
                 
                 
                   19.9 
                 
                 
                   18.3 
                 
                 
                   18.6 
                 
                 
                   27.4 
                 
                 
                   25.7 
                 
                 
                   12.4 
                 
                 
                   35.3 
                 
                 
                   32.6 
                 
                 
                   13.4 
                 
               
               
                 11. 
                 SEQID22 
                 
                   34 
                 
                 
                   29.1 
                 
                 
                   19.6 
                 
                 
                   18.6 
                 
                 
                   17.5 
                 
                 
                   17.2 
                 
                 
                   14.7 
                 
                 
                   26.8 
                 
                 
                   29.9 
                 
                 
                   9.9 
                 
                 
                   34 
                 
                 
                   30.2 
                 
                 
                   12.8 
                 
               
               
                 12. 
                 SEQID24 
                 
                   12.9 
                 
                 
                   14.8 
                 
                 
                   13.2 
                 
                 
                   16.2 
                 
                 
                   13.2 
                 
                 
                   13.5 
                 
                 
                   14.3 
                 
                 
                   18.3 
                 
                 
                   17.4 
                 
                 
                   18.9 
                 
                 
                   20.3 
                 
                 
                   18.6 
                 
                 
                   28.3 
                 
               
               
                 13. 
                 SEQID26 
                 
                   24.5 
                 
                 
                   24.8 
                 
                 
                   20.2 
                 
                 
                   21 
                 
                 
                   18.2 
                 
                 
                   18.2 
                 
                 
                   13.9 
                 
                 
                   22.6 
                 
                 
                   23.3 
                 
                 
                   10.6 
                 
                 
                   22.9 
                 
                 
                   23.5 
                 
                 
                   13.5 
                 
               
               
                 14. 
                 SEQID28 
                 
                   21.8 
                 
                 
                   22.7 
                 
                 
                   22 
                 
                 
                   17.8 
                 
                 
                   13.9 
                 
                 
                   14 
                 
                 
                   14.6 
                 
                 
                   13 
                 
                 
                   19.1 
                 
                 
                   8.6 
                 
                 
                   18.5 
                 
                 
                   22.5 
                 
                 
                   10.2 
                 
               
               
                 15. 
                 SEQID30 
                 
                   32.8 
                 
                 
                   32.8 
                 
                 
                   21.6 
                 
                 
                   19.4 
                 
                 
                   16.6 
                 
                 
                   18.4 
                 
                 
                   11.6 
                 
                 
                   34.1 
                 
                 
                   30.5 
                 
                 
                   13.2 
                 
                 
                   44.6 
                 
                 27.6 
                 
                   17 
                 
               
               
                 16. 
                 SEQID32 
                 
                   24.4 
                 
                 
                   23.9 
                 
                 
                   19.6 
                 
                 
                   18.5 
                 
                 
                   18.5 
                 
                 
                   17.1 
                 
                 
                   13 
                 
                 
                   19 
                 
                 
                   19.9 
                 
                 
                   8.9 
                 
                 
                   20.4 
                 
                 
                   22.5 
                 
                 
                   11.2 
                 
               
               
                 17. 
                 SEQID34 
                 
                   16.3 
                 
                 
                   15.6 
                 
                 
                   15.8 
                 
                 
                   15.7 
                 
                 
                   12.4 
                 
                 
                   12.2 
                 
                 
                   14.3 
                 
                 
                   15.8 
                 
                 
                   17.5 
                 
                 
                   17.8 
                 
                 
                   14.5 
                 
                 
                   13.4 
                 
                 
                   27.6 
                 
               
               
                 18. 
                 SEQID36 
                 
                   28.4 
                 
                 
                   26.5 
                 
                 
                   12.8 
                 
                 
                   17.9 
                 
                 
                   17.9 
                 
                 
                   15.1 
                 
                 
                   12 
                 
                 
                   37.4 
                 
                 
                   30.4 
                 
                 
                   13.1 
                 
                 
                   55.2 
                 
                 
                   26.9 
                 
                 
                   18.4 
                 
               
               
                 19. 
                 SEQID38 
                 
                   39.9 
                 
                 
                   36.2 
                 
                 
                   18.7 
                 
                 
                   16.2 
                 
                 
                   20.3 
                 
                 
                   16.3 
                 
                 
                   18.9 
                 
                 
                   25.7 
                 
                 
                   30.9 
                 
                 
                   9.8 
                 
                 
                   33.1 
                 
                 
                   32.1 
                 
                 
                   12.6 
                 
               
               
                 20. 
                 SEQID40 
                 
                   28.9 
                 
                 
                   28 
                 
                 
                   21 
                 
                 
                   18.4 
                 
                 
                   18.1 
                 
                 
                   18.8 
                 
                 
                   12.6 
                 
                 
                   32.9 
                 
                 
                   31.7 
                 
                 
                   11.8 
                 
                 
                   33.3 
                 
                 
                   29.3 
                 
                 
                   15 
                 
               
               
                 21. 
                 SEQID42 
                 
                   14.5 
                 
                 
                   13.1 
                 
                 
                   11.7 
                 
                 
                   13.4 
                 
                 
                   12.1 
                 
                 
                   12.9 
                 
                 
                   19.8 
                 
                 
                   20 
                 
                 
                   19.3 
                 
                 
                   16.8 
                 
                 
                   15.4 
                 
                 
                   15.8 
                 
                 
                   20.1 
                 
               
               
                 22. 
                 SEQID44 
                 
                   29.9 
                 
                 
                   29.6 
                 
                 
                   17.2 
                 
                 
                   20.4 
                 
                 
                   17.4 
                 
                 
                   16.3 
                 
                 
                   12.6 
                 
                 
                   36.1 
                 
                 
                   30.9 
                 
                 
                   13.2 
                 
                 
                   45 
                 
                 
                   28.7 
                 
                 
                   15 
                 
               
               
                 23. 
                 SEQID46 
                 
                   58.7 
                 
                 
                   40.4 
                 
                 
                   23.4 
                 
                 
                   18.5 
                 
                 
                   20.6 
                 
                 
                   17.4 
                 
                 
                   11.9 
                 
                 
                   29.4 
                 
                 
                   33.2 
                 
                 
                   12.4 
                 
                 
                   32.8 
                 
                 
                   30.3 
                 
                 
                   16 
                 
               
               
                 24. 
                 SEQID48 
                 
                   46.4 
                 
                 
                   52.4 
                 
                 
                   23.5 
                 
                 
                   18.8 
                 
                 
                   19.9 
                 
                 
                   17.6 
                 
                 
                   14.6 
                 
                 
                   26.9 
                 
                 
                   28.7 
                 
                 
                   11.4 
                 
                 
                   31.5 
                 
                 
                   28.7 
                 
                 
                   14.6 
                 
               
               
                 25. 
                 SEQID50 
                 
                   16.8 
                 
                 
                   20.9 
                 
                 
                   18.8 
                 
                 
                   18.2 
                 
                 
                   18.5 
                 
                 
                   16.5 
                 
                 
                   12.7 
                 
                 
                   14.5 
                 
                 
                   16.7 
                 
                 
                   11.5 
                 
                 
                   14.2 
                 
                 
                   16.4 
                 
                 
                   16.8 
                 
               
               
                 26. 
                 SEQID52 
                 
                   11.8 
                 
                 
                   15.6 
                 
                 
                   14.2 
                 
                 
                   13.1 
                 
                 
                   13.8 
                 
                 
                   13.6 
                 
                 
                   15.7 
                 
                 
                   15.9 
                 
                 
                   19.8 
                 
                 
                   14.3 
                 
                 
                   17.3 
                 
                 
                   17.4 
                 
                 
                   20.6 
                 
               
               
                 27. 
                 SEQID54 
                   
                 
                   41.5 
                 
                 
                   19.9 
                 
                 
                   20.8 
                 
                 
                   20.8 
                 
                 
                   16.7 
                 
                 
                   13.9 
                 
                 
                   26.9 
                 
                 
                   28.8 
                 
                 
                   10.8 
                 
                 
                   31.1 
                 
                 
                   32.7 
                 
                 
                   14.2 
                 
               
               
                 28. 
                 SEQID56 
                 57.1 
                   
                 
                   21.6 
                 
                 
                   18.8 
                 
                 
                   19.9 
                 
                 
                   19.1 
                 
                 
                   16.7 
                 
                 
                   24.3 
                 
                 
                   27.2 
                 
                 
                   11.3 
                 
                 
                   30.5 
                 
                 
                   31.8 
                 
                 
                   15.4 
                 
               
               
                 29. 
                 SEQID58 
                 35.5 
                 34.6 
                   
                 
                   24.9 
                 
                 
                   27.1 
                 
                 
                   24.3 
                 
                 
                   13.1 
                 
                 
                   16.7 
                 
                 
                   17.8 
                 
                 
                   11.4 
                 
                 
                   19.7 
                 
                 
                   19.8 
                 
                 
                   16.3 
                 
               
               
                 30. 
                 SEQID60 
                 34.3 
                 32.7 
                 35.5 
                   
                 
                   37.1 
                 
                 
                   38.9 
                 
                 
                   12.2 
                 
                 
                   18.5 
                 
                 
                   21.9 
                 
                 
                   12 
                 
                 
                   19.3 
                 
                 
                   20.2 
                 
                 
                   15.4 
                 
               
               
                 31. 
                 SEQID62 
                 37.2 
                 34.9 
                 40.5 
                 48.5 
                   
                 
                   72.8 
                 
                 
                   13.1 
                 
                 
                   19.2 
                 
                 
                   20.8 
                 
                 
                   11.3 
                 
                 
                   18.2 
                 
                 
                   17.6 
                 
                 
                   15.4 
                 
               
               
                 32. 
                 SEQID64 
                 34 
                 33.7 
                 37.3 
                 54.8 
                 75.7 
                   
                 
                   12.1 
                 
                 
                   19.6 
                 
                 
                   18.3 
                 
                 
                   12.1 
                 
                 
                   17.9 
                 
                 
                   16.3 
                 
                 
                   16.6 
                 
               
               
                 33. 
                 SEQID66 
                 22.6 
                 28.9 
                 20.9 
                 20.6 
                 23.8 
                 21.3 
                   
                 
                   12 
                 
                 
                   13.2 
                 
                 
                   7.4 
                 
                 
                   13.5 
                 
                 
                   15.6 
                 
                 
                   11 
                 
               
               
                 34. 
                 SEQID68 
                 39.2 
                 33.9 
                 27.4 
                 33.5 
                 30 
                 36.6 
                 19.6 
                   
                 
                   26.8 
                 
                 
                   13.4 
                 
                 
                   37.7 
                 
                 
                   25.7 
                 
                 
                   15.8 
                 
               
               
                 35. 
                 SEQID70 
                 45.4 
                 38.6 
                 35.1 
                 35.8 
                 34.2 
                 34.8 
                 22.1 
                 38.4 
                   
                 
                   14.4 
                 
                 
                   29.7 
                 
                 
                   33 
                 
                 
                   16.8 
                 
               
               
                 36. 
                 SEQID72 
                 19.1 
                 17.9 
                 19.7 
                 21.8 
                 18.8 
                 22.9 
                 12 
                 20.6 
                 22.5 
                   
                 
                   12.2 
                 
                 
                   11 
                 
                 
                   21.5 
                 
               
               
                 37. 
                 SEQID74 
                 47.8 
                 45.3 
                 35.8 
                 33.5 
                 34 
                 32.6 
                 22.3 
                 51.2 
                 44.5 
                 20.9 
                   
                 
                   30.5 
                 
                 
                   16 
                 
               
               
                 38. 
                 SEQID76 
                 47.7 
                 47.4 
                 34 
                 29.9 
                 31.2 
                 28.2 
                 24.9 
                 36.8 
                 44.2 
                 17.4 
                 43.1 
                   
                 
                   14.5 
                 
               
               
                 39. 
                 SEQID78 
                 24 
                 23 
                 25.3 
                 27.9 
                 22.6 
                 26.3 
                 16.5 
                 25.3 
                 25.5 
                 34.4 
                 28.9 
                 23.8 
                   
               
               
                 40. 
                 SEQID80 
                 23.3 
                 24.8 
                 26.3 
                 30.5 
                 26.6 
                 29.8 
                 17.7 
                 32.2 
                 25.5 
                 32.7 
                 27.4 
                 22.2 
                 59.9 
               
               
                 41. 
                 SEQID82 
                 27.1 
                 24.4 
                 28.8 
                 28.8 
                 25.9 
                 32.6 
                 20.8 
                 33 
                 27.3 
                 32 
                 30.8 
                 23.3 
                 46.4 
               
               
                 42. 
                 SEQID84 
                 22.3 
                 21.3 
                 23.4 
                 27.3 
                 21.7 
                 21.9 
                 15 
                 26.8 
                 25.3 
                 45.3 
                 21.2 
                 21.9 
                 39.7 
               
               
                 43. 
                 SEQID86 
                 20.3 
                 20.8 
                 22 
                 25.5 
                 20.8 
                 22.4 
                 15 
                 27.2 
                 23.8 
                 48.7 
                 21.7 
                 20.3 
                 39.8 
               
               
                 44. 
                 SEQID88 
                 17.6 
                 16.4 
                 19.1 
                 21.7 
                 17.6 
                 20.3 
                 11.1 
                 21.2 
                 19.9 
                 53.9 
                 18.8 
                 16.8 
                 32.2 
               
               
                 45. 
                 SEQID90 
                 18.4 
                 18 
                 19.6 
                 22.3 
                 17.2 
                 21 
                 12.7 
                 21.7 
                 20.2 
                 56 
                 18.5 
                 18.5 
                 34.4 
               
               
                 46. 
                 SEQID94 
                 17.3 
                 18.5 
                 18.1 
                 20.7 
                 17.2 
                 19.8 
                 11.6 
                 22.3 
                 21.2 
                 52.6 
                 19.5 
                 17.1 
                 32.1 
               
               
                 47. 
                 SEQID96 
                 16.9 
                 16.4 
                 19.3 
                 20.5 
                 18.2 
                 20.3 
                 12.1 
                 22.8 
                 21.7 
                 54.5 
                 20.2 
                 17.7 
                 31.4 
               
               
                 48. 
                 SEQID100 
                 27 
                 27.3 
                 24.8 
                 27.3 
                 24.3 
                 26.4 
                 18.7 
                 29.3 
                 27.3 
                 43.1 
                 27.7 
                 23.6 
                 39.3 
               
               
                 49. 
                 SEQID102 
                 31.7 
                 27.1 
                 27.7 
                 26.6 
                 27.5 
                 24 
                 26.4 
                 26.9 
                 31.3 
                 32.4 
                 27.7 
                 32.1 
                 32.8 
               
               
                 50. 
                 SEQID104 
                 25.3 
                 27.3 
                 27.3 
                 29.8 
                 24.6 
                 27.5 
                 17.4 
                 28.2 
                 25.1 
                 43.3 
                 29.1 
                 26.2 
                 41.3 
               
               
                 51. 
                 SEQID106 
                 25 
                 25.5 
                 25.9 
                 26.1 
                 23.4 
                 28 
                 17.9 
                 34.2 
                 25 
                 31.7 
                 32.6 
                 25.7 
                 46.6 
               
               
                 52. 
                 SEQID108 
                 22.7 
                 23.8 
                 24.5 
                 27.2 
                 25.6 
                 27.6 
                 18 
                 28.7 
                 28.1 
                 31.8 
                 27.4 
                 25.2 
                 66.6 
               
               
                 53. 
                 SEQID110 
                 31.7 
                 33.8 
                 27.7 
                 26.6 
                 27.9 
                 28.7 
                 22.6 
                 31.1 
                 32.4 
                 23.8 
                 38.1 
                 36.2 
                 36 
               
               
                 54. 
                 SEQID124 
                 31.6 
                 27.6 
                 25.1 
                 26.6 
                 24.8 
                 30.1 
                 28.5 
                 32.1 
                 36 
                 23.5 
                 39.3 
                 35.3 
                 31.4 
               
               
                 55. 
                 SEQID126 
                 31.4 
                 31.8 
                 29.3 
                 26.9 
                 30.2 
                 29.3 
                 36 
                 32.9 
                 32.4 
                 23.6 
                 37.4 
                 29.7 
                 31.8 
               
               
                 56. 
                 SEQID134 
                 27.8 
                 25.4 
                 27.5 
                 25.9 
                 32.9 
                 27.6 
                 32.6 
                 30.5 
                 36.3 
                 25.2 
                 37.2 
                 35 
                 35 
               
               
                 57. 
                 SEQID140 
                 33.4 
                 30.4 
                 26.5 
                 24.4 
                 27.9 
                 27.9 
                 32.7 
                 30.3 
                 32.7 
                 22.7 
                 33.3 
                 36.1 
                 31.4 
               
               
                   
               
               
                   
                   
                 40 
                 41 
                 42 
                 43 
                 44 
                 45 
                 46 
                 47 
                 48 
                 49 
                 50 
                 51 
                 52 
               
               
                   
               
               
                 1. 
                 SEQID2 
                 
                   25.3 
                 
                 
                   22.4 
                 
                 
                   39.5 
                 
                 
                   38.3 
                 
                 
                   41.7 
                 
                 
                   41.1 
                 
                 
                   39.7 
                 
                 
                   37.9 
                 
                 
                   38.3 
                 
                 
                   22.4 
                 
                 
                   36.5 
                 
                 
                   23.8 
                 
                 
                   23.8 
                 
               
               
                 2. 
                 SEQID4 
                 
                   23.7 
                 
                 
                   23.1 
                 
                 
                   38.8 
                 
                 
                   39.6 
                 
                 
                   46.7 
                 
                 
                   46.9 
                 
                 
                   45.1 
                 
                 
                   43.1 
                 
                 
                   37.5 
                 
                 
                   21.2 
                 
                 
                   37.8 
                 
                 
                   22.2 
                 
                 
                   23.5 
                 
               
               
                 3. 
                 SEQID6 
                 
                   22.7 
                 
                 
                   22.3 
                 
                 
                   17.9 
                 
                 
                   17.9 
                 
                 
                   14.3 
                 
                 
                   15.1 
                 
                 
                   15.6 
                 
                 
                   14.5 
                 
                 
                   22.4 
                 
                 
                   29 
                 
                 
                   20.3 
                 
                 
                   25.2 
                 
                 
                   22.3 
                 
               
               
                 4. 
                 SEQID8 
                 
                   22.5 
                 
                 
                   25 
                 
                 
                   19.4 
                 
                 
                   18 
                 
                 
                   15.3 
                 
                 
                   15.4 
                 
                 
                   15.4 
                 
                 
                   15.2 
                 
                 
                   23.5 
                 
                 
                   25.1 
                 
                 
                   21 
                 
                 
                   24.7 
                 
                 
                   22 
                 
               
               
                 5. 
                 SEQID10 
                 
                   21.9 
                 
                 
                   21.9 
                 
                 
                   18.7 
                 
                 
                   15.5 
                 
                 
                   13 
                 
                 
                   12.9 
                 
                 
                   13.4 
                 
                 
                   13.3 
                 
                 
                   20.4 
                 
                 
                   30.3 
                 
                 
                   21.3 
                 
                 
                   23.6 
                 
                 
                   20.8 
                 
               
               
                 6. 
                 SEQID12 
                 
                   22.8 
                 
                 
                   24.3 
                 
                 
                   17.6 
                 
                 
                   18 
                 
                 
                   14.1 
                 
                 
                   14.6 
                 
                 
                   14.2 
                 
                 
                   15.9 
                 
                 
                   20.9 
                 
                 
                   28 
                 
                 
                   20.7 
                 
                 
                   25.8 
                 
                 
                   21.4 
                 
               
               
                 7. 
                 SEQID14 
                 
                   22.7 
                 
                 
                   23.9 
                 
                 
                   18.6 
                 
                 
                   17.7 
                 
                 
                   14 
                 
                 
                   14.6 
                 
                 
                   14.1 
                 
                 
                   14.6 
                 
                 
                   22.7 
                 
                 
                   30.1 
                 
                 
                   21.6 
                 
                 
                   23.2 
                 
                 
                   23.8 
                 
               
               
                 8. 
                 SEQID16 
                 
                   28.2 
                 
                 
                   31 
                 
                 
                   25.7 
                 
                 
                   23.4 
                 
                 
                   17.9 
                 
                 
                   18.4 
                 
                 
                   18.2 
                 
                 
                   18.9 
                 
                 
                   26.9 
                 
                 
                   31.3 
                 
                 
                   25.6 
                 
                 
                   31 
                 
                 
                   30.8 
                 
               
               
                 9. 
                 SEQID18 
                 
                   14.3 
                 
                 
                   14.4 
                 
                 
                   12.7 
                 
                 
                   12.2 
                 
                 
                   10.5 
                 
                 
                   11.2 
                 
                 
                   12 
                 
                 
                   10.9 
                 
                 
                   14.1 
                 
                 
                   14.9 
                 
                 
                   14.6 
                 
                 
                   13.8 
                 
                 
                   14.5 
                 
               
               
                 10. 
                 SEQID20 
                 
                   14.7 
                 
                 
                   15.9 
                 
                 
                   11.9 
                 
                 
                   12.1 
                 
                 
                   11.2 
                 
                 
                   10.4 
                 
                 
                   12.6 
                 
                 
                   10.6 
                 
                 
                   14.1 
                 
                 
                   17.1 
                 
                 
                   13 
                 
                 
                   13.8 
                 
                 
                   13.3 
                 
               
               
                 11. 
                 SEQID22 
                 
                   14.2 
                 
                 
                   15.2 
                 
                 
                   13.9 
                 
                 
                   11.5 
                 
                 
                   10.9 
                 
                 
                   9.8 
                 
                 
                   11.2 
                 
                 
                   10.8 
                 
                 
                   15.2 
                 
                 
                   16.6 
                 
                 
                   13.1 
                 
                 
                   15.9 
                 
                 
                   14.3 
                 
               
               
                 12. 
                 SEQID24 
                 
                   27.5 
                 
                 
                   29.8 
                 
                 
                   23.5 
                 
                 
                   21.4 
                 
                 
                   17.3 
                 
                 
                   17.1 
                 
                 
                   17.2 
                 
                 
                   17.8 
                 
                 
                   25.3 
                 
                 
                   31.1 
                 
                 
                   24 
                 
                 
                   30.2 
                 
                 
                   30.1 
                 
               
               
                 13. 
                 SEQID26 
                 
                   13.8 
                 
                 
                   16.9 
                 
                 
                   13.5 
                 
                 
                   14.1 
                 
                 
                   11.8 
                 
                 
                   11.6 
                 
                 
                   10.4 
                 
                 
                   10.9 
                 
                 
                   15.3 
                 
                 
                   12.5 
                 
                 
                   15.6 
                 
                 
                   15.3 
                 
                 
                   15.1 
                 
               
               
                 14. 
                 SEQID28 
                 
                   14 
                 
                 
                   11.5 
                 
                 
                   11.8 
                 
                 
                   11 
                 
                 
                   9.6 
                 
                 
                   9.7 
                 
                 
                   9.5 
                 
                 
                   8.5 
                 
                 
                   13.1 
                 
                 
                   15.3 
                 
                 
                   12.4 
                 
                 
                   12.4 
                 
                 
                   12.2 
                 
               
               
                 15. 
                 SEQID30 
                 
                   16.1 
                 
                 
                   15.9 
                 
                 
                   13.4 
                 
                 
                   14.2 
                 
                 
                   13.6 
                 
                 
                   13.8 
                 
                 
                   12.7 
                 
                 
                   12.3 
                 
                 
                   14.9 
                 
                 
                   15.9 
                 
                 
                   16.6 
                 
                 
                   13.7 
                 
                 
                   14.7 
                 
               
               
                 16. 
                 SEQID32 
                 
                   11.7 
                 
                 
                   12.2 
                 
                 
                   11.2 
                 
                 
                   10.7 
                 
                 
                   7.6 
                 
                 
                   8.4 
                 
                 
                   8.8 
                 
                 
                   8.5 
                 
                 
                   11 
                 
                 
                   13.9 
                 
                 
                   12.8 
                 
                 
                   12.4 
                 
                 
                   12.5 
                 
               
               
                 17. 
                 SEQID34 
                 
                   28 
                 
                 
                   29.4 
                 
                 
                   22.7 
                 
                 
                   21.6 
                 
                 
                   16.8 
                 
                 
                   18 
                 
                 
                   16.8 
                 
                 
                   16.8 
                 
                 
                   28.3 
                 
                 
                   33.2 
                 
                 
                   26.2 
                 
                 
                   33.3 
                 
                 
                   29.5 
                 
               
               
                 18. 
                 SEQID36 
                 
                   17.4 
                 
                 
                   19.2 
                 
                 
                   14.7 
                 
                 
                   13.4 
                 
                 
                   13 
                 
                 
                   12.6 
                 
                 
                   11.8 
                 
                 
                   13.1 
                 
                 
                   16.4 
                 
                 
                   15.5 
                 
                 
                   15.3 
                 
                 
                   19.5 
                 
                 
                   16.4 
                 
               
               
                 19. 
                 SEQID38 
                 
                   12.7 
                 
                 
                   12.8 
                 
                 
                   10.5 
                 
                 
                   12.4 
                 
                 
                   9.5 
                 
                 
                   9.4 
                 
                 
                   10.1 
                 
                 
                   10.2 
                 
                 
                   14.2 
                 
                 
                   13.7 
                 
                 
                   14.2 
                 
                 
                   14.4 
                 
                 
                   12.7 
                 
               
               
                 20. 
                 SEQID40 
                 
                   15.1 
                 
                 
                   14.6 
                 
                 
                   13.4 
                 
                 
                   12.4 
                 
                 
                   12.5 
                 
                 
                   11.2 
                 
                 
                   11.2 
                 
                 
                   9.9 
                 
                 
                   14 
                 
                 
                   16.2 
                 
                 
                   16.1 
                 
                 
                   15.1 
                 
                 
                   14.9 
                 
               
               
                 21. 
                 SEQID42 
                 
                   22.6 
                 
                 
                   21.5 
                 
                 
                   19.5 
                 
                 
                   18.5 
                 
                 
                   15.5 
                 
                 
                   16.6 
                 
                 
                   16.6 
                 
                 
                   15.7 
                 
                 
                   23.2 
                 
                 
                   28.2 
                 
                 
                   23.2 
                 
                 
                   22 
                 
                 
                   23.1 
                 
               
               
                 22. 
                 SEQID44 
                 
                   14.4 
                 
                 
                   15.6 
                 
                 
                   15.6 
                 
                 
                   14.8 
                 
                 
                   13.5 
                 
                 
                   12.6 
                 
                 
                   13.1 
                 
                 
                   12.5 
                 
                 
                   13.9 
                 
                 
                   15.5 
                 
                 
                   18.1 
                 
                 
                   13.9 
                 
                 
                   13.5 
                 
               
               
                 23. 
                 SEQID46 
                 
                   16.1 
                 
                 
                   16.6 
                 
                 
                   14.2 
                 
                 
                   14.8 
                 
                 
                   11.6 
                 
                 
                   13.1 
                 
                 
                   10.1 
                 
                 
                   12.4 
                 
                 
                   14.6 
                 
                 
                   13.5 
                 
                 
                   16.7 
                 
                 
                   14.8 
                 
                 
                   15.8 
                 
               
               
                 24. 
                 SEQID48 
                 
                   14 
                 
                 
                   14.6 
                 
                 
                   13.2 
                 
                 
                   12.6 
                 
                 
                   10.4 
                 
                 
                   12 
                 
                 
                   10.8 
                 
                 
                   11.9 
                 
                 
                   13.5 
                 
                 
                   16.1 
                 
                 
                   13.1 
                 
                 
                   14.6 
                 
                 
                   14.5 
                 
               
               
                 25. 
                 SEQID50 
                 
                   14.5 
                 
                 
                   14.5 
                 
                 
                   14 
                 
                 
                   14.1 
                 
                 
                   11.2 
                 
                 
                   11.3 
                 
                 
                   9.6 
                 
                 
                   9.6 
                 
                 
                   12.9 
                 
                 
                   15 
                 
                 
                   13.7 
                 
                 
                   13.1 
                 
                 
                   16.8 
                 
               
               
                 26. 
                 SEQID52 
                 
                   18.6 
                 
                 
                   19.7 
                 
                 
                   18.3 
                 
                 
                   17 
                 
                 
                   12.6 
                 
                 
                   13.8 
                 
                 
                   13.9 
                 
                 
                   13.9 
                 
                 
                   20.4 
                 
                 
                   26 
                 
                 
                   20.9 
                 
                 
                   19.5 
                 
                 
                   20.9 
                 
               
               
                 27. 
                 SEQID54 
                 
                   14.5 
                 
                 
                   14.4 
                 
                 
                   14.9 
                 
                 
                   13.7 
                 
                 
                   10.6 
                 
                 
                   11.2 
                 
                 
                   10.4 
                 
                 
                   10.5 
                 
                 
                   14.8 
                 
                 
                   11.9 
                 
                 
                   14 
                 
                 
                   12.8 
                 
                 
                   14.3 
                 
               
               
                 28. 
                 SEQID56 
                 
                   15.9 
                 
                 
                   13.3 
                 
                 
                   12.7 
                 
                 
                   12 
                 
                 
                   11.1 
                 
                 
                   11.5 
                 
                 
                   11.5 
                 
                 
                   9.8 
                 
                 
                   16.4 
                 
                 
                   11.7 
                 
                 
                   17 
                 
                 
                   14.4 
                 
                 
                   15.1 
                 
               
               
                 29. 
                 SEQID58 
                 
                   15.1 
                 
                 
                   14.4 
                 
                 
                   13.5 
                 
                 
                   13.1 
                 
                 
                   10.5 
                 
                 
                   12 
                 
                 
                   10.8 
                 
                 
                   11.5 
                 
                 
                   13.7 
                 
                 
                   15.3 
                 
                 
                   15.9 
                 
                 
                   16.1 
                 
                 
                   14.3 
                 
               
               
                 30. 
                 SEQID60 
                 
                   15.5 
                 
                 
                   13.5 
                 
                 
                   12.2 
                 
                 
                   12.1 
                 
                 
                   12.5 
                 
                 
                   11.6 
                 
                 
                   12.6 
                 
                 
                   12.3 
                 
                 
                   11.9 
                 
                 
                   14.1 
                 
                 
                   13.5 
                 
                 
                   12.4 
                 
                 
                   13.7 
                 
               
               
                 31. 
                 SEQID62 
                 
                   12.5 
                 
                 
                   12 
                 
                 
                   11.8 
                 
                 
                   12 
                 
                 
                   9.8 
                 
                 
                   10.4 
                 
                 
                   10.8 
                 
                 
                   10.9 
                 
                 
                   12.1 
                 
                 
                   12.8 
                 
                 
                   13.9 
                 
                 
                   11.6 
                 
                 
                   14.9 
                 
               
               
                 32. 
                 SEQID64 
                 
                   15.3 
                 
                 
                   16 
                 
                 
                   11.3 
                 
                 
                   13.4 
                 
                 
                   11.6 
                 
                 
                   12.6 
                 
                 
                   13.4 
                 
                 
                   11.3 
                 
                 
                   13.3 
                 
                 
                   13.2 
                 
                 
                   14.1 
                 
                 
                   13.8 
                 
                 
                   15.8 
                 
               
               
                 33. 
                 SEQID66 
                 
                   11 
                 
                 
                   12.4 
                 
                 
                   9.9 
                 
                 
                   9.5 
                 
                 
                   7.8 
                 
                 
                   7.7 
                 
                 
                   8.1 
                 
                 
                   8.1 
                 
                 
                   12.2 
                 
                 
                   13.9 
                 
                 
                   10.8 
                 
                 
                   11 
                 
                 
                   11.6 
                 
               
               
                 34. 
                 SEQID68 
                 
                   18 
                 
                 
                   18.4 
                 
                 
                   15.8 
                 
                 
                   14.3 
                 
                 
                   13.8 
                 
                 
                   13.4 
                 
                 
                   14.2 
                 
                 
                   12.7 
                 
                 
                   17.5 
                 
                 
                   17 
                 
                 
                   17.2 
                 
                 
                   18.7 
                 
                 
                   16.2 
                 
               
               
                 35. 
                 SEQID70 
                 
                   15.9 
                 
                 
                   15.5 
                 
                 
                   13.6 
                 
                 
                   14.6 
                 
                 
                   12.2 
                 
                 
                   10.7 
                 
                 
                   12.8 
                 
                 
                   13.3 
                 
                 
                   15.1 
                 
                 
                   16.8 
                 
                 
                   17.1 
                 
                 
                   13.9 
                 
                 
                   15.5 
                 
               
               
                 36. 
                 SEQID72 
                 
                   22 
                 
                 
                   21.2 
                 
                 
                   35.1 
                 
                 
                   35.3 
                 
                 
                   40 
                 
                 
                   40 
                 
                 
                   37.9 
                 
                 
                   39.8 
                 
                 
                   34 
                 
                 
                   29 
                 
                 
                   34.4 
                 
                 
                   22.6 
                 
                 
                   22.3 
                 
               
               
                 37. 
                 SEQID74 
                 
                   16.7 
                 
                 
                   17.2 
                 
                 
                   12.5 
                 
                 
                   13.9 
                 
                 
                   12 
                 
                 
                   12 
                 
                 
                   11.4 
                 
                 
                   11.9 
                 
                 
                   16.6 
                 
                 
                   13 
                 
                 
                   17.3 
                 
                 
                   17.9 
                 
                 
                   15 
                 
               
               
                 38. 
                 SEQID76 
                 
                   13 
                 
                 
                   11.5 
                 
                 
                   13.9 
                 
                 
                   12.9 
                 
                 
                   10.7 
                 
                 
                   11.5 
                 
                 
                   9.6 
                 
                 
                   11.4 
                 
                 
                   14.2 
                 
                 
                   13.3 
                 
                 
                   16.4 
                 
                 
                   14.6 
                 
                 
                   16.9 
                 
               
               
                 39. 
                 SEQID78 
                 
                   46.4 
                 
                 
                   32.7 
                 
                 
                   25.1 
                 
                 
                   25.5 
                 
                 
                   22.1 
                 
                 
                   24 
                 
                 
                   21.9 
                 
                 
                   21 
                 
                 
                   26.3 
                 
                 
                   24 
                 
                 
                   26.6 
                 
                 
                   33.5 
                 
                 
                   58.2 
                 
               
               
                 40. 
                 SEQID80 
                   
                 
                   31.2 
                 
                 
                   27.1 
                 
                 
                   25.2 
                 
                 
                   20.9 
                 
                 
                   22.4 
                 
                 
                   21.9 
                 
                 
                   21.4 
                 
                 
                   29.1 
                 
                 
                   24.6 
                 
                 
                   28.3 
                 
                 
                   34.1 
                 
                 
                   47 
                 
               
               
                 41. 
                 SEQID82 
                 49.2 
                   
                 
                   24.5 
                 
                 
                   25.9 
                 
                 
                   20 
                 
                 
                   20.3 
                 
                 
                   20.1 
                 
                 
                   19.9 
                 
                 
                   27.6 
                 
                 
                   25.8 
                 
                 
                   26.9 
                 
                 
                   33.1 
                 
                 
                   31.8 
                 
               
               
                 42. 
                 SEQID84 
                 40.8 
                 38.6 
                   
                 
                   71.1 
                 
                 
                   36 
                 
                 
                   36.3 
                 
                 
                   35.8 
                 
                 
                   36 
                 
                 
                   43.5 
                 
                 
                   26.2 
                 
                 
                   41.9 
                 
                 
                   27.1 
                 
                 
                   27.1 
                 
               
               
                 43. 
                 SEQID86 
                 38.7 
                 37.7 
                 79.7 
                   
                 
                   35.5 
                 
                 
                   37.9 
                 
                 
                   38 
                 
                 
                   36.8 
                 
                 
                   40 
                 
                 
                   24.4 
                 
                 
                   41 
                 
                 
                   26.2 
                 
                 
                   26.9 
                 
               
               
                 44. 
                 SEQID88 
                 32.4 
                 30.6 
                 45.6 
                 46.1 
                   
                 
                   64.6 
                 
                 
                   55.8 
                 
                 
                   53.6 
                 
                 
                   34.5 
                 
                 
                   19 
                 
                 
                   33.7 
                 
                 
                   21.1 
                 
                 
                   20.1 
                 
               
               
                 45. 
                 SEQID90 
                 32.5 
                 32.2 
                 46.6 
                 49.7 
                 73 
                   
                 
                   51.3 
                 
                 
                   51.7 
                 
                 
                   35.1 
                 
                 
                   20.1 
                 
                 
                   34.9 
                 
                 
                   22.3 
                 
                 
                   24 
                 
               
               
                 46. 
                 SEQID94 
                 31.8 
                 32.9 
                 47.6 
                 51.2 
                 67.6 
                 65.5 
                   
                 
                   49.7 
                 
                 
                   34.8 
                 
                 
                   19.4 
                 
                 
                   33.7 
                 
                 
                   21.5 
                 
                 
                   21.3 
                 
               
               
                 47. 
                 SEQID96 
                 30.7 
                 30.1 
                 45.8 
                 46.3 
                 66.7 
                 64.2 
                 63.4 
                   
                 
                   34.3 
                 
                 
                   18.9 
                 
                 
                   34.4 
                 
                 
                   21.6 
                 
                 
                   21.7 
                 
               
               
                 48. 
                 SEQID100 
                 42.1 
                 42.1 
                 54.3 
                 50.1 
                 42.8 
                 43.8 
                 42.4 
                 42.9 
                   
                 
                   29.7 
                 
                 
                   72.2 
                 
                 
                   28.3 
                 
                 
                   28.2 
                 
               
               
                 49. 
                 SEQID102 
                 35.2 
                 36.4 
                 33 
                 31.2 
                 25.5 
                 25.9 
                 25.2 
                 24.4 
                 41.2 
                   
                 
                   29.6 
                 
                 
                   25.5 
                 
                 
                   26.9 
                 
               
               
                 50. 
                 SEQID104 
                 44.1 
                 42.6 
                 51.7 
                 49.7 
                 41 
                 44 
                 41.9 
                 42.5 
                 81.3 
                 39.5 
                   
                 
                   27.7 
                 
                 
                   27.3 
                 
               
               
                 51. 
                 SEQID106 
                 50.3 
                 51.7 
                 39.3 
                 36.7 
                 30.3 
                 31.1 
                 32.3 
                 31.6 
                 43.7 
                 36.2 
                 39.5 
                   
                 
                   34.7 
                 
               
               
                 52. 
                 SEQID108 
                 61.3 
                 49 
                 38.2 
                 39.1 
                 28.9 
                 33.2 
                 31.3 
                 32.3 
                 43.9 
                 37.2 
                 41.2 
                 48.6 
                   
               
               
                 53. 
                 SEQID110 
                 34.6 
                 39 
                 30.1 
                 28.2 
                 21.1 
                 23.1 
                 23.5 
                 22.4 
                 34.2 
                 51.6 
                 33.9 
                 51.6 
                 37 
               
               
                 54. 
                 SEQID124 
                 33.5 
                 35.3 
                 30.7 
                 28.1 
                 22.8 
                 24.3 
                 21.8 
                 24 
                 34 
                 42.4 
                 35.7 
                 37.2 
                 35.9 
               
               
                 55. 
                 SEQID126 
                 31.7 
                 37 
                 30 
                 28.4 
                 24.1 
                 23.1 
                 22.2 
                 22.2 
                 34.7 
                 50.3 
                 34.8 
                 35.1 
                 34.5 
               
               
                 56. 
                 SEQID134 
                 36.1 
                 37.5 
                 32.6 
                 30.8 
                 24.3 
                 24.8 
                 24.5 
                 23.8 
                 34.2 
                 41.7 
                 34.1 
                 37.8 
                 36.1 
               
               
                 57. 
                 SEQID140 
                 31.1 
                 33.5 
                 28.8 
                 27.2 
                 20.1 
                 22.3 
                 22.3 
                 19.2 
                 32.9 
                 50 
                 31.8 
                 33.3 
                 32.7 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
            
               
                   
                   
                   
                 53 
                 54 
                 55 
                 56 
                 57 
               
               
                   
               
               
                   
                 1. 
                 SEQID2 
                 
                   18 
                 
                 
                   19.6 
                 
                 
                   18.5 
                 
                 
                   17 
                 
                 
                   17.6 
                 
               
               
                   
                 2. 
                 SEQID4 
                 
                   17.2 
                 
                 
                   15.7 
                 
                 
                   15.6 
                 
                 
                   17.1 
                 
                 
                   16.4 
                 
               
               
                   
                 3. 
                 SEQID6 
                 
                   28.9 
                 
                 
                   47.3 
                 
                 
                   48.4 
                 
                 
                   44.6 
                 
                 
                   59.7 
                 
               
               
                   
                 4. 
                 SEQID8 
                 
                   26.8 
                 
                 
                   60.2 
                 
                 
                   52.8 
                 
                 
                   53.3 
                 
                 
                   44.8 
                 
               
               
                   
                 5. 
                 SEQID10 
                 
                   29.8 
                 
                 
                   47.5 
                 
                 
                   49 
                 
                 
                   46.9 
                 
                 
                   46.2 
                 
               
               
                   
                 6. 
                 SEQID12 
                 
                   28.7 
                 
                 
                   50 
                 
                 
                   46.1 
                 
                 
                   51.1 
                 
                 
                   45.8 
                 
               
               
                   
                 7. 
                 SEQID14 
                 
                   27.8 
                 
                 
                   46.1 
                 
                 
                   51.8 
                 
                 
                   46.2 
                 
                 
                   65.2 
                 
               
               
                   
                 8. 
                 SEQID16 
                 
                   34.1 
                 
                 
                   29.2 
                 
                 
                   25.6 
                 
                 
                   27.3 
                 
                 
                   27.1 
                 
               
               
                   
                 9. 
                 SEQID18 
                 
                   18.7 
                 
                 
                   15.1 
                 
                 
                   15.3 
                 
                 
                   17.9 
                 
                 
                   15.1 
                 
               
               
                   
                 10. 
                 SEQID20 
                 
                   19.3 
                 
                 
                   15 
                 
                 
                   15.9 
                 
                 
                   13.9 
                 
                 
                   14.2 
                 
               
               
                   
                 11. 
                 SEQID22 
                 
                   18.5 
                 
                 
                   17.7 
                 
                 
                   16.5 
                 
                 
                   19.2 
                 
                 
                   17.4 
                 
               
               
                   
                 12. 
                 SEQID24 
                 
                   32.9 
                 
                 
                   30.8 
                 
                 
                   25.7 
                 
                 
                   27.8 
                 
                 
                   26.3 
                 
               
               
                   
                 13. 
                 SEQID26 
                 
                   19.4 
                 
                 
                   20.6 
                 
                 
                   18.1 
                 
                 
                   19.7 
                 
                 
                   19.3 
                 
               
               
                   
                 14. 
                 SEQID28 
                 
                   13.4 
                 
                 
                   14.2 
                 
                 
                   17 
                 
                 
                   15 
                 
                 
                   13.5 
                 
               
               
                   
                 15. 
                 SEQID30 
                 
                   19.8 
                 
                 
                   16.7 
                 
                 
                   18.4 
                 
                 
                   18.6 
                 
                 
                   15.6 
                 
               
               
                   
                 16. 
                 SEQID32 
                 
                   13.1 
                 
                 
                   15.2 
                 
                 
                   14.9 
                 
                 
                   12.4 
                 
                 
                   13.8 
                 
               
               
                   
                 17. 
                 SEQID34 
                 
                   40.1 
                 
                 
                   27.9 
                 
                 
                   30.1 
                 
                 
                   25.7 
                 
                 
                   30.2 
                 
               
               
                   
                 18. 
                 SEQID36 
                 
                   19 
                 
                 
                   19.7 
                 
                 
                   17.8 
                 
                 
                   19.7 
                 
                 
                   19.4 
                 
               
               
                   
                 19. 
                 SEQID38 
                 
                   19 
                 
                 
                   18.8 
                 
                 
                   16.1 
                 
                 
                   18.4 
                 
                 
                   18.1 
                 
               
               
                   
                 20. 
                 SEQID40 
                 
                   17.9 
                 
                 
                   19.3 
                 
                 
                   13.7 
                 
                 
                   19.4 
                 
                 
                   16.2 
                 
               
               
                   
                 21. 
                 SEQID42 
                 
                   24.3 
                 
                 
                   36.4 
                 
                 
                   33.9 
                 
                 
                   35.3 
                 
                 
                   35.8 
                 
               
               
                   
                 22. 
                 SEQID44 
                 
                   19 
                 
                 
                   17.9 
                 
                 
                   16.8 
                 
                 
                   17.9 
                 
                 
                   17.8 
                 
               
               
                   
                 23. 
                 SEQID46 
                 
                   20.5 
                 
                 
                   19.6 
                 
                 
                   19 
                 
                 
                   18.4 
                 
                 
                   15.6 
                 
               
               
                   
                 24. 
                 SEQID48 
                 
                   15.1 
                 
                 
                   12.1 
                 
                 
                   14.2 
                 
                 
                   11.4 
                 
                 
                   14.5 
                 
               
               
                   
                 25. 
                 SEQID50 
                 
                   12.6 
                 
                 
                   14.6 
                 
                 
                   16.1 
                 
                 
                   16.6 
                 
                 
                   16.8 
                 
               
               
                   
                 26. 
                 SEQID52 
                 
                   25.2 
                 
                 
                   30 
                 
                 
                   30.8 
                 
                 
                   28.6 
                 
                 
                   36.3 
                 
               
               
                   
                 27. 
                 SEQID54 
                 
                   15.6 
                 
                 
                   14.2 
                 
                 
                   17.2 
                 
                 
                   14.4 
                 
                 
                   15.5 
                 
               
               
                   
                 28. 
                 SEQID56 
                 
                   18.2 
                 
                 
                   13.9 
                 
                 
                   13.8 
                 
                 
                   14.1 
                 
                 
                   13.1 
                 
               
               
                   
                 29. 
                 SEQID58 
                 
                   13.2 
                 
                 
                   12.2 
                 
                 
                   15 
                 
                 
                   10.9 
                 
                 
                   14 
                 
               
               
                   
                 30. 
                 SEQID60 
                 
                   15.8 
                 
                 
                   14 
                 
                 
                   14.2 
                 
                 
                   14.1 
                 
                 
                   13.4 
                 
               
               
                   
                 31. 
                 SEQID62 
                 
                   12.2 
                 
                 
                   13.9 
                 
                 
                   15.1 
                 
                 
                   14.9 
                 
                 
                   15.2 
                 
               
               
                   
                 32. 
                 SEQID64 
                 
                   13.9 
                 
                 
                   13.7 
                 
                 
                   14 
                 
                 
                   10.9 
                 
                 
                   14.3 
                 
               
               
                   
                 33. 
                 SEQID66 
                 
                   12.1 
                 
                 
                   23.1 
                 
                 
                   28.8 
                 
                 
                   22.8 
                 
                 
                   19.5 
                 
               
               
                   
                 34. 
                 SEQID68 
                 
                   18.7 
                 
                 
                   19 
                 
                 
                   17.4 
                 
                 
                   17.8 
                 
                 
                   17.8 
                 
               
               
                   
                 35. 
                 SEQID70 
                 
                   18.6 
                 
                 
                   20.1 
                 
                 
                   20.5 
                 
                 
                   20 
                 
                 
                   19.4 
                 
               
               
                   
                 36. 
                 SEQID72 
                 
                   17 
                 
                 
                   15.2 
                 
                 
                   16 
                 
                 
                   16.3 
                 
                 
                   14.6 
                 
               
               
                   
                 37. 
                 SEQID74 
                 
                   21.2 
                 
                 
                   19.9 
                 
                 
                   21.6 
                 
                 
                   20.2 
                 
                 
                   20.2 
                 
               
               
                   
                 38. 
                 SEQID76 
                 
                   21.3 
                 
                 
                   21.5 
                 
                 
                   14.9 
                 
                 
                   20.6 
                 
                 
                   16.8 
                 
               
               
                   
                 39. 
                 SEQID78 
                 
                   25.9 
                 
                 
                   22.6 
                 
                 
                   21.8 
                 
                 
                   22.5 
                 
                 
                   22.2 
                 
               
               
                   
                 40. 
                 SEQID80 
                 
                   25.5 
                 
                 
                   22.6 
                 
                 
                   21.6 
                 
                 
                   24.3 
                 
                 
                   23.3 
                 
               
               
                   
                 41. 
                 SEQID82 
                 
                   29.2 
                 
                 
                   22 
                 
                 
                   22.8 
                 
                 
                   24.2 
                 
                 
                   22.4 
                 
               
               
                   
                 42. 
                 SEQID84 
                 
                   21.6 
                 
                 
                   19.1 
                 
                 
                   19.9 
                 
                 
                   19.5 
                 
                 
                   18.7 
                 
               
               
                   
                 43. 
                 SEQID86 
                 
                   19.3 
                 
                 
                   17.9 
                 
                 
                   17.9 
                 
                 
                   18.1 
                 
                 
                   17.2 
                 
               
               
                   
                 44. 
                 SEQID88 
                 
                   15.6 
                 
                 
                   14.7 
                 
                 
                   15.1 
                 
                 
                   15.3 
                 
                 
                   14.4 
                 
               
               
                   
                 45. 
                 SEQID90 
                 
                   16.2 
                 
                 
                   14.8 
                 
                 
                   15.9 
                 
                 
                   15.4 
                 
                 
                   14.7 
                 
               
               
                   
                 46. 
                 SEQID94 
                 
                   17.3 
                 
                 
                   14.5 
                 
                 
                   14.9 
                 
                 
                   15.7 
                 
                 
                   14.1 
                 
               
               
                   
                 47. 
                 SEQID96 
                 
                   16.8 
                 
                 
                   15 
                 
                 
                   15.1 
                 
                 
                   14.8 
                 
                 
                   13.4 
                 
               
               
                   
                 48. 
                 SEQID100 
                 
                   24.2 
                 
                 
                   21.2 
                 
                 
                   24 
                 
                 
                   20.7 
                 
                 
                   21.1 
                 
               
               
                   
                 49. 
                 SEQID102 
                 
                   33.3 
                 
                 
                   26.1 
                 
                 
                   28.2 
                 
                 
                   25.9 
                 
                 
                   30.2 
                 
               
               
                   
                 50. 
                 SEQID104 
                 
                   22.8 
                 
                 
                   21.8 
                 
                 
                   24 
                 
                 
                   21.5 
                 
                 
                   22 
                 
               
               
                   
                 51. 
                 SEQID106 
                 
                   46.2 
                 
                 
                   23.5 
                 
                 
                   24.1 
                 
                 
                   25.3 
                 
                 
                   22 
                 
               
               
                   
                 52. 
                 SEQID108 
                 
                   25.9 
                 
                 
                   22.8 
                 
                 
                   23.8 
                 
                 
                   22.2 
                 
                 
                   23.2 
                 
               
               
                   
                 53. 
                 SEQID110 
                   
                 
                   27.4 
                 
                 
                   29.2 
                 
                 
                   27.4 
                 
                 
                   27.9 
                 
               
               
                   
                 54. 
                 SEQID124 
                 44 
                   
                 
                   54.2 
                 
                 
                   54.9 
                 
                 
                   44 
                 
               
               
                   
                 55. 
                 SEQID126 
                 44.6 
                 64.1 
                   
                 
                   54.5 
                 
                 
                   49.8 
                 
               
               
                   
                 56. 
                 SEQID134 
                 40.8 
                 68 
                 65.6 
                   
                 
                   43.8 
                 
               
               
                   
                 57. 
                 SEQID140 
                 41.8 
                 55.1 
                 59.8 
                 52.6 
               
               
                   
               
            
           
         
       
     
     Example 4 
     Identification of Domains Comprised in CCA1 
     The Integrated Resource of Protein Families, Domains and Sites (InterPro) database is an integrated interface for the commonly used signature databases for text- and sequence-based searches. The InterPro database combines these databases, which use different methodologies and varying degrees of biological information about well-characterized proteins to derive protein signatures. Collaborating databases include SWISS-PROT, PROSITE, TrEMBL, PRINTS, ProDom and Pfam, Smart and TIGRFAMs. Interpro is hosted at the European Bioinformatics Institute in the United Kingdom. 
     The results of the InterPro scan of the polypeptide sequence as represented by SEQ ID NO: 2 are presented in Table A2. 
     
       
         
           
               
             
               
                 TABLE A2 
               
             
            
               
                   
               
               
                 InterPro scan results of the polypeptide sequence as represented by  
               
               
                 SEQ ID NO: 2 
               
            
           
           
               
               
               
            
               
                 Database 
                 Accession number 
                 Accession name 
               
               
                   
               
               
                 Interpro 
                 IPR001005 
                 Myb, DNA-binding 
               
               
                 PFAM 
                 PF00249 
                 Myb_DNA-binding 
               
               
                 SMART 
                 SM00717 
                 SANT domain 
               
               
                 PROFILE 
                 PS50090 
                 MYB_3 
               
               
                 Interpro 
                 IPR006447 
                 Myb-like DNA-binding region,  
               
               
                   
                   
                 SHAQKYF class 
               
               
                 TIGRFAMs 
                 TIGR01557 
                 myb_SHAQKYF 
               
               
                 Interpro 
                 IPR009057 
                 Homeodomain-like 
               
               
                 SUPERFAMILY 
                 SSF46689 
                 Homeodomain_like 
               
               
                   
               
            
           
         
       
     
     Example 5 
     Topology Prediction of the Polypeptide Sequences Useful in Performing the Methods of the Invention (Subcellular Localization, Transmembrane . . . ) 
     TargetP 1.1 predicts the subcellular location of eukaryotic proteins. The location assignment is based on the predicted presence of any of the N-terminal pre-sequences: chloroplast transit peptide (cTP), mitochondrial targeting peptide (mTP) or secretory pathway signal peptide (SP). Scores on which the final prediction is based are not really probabilities, and they do not necessarily add to one. However, the location with the highest score is the most likely according to TargetP, and the relationship between the scores (the reliability class) may be an indication of how certain the prediction is. The reliability class (RC) ranges from 1 to 5, where 1 indicates the strongest prediction. TargetP is maintained at the server of the Technical University of Denmark. 
     For the sequences predicted to contain an N-terminal presequence a potential cleavage site can also be predicted. 
     A number of parameters were selected, such as organism group (non-plant or plant), cutoff sets (none, predefined set of cutoffs, or user-specified set of cutoffs), and the calculation of prediction of cleavage sites (yes or no). 
     The results of TargetP 1.1 analysis of the polypeptide sequence as represented by SEQ ID NO: 2 are presented Table A3. The “plant” organism group has been selected, no cutoffs defined, and the predicted length of the transit peptide requested. The subcellular localization of the polypeptide sequence as represented by SEQ ID NO: 2 is likely the cytoplasm or nucleus. However, it should be noticed that the observed effects on yield as described in the present application are not the result of a particular localisation of the protein. 
     
       
         
           
               
             
               
                 TABLE A3 
               
               
                   
               
               
                 TargetP 1.1 analysis of the polypeptide sequence as represented by 
               
               
                 SEQ ID NO: 2 
               
               
                   
               
             
            
               
                   
               
            
           
           
               
               
               
            
               
                   
                 Length (AA) 
                 608 
               
               
                   
                 Chloroplastic transit peptide 
                 0.160 
               
               
                   
                 Mitochondrial transit peptide 
                 0.149 
               
               
                   
                 Secretory pathway signal peptide 
                 0.027 
               
               
                   
                 Other subcellular targeting 
                 0.900 
               
               
                   
                 Predicted Location 
                 other 
               
               
                   
                 Reliability class 
                 2 
               
               
                   
                 Predicted transit peptide length 
                 / 
               
               
                   
                   
               
            
           
         
       
     
     Many other algorithms can be used to perform such analyses, including:
         ChloroP 1.1 hosted on the server of the Technical University of Denmark;   Protein Prowler Subcellular Localisation Predictor version 1.2 hosted on the server of the Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia;   PENCE Proteome Analyst PA-GOSUB 2.5 hosted on the server of the University of Alberta, Edmonton, Alberta, Canada;   TMHMM, hosted on the server of the Technical University of Denmark       

     Example 6 
     Assay Related to the CCA1 Polypeptide Sequences 
     CCA1-like proteins (at least in their native form) typically have DNA binding activity. DNA binding assays are part of the state of the art (see for example Current Protocols in Molecular Biology, Volumes 1 and 2, Ausubel et al. (1994), Current Protocols). In particular, a DNA binding assay for CCA1-like transcription factors using the A2 fragment of the Lhcb1*3 gene is described in Wang et al. (Plant Cell 9, 497-507, 1197). Briefly, polypeptides comprising the MYB repeat were expressed and purified, and used in an Electrophoretic Mobility Shift Assay (EMSA). The purified polypeptides were incubated with radiolabeled and purified A2 fragment of the Lhcb1*3 gene and poly (dldC) during 15 minutes at 30° C. Next, the samples were separated on a 8% polyacrylamide gel and autoradiographed. Protein bands corresponding to CCA1 clearly bound radioactive probe, indicative of the formation of a protein-DNA complex. 
     Furthermore, overexpression of a CCA1-like protein in a plant leads to delayed flowering and abolishes the circadian expression of Lhcb or other circadianly expressed genes in continuous light or continuous dark conditions. Alternatively, expression of a CCA1-like protein according to the methods of the present invention results in increased seed yield as described below. 
     Example 7 
     Cloning of Nucleic Acid Sequence as Represented by SEQ ID NO: 1 
     Unless otherwise stated, recombinant DNA techniques are performed according to standard protocols described in (Sambrook (2001) Molecular Cloning: a laboratory manual, 3rd Edition Cold Spring Harbor Laboratory Press, CSH, New York) or in Volumes 1 and 2 of Ausubel et al. (1994), Current Protocols in Molecular Biology, Current Protocols. Standard materials and methods for plant molecular work are described in Plant Molecular Biology Labfax (1993) by R. D. D. Croy, published by BIOS Scientific Publications Ltd (UK) and Blackwell Scientific Publications (UK). 
     The  Arabidopsis thaliana  CCA1-like gene was amplified by PCR using as template an  Arabidopsis thaliana  seedling cDNA library (Invitrogen, Paisley, UK). Primers prm07263 (SEQ ID NO: 146; sense, start codon in bold, AttB1 site in italic: 5′-ggggacaagtttgtacaaaaaagcaggcttaaacaatggagacaaattcgtctgga-3′) and prm07264: (SEQ ID NO: 147; reverse, complementary, AttB2 site in italic: 5′-ggggaccactttgtacaagaaagctgggtgaaaatagagtctcatgtggaagc-3′), which include the AttB sites for Gateway recombination, were used for PCR amplification. PCR was performed using Hifi Taq DNA polymerase in standard conditions. A PCR fragment was amplified and purified also using standard methods. The first step of the Gateway procedure, the BP reaction, was then performed, during which the PCR fragment recombines in vivo with the pDONR201 plasmid to produce, according to the Gateway terminology, an “entry clone”, pCCA1. Plasmid pDONR201 was purchased from Invitrogen, as part of the Gateway® technology. 
     Example 8 
     Expression Vector Construction Using the Nucleic Acid Sequence as Represented by SEQ ID NO: 1 
     The entry clone pCCA1 was subsequently used in an LR reaction with pGOS2, a destination vector used for  Oryza sativa  transformation. This vector contains as functional elements within the T-DNA borders: a plant selectable marker; a screenable marker expression cassette; and a Gateway cassette intended for LR in vivo recombination with the nucleic acid sequence of interest already cloned in the entry clone. A rice GOS2 promoter (SEQ ID NO: 145) for constitutive expression was located upstream of this Gateway cassette. 
     After the LR recombination step, the resulting expression vector pGOS2::CCA1 ( FIG. 3 ) was transformed into  Agrobacterium  strain LBA4044 according to methods well known in the art. 
     Example 9 
     Plant Transformation 
     Rice Transformation 
     The  Agrobacterium  containing the expression vector was used to transform  Oryza sativa  plants. Mature dry seeds of the rice japonica cultivar Nipponbare were dehusked. Sterilization was carried out by incubating for one minute in 70% ethanol, followed by 30 minutes in 0.2% HgCl 2 , followed by a 6 times 15 minutes wash with sterile distilled water. The sterile seeds were then germinated on a medium containing 2,4-D (callus induction medium). After incubation in the dark for four weeks, embryogenic, scutellum-derived calli were excised and propagated on the same medium. After two weeks, the calli were multiplied or propagated by subculture on the same medium for another 2 weeks. Embryogenic callus pieces were sub-cultured on fresh medium 3 days before co-cultivation (to boost cell division activity). 
       Agrobacterium  strain LBA4404 containing the expression vector was used for co-cultivation.  Agrobacterium  was inoculated on AB medium with the appropriate antibiotics and cultured for 3 days at 28° C. The bacteria were then collected and suspended in liquid co-cultivation medium to a density (OD 600 ) of about 1. The suspension was then transferred to a Petri dish and the calli immersed in the suspension for 15 minutes. The callus tissues were then blotted dry on a filter paper and transferred to solidified, co-cultivation medium and incubated for 3 days in the dark at 25° C. Co-cultivated calli were grown on 2,4-D-containing medium for 4 weeks in the dark at 28° C. in the presence of a selection agent. During this period, rapidly growing resistant callus islands developed. After transfer of this material to a regeneration medium and incubation in the light, the embryogenic potential was released and shoots developed in the next four to five weeks. Shoots were excised from the calli and incubated for 2 to 3 weeks on an auxin-containing medium from which they were transferred to soil. Hardened shoots were grown under high humidity and short days in a greenhouse. 
     Approximately 35 independent T0 rice transformants were generated for one construct. The primary transformants were transferred from a tissue culture chamber to a greenhouse. After a quantitative PCR analysis to verify copy number of the T-DNA insert, only single copy transgenic plants that exhibit tolerance to the selection agent were kept for harvest of T1 seed. Seeds were then harvested three to five months after transplanting. The method yielded single locus transformants at a rate of over 50% (Aldemita and Hodges 1996, Chan et al. 1993, Hiei et al. 1994). 
     Corn Transformation 
     Transformation of maize ( Zea mays ) is performed with a modification of the method described by Ishida et al. (1996) Nature Biotech 14(6): 745-50. Transformation is genotype-dependent in corn and only specific genotypes are amenable to transformation and regeneration. The inbred line A188 (University of Minnesota) or hybrids with A188 as a parent are good sources of donor material for transformation, but other genotypes can be used successfully as well. Ears are harvested from corn plant approximately 11 days after pollination (DAP) when the length of the immature embryo is about 1 to 1.2 mm. Immature embryos are cocultivated with  Agrobacterium tumefaciens  containing the expression vector, and transgenic plants are recovered through organogenesis. Excised embryos are grown on callus induction medium, then maize regeneration medium, containing the selection agent (for example imidazolinone but various selection markers can be used). The Petri plates are incubated in the light at 25° C. for 2-3 weeks, or until shoots develop. The green shoots are transferred from each embryo to maize rooting medium and incubated at 25° C. for 2-3 weeks, until roots develop. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert. 
     Wheat Transformation 
     Transformation of wheat is performed with the method described by Ishida et al. (1996) Nature Biotech 14(6): 745-50. The cultivar Bobwhite (available from CIMMYT, Mexico) is commonly used in transformation. Immature embryos are co-cultivated with  Agrobacterium tumefaciens  containing the expression vector, and transgenic plants are recovered through organogenesis. After incubation with  Agrobacterium , the embryos are grown in vitro on callus induction medium, then regeneration medium, containing the selection agent (for example imidazolinone but various selection markers can be used). The Petri plates are incubated in the light at 25° C. for 2-3 weeks, or until shoots develop. The green shoots are transferred from each embryo to rooting medium and incubated at 25° C. for 2-3 weeks, until roots develop. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert. 
     Soybean Transformation 
     Soybean is transformed according to a modification of the method described in the Texas A&amp;M U.S. Pat. No. 5,164,310. Several commercial soybean varieties are amenable to transformation by this method. The cultivar Jack (available from the Illinois Seed foundation) is commonly used for transformation. Soybean seeds are sterilised for in vitro sowing. The hypocotyl, the radicle and one cotyledon are excised from seven-day old young seedlings. The epicotyl and the remaining cotyledon are further grown to develop axillary nodes. These axillary nodes are excised and incubated with  Agrobacterium tumefaciens  containing the expression vector. After the cocultivation treatment, the explants are washed and transferred to selection media. Regenerated shoots are excised and placed on a shoot elongation medium. Shoots no longer than 1 cm are placed on rooting medium until roots develop. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert. 
     Rapeseed/Canola Transformation 
     Cotyledonary petioles and hypocotyls of 5-6 day old young seedling are used as explants for tissue culture and transformed according to Babic et al. (1998, Plant Cell Rep 17: 183-188). The commercial cultivar Westar (Agriculture Canada) is the standard variety used for transformation, but other varieties can also be used. Canola seeds are surface-sterilized for in vitro sowing. The cotyledon petiole explants with the cotyledon attached are excised from the in vitro seedlings, and inoculated with  Agrobacterium  (containing the expression vector) by dipping the cut end of the petiole explant into the bacterial suspension. The explants are then cultured for 2 days on MSBAP-3 medium containing 3 mg/l BAP, 3% sucrose, 0.7% Phytagar at 23° C., 16 hr light. After two days of co-cultivation with  Agrobacterium , the petiole explants are transferred to MSBAP-3 medium containing 3 mg/l BAP, cefotaxime, carbenicillin, or timentin (300 mg/l) for 7 days, and then cultured on MSBAP-3 medium with cefotaxime, carbenicillin, or timentin and selection agent until shoot regeneration. When the shoots are 5-10 mm in length, they are cut and transferred to shoot elongation medium (MSBAP-0.5, containing 0.5 mg/l BAP). Shoots of about 2 cm in length are transferred to the rooting medium (MS0) for root induction. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert. 
     Alfalfa Transformation 
     A regenerating clone of alfalfa ( Medicago sativa ) is transformed using the method of (McKersie et al., 1999 Plant Physiol 119: 839-847). Regeneration and transformation of alfalfa is genotype dependent and therefore a regenerating plant is required. Methods to obtain regenerating plants have been described. For example, these can be selected from the cultivar Rangelander (Agriculture Canada) or any other commercial alfalfa variety as described by Brown DCW and A Atanassov (1985. Plant Cell Tissue Organ Culture 4: 111-112). Alternatively, the RA3 variety (University of Wisconsin) has been selected for use in tissue culture (Walker et al., 1978 Am J Bot 65:654-659). Petiole explants are cocultivated with an overnight culture of  Agrobacterium tumefaciens  C58C1 pMP90 (McKersie et al., 1999 Plant Physiol 119: 839-847) or LBA4404 containing the expression vector. The explants are cocultivated for 3 d in the dark on SH induction medium containing 288 mg/L Pro, 53 mg/L thioproline, 4.35 g/L K2SO4, and 100 μm acetosyringinone. The explants are washed in half-strength Murashige-Skoog medium (Murashige and Skoog, 1962) and plated on the same SH induction medium without acetosyringinone but with a suitable selection agent and suitable antibiotic to inhibit  Agrobacterium  growth. After several weeks, somatic embryos are transferred to BOi2Y development medium containing no growth regulators, no antibiotics, and 50 g/L sucrose. Somatic embryos are subsequently germinated on half-strength Murashige-Skoog medium. Rooted seedlings were transplanted into pots and grown in a greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert. 
     Cotton Transformation 
     Cotton is transformed using  Agrobacterium tumefaciens  according to the method described in U.S. Pat. No. 5,159,135. Cotton seeds are surface sterilised in 3% sodium hypochlorite solution during 20 minutes and washed in distilled water with 500 μg/ml cefotaxime. The seeds are then transferred to SH-medium with 50 μg/ml benomyl for germination. Hypocotyls of 4 to 6 days old seedlings are removed, cut into 0.5 cm pieces and are placed on 0.8% agar. An  Agrobacterium  suspension (approx. 108 cells per ml, diluted from an overnight culture transformed with the gene of interest and suitable selection markers) is used for inoculation of the hypocotyl explants. After 3 days at room temperature and lighting, the tissues are transferred to a solid medium (1.6 g/l Gelrite) with Murashige and Skoog salts with B5 vitamins (Gamborg et al., Exp. Cell Res. 50:151-158 (1968)), 0.1 mg/l 2,4-D, 0.1 mg/l 6-furfurylaminopurine and 750 μg/ml MgCL2, and with 50 to 100 μg/ml cefotaxime and 400-500 μg/ml carbenicillin to kill residual bacteria. Individual cell lines are isolated after two to three months (with subcultures every four to six weeks) and are further cultivated on selective medium for tissue amplification (30° C., 16 hr photoperiod). Transformed tissues are subsequently further cultivated on non-selective medium during 2 to 3 months to give rise to somatic embryos. Healthy looking embryos of at least 4 mm length are transferred to tubes with SH medium in fine vermiculite, supplemented with 0.1 mg/l indole acetic acid, 6 furfurylaminopurine and gibberellic acid. The embryos are cultivated at 30° C. with a photoperiod of 16 hrs, and plantlets at the 2 to 3 leaf stage are transferred to pots with vermiculite and nutrients. The plants are hardened and subsequently moved to the greenhouse for further cultivation. 
     Example 10 
     Phenotypic Evaluation Procedure 
     10.1 Evaluation Setup 
     Approximately 35 independent T0 rice transformants were generated. The primary transformants were transferred from a tissue culture chamber to a greenhouse for growing and harvest of T1 seed. Seven events, of which the T1 progeny segregated 3:1 for presence/absence of the transgene, were retained. For each of these events, approximately 10 T1 seedlings containing the transgene (hetero- and homo-zygotes) and approximately 10 T1 seedlings lacking the transgene (nullizygotes) were selected by monitoring visual marker expression. The transgenic plants and the corresponding nullizygotes were grown side-by-side at random positions. Greenhouse conditions were of shorts days (12 hours light), 28° C. in the light and 22° C. in the dark, and a relative humidity of 70%. 
     Four T1 events were further evaluated in the T2 generation following the same evaluation procedure as for the T1 generation but with more individuals per event. From the stage of sowing until the stage of maturity the plants were passed several times through a digital imaging cabinet. At each time point digital images (2048×1536 pixels, 16 million colours) were taken of each plant from at least 6 different angles. 
     10.2 Statistical analysis: F-test 
     A two factor ANOVA (analysis of variants) was used as a statistical model for the overall evaluation of plant phenotypic characteristics. An F-test was carried out on all the parameters measured of all the plants of all the events transformed with the gene of the present invention. The F-test was carried out to check for an effect of the gene over all the transformation events and to verify for an overall effect of the gene, also known as a global gene effect. The threshold for significance for a true global gene effect was set at a 5% probability level for the F-test. A significant F-test value points to a gene effect, meaning that it is not only the mere presence or position of the gene that is causing the differences in phenotype. 
     10.3 Parameters Measured 
     Biomass-Related Parameter Measurement 
     From the stage of sowing until the stage of maturity the plants were passed several times through a digital imaging cabinet. At each time point digital images (2048×1536 pixels, 16 million colours) were taken of each plant from at least 6 different angles. 
     The plant aboveground area (or leafy biomass) was determined by counting the total number of pixels on the digital images from aboveground plant parts discriminated from the background. This value was averaged for the pictures taken on the same time point from the different angles and was converted to a physical surface value expressed in square mm by calibration. Experiments show that the aboveground plant area measured this way correlates with the biomass of plant parts above ground. The above ground area is the area measured at the time point at which the plant had reached its maximal leafy biomass. The early vigour is the plant (seedling) aboveground area three weeks post-germination. 
     Seed-Related Parameter Measurements 
     The mature primary panicles were harvested, counted, bagged, barcode-labelled and then dried for three days in an oven at 37° C. The panicles were then threshed and all the seeds were collected and counted. The filled husks were separated from the empty ones using an air-blowing device. The empty husks were discarded and the remaining fraction was counted again. The filled husks were weighed on an analytical balance. The number of filled seeds was determined by counting the number of filled husks that remained after the separation step. The total seed yield was measured by weighing all filled husks harvested from a plant. Total seed number per plant was measured by counting the number of husks harvested from a plant. Thousand Kernel Weight (TKW) is extrapolated from the number of filled seeds counted and their total weight. The Harvest Index (HI) in the present invention is defined as the ratio between the total seed yield and the above ground area (mm 2 ), multiplied by a factor 10 6 . The total number of flowers per panicle as defined in the present invention is the ratio between the total number of seeds and the number of mature primary panicles. The seed fill rate as defined in the present invention is the proportion (expressed as a %) of the number of filled seeds over the total number of seeds (or florets). 
     Example 11 
     Results of the Phenotypic Evaluation of the Transgenic Plants 
     The results of the evaluation of transgenic rice plants expressing the CCA1 nucleic acid sequence are presented in Table A4. The percentage difference between the transgenics and the corresponding nullizygotes is also shown, with a P value from the F test below 0.05. 
     Total seed yield, number of filled seeds, seed fill rate and harvest index are significantly increased in the transgenic plants expressing the nucleic acid sequence useful in performing the methods of the invention, compared to the control plants (in this case, the nullizygotes). 
     
       
         
           
               
             
               
                 TABLE A4 
               
             
            
               
                   
               
               
                 Results of the evaluation of transgenic rice plants expressing the nucleic  
               
               
                 acid sequence useful in performing the methods of the invention. 
               
            
           
           
               
               
               
            
               
                   
                 % Increase in 
                 % Increase in 
               
               
                 Trait 
                 T1 generation 
                 T2 generation 
               
               
                   
               
            
           
           
               
               
               
            
               
                 Total seed yield 
                 26.7 
                 38.6 
               
               
                 Number of filled seeds 
                 22.9 
                 28.6 
               
               
                 Fill rate 
                 11.2 
                 9.6 
               
               
                 Harvest index 
                 15.4 
                 15.6 
               
               
                 Flowers per panicle 
                 16.5 
                 16.9 
               
               
                 Thousand Kernel Weight 
                 2.7 
                 7.2 
               
               
                   
               
            
           
         
       
     
     Part II. VPE 
     Example 12 
     Identification of Sequences Related to VPE Sequences of SEQ ID NO: 149 and SEQ ID NO: 150 
     Sequences (full length cDNA, ESTs or genomic) related to SEQ ID NO: 149 and/or protein sequences related to SEQ ID NO: 150 were identified amongst those maintained in the Entrez Nucleotides database at the National Center for Biotechnology Information (NCBI) using database sequence search tools, such as the Basic Local Alignment Tool (BLAST) (Altschul et al. (1990) J. Mol. Biol. 215:403-410; and Altschul et al. (1997) Nucleic Acids Res. 25:3389-3402). The program was used to find regions of local similarity between sequences by comparing nucleic acid or polypeptide sequences to sequence databases and by calculating the statistical significance of matches. The polypeptide encoded by SEQ ID NO: 149 was used for the TBLASTN algorithm, with default settings and the filter to ignore low complexity sequences set off. The output of the analysis was viewed by pairwise comparison, and ranked according to the probability score (E-value), where the score reflects the probability that a particular alignment occurs by chance (the lower the E-value, the more significant the hit). In addition to E-values, comparisons were also scored by percentage identity (percentage identity referring to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length). In some instances, the default parameters were adjusted to modify the stringency of the search. 
     Table B1 provides a list of nucleic acid and protein sequences related to the nucleic acid sequence as represented by SEQ ID NO: 149 and the protein sequence represented by SEQ ID NO: 150. 
     
       
         
           
               
             
               
                 TABLE B1 
               
             
            
               
                   
               
               
                 Nucleic acid sequences related to SEQ ID NO: 149 and corresponding deduced 
               
               
                 polypeptides. 
               
            
           
           
               
               
               
               
            
               
                   
                   
                 Nucleotide (Nt) or  
                   
               
               
                 Name 
                 SEQ ID NO: 
                 protein (PROT) 
                 Origin 
               
               
                   
               
               
                 VPEg 
                 SEQ ID NO: 149 
                 Nt 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 VPEg 
                 SEQ ID NO: 150 
                 PROT 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 &gt;TA0704@contig9701 
                 SEQ ID NO: 151 
                 Nt 
                 
                   Triticum 
                   aestivum 
                 
               
               
                 &gt;TA0704@contig9701 
                 SEQ ID NO: 152 
                 PROT 
                 
                   Triticum 
                   aestivum 
                 
               
               
                 &gt;TA0704@contig15207 
                 SEQ ID NO: 153 
                 Nt 
                 
                   Triticum 
                   aestivum 
                 
               
               
                 &gt;TA0704@contig15207 
                 SEQ ID NO: 154 
                 PROT 
                 
                   Triticum 
                   aestivum 
                 
               
               
                 &gt;TA0704@contig14121 
                 SEQ ID NO: 155 
                 Nt 
                 
                   Triticum 
                   aestivum 
                 
               
               
                 &gt;TA0704@contig14121 
                 SEQ ID NO: 156 
                 PROT 
                 
                   Triticum 
                   aestivum 
                 
               
               
                 &gt;TA0704@contig11093 
                 SEQ ID NO: 157 
                 Nt 
                 
                   Triticum 
                   aestivum 
                 
               
               
                 &gt;TA0704@contig11093 
                 SEQ ID NO: 158 
                 PROT 
                 
                   Triticum 
                   aestivum 
                 
               
               
                 &gt;HV0704@contig6924 
                 SEQ ID NO: 159 
                 Nt 
                 
                   Hordeum 
                   vulgare 
                 
               
               
                 &gt;HV0704@contig6924 
                 SEQ ID NO: 160 
                 PROT 
                 
                   Hordeum 
                   vulgare 
                 
               
               
                 &gt;GM0604@contig24378 
                 SEQ ID NO: 161 
                 Nt 
                 
                   Glycine 
                   max 
                 
               
               
                 &gt;GM0604@contig24378 
                 SEQ ID NO: 162 
                 PROT 
                 
                   Glycine 
                   max 
                 
               
               
                 &gt;GM0604@contig20207 
                 SEQ ID NO: 163 
                 Nt 
                 
                   Glycine 
                   max 
                 
               
               
                 &gt;GM0604@contig20207 
                 SEQ ID NO: 164 
                 PROT 
                 
                   Glycine 
                   max 
                 
               
               
                 &gt;GM0604@contig13648 
                 SEQ ID NO: 165 
                 Nt 
                 
                   Glycine 
                   max 
                 
               
               
                 &gt;GM0604@contig13648 
                 SEQ ID NO: 166 
                 PROT 
                 
                   Glycine 
                   max 
                 
               
               
                 &gt;BN0204@contig29409 
                 SEQ ID NO: 167 
                 Nt 
                 
                   Brassica 
                   napa 
                 
               
               
                 &gt;BN0204@contig29409 
                 SEQ ID NO: 168 
                 PROT 
                 
                   Brassica 
                   napa 
                 
               
               
                 &gt;BN0204@contig26590 
                 SEQ ID NO: 169 
                 Nt 
                 
                   Brassica 
                   napa 
                 
               
               
                 &gt;BN0204@contig26590 
                 SEQ ID NO: 170 
                 PROT 
                 
                   Brassica 
                   napa 
                 
               
               
                 &gt;ZM0404@contig11971 
                 SEQ ID NO: 171 
                 Nt 
                 
                   Zea 
                   mays 
                 
               
               
                 &gt;ZM0404@contig11971 
                 SEQ ID NO: 172 
                 PROT 
                 
                   Zea 
                   mays 
                 
               
               
                 &gt;AT2G25940 Alpha-VPE  
                 SEQ ID NO: 173 
                 Nt 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 &gt;AT2G25940 Alpha-VPE  
                 SEQ ID NO: 174 
                 PROT 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 &gt;AT1G62710 BETA-VPE 
                 SEQ ID NO: 175 
                 Nt 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 &gt;AT1G62710 BETA-VPE 
                 SEQ ID NO: 176 
                 PROT 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 &gt;AT3G20210 DELTA-VPE  
                 SEQ ID NO: 177 
                 Nt 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 &gt;AT3G20210 DELTA-VPE  
                 SEQ ID NO: 178 
                 PROT 
                 
                   Arabidopsis 
                   thaliana 
                 
               
               
                 &gt;Os01g0559600 
                 SEQ ID NO: 179 
                 Nt 
                 
                   Oryza 
                   sativa 
                 
               
               
                 &gt;Os01g0559600 
                 SEQ ID NO: 180 
                 PROT 
                 
                   Oryza 
                   sativa 
                 
               
               
                 &gt;Os02g0644000 
                 SEQ ID NO: 181 
                 Nt 
                 
                   Oryza 
                   sativa 
                 
               
               
                 &gt;Os02g0644000 
                 SEQ ID NO: 182 
                 PROT 
                 
                   Oryza 
                   sativa 
                 
               
               
                 &gt;Os04g0537900 
                 SEQ ID NO: 183 
                 Nt 
                 
                   Oryza 
                   sativa 
                 
               
               
                 &gt;Os04g0537900 
                 SEQ ID NO: 184 
                 PROT 
                 
                   Oryza 
                   sativa 
                 
               
               
                 &gt;Os05g0593900 
                 SEQ ID NO: 185 
                 Nt 
                 
                   Oryza 
                   sativa 
                 
               
               
                 &gt;Os05g0593900 
                 SEQ ID NO: 186 
                 PROT 
                 
                   Oryza 
                   sativa 
                 
               
               
                 &gt;lcl_scaff_127.44 
                 SEQ ID NO: 187 
                 Nt 
                 
                   Populus 
                   trichocarpa 
                 
               
               
                 &gt;lcl_scaff_127.44 
                 SEQ ID NO: 188 
                 PROT 
                 
                   Populus 
                   trichocarpa 
                 
               
               
                 &gt;lcl_scaff_VI.1657 
                 SEQ ID NO: 189 
                 Nt 
                 
                   Populus 
                   trichocarpa 
                 
               
               
                 &gt;lcl_scaff_VI.1657 
                 SEQ ID NO: 190 
                 PROT 
                 
                   Populus 
                   trichocarpa 
                 
               
               
                 &gt;lcl_scaff_VIII.21 
                 SEQ ID NO: 191 
                 Nt 
                 
                   Populus 
                   trichocarpa 
                 
               
               
                 &gt;lcl_scaff_VIII.21 
                 SEQ ID NO: 192 
                 PROT 
                 
                   Populus 
                   trichocarpa 
                 
               
               
                 &gt;Le_CAH56498.1_VPEg 
                 SEQ ID NO: 193 
                 Nt 
                 
                   Solanum 
                   lycopersicum 
                 
               
               
                 &gt;Le_CAH56498.1_VPEg 
                 SEQ ID NO: 194 
                 PROT 
                 
                   Solanum 
                   lycopersicum 
                 
               
               
                 &gt;Nt_BAC54827.1 VPEg 
                 SEQ ID NO: 195 
                 Nt 
                 
                   Nicotiana 
                   tabacum 
                 
               
               
                 &gt;Nt_BAC54827.1 VPEg 
                 SEQ ID NO: 196 
                 PROT 
                 
                   Nicotiana 
                   tabacum 
                 
               
               
                 &gt;So_ABF00019.1_VPEg 
                 SEQ ID NO: 197 
                 Nt 
                 
                   Saccharum 
                   officinarum 
                 
               
               
                 &gt;So_ABF00019.1_VPEg 
                 SEQ ID NO: 198 
                 PROT 
                 
                   Saccharum 
                   officinarum 
                 
               
               
                 &gt;Zm_See2a 
                 SEQ ID NO: 199 
                 Nt 
                 
                   Zea 
                   mays 
                 
               
               
                 &gt;Zm_See2a 
                 SEQ ID NO: 200 
                 PROT 
                 
                   Zea 
                   mays 
                 
               
               
                 &gt;Zm_See2b 
                 SEQ ID NO: 201 
                 Nt 
                 
                   Zea 
                   mays 
                 
               
               
                 &gt;Zm_See2b 
                 SEQ ID NO: 202 
                 PROT 
                 
                   Zea 
                   mays 
                 
               
               
                 &gt;Zm_VPE1 
                 SEQ ID NO: 203 
                 Nt 
                 
                   Zea 
                   mays 
                 
               
               
                 &gt;Zm_VPE1 
                 SEQ ID NO: 204 
                 PROT 
                 
                   Zea 
                   mays 
                 
               
               
                   
               
            
           
         
       
     
     Example 13 
     Alignment of VPEs 
     AlignX from Vector NTI (Invitrogen), based on the popular Clustal algorithm of progressive alignment (Thompson et al. (1997) Nucleic Acids Res 25: 4876-4882; Chema et al. (2003). Nucleic Acids Res 31: 3497-3500) was used for the alignment of VPE sequences. A phylogenetic tree was constructed using a neighbour-joining clustering algorithm. Default values were used for the gap open penalty of 10, for the gap extension penalty of 0.1 and the selected weight matrix was Blosum 62. 
     The result of the multiple sequence alignment performed with AlignX from the Vector NTI (Invitrogen) using default parameters is shown in  FIG. 6B . A multiple sequence alignment and the corresponding the phylogenetic tree of VPE polypeptides and peptidases representative of other protein clans was performed using the AlignX from the Vector NTI (Invitrogen) set to default parameters ( FIG. 6A ). VPE polypeptides cluster together, apart from peptidases belonging a different clan. VPE polypeptides cluster in four subclasses. VPEs in class alpha are the closest to VPEs in class gamma, the class to which SEQ ID NO: 150 belongs. 
     Example 14 
     Calculation of Global Percentage Identity Between Polypeptide Sequences Useful in Performing the Methods of the Invention 
     Global percentages of similarity and identity between full length polypeptide sequences useful in performing the methods of the invention were determined using one of the methods available in the art, the MatGAT (Matrix Global Alignment Tool) software (BMC Bioinformatics. 2003 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences. Campanella J J, Bitincka L, Smalley J; software hosted by Ledion Bitincka). MatGAT software generates similarity/identity matrices for DNA or protein sequences without needing pre-alignment of the data. The program performs a series of pair-wise alignments using the Myers and Miller global alignment algorithm (with a gap opening penalty of 12, and a gap extension penalty of 2), calculates similarity and identity using for example Blosum 62 (for polypeptides), and then places the results in a distance matrix. Sequence similarity is shown in the bottom half of the dividing line and sequence identity is shown in the top half of the diagonal dividing line. 
     Parameters used in the comparison were: 
     
         
         
           
             Scoring matrix: Blosum62 
             First Gap: 12 
             Extending gap: 2 
           
         
       
    
     Results of the software analysis are shown in Table B2 for the global similarity and identity over the full length of the polypeptide sequences (excluding the partial polypeptide sequences). Percentage identity is given above the diagonal and percentage similarity is given below the diagonal. 
     The percentage identity between VPEs start at about 45% amino acid identity compared to SEQ ID NO: 150. 
     Table B2 and B3: MatGAT results for global similarity and identity over the full length of the polypeptide sequences. 
     
       
         
           
               
             
               
                 TABLE B2 
               
             
            
               
                   
               
               
                 Global similarity amongst VPE polypeptides from dicotyledonous plants. 
               
            
           
           
               
               
               
               
               
               
               
               
               
               
               
               
               
            
               
                   
                 1 
                 2 
                 3 
                 4 
                 5 
                 6 
                 7 
                 8 
                 9 
                 10 
                 11 
                 12 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
               
               
               
               
               
               
            
               
                 1. 
                 SEQ ID NO: 150 
                   
                 73.9 
                 59 
                 71.7 
                 87.1 
                 48.8 
                 73.1 
                 73.3 
                 80 
                 100 
                 58.6 
                 48.1 
               
               
                 2. 
                 GM0604@contig24378 
                 85 
                   
                 57.9 
                 78.8 
                 75.4 
                 49.5 
                 75.2 
                 75.2 
                 73.3 
                 73.9 
                 57.3 
                 49.9 
               
               
                 3. 
                 GM0604@contig20207 
                 73.3 
                 70.1 
                   
                 57.5 
                 58.8 
                 44.8 
                 56 
                 56 
                 55.8 
                 59 
                 66.4 
                 43.1 
               
               
                 4. 
                 GM0604@contig13648 
                 82.2 
                 87.4 
                 71.9 
                   
                 74.1 
                 50.4 
                 74.3 
                 73.9 
                 70.5 
                 71.7 
                 58.9 
                 50.5 
               
               
                 5. 
                 BN0204@contig29409 
                 91.9 
                 86.7 
                 71.3 
                 83.6 
                   
                 48.5 
                 75.8 
                 73.2 
                 79.5 
                 87.1 
                 57.1 
                 47.9 
               
               
                 6. 
                 BN0204@contig26590 
                 64.2 
                 64.3 
                 59.8 
                 65.1 
                 63.2 
                   
                 50.1 
                 49.2 
                 49.7 
                 48.8 
                 47.5 
                 76.3 
               
               
                 7. 
                 Le_CAH56498.1_VPEg 
                 83.8 
                 86.2 
                 70.3 
                 84.6 
                 84.2 
                 66 
                   
                 81.1 
                 73.2 
                 73.1 
                 57.5 
                 50 
               
               
                 8. 
                 Nt_BAC54827.1VPEg 
                 84.2 
                 87.3 
                 69.5 
                 85.7 
                 84.1 
                 64.5 
                 89 
                   
                 71.1 
                 73.3 
                 55.8 
                 49.9 
               
               
                 9. 
                 AT2G25940 
                 89.3 
                 85.5 
                 70.5 
                 83 
                 88.1 
                 65.9 
                 85.2 
                 84.9 
                   
                 80 
                 57 
                 48.6 
               
               
                 10. 
                 AT4G32940 
                 100 
                 85 
                 73.5 
                 82.2 
                 91.9 
                 64.2 
                 83.8 
                 84.2 
                 89.3 
                   
                 58.6 
                 48.1 
               
               
                 11. 
                 AT1G62710 
                 71.3 
                 72 
                 78.4 
                 72.2 
                 71.9 
                 62.1 
                 71 
                 70.8 
                 71.8 
                 71.3 
                   
                 47.1 
               
               
                 12. 
                 AT3G20210 
                 64.4 
                 66.5 
                 58.4 
                 65.1 
                 65.1 
                 87.6 
                 66.5 
                 65.9 
                 66.5 
                 64.4 
                 62.8 
               
               
                   
               
            
           
         
       
     
     
       
         
           
               
             
               
                 TABLE B3 
               
             
            
               
                   
               
               
                 Global similarity amongst VPE polypeptides from monocotyledonous plants. 
               
            
           
           
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
            
               
                   
                 1 
                 2 
                 3 
                 4 
                 5 
                 6 
                 7 
                 8 
                 9 
                 10 
                 11 
                 12 
                 13 
                 14 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
            
               
                 1. 
                 SEQ ID NO 150 
                   
                 67.7 
                 41.7 
                 46.6 
                 68.5 
                 55.6 
                 67.5 
                 67.1 
                 67.3 
                 66.3 
                 67.1 
                 49.3 
                 57.6 
                 54.1 
               
               
                 2. 
                 ZM0404@contig11971 
                 81.2 
                   
                 48.1 
                 45.7 
                 84.8 
                 54.7 
                 85.4 
                 83.4 
                 92.2 
                 97.3 
                 83.4 
                 50 
                 57.3 
                 60 
               
               
                 3. 
                 TA0704@contig9701 
                 55.9 
                 58.8 
                   
                 31 
                 47.1 
                 38.6 
                 48 
                 47.4 
                 47.4 
                 47.6 
                 47.4 
                 31 
                 38.1 
                 47.3 
               
               
                 4. 
                 TA0704@contig15207 
                 55.7 
                 58 
                 43.7 
                   
                 47.9 
                 50.9 
                 48.5 
                 45.3 
                 46.5 
                 46.5 
                 45.3 
                 48.1 
                 55.9 
                 41.7 
               
               
                 5. 
                 TA0704@contig14121 
                 81.6 
                 92.3 
                 58.6 
                 58.4 
                   
                 53.2 
                 94.1 
                 83.4 
                 83.5 
                 84.6 
                 83.4 
                 49.5 
                 55.9 
                 58.2 
               
               
                 6. 
                 TA0704@contig11093 
                 70 
                 70.6 
                 53.6 
                 60.5 
                 70 
                   
                 55 
                 54.9 
                 55.6 
                 54.8 
                 54.9 
                 56.9 
                 70.6 
                 46.8 
               
               
                 7. 
                 HV0704@contig6924 
                 79.6 
                 92.4 
                 57.9 
                 58.3 
                 95.7 
                 70.2 
                   
                 82.4 
                 83 
                 84.8 
                 82.4 
                 49.8 
                 56.5 
                 57.6 
               
               
                 8. 
                 OS_BAB85400_VPEg 
                 80.8 
                 91 
                 57.5 
                 56.3 
                 89 
                 70.3 
                 87.8 
                   
                 81 
                 83 
                 100 
                 49.1 
                 59.2 
                 57.5 
               
               
                 9. 
                 So_ABF00019.1_VPE 
                 81.6 
                 96.3 
                 59.8 
                 57.8 
                 91.7 
                 71.1 
                 91 
                 88.8 
                   
                 92 
                 81 
                 49.4 
                 57.9 
                 58.4 
               
               
                 10. 
                 ZM_CAC18100.1VPEg 
                 80.2 
                 97.7 
                 58.1 
                 58.1 
                 91.9 
                 70.4 
                 91.8 
                 90 
                 95.7 
                   
                 83 
                 49.7 
                 57.1 
                 59.3 
               
               
                 11. 
                 Os01g0559600 
                 80.8 
                 91 
                 57.5 
                 56.3 
                 89 
                 70.3 
                 87.8 
                 100 
                 88.8 
                 90 
                   
                 49.1 
                 59.2 
                 57.5 
               
               
                 12. 
                 Os02g0644000 
                 59.3 
                 61.3 
                 44.3 
                 64.7 
                 60.6 
                 66.4 
                 60.5 
                 59.9 
                 61.9 
                 61.2 
                 59.9 
                   
                 61 
                 43.7 
               
               
                 13. 
                 Os04g0537900 
                 71.2 
                 72.8 
                 52.9 
                 63.8 
                 72.2 
                 82.5 
                 71.2 
                 72.9 
                 73 
                 72.4 
                 72.9 
                 69.8 
                   
                 48.6 
               
               
                 14. 
                 Os05g0593900 
                 70.2 
                 73.5 
                 58.9 
                 55.7 
                 71.8 
                 63.4 
                 71.5 
                 71.1 
                 73.2 
                 73.4 
                 71.1 
                 57 
                 65.2 
               
               
                   
               
            
           
         
       
     
     Example 15 
     Identification of Domains Comprised in VPEs 
     The Integrated Resource of Protein Families, Domains and Sites (InterPro) database is an integrated interface for the commonly used signature databases for text- and sequence-based searches. The InterPro database combines these databases, which use different methodologies and varying degrees of biological information about well-characterized proteins to derive protein signatures. Collaborating databases include SWISS-PROT, PROSITE, TrEMBL, PRINTS, ProDom and Pfam, Smart and TIGRFAMs. Interpro is hosted at the European Bioinformatics Institute in the United Kingdom. 
     The results of the InterPro scan of the polypeptide sequence as represented by SEQ ID NO: 150 are presented in Table B4. 
     
       
         
           
               
             
               
                 TABLE B4 
               
             
            
               
                   
               
               
                 InterPro scan results of the polypeptide sequence as represented by  
               
               
                 SEQ ID NO: 150 
               
            
           
           
               
               
               
               
               
            
               
                   
                 Accession  
                 Accession  
                   
                 aa coordinates in SEQ ID 
               
               
                 Database 
                 number 
                 name 
                 e-value  
                 150 for the domain 
               
               
                   
               
               
                 Pfam 
                 PF01650 
                 Peptidase_C13 
                 1.0E125 
                 54-478 
               
               
                   
               
            
           
         
       
     
     Example 16 
     Topology Prediction for VPEs 
     TargetP 1.1 predicts the subcellular location of eukaryotic proteins. The location assignment is based on the predicted presence of any of the N-terminal pre-sequences: chloroplast transit peptide (cTP), mitochondrial targeting peptide (mTP) or secretory pathway signal peptide (SP). Scores on which the final prediction is based are not really probabilities, and they do not necessarily add to one. However, the location with the highest score is the most likely according to TargetP, and the relationship between the scores (the reliability class) may be an indication of how certain the prediction is. The reliability class (RC) ranges from 1 to 5, where 1 indicates the strongest prediction. TargetP is maintained at the server of the Technical University of Denmark. 
     For the sequences predicted to contain an N-terminal pre-sequence a potential cleavage site can also be predicted. 
     A number of parameters were selected, such as organism group (non-plant or plant), cut-off sets (none, predefined set of cut-offs, or user-specified set of cut-offs), and the calculation of prediction of cleavage sites (yes or no). 
     The results of TargetP 1.1 analysis of the polypeptide sequence as represented by SEQ ID NO: 150 are presented Table B5. The “plant” organism group was selected, no cutoffs defined, and the predicted length of the transit peptide requested. The subcellular localization of the polypeptide sequence as represented by SEQ ID NO: 150 is the secretory pathway and the predicted length of the transit peptide is of 20 amino acids starting from the N-terminus (not as reliable as the prediction of the subcellular localization itself, may vary in length of a few amino acids). Highest score was for the secretory pathway signal indicating that there is a high probability that the VPEg protein is tarteted to the secretory pathway. 
     
       
         
           
               
             
               
                 TABLE B5 
               
               
                   
               
               
                 TargetP 1.1 analysis of the polypeptide sequence as represented by  
               
               
                 SEQ ID NO: 150 
               
               
                   
               
             
            
               
                   
               
            
           
           
               
               
               
            
               
                   
                 Length (AA) 
                 494 
               
               
                   
                 Mitochondrial transit peptide 
                 0.108 
               
               
                   
                 Secretory pathway signal peptide 
                 0.966 
               
               
                   
                 Other subcellular targeting 
                 0.006 
               
               
                   
                 Predicted Location 
                 Secretory pathway 
               
               
                   
                 Reliability class 
                 2 
               
               
                   
                 Predicted transit peptide length 
                 20 
               
               
                   
                   
               
            
           
         
       
     
     Many other algorithms can be used to perform such analyses, including:
         ChloroP 1.1 hosted on the server of the Technical University of Denmark;   Protein Prowler Subcellular Localisation Predictor version 1.2 hosted on the server of the Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia;   PENCE Proteome Analyst PA-GOSUB 2.5 hosted on the server of the University of Alberta, Edmonton, Alberta, Canada;   TMHMM, hosted on the server of the Technical University of Denmark       

     Example 17 
     Assay for VPEs 
     The peptidase activity of VPEg is assayed by incubating the protein with the substrate proteins and determining the cleaved products as previously described (Rojo et al. 2004 Current Biology 14, 1897-1906; Haraiwa et al. 1999, FEBS 447:213-216; Hatsugai et al. 2004, Science 6: Vol. 305. no. 5685, pp. 855-858). The synthetic decapeptide Ser-Glu-Ser-Glu-Asn-Gly-Leu-Glu-Glu-Thr as described by Haraiwa et al. 1999, the carboxypeptidase Y and the VPEg itself are chosen as substrates in the cleavage reaction. Cleaved products are separated by capillary electrophoresis and detected by absorbance at 200 nm or by western blot. 
     Example 18 
     Cloning of Nucleic Acid Sequence as Represented by SEQ ID NO: 149 
     Unless otherwise stated, recombinant DNA techniques were performed according to standard protocols described in (Sambrook (2001) Molecular Cloning: a laboratory manual, 3rd Edition Cold Spring Harbor Laboratory Press, CSH, New York) or in Volumes 1 and 2 of Ausubel et al. (1994), Current Protocols in Molecular Biology, Current Protocols. Standard materials and methods for plant molecular work are described in Plant Molecular Biology Labfax (1993) by R. D. D. Croy, published by BIOS Scientific Publications Ltd (UK) and Blackwell Scientific Publications (UK). 
     The  Arabidopsis thaliana  VPEg gene was amplified by PCR using as template an  Arabidopsis thaliana  seedling cDNA library (Invitrogen, Paisley, UK). Primers SEQ ID NO: 206; sense, 5′-ggggacaagtttgtacaaaaaagcaggcttaaacaatggccacaacgatgaca-3′) and SEQ ID NO: 207; reverse, complementary: 5′-ggggaccactttgtacaagaaagctgggtcggtttagggtttctatgcac-3′), which include the AttB sites for Gateway recombination, were used for PCR amplification. PCR was performed using Hifi Taq DNA polymerase in standard conditions. A PCR fragment of the expected length (including attB sites) was amplified and purified also using standard methods. The first step of the Gateway procedure, the BP reaction, was then performed, during which the PCR fragment recombined in vivo with the pDONR201 plasmid to produce, according to the Gateway terminology, an “entry clone”, pVPEg. Plasmid pDONR201 was purchased from Invitrogen, as part of the Gateway® technology. 
     Example 19 
     Expression Vector Construction Using the Nucleic Acid Sequence as Represented by SEQ ID NO: 149 
     The entry clone pVPEg was subsequently used in an LR reaction with a destination vector used for  Oryza sativa  transformation. This vector contains as functional elements within the T-DNA borders: a plant selectable marker; a screenable marker expression cassette; and a Gateway cassette intended for LR in vivo recombination with the nucleic acid sequence of interest already cloned in the entry clone. A rice WSI18 promoter (SEQ ID NO: 205) for seed specific expression was located upstream of this Gateway cassette. 
     After the LR recombination step, the resulting expression vector pWSI18::VPE ( FIG. 7 ) was transformed into  Agrobacterium  strain LBA4044 according to methods well known in the art. 
     Example 20 
     Plant Transformation 
     See Example 9 above for details of plant transformation. 
     Example 21 
     Phenotypic Evaluation Procedure 
     For details see Example 10 above. 
     Example 22 
     Examples of abiotic stress screens 
     Drought Screen 
     Plants from a selected number of events are grown in potting soil under normal conditions until they approached the heading stage. They are then transferred to a “dry” section where irrigation is withheld. Humidity probes are inserted in randomly chosen pots to monitor the soil water content (SWC). When SWC go below certain thresholds, the plants are automatically re-watered continuously until a normal level is reached again. The plants are then re-transferred to normal conditions. The rest of the cultivation (plant maturation, seed harvest) is the same as for plants not grown under abiotic stress conditions. Growth and yield parameters are recorded as detailed for growth under normal conditions. 
     Salt Stress Screen 
     Plants are grown on a substrate made of coco fibers and argex (3 to 1 ratio). A normal nutrient solution is used during the first two weeks after transplanting the plantlets in the greenhouse. After the first two weeks, 25 mM of salt (NaCl) is added to the nutrient solution, until the plants were harvested. Growth and yield parameters are recorded as detailed for growth under normal conditions. 
     Reduced Nutrient (Nitrogen) Availability Screen 
     Plants from six events (T2 seeds) were grown in potting soil under normal conditions except for the nutrient solution. The pots were watered from transplantation to maturation with a specific nutrient solution containing reduced N nitrogen (N) content, usually between 7 to 8 times less. The rest of the cultivation (plant maturation, seed harvest) was the same as for plants not grown under abiotic stress. Growth and yield parameters were recorded as detailed for growth under normal conditions (see Example 10). 
     Example 23 
     Results of the Phenotypic Evaluation of the Transgenic Plants 
     The results of the evaluation of transgenic rice plants expressing the VPE are presented in Tables B6-B9 (unless otherwise indicated, the results are obtained on plants grown under non-stress conditions). The percentage difference between the transgenics and the corresponding nullizygotes is also shown, with a P value from the F test below 0.05. 
     Total seed yield, number of filled seeds, seed fill rate and harvest index are significantly increased, compared to the control plants (in this case, the nullizygotes). 
     
       
         
           
               
             
               
                 TABLE B6 
               
             
            
               
                   
               
               
                 Results of the evaluation of transgenic rice plants pWSI::VPE. 
               
            
           
           
               
               
               
            
               
                   
                 Trait 
                 % Increase 
               
               
                   
                   
               
            
           
           
               
               
               
            
               
                   
                 Total seed yield 
                 18 
               
               
                   
                 Number of filled seeds 
                 28 
               
               
                   
                 Fill rate 
                 18 
               
               
                   
                 Harvest index 
                 17 
               
               
                   
                 Root shoot index 
                 7 
               
               
                   
                   
               
            
           
         
       
     
     The results of the evaluation of transgenic rice plants grown under reduced nitrogen availability and expressing pWSI::VPE according to Example 19 are given in Table B7 below. 
     
       
         
           
               
             
               
                 TABLE B7 
               
             
            
               
                   
               
               
                 Results of the evaluation of VPE::pwsi18 under reduced  
               
               
                 nitrogen availability 
               
            
           
           
               
               
               
            
               
                   
                 Parameter 
                 % Diff 
               
               
                   
                   
               
               
                   
                 Aboveground biomass 
                 16.1 
               
               
                   
                 Emergence Vigour 
                 43.2 
               
               
                   
                 Total weight seeds 
                 20.7 
               
               
                   
                 No. filled seeds 
                 18.8 
               
               
                   
                 Harvest index 
                 12.3 
               
               
                   
                   
               
            
           
         
       
     
     The results of the evaluation of transgenic rice plants grown under reduced nitrogen availability and expressing a VPE construct according to Example 19 except where the wsi18 promoter is replaced with a constitutive GOS2 promoter are given in Table B8 below. This same construct with the GOS2 promoter gave the results shown in Table B9 under non-stress conditions. 
     
       
         
           
               
             
               
                 TABLE B8 
               
             
            
               
                   
               
               
                 Results of the evaluation of VPE::pGOS2 under  
               
               
                 reduced nitrogen availability 
               
            
           
           
               
               
               
            
               
                   
                 Parameter 
                 % Diff 
               
               
                   
                   
               
            
           
           
               
               
               
            
               
                   
                 Aboveground biomass 
                 5 
               
               
                   
                 Root Biomass 
                 6 
               
               
                   
                 Emergence Vigour 
                 25 
               
               
                   
                 No. flowers per panicle 
                 7 
               
               
                   
                   
               
            
           
         
       
     
     
       
         
           
               
             
               
                 TABLE B9 
               
             
            
               
                   
               
               
                 Results of the evaluation of VPE::pGOS2 under non- 
               
               
                 stress conditions 
               
            
           
           
               
               
               
            
               
                   
                 Parameter 
                 % Diff 
               
               
                   
                   
               
            
           
           
               
               
               
            
               
                   
                 Aboveground biomass 
                 5 
               
               
                   
                 Root biomass 
                 5 
               
               
                   
                 Total weight seeds 
                 8.9 
               
               
                   
                 No. filled seed 
                 8.5 
               
               
                   
                 No. flower per panicle 
                 6.9 
               
               
                   
                 No. total seeds 
                 8.3 
               
               
                   
                   
               
            
           
         
       
     
     Part III. SAP 
     Example 24 
     Identification of Sequences Related to SAP Sequences According to SEQ ID NO: 210 and SEQ ID NO: 211 
     Sequences (full length cDNA, ESTs or genomic) related to SEQ ID NO: 210 and/or protein sequences related to SEQ ID NO: 211 were identified amongst those maintained in the Entrez Nucleotides database at the National Center for Biotechnology Information (NCBI) using database sequence search tools, such as the Basic Local Alignment Tool (BLAST) (Altschul et al. (1990) J. Mol. Biol. 215:403-410; and Altschul et al. (1997) Nucleic Acids Res. 25:3389-3402). The program is used to find regions of local similarity between sequences by comparing nucleic acid or polypeptide sequences to sequence databases and by calculating the statistical significance of matches. The polypeptide encoded by SEQ ID NO: 210 was used for the TBLASTN algorithm, with default settings and the filter to ignore low complexity sequences set off. The output of the analysis was viewed by pairwise comparison, and ranked according to the probability score (E-value), where the score reflects the probability that a particular alignment occurs by chance (the lower the E-value, the more significant the hit). In addition to E-values, comparisons were also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In some instances, the default parameters may be adjusted to modify the stringency of the search. 
     In addition to the publicly available nucleic acid sequences available at NCBI, proprietary sequence databases are also searched following the same procedure as described herein above. 
     Table C1 provides a list of nucleic acid and protein sequences related to the nucleic acid sequence as represented by SEQ ID NO: 210 and the protein sequence represented by SEQ ID NO: 211. 
     
       
         
           
               
             
               
                 TABLE C1 
               
             
            
               
                   
               
               
                 Nucleic acid sequences related to the SAP-encoding nucleic acid sequence of SEQ 
               
               
                 ID NO: 210, and the corresponding deduced polypeptides. 
               
            
           
           
               
               
               
               
               
            
               
                   
                   
                 Nucleic acid 
                 Poly-peptide 
                   
               
               
                 Name 
                 Source organism 
                 SEQ ID NO: 
                 SEQ ID NO: 
                 Status 
               
               
                   
               
            
           
           
               
               
               
               
               
            
               
                 SAP_Like 
                 
                   Oryza 
                   sativa 
                 
                 210 
                 211 
                 Full length 
               
               
                 GM0604@contig350. 
                 
                   Glycine 
                   maxima 
                 
                 212 
                 213 
                 Full length 
               
               
                 TAG01@SIN_31b-CS. 
                   Tagetes  spp 
                 214 
                 215 
                 Partial 
               
               
                 BN0204@contig380.. 
                 
                   Brassica 
                   napa 
                 
                 216 
                 217 
                 Full length 
               
               
                 HV0704@contig195 
                 
                   Hordeum 
                   vulgare 
                 
                 218 
                 219 
                 Full length 
               
               
                 TA0704@54203527. 
                 
                   Triticum 
                   aestivum 
                 
                 220 
                 221 
                 Partial 
               
               
                 TA0704@54582401 
                 
                   Triticum 
                   aestivum 
                 
                 222 
                 223 
                 Partial 
               
               
                 TA0704@gi_205507 
                 
                   Triticum 
                   aestivum 
                 
                 224 
                 225 
                 Partial 
               
               
                 ZM0404@contig115 
                 
                   Zea 
                   mays 
                 
                 226 
                 227 
                 Partial 
               
               
                 ZM0404@contig319. 
                 
                   Zea 
                   mays 
                 
                 228 
                 229 
                 Partial 
               
               
                 OS_AAK92634.1 
                 
                   Oryza 
                   sativa 
                 
                 230 
                 231 
                 Full length 
               
               
                 OS_Os01g0205300 
                 
                   Oryza 
                   sativa 
                 
                 232 
                 233 
                 Full length 
               
               
                 Mb_ABF70123.1 
                 
                   Musa 
                   balbisiana 
                 
                 234 
                 235 
                 Full length 
               
               
                 AT1G06190 
                 
                   Arabidopsis 
                   thaliana 
                 
                 236 
                 237 
                 Full length 
               
               
                 AT4g18740 
                 
                   Arabidopsis 
                   thaliana 
                 
                 238 
                 239 
                 Full length 
               
               
                   
               
            
           
         
       
     
     Example 25 
     Alignment of SAP-Like Polypeptide Sequences 
     Alignment of polypeptide sequences was performed using the AlignX programme from the Vector NTI (Invitrogen) which is based on the popular Clustal algorithm of progressive alignment (Thompson et al. (1997) Nucleic Acids Res 25:4876-4882; Chema et al. (2003). Nucleic Acids Res 31:3497-3500). Default values are for the gap open penalty of 10, for the gap extension penalty of 0.1 and the selected weight matrix is Blosum 62 (if polypeptides are aligned). Results in  FIG. 10  show that SAP-like proteins share regions of high sequence conservation. Motif1, Motif2 and Motif3 represent the regions with highest sequence homology. 
     A phylogenetic tree of SAP and SAP-like polypeptides was constructed using a neighbour-joining clustering algorithm as provided in the AlignX programme from the Vector NTI (Invitrogen).  FIG. 11  shows how SAP-like polypeptide cluster with SEQ ID NO: 211 rather than with SAP proteins such as SAFB2 polypeptide. 
     Example 26 
     Calculation of Global Percentage Identity Between SAP-Like Polypeptides 
     Global percentages of similarity and identity between full length polypeptide sequences useful in performing the methods of the invention were determined using one of the methods available in the art, the MatGAT (Matrix Global Alignment Tool) software (BMC Bioinformatics. 2003 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences. Campanella J J, Bitincka L, Smalley J; software hosted by Ledion Bitincka). MatGAT software generates similarity/identity matrices for DNA or protein sequences without needing pre-alignment of the data. The program performs a series of pair-wise alignments using the Myers and Miller global alignment algorithm (with a gap opening penalty of 12, and a gap extension penalty of 2), calculates similarity and identity using for example Blosum 62 (for polypeptides), and then places the results in a distance matrix. Sequence similarity is shown in the bottom half of the dividing line and sequence identity is shown in the top half of the diagonal dividing line. 
     Parameters used in the comparison were: 
     
         
         
           
             Scoring matrix: Blosum62 
             First Gap: 12 
             Extending gap: 2 
           
         
       
    
     Results of the software analysis are shown in Table C2 for the global similarity and identity over the full length of the polypeptide sequences. Percentage identity is given above the diagonal and percentage similarity is given below the diagonal. 
     The percentage identity between the SAP-like polypeptide sequences start at 13% amino acid identity compared to SEQ ID NO: 211. 
     
       
         
           
               
             
               
                 TABLE C2 
               
             
            
               
                   
               
               
                 MatGAT results for global similarity and identity over the full length of the 
               
               
                 polypeptide sequences. 
               
            
           
           
               
               
               
               
               
               
               
               
               
               
            
               
                   
                 1 
                 2 
                 3 
                 4 
                 5 
                 6 
                 7 
                 8 
                 9 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
               
               
            
               
                 1. SEQ_ID_NO: 211 
                   
                 35.3 
                 21.6 
                 15 
                 57.8 
                 14.7 
                 32.3 
                 34.9 
                 20.1 
               
               
                 2. SEQ_ID_NO: 213 
                 55.2 
                   
                 23 
                 14.7 
                 22.5 
                 15 
                 30.6 
                 40.2 
                 22.3 
               
               
                 3. SEQ_ID_NO: 217 
                 34.1 
                 37 
                   
                 19.7 
                 13.4 
                 18 
                 27.2 
                 43.1 
                 20 
               
               
                 4. SEQ_ID_NO: 219 
                 24.5 
                 23.9 
                 30.6 
                   
                 9.6 
                 30.4 
                 19.7 
                 14.4 
                 19.9 
               
               
                 5. SEQ_ID_NO: 231 
                 58.5 
                 35.1 
                 21 
                 15.5 
                   
                 8.5 
                 18.9 
                 22.6 
                 13.2 
               
               
                 6. SEQ_ID_NO: 233 
                 22.1 
                 23.9 
                 30.2 
                 40.6 
                 13.6 
                   
                 19.3 
                 12 
                 19.5 
               
               
                 7. SEQ_ID_NO: 235 
                 46.9 
                 42.9 
                 47.3 
                 31.8 
                 27.8 
                 29.5 
                   
                 28.9 
                 21.3 
               
               
                 8. SEQ_ID_NO: 237 
                 52.9 
                 53.6 
                 52.1 
                 23.4 
                 34.3 
                 19.7 
                 40.4 
                   
                 19.9 
               
               
                 9. SEQ_ID_NO: 239 
                 35.2 
                 35.7 
                 36.5 
                 33.1 
                 22.4 
                 31.5 
                 40.3 
                 32.2 
               
               
                   
               
            
           
         
       
     
     Example 27 
     Identification of Domains Comprised in SEQ ID NO: 211 
     Conserved domains in the sequence of SAP-like polypeptide SEQ ID NO: 211 were identified by searching for similarity with protein domains and protein families present in the Pfam database. Table C3 summarizes the domains found. The beginning and end of the conserved domain in SEQ ID NO: 211 is indicated by the corresponding amino acid coordinate. 
     
       
         
           
               
             
               
                 TABLE C3 
               
             
            
               
                   
               
               
                 Pfam scan results of the polypeptide sequence as represented by SEQ ID NO: 211 
               
            
           
           
               
               
               
               
               
               
               
               
               
            
               
                 Database/ 
                   
                 aa 
                 aa 
                   
                   
                   
                   
                   
               
               
                 accession 
                 Seq 
                 Coordinate 
                 Coordinate 
                   
                   
                   
                   
                 Accession 
               
               
                 number 
                 from 
                 Begin 
                 End 
                 Score 
                 E-value 
                 Alignment 
                 Description 
                 description 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
               
            
               
                 Pfam/ 
                 DUF1098 
                 212 
                 250 
                 39 
                 9.6 
                 0.037 
                 local 
                 Protein of unknown 
               
               
                 DUF1098 
                   
                   
                   
                   
                   
                   
                   
                 function (DUF1098) 
               
               
                 Pfam/ 
                 Rho_N 
                 338 
                 371 
                 35 
                 37.7 
                 4.70E−10 
                 local 
                 Rho termination factor, 
               
               
                 PF07498 
                   
                   
                   
                   
                   
                   
                   
                 N-terminal domain 
               
               
                 Pfam/ 
                 SAP 
                 339 
                 355 
                 17 
                 12.5 
                 0.02 
                 local 
                 SAP domain 
               
               
                 PF02037 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 Pfam/ 
                 SAP 
                 359 
                 372 
                 14 
                 1.6 
                 22 
                 local 
                 SAP domain 
               
               
                 PF02037 
               
               
                   
               
            
           
         
       
     
     Example 28 
     Activity Assay Related to SEQ ID NO:211 
     DNA binding activity of the rice SAP-like protein in SEQ ID NO: 211 is determined in an in vitro assay as previously reported by Chen et al. 2003. SEQ ID NO: 211 is overexpressed in  E. coli  cells and purified. The purified protein is incubated with substrate DNA. A DNA fragment of 31 bp (base pairs) derived from the rice Waxy gene is chosen as DNA substrate. The Protein-DNA complexes can be identified by electrophoresis in gel retardation assays. 
     Example 29 
     Cloning of Nucleic Acid Sequence as Represented by SEQ ID NO: 210 
     Unless otherwise stated, recombinant DNA techniques are performed according to standard protocols described in (Sambrook (2001) Molecular Cloning: a laboratory manual, 3rd Edition Cold Spring Harbor Laboratory Press, CSH, New York) or in Volumes 1 and 2 of Ausubel et al. (1994), Current Protocols in Molecular Biology, Current Protocols. Standard materials and methods for plant molecular work are described in Plant Molecular Biology Labfax (1993) by R. D. D. Croy, published by BIOS Scientific Publications Ltd (UK) and Blackwell Scientific Publications (UK). 
     The  Oryza sativa  SAP-like gene was amplified by PCR using as template an  Oryza sativa  seedling cDNA library (Invitrogen, Paisley, UK). Primers prm08655 (SEQ ID NO: 247; sense: 5′-ggggacaagtttgtacaaaaaagcaggcttaaacaatggccacaacgatgacac-3′) and prm08656 (SEQ ID NO: 248; reverse, complementary: 5′-ggggaccactttgtaca agaaagctgggtcggtttagggtttctatgcac-3′), which include the AttB sites for Gateway recombination, were used for PCR amplification. PCR was performed using Hifi Taq DNA polymerase in standard conditions. A PCR fragment of the expected length (including attB sites) was amplified and purified also using standard methods. The first step of the Gateway procedure, the BP reaction, was then performed, during which the PCR fragment recombines in vivo with the pDONR201 plasmid to produce, according to the Gateway terminology, an “entry clone”. Plasmid pDONR201 was purchased from Invitrogen, as part of the Gateway® technology. 
     Example 30 
     Expression Vector Construction Using the Nucleic Acid Sequence as Represented by SEQ ID NO: 210 
     The entry clone containing SEQ ID NO: 210, pSAP-like, was subsequently used in an LR reaction with pRCC3, a destination vector used for  Oryza sativa  transformation. This vector contains as functional elements within the T-DNA borders: a plant selectable marker; a screenable marker expression cassette; and a Gateway cassette intended for LR in vivo recombination with the nucleic acid sequence of interest already cloned in the entry clone. A rice RCC3 promoter (SEQ ID NO: 246) for root specific expression was located upstream of this Gateway cassette. 
     After the LR recombination step, the resulting expression vector pRCC3::SAP-like ( FIG. 11 ) was transformed into  Agrobacterium  strain LBA4044 according to methods well known in the art. 
     Example 31 
     Plant Transformation 
     See Example 9 above 
     Example 32 
     Phenotypic Evaluation Procedure 
     For details see Examples 10 and Example 22 
     Example 33 
     Results of the Phenotypic Evaluation of the Transgenic Plants 
     The results of the evaluation of transgenic rice plants expressing the nucleic acid sequence useful in performing the methods of the invention are presented in Table C4 to C9. The percentage difference between the transgenics and the corresponding nullizygotes is also shown, with a P value from the F test below 0.1. 
     Total seed yield, number of filled seeds, seed fill rate, harvest index, the number of flowers per panicle, the thousand kernel weight, the plant height and the emergence vigour are significantly increased in the transgenic plants expressing the nucleic acid sequence useful in performing the methods of the invention, compared to the control plants (in this case, the nullizygotes). 
     
       
         
           
               
             
               
                 TABLE C4 
               
             
            
               
                   
               
               
                 Results of the evaluation of rice plants transformed 
               
               
                 with pRCC3::SAP-like vector. The SAP-like 
               
               
                 nucleic acid in these transgenic plants is expressed in 
               
               
                 the roots under the control of the rice RCC3 promoter. 
               
            
           
           
               
               
               
            
               
                   
                   
                 % Increase in transgenic 
               
               
                   
                 Trait 
                 versus control plants 
               
               
                   
                   
               
            
           
           
               
               
               
            
               
                   
                 Total seed yield 
                 29 
               
               
                   
                 Number of filled seeds 
                 26 
               
               
                   
                 Fill rate 
                 19 
               
               
                   
                 Harvest index 
                 27 
               
               
                   
                 Number flower per panicle 
                 5 
               
               
                   
                 TKW 
                 3 
               
               
                   
                 Plant Height 
                 7 
               
               
                   
                 Emergence vigour 
                 28 
               
               
                   
                   
               
            
           
         
       
     
     
       
         
           
               
             
               
                 TABLE C5 
               
             
            
               
                   
               
               
                 Results of the evaluation of rice plants transformed with 
               
               
                 pGOS2::SAP-like vector. The SAP-like nucleic acid 
               
               
                 in these transgenic plants is expressed constitutively 
               
               
                 under the control of the rice GOS2 promoter (de Pater et al,  
               
               
                 Plant J Nov; 2(6): 837-44, 1992, WO 2004/065596). 
               
            
           
           
               
               
               
            
               
                   
                   
                 % Increase in transgenic 
               
               
                   
                 Trait 
                 versus control plants 
               
               
                   
                   
               
               
                   
                 Total seed yield 
                 7 
               
               
                   
                   
               
            
           
         
       
     
     
       
         
           
               
             
               
                 TABLE C6 
               
             
            
               
                   
               
               
                 Results of the evaluation of rice plants transformed with  
               
               
                 p(PcR)::SAP-like vector. The SAP-like nucleic 
               
               
                 acid in these transgenic plants is expressed 
               
               
                 constitutively under the control of the rice putative  
               
               
                 protochlorophyllide reductase promoter (WO 2004/070039). 
               
            
           
           
               
               
               
            
               
                   
                   
                 % Increase in transgenic 
               
               
                   
                 Trait 
                 versus control plants 
               
               
                   
                   
               
               
                   
                 Total seed yield 
                 12 
               
               
                   
                   
               
            
           
         
       
     
     
       
         
           
               
             
               
                 TABLE C7 
               
             
            
               
                   
               
               
                 Results of the evaluation of rice plants tested under 
               
               
                 drought conditions as described in Example 22 
               
               
                 and transformed a vector pRCC3::SAP-like. 
               
            
           
           
               
               
               
            
               
                   
                 Parameter 
                 % Diff 
               
               
                   
                   
               
            
           
           
               
               
               
            
               
                   
                 Total seed weight 
                 14.2 
               
               
                   
                 No. filled seeds 
                 15.5 
               
               
                   
                 Fill rate 
                 22 
               
               
                   
                 Harvest index 
                 22.6 
               
               
                   
                   
               
            
           
         
       
     
     
       
         
           
               
             
               
                 TABLE C8 
               
             
            
               
                   
               
               
                 Results of the evaluation of rice plants tested under 
               
               
                 reduced nitrogen availability as described in Example 22 
               
               
                 and transformed with a vector pRCC3::SAP-like. 
               
            
           
           
               
               
               
            
               
                   
                 Parameter 
                 % Diff 
               
               
                   
                   
               
            
           
           
               
               
               
            
               
                   
                 Aboveground biomass 
                 9.1 
               
               
                   
                 Ermergence vigour 
                 20.1 
               
               
                   
                   
               
            
           
         
       
     
     
       
         
           
               
             
               
                 TABLE C9 
               
             
            
               
                   
               
               
                 Results of the evaluation of rice plants under drought conditions as 
               
               
                 described in Example 22 and transformed with a p(PcR)::SAP-like 
               
               
                 vector. The SAP-like nucleic acid in these transgenic plants is 
               
               
                 expressed constitutively under the control of the rice putative 
               
               
                 protochlorophyllide reductase promoter (WO 2004/070039). 
               
            
           
           
               
               
               
            
               
                   
                   
                 % Increase in transgenic 
               
               
                   
                 Trait 
                 versus control plants 
               
               
                   
                   
               
               
                   
                 Seed filling 
                 14 
               
               
                   
                   
               
            
           
         
       
     
     Part IV. RCA 
     Example 34 
     Identification of Sequences Related to RCA Sequences According to SEQ ID NO: 250 and SEQ ID NO: 251 
     Sequences (full length cDNA, ESTs or genomic) related to SEQ ID NO: 250 and/or protein sequences related to SEQ ID NO: 251 were identified amongst those maintained in the Entrez Nucleotides database at the National Center for Biotechnology Information (NCBI) using database sequence search tools, such as the Basic Local Alignment Tool (BLAST) (Altschul et al. (1990) J. Mol. Biol. 215:403-410; and Altschul et al. (1997) Nucleic Acids Res. 25:3389-3402). The program is used to find regions of local similarity between sequences by comparing nucleic acid or polypeptide sequences to sequence databases and by calculating the statistical significance of matches. The polypeptide encoded by SEQ ID NO: 250 was used for the TBLASTN algorithm, with default settings and the filter to ignore low complexity sequences set off. The output of the analysis was viewed by pairwise comparison, and ranked according to the probability score (E-value), where the score reflects the probability that a particular alignment occurs by chance (the lower the E-value, the more significant the hit). In addition to E-values, comparisons were also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In some instances, the default parameters may be adjusted to modify the stringency of the search. 
     In addition to the publicly available nucleic acid sequences available at NCBI, proprietary sequence databases are also searched following the same procedure as described herein above. 
     Table D1 provides a list of nucleic acid and polypeptide sequences related to the nucleic acid sequence as represented by SEQ ID NO: 250 and the protein sequence represented by SEQ ID NO: 251. Such nucleic acid sequences encode naturally occurring beta (short form, or SF) RCA polypeptides, or from alpha (long form, or LF)) RCA polypeptides that have to be truncated or mutated in the C-terminal extension to prevent redox regulation. 
     
       
         
           
               
             
               
                 TABLE D1 
               
             
            
               
                   
               
               
                 Nucleic acid sequences related to the nucleic acid sequence (SEQ ID NO: 250) 
               
               
                 useful in the methods of the present invention, and the corresponding deduced polypeptides. 
               
            
           
           
               
               
               
               
               
               
            
               
                   
                   
                 Nucleic 
                   
                 Database 
                   
               
               
                   
                   
                 acid SEQ 
                 Polypeptide 
                 accession 
                   
               
               
                 Name 
                 Source organism 
                 ID NO: 
                 SEQ ID NO: 
                 number 
                 Status 
               
               
                   
               
            
           
           
               
               
               
               
               
               
            
               
                 Chlre_RCA 
                 
                   Chlamydomonas 
                 
                 250 
                 251 
                 AY461703 
                 Full length 
               
               
                   
                 
                   reinhardtii 
                 
                   
                   
                   
                   
               
               
                 Chlli_RCA 
                 
                   Chlorococcum 
                   littorale 
                 
                 252 
                 253 
                 Y10657 
                 Full length 
               
               
                 Ostta_RCA 
                   Ostreococcus   tauri  strain  
                 254 
                 255 
                 CR954204 
                 Full length 
               
               
                   
                 OTTH0595 
                   
                   
                   
                   
               
               
                 Arath_RCA SF 
                 
                   Arabidopsis 
                   thaliana 
                 
                 256 
                 257 
                 NM_179989 
                 Full length 
               
               
                   
                   
                   
                   
                 AT2G39730.2 
                   
               
               
                 Arath_RCA LF 
                 
                   Arabidopsis 
                   thaliana 
                 
                 258 
                 259 
                 X14212 
                 Full length 
               
               
                 Aceru_RCA SF 
                 
                   Acer 
                   rubrum 
                 
                 260 
                 261 
                 DQ915973 
                 Full length 
               
               
                 Aceru_RCA LF 
                 
                   Acer 
                   rubrum 
                 
                 262 
                 263 
                 DQ915974 
                 Full length 
               
               
                 Chequ_RCA SF 
                 
                   Chenopodium 
                   quinoa 
                 
                 264 
                 265 
                 AY117142 
                 Full length 
               
               
                 Desan_RCA SF 
                 
                   Deschampsia 
                   antartica 
                 
                 266 
                 267 
                 AY312574 
                 Full length 
               
               
                 Desan_RCA LF 
                 
                   Deschampsia 
                   antartica 
                 
                 268 
                 269 
                 AY312573 
                 Full length 
               
               
                 Glyma_RCA LF 
                 
                   Glycine 
                   max 
                 
                 270 
                 271 
                   
                 Full length 
               
               
                 Goshi_RCA SF 
                 
                   Gossypium 
                   hirsutum 
                 
                 272 
                 273 
                 AF329934 
                 Full length 
               
               
                 Horvu_RCA SF 
                 
                   Hordeum 
                   vulgare 
                 
                 274 
                 275 
                 M55447.1_B 
                 Full length 
               
               
                   
                   
                   
                   
                 LYRCAA2 
                   
               
               
                 Horvu_RCA SFII 
                 
                   Hordeum 
                   vulgare 
                 
                 276 
                 277 
                 M55448.1_B 
                 Full length 
               
               
                   
                   
                   
                   
                 LYRCAB 
                   
               
               
                 Lartr_RCA SF 
                 
                   Larrea 
                   tridentata 
                 
                 278 
                 279 
                 AY312576 
                 Full length 
               
               
                 Lycpe_RCA LF 
                 
                   Lycopersicon 
                   pennellii 
                 
                 280 
                 281 
                 AF037361 
                 Full length 
               
               
                 Maldo_RCA SF 
                 
                   Malus 
                   domestica 
                 
                 282 
                 283 
                 Z21794 
                 Full length 
               
               
                 Nicta_RCA SF 
                 
                   Nicotiana 
                   tabacum 
                 
                 284 
                 285 
                 U35111 
                 Full length 
               
               
                 Orysa_RCA LF 
                 
                   Oryza 
                   sativa 
                 
                 286 
                 287 
                 AB034698 
                 Full length 
               
               
                 Orysa_RCA SF 
                 
                   Oryza 
                   sativa 
                 
                 288 
                 289 
                 AB034748 
                 Full length 
               
               
                 Phavu_RCA SF 
                 
                   Phaseolus 
                   vulgaris 
                 
                 290 
                 291 
                 AF041068 
                 Full length 
               
               
                 Triae_RCA SF 
                 
                   Triticum 
                   aestivum 
                 
                 292 
                 293 
                 AF251264 
                 Full length 
               
               
                 Zeama_RCA SF 
                 
                   Zea 
                   mays 
                 
                 294 
                 295 
                 Contig of 
                 Full length 
               
               
                   
                   
                   
                   
                 EE034185.1 
                   
               
               
                   
                   
                   
                   
                 BI675068 
                   
               
               
                 Datgl_RCA 
                 
                   Datisca 
                   glomerata 
                 
                 296 
                 297 
                 AF047352 
                 Partial 
               
               
                 Zanae_RCA 
                 
                   Zantedeschia 
                   aethiopica 
                 
                 298 
                 299 
                 AF338240 
                 Partial 
               
               
                 Partial 3&#39; 
                   
                   
                   
                   
                   
               
               
                 Anasp_RCA 
                 
                   Anabaena 
                   variabilis 
                 
                 300 
                 301 
                 CP000117.1 
                 Full length 
               
               
                   
                 ATCC 29413 
                   
                   
                   
                   
               
               
                 Nossp_RCA 
                   Nostoc  sp. PCC 7120 
                 302 
                 303 
                 BA000019.2 
                 Full length 
               
               
                 Synco_RCA 
                   Synechococcus  sp. JA- 
                 304 
                 305 
                 CP000239 
                 Full length 
               
               
                   
                 3-3Ab 
                   
                   
                   
                   
               
               
                 Flabi_RCA 
                 
                   Flaveria 
                   bidentis 
                 
                 313 
                 314 
                 EU202926.1 
                 Full length 
               
               
                 Ostlu_RCA 
                 
                   Ostreococcus 
                 
                 315 
                 316 
                 jgi_Ost9901_3_31184_eugene.0400010260 
                 Full length 
               
               
                   
                 
                   lucimarinus 
                 
                   
                   
                   
                   
               
               
                 Vigra_RCA 
                 
                   Vigna 
                   radiata 
                 
                 317 
                 318 
                 AF126870 
                 Full length 
               
               
                 Volva_RCA 
                 
                   Volvox 
                   carteri 
                 
                 319 
                 320 
                 jgi_Volca1_105291_est 
                 Full length 
               
               
                   
                   
                   
                   
                 Ext_fgenesh4_pg.C_260106 
               
               
                   
               
            
           
         
       
     
     In some instances, related sequences have tentatively been assembled and publicly disclosed by research institutions, such as The Institute for Genomic Research (TIGR). The Eukaryotic Gene Orthologs (EGO) database may be used to identify such related sequences, either by keyword search or by using the BLAST algorithm with the nucleic acid sequence or polypeptide sequence of interest. On other instances, special nucleic acid sequence databases have been created for particular organisms, such as by the Joint Genome Institute, for example for  Ostreococcus lucimarinus  and  Volvox carteri.    
     Example 35 
     Alignment of Relevant Polypeptide Sequences 
     AlignX from the Vector NTI (Invitrogen) is based on the popular Clustal algorithm of progressive alignment (Thompson et al. (1997) Nucleic Acids Res 25:4876-4882; Chema et al. (2003). Nucleic Acids Res 31:3497-3500). A phylogenetic tree can be constructed using a neighbour-joining clustering algorithm. Default values are for the gap open penalty of 10, for the gap extension penalty of 0.1 and the selected weight matrix is Blosum 62 (if polypeptides are aligned). 
     The result of the multiple sequence alignment using polypeptides relevant in identifying the ones useful in performing the methods of the invention is shown in  FIG. 15 . The sequences were aligned using AlignX program from Vector NTI suite (InforMax, Bethesda, Md.). Multiple alignment was done with a gap opening penalty of 10 and a gap extension of 0.01. The beginning of sequence conservation between eukaryotic RCA polypeptides is delineated with a bracket (the amino acid sequence N-terminal upstream of this bracket is considered as comprising the transit peptide for plastidic subcellular targeting), as are the beginning and the end of the AAA domain. The P loop is boxed, and corresponds to Motif 1 as represented by SEQ ID NO: 312. The beginning of the C-terminal extension is also marker with a bracket. Within this C-terminal extension, the Cys residues involved in redox regulation are marked in bold in the alpha (long form or LF) RCA polypeptides. These are preferred targets for site-directed mutagenesis (into Ala residues, for example) to prevent the formation of disulfide bridges, and thus, redox regulation. 
     Example 36 
     Calculation of Global Percentage Identity Between Polypeptide Sequences Useful in Performing the Methods of the Invention 
     Global percentages of similarity and identity between full length polypeptide sequences useful in performing the methods of the invention were determined using one of the methods available in the art, the MatGAT (Matrix Global Alignment Tool) software (BMC Bioinformatics. 2003 4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences. Campanella J J, Bitincka L, Smalley J; software hosted by Ledion Bitincka). MatGAT software generates similarity/identity matrices for DNA or protein sequences without needing pre-alignment of the data. The program performs a series of pair-wise alignments using the Myers and Miller global alignment algorithm (with a gap opening penalty of 12, and a gap extension penalty of 2), calculates similarity and identity using for example Blosum 62 (for polypeptides), and then places the results in a distance matrix. Sequence similarity is shown in the bottom half of the dividing line and sequence identity is shown in the top half of the diagonal dividing line. 
     Parameters used in the comparison were: 
     
         
         
           
             Scoring matrix: Blosum62 
             First Gap: 12 
             Extending gap: 2 
           
         
       
    
     Results of the software analysis are shown in Table D2 for the global similarity and identity over the full length of the polypeptide sequences (excluding the partial polypeptide sequences). Percentage identity is given above the diagonal and percentage similarity is given below the diagonal. 
     The percentage identity between the polypeptide sequences useful in performing the methods of the invention can be as low as 50% amino acid identity compared to SEQ ID NO: 251. 
     
       
         
           
               
             
               
                 TABLE D2 
               
             
            
               
                   
               
               
                 MatGAT results for global similarity and identity over the full length of the RCA 
               
               
                 polypeptide sequences. 
               
            
           
           
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
            
               
                   
                 1 
                 2 
                 3 
                 4 
                 5 
                 6 
                 7 
                 8 
                 9 
                 10 
                 11 
                 12 
                 13 
                 14 
                 15 
                 16 
                 17 
                 18 
                 19 
                 20 
                 21 
                 22 
                 23 
                 24 
                 25 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
            
               
                 1. 
                 Aceru_RCA\LS 
                   
                 92 
                 77 
                 75 
                 55 
                 72 
                 56 
                 66 
                 77 
                 72 
                 85 
                 79 
                 70 
                 71 
                 80 
                 73 
                 78 
                 73 
                 78 
                 73 
                 53 
                 75 
                 71 
                 75 
                 70 
               
               
                 2. 
                 Aceru_RCA\SF 
                 92 
                   
                 72 
                 79 
                 59 
                 78 
                 60 
                 72 
                 71 
                 78 
                 79 
                 85 
                 76 
                 77 
                 86 
                 75 
                 85 
                 79 
                 72 
                 78 
                 56 
                 81 
                 77 
                 81 
                 76 
               
               
                 3. 
                 Arath_RCA\LF 
                 86 
                 80 
                   
                 91 
                 54 
                 70 
                 55 
                 60 
                 75 
                 69 
                 78 
                 74 
                 68 
                 69 
                 73 
                 70 
                 72 
                 71 
                 77 
                 71 
                 54 
                 69 
                 69 
                 70 
                 67 
               
               
                 4. 
                 Arath_RCA\SF 
                 84 
                 88 
                 91 
                   
                 59 
                 76 
                 59 
                 66 
                 72 
                 76 
                 75 
                 81 
                 74 
                 76 
                 80 
                 75 
                 79 
                 77 
                 73 
                 78 
                 58 
                 76 
                 76 
                 76 
                 74 
               
               
                 5. 
                 Chlre_RCA 
                 66 
                 71 
                 64 
                 70 
                   
                 58 
                 76 
                 54 
                 56 
                 59 
                 55 
                 58 
                 59 
                 61 
                 58 
                 54 
                 59 
                 58 
                 56 
                 60 
                 63 
                 58 
                 60 
                 59 
                 59 
               
               
                 6. 
                 Chequ_RCA 
                 81 
                 87 
                 78 
                 85 
                 69 
                   
                 57 
                 66 
                 70 
                 76 
                 73 
                 81 
                 75 
                 75 
                 80 
                 74 
                 80 
                 79 
                 69 
                 74 
                 59 
                 78 
                 74 
                 79 
                 74 
               
               
                 7. 
                 Chlli_RCA 
                 67 
                 72 
                 65 
                 71 
                 87 
                 70 
                   
                 52 
                 57 
                 61 
                 55 
                 58 
                 61 
                 62 
                 59 
                 55 
                 57 
                 58 
                 57 
                 60 
                 64 
                 58 
                 61 
                 58 
                 60 
               
               
                 8. 
                 Datgl_RCA 
                 73 
                 79 
                 67 
                 74 
                 66 
                 73 
                 67 
                   
                 59 
                 65 
                 66 
                 73 
                 63 
                 65 
                 72 
                 63 
                 73 
                 68 
                 61 
                 66 
                 52 
                 69 
                 64 
                 68 
                 64 
               
               
                 9. 
                 Desan_RCA\\LF 
                 86 
                 81 
                 84 
                 82 
                 66 
                 80 
                 68 
                 68 
                   
                 91 
                 77 
                 72 
                 88 
                 79 
                 72 
                 70 
                 70 
                 70 
                 90 
                 83 
                 55 
                 67 
                 80 
                 70 
                 77 
               
               
                 10. 
                 Desan_RCA\SF 
                 80 
                 87 
                 77 
                 85 
                 72 
                 86 
                 73 
                 74 
                 91 
                   
                 71 
                 79 
                 95 
                 85 
                 78 
                 72 
                 76 
                 76 
                 83 
                 89 
                 59 
                 73 
                 86 
                 76 
                 84 
               
               
                 11. 
                 Glyma_RCA 
                 93 
                 86 
                 86 
                 83 
                 66 
                 81 
                 67 
                 72 
                 85 
                 79 
                   
                 80 
                 70 
                 71 
                 79 
                 73 
                 79 
                 74 
                 79 
                 74 
                 55 
                 80 
                 71 
                 74 
                 70 
               
               
                 12. 
                 Goshi_RCA 
                 86 
                 93 
                 81 
                 88 
                 72 
                 89 
                 71 
                 78 
                 82 
                 88 
                 85 
                   
                 77 
                 80 
                 88 
                 75 
                 85 
                 80 
                 75 
                 80 
                 59 
                 82 
                 79 
                 81 
                 78 
               
               
                 13. 
                 Horvu_RCA\SF 
                 79 
                 85 
                 76 
                 83 
                 72 
                 85 
                 74 
                 72 
                 89 
                 97 
                 78 
                 87 
                   
                 84 
                 76 
                 71 
                 75 
                 76 
                 82 
                 89 
                 59 
                 72 
                 85 
                 76 
                 82 
               
               
                 14. 
                 Horvu_RCASFII 
                 79 
                 85 
                 76 
                 83 
                 73 
                 83 
                 73 
                 73 
                 85 
                 93 
                 79 
                 87 
                 92 
                   
                 77 
                 71 
                 79 
                 75 
                 79 
                 85 
                 59 
                 75 
                 96 
                 78 
                 83 
               
               
                 15. 
                 Lartr_RCA\SF 
                 87 
                 94 
                 82 
                 89 
                 71 
                 89 
                 72 
                 79 
                 82 
                 88 
                 86 
                 94 
                 87 
                 87 
                   
                 76 
                 84 
                 81 
                 73 
                 78 
                 57 
                 82 
                 77 
                 80 
                 78 
               
               
                 16. 
                 Lycpe_RCA 
                 85 
                 87 
                 81 
                 85 
                 68 
                 82 
                 70 
                 73 
                 82 
                 82 
                 82 
                 84 
                 81 
                 81 
                 85 
                   
                 75 
                 85 
                 72 
                 73 
                 55 
                 71 
                 70 
                 71 
                 70 
               
               
                 17. 
                 Maldo_RCA\SF 
                 86 
                 94 
                 81 
                 88 
                 71 
                 88 
                 72 
                 79 
                 81 
                 87 
                 85 
                 92 
                 85 
                 87 
                 92 
                 85 
                   
                 81 
                 73 
                 78 
                 58 
                 80 
                 78 
                 82 
                 77 
               
               
                 18. 
                 Nicta_RCA 
                 83 
                 89 
                 79 
                 86 
                 70 
                 86 
                 71 
                 76 
                 79 
                 83 
                 82 
                 88 
                 84 
                 84 
                 89 
                 90 
                 89 
                   
                 71 
                 76 
                 56 
                 77 
                 75 
                 77 
                 75 
               
               
                 19. 
                 Orysa_RCA\LF 
                 88 
                 83 
                 84 
                 82 
                 67 
                 79 
                 68 
                 68 
                 95 
                 88 
                 87 
                 84 
                 87 
                 85 
                 83 
                 83 
                 81 
                 80 
                   
                 92 
                 56 
                 70 
                 80 
                 72 
                 78 
               
               
                 20. 
                 Orysa_RCA\SF 
                 81 
                 88 
                 77 
                 84 
                 71 
                 85 
                 73 
                 73 
                 88 
                 95 
                 81 
                 89 
                 94 
                 91 
                 89 
                 83 
                 87 
                 84 
                 92 
                   
                 60 
                 75 
                 86 
                 77 
                 84 
               
               
                 21. 
                 Ostta_RCA 
                 65 
                 69 
                 65 
                 71 
                 78 
                 68 
                 78 
                 66 
                 67 
                 72 
                 66 
                 72 
                 72 
                 72 
                 71 
                 67 
                 72 
                 69 
                 67 
                 72 
                   
                 57 
                 59 
                 58 
                 59 
               
               
                 22. 
                 Phavu_RCA\SF 
                 85 
                 91 
                 81 
                 88 
                 72 
                 87 
                 71 
                 76 
                 82 
                 86 
                 86 
                 90 
                 86 
                 87 
                 92 
                 85 
                 91 
                 88 
                 82 
                 86 
                 70 
                   
                 74 
                 76 
                 77 
               
               
                 23. 
                 Triae_RCA\SF 
                 80 
                 86 
                 77 
                 84 
                 72 
                 85 
                 73 
                 71 
                 86 
                 93 
                 79 
                 87 
                 92 
                 97 
                 87 
                 82 
                 85 
                 84 
                 86 
                 92 
                 72 
                 87 
                   
                 77 
                 84 
               
               
                 24. 
                 Zanae_RCA\SF 
                 83 
                 90 
                 78 
                 85 
                 72 
                 87 
                 72 
                 75 
                 80 
                 86 
                 82 
                 90 
                 86 
                 86 
                 90 
                 83 
                 90 
                 86 
                 82 
                 87 
                 69 
                 88 
                 86 
                   
                 74 
               
               
                 25. 
                 Zeama_RCA\SF 
                 80 
                 86 
                 76 
                 83 
                 73 
                 83 
                 72 
                 73 
                 85 
                 92 
                 79 
                 88 
                 91 
                 91 
                 87 
                 81 
                 87 
                 82 
                 87 
                 93 
                 72 
                 87 
                 92 
                 86 
               
               
                   
               
            
           
         
       
     
     The percentage identity between the AAA domain of the RCA polypeptide sequences useful in performing the methods of the invention can be increased to 60% amino acid identity compared to SEQ ID NO: 311. 
     
       
         
           
               
             
               
                 TABLE D3 
               
             
            
               
                   
               
               
                 MatGAT results for global similarity and identity between the AAA domain of the 
               
               
                 RCA polypeptide sequences. 
               
            
           
           
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
            
               
                   
                 1 
                 2 
                 3 
                 4 
                 5 
                 6 
                 7 
                 8 
                 9 
                 10 
                 11 
                 12 
                 13 
                 14 
                 15 
                 16 
                 17 
                 18 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
            
               
                 1. 
                 AAA_Aceru_RCA 
                   
                 69 
                 92 
                 93 
                 82 
                 84 
                 93 
                 93 
                 95 
                 93 
                 95 
                 91 
                 94 
                 91 
                 69 
                 94 
                 78 
                 65 
               
               
                 2. 
                 AAA_Anasp_RCA 
                 81 
                   
                 68 
                 68 
                 67 
                 68 
                 67 
                 70 
                 69 
                 67 
                 68 
                 66 
                 68 
                 67 
                 99 
                 69 
                 64 
                 76 
               
               
                 3. 
                 AAA_Arath_RCA 
                 96 
                 79 
                   
                 92 
                 81 
                 82 
                 92 
                 92 
                 94 
                 92 
                 95 
                 91 
                 92 
                 92 
                 68 
                 94 
                 78 
                 65 
               
               
                 4. 
                 AAA_Chequ_RCA 
                 96 
                 81 
                 95 
                   
                 81 
                 82 
                 92 
                 94 
                 96 
                 92 
                 95 
                 94 
                 93 
                 95 
                 68 
                 93 
                 79 
                 64 
               
               
                 5. 
                 AAA_Chlli_RCA 
                 91 
                 82 
                 89 
                 88 
                   
                 93 
                 81 
                 80 
                 82 
                 82 
                 81 
                 79 
                 81 
                 80 
                 67 
                 80 
                 80 
                 64 
               
               
                 6. 
                 AAA_Chlre_RCA 
                 90 
                 83 
                 89 
                 88 
                 95 
                   
                 83 
                 82 
                 84 
                 83 
                 83 
                 81 
                 82 
                 81 
                 68 
                 81 
                 80 
                 64 
               
               
                 7. 
                 AAA_Desan_RCA 
                 97 
                 80 
                 95 
                 95 
                 88 
                 88 
                   
                 93 
                 94 
                 98 
                 95 
                 92 
                 92 
                 92 
                 67 
                 94 
                 78 
                 64 
               
               
                 8. 
                 AAA_Glyma_RCA 
                 97 
                 82 
                 95 
                 98 
                 91 
                 91 
                 96 
                   
                 97 
                 93 
                 95 
                 91 
                 95 
                 92 
                 70 
                 96 
                 79 
                 65 
               
               
                 9. 
                 AAA_Goshi_RCA 
                 98 
                 81 
                 96 
                 97 
                 90 
                 90 
                 97 
                 99 
                   
                 94 
                 98 
                 93 
                 95 
                 95 
                 69 
                 96 
                 80 
                 65 
               
               
                 10. 
                 AAA_Horvu_RCA 
                 97 
                 80 
                 95 
                 96 
                 89 
                 88 
                 98 
                 97 
                 97 
                   
                 94 
                 92 
                 91 
                 92 
                 67 
                 95 
                 78 
                 64 
               
               
                 11. 
                 AAA_Lartr_RCA 
                 98 
                 81 
                 97 
                 97 
                 90 
                 89 
                 97 
                 99 
                 99 
                 98 
                   
                 95 
                 95 
                 95 
                 68 
                 97 
                 79 
                 65 
               
               
                 12. 
                 AAA_Lycpe_RCA 
                 97 
                 81 
                 96 
                 97 
                 89 
                 89 
                 97 
                 97 
                 97 
                 98 
                 98 
                   
                 91 
                 98 
                 66 
                 94 
                 79 
                 65 
               
               
                 13. 
                 AAA_Maldo_RCA 
                 98 
                 82 
                 95 
                 97 
                 91 
                 92 
                 96 
                 99 
                 98 
                 96 
                 98 
                 96 
                   
                 92 
                 68 
                 93 
                 78 
                 67 
               
               
                 14. 
                 AAA_Nicta_RCA 
                 96 
                 80 
                 95 
                 96 
                 89 
                 89 
                 95 
                 97 
                 98 
                 96 
                 97 
                 99 
                 96 
                   
                 67 
                 94 
                 79 
                 65 
               
               
                 15. 
                 AAA_Nossp_RCA 
                 81 
                 99 
                 79 
                 80 
                 82 
                 83 
                 79 
                 81 
                 81 
                 80 
                 81 
                 80 
                 81 
                 80 
                   
                 69 
                 64 
                 75 
               
               
                 16. 
                 AAA_Orysa_RCA 
                 99 
                 81 
                 97 
                 97 
                 90 
                 90 
                 98 
                 99 
                 99 
                 98 
                 99 
                 98 
                 98 
                 98 
                 81 
                   
                 79 
                 65 
               
               
                 17. 
                 AAA_Ostta_RCA 
                 89 
                 80 
                 87 
                 88 
                 89 
                 88 
                 87 
                 89 
                 89 
                 88 
                 88 
                 88 
                 89 
                 88 
                 79 
                 89 
                   
                 64 
               
               
                 18. 
                 AAA_Synco_RCA 
                 81 
                 85 
                 79 
                 79 
                 81 
                 80 
                 79 
                 81 
                 81 
                 80 
                 81 
                 80 
                 82 
                 80 
                 85 
                 81 
                 82 
                   
               
               
                 19. 
                 AAA_Triae_RCA 
                 97 
                 80 
                 95 
                 96 
                 88 
                 88 
                 98 
                 97 
                 98 
                 99 
                 98 
                 98 
                 96 
                 96 
                 79 
                 99 
                 87 
                 79 
               
               
                   
               
            
           
         
       
     
     Example 37 
     Identification of Domains Comprised in Polypeptide Sequences Useful in Performing the Methods of the Invention 
     The Integrated Resource of Protein Families, Domains and Sites (InterPro) database is an integrated interface for the commonly used signature databases for text- and sequence-based searches. The InterPro database combines these databases, which use different methodologies and varying degrees of biological information about well-characterized proteins to derive protein signatures. Collaborating databases include SWISS-PROT, PROSITE, TrEMBL, PRINTS, ProDom and Pfam, Smart and TIGRFAMs. Interpro is hosted at the European Bioinformatics Institute in the United Kingdom. 
     The results of the InterPro scan of the polypeptide sequence as represented by SEQ ID NO: 251 are presented in Table D4. 
     
       
         
           
               
             
               
                 TABLE D4 
               
             
            
               
                   
               
               
                 InterPro scan results of the polypeptide sequence as represented 
               
               
                 by SEQ ID NO: 251 
               
            
           
           
               
               
               
            
               
                 Database 
                 Accession number 
                 Accession name 
               
               
                   
               
               
                 InterPro 
                 IPR003959 
                 AAA ATPase, core 
               
               
                 Pfam 
                 PF00004 
                 AAA, ATPase family associated with 
               
               
                   
                   
                 various cellular activities; Clan: 
               
               
                   
                   
                 P-loop containing nucleoside 
               
               
                   
                   
                 triphosphate hydrolase superfamily;  
               
               
                   
                   
                 residues 133-331 of SEQ ID NO: 251. 
               
               
                   
               
            
           
         
       
     
     A key feature of the AAA family members is that they share a conserved region of about 200 amino acids that contains an ATP-binding site (P-loop). For example, the AAA domain of SEQ ID NO: 251 is as represented by SEQ ID NO: 311. 
     Example 38 
     Topology Prediction of the Polypeptide Sequences Useful in Performing the Methods of the Invention (Subcellular Localization, Transmembrane . . . ) 
     TargetP 1.1 predicts the subcellular location of eukaryotic proteins. The location assignment is based on the predicted presence of any of the N-terminal pre-sequences: chloroplast transit peptide (cTP), mitochondrial targeting peptide (mTP) or secretory pathway signal peptide (SP). Scores on which the final prediction is based are not really probabilities, and they do not necessarily add to one. However, the location with the highest score is the most likely according to TargetP, and the relationship between the scores (the reliability class) may be an indication of how certain the prediction is. The reliability class (RC) ranges from 1 to 5, where 1 indicates the strongest prediction. TargetP is maintained at the server of the Technical University of Denmark. 
     For the sequences predicted to contain an N-terminal presequence a potential cleavage site can also be predicted. 
     A number of parameters were selected, such as organism group (non-plant or plant), cutoff sets (none, predefined set of cutoffs, or user-specified set of cutoffs), and the calculation of prediction of cleavage sites (yes or no). 
     The subcellular localization of the polypeptide sequence as represented by SEQ ID NO: 251 is the chloroplast, and the predicted length of the transit peptide is of 32 amino acids starting from the N-terminus (not as reliable as the prediction of the subcellular localization itself, may vary in length by a few amino acids). When aligning RCA polypeptides with the RCA polypeptide of SEQ ID NO: 251, it is possible to deduce the length of the transit peptide in the latter (see  FIG. 15 ). Alternatively, in a broader definition, the transit peptide is the amino acid sequence preceding the beginning of sequence conservation between eukaryotic RCA polypeptides, as shown in  FIG. 15 . 
     Many algorithms can be used to perform such analyses, including:
         ChloroP 1.1 hosted on the server of the Technical University of Denmark;   Protein Prowler Subcellular Localisation Predictor version 1.2 hosted on the server of the Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia;   PENCE Proteome Analyst PA-GOSUB 2.5 hosted on the server of the University of Alberta, Edmonton, Alberta, Canada;   TMHMM, hosted on the server of the Technical University of Denmark       

     Example 39 
     Assay Related to the Polypeptide Sequences Useful in Performing The Methods of the Invention 
     ATP hydrolysis by RCA activity is measured by coupling ADP production to NADH oxidation as described by Li et al. ((2005) J Biol Chem 280(26): 24864-24869; and references including therein), RuBisCo activation by RCA activity is assayed spectrophotometrically as reported by Esau et al., ((1996) Arch Biochem Biophys 326: 100-105). 
     Example 40 
     Cloning of Nucleic Acid Sequence as Represented by SEQ ID NO: 250 
     Unless otherwise stated, recombinant DNA techniques are performed according to standard protocols described in (Sambrook (2001) Molecular Cloning: a laboratory manual, 3rd Edition Cold Spring Harbor Laboratory Press, CSH, New York) or in Volumes 1 and 2 of Ausubel et al. (1994), Current Protocols in Molecular Biology, Current Protocols. Standard materials and methods for plant molecular work are described in Plant Molecular Biology Labfax (1993) by R. D. D. Croy, published by BIOS Scientific Publications Ltd (UK) and Blackwell Scientific Publications (UK). 
     The nucleic acid sequence used in the methods of the invention was amplified by PCR using as template a  Chlamydomonas  reinhardtii CC-1690 cDNA library (“Core Library”) (in Lambda ZAP II vector from Stratagene) purchased at the Chlamy Center (formerly the  Chlamydomonas  Genetics Center) at Duke University, North Carolina, USA. PCR was performed using Hifi Taq DNA polymerase in standard conditions, using 200 ng of template in a 50 μl PCR mix. The primers used were 
                    -prm08444 SEQ ID NO: 310; sense, AttB1 site in       lower case:       5′-ggggacaagtttgtacaaaaaagcaggcttaaacaATGCAGGTCAC       CATGAAGAG-3′; and               -prm08445 SEQ ID NO: 311 reverse, complementary,       AttB2 site in lower case:       5′-ggggaccactttgtacaagaaagctgggtCTCCTACAGAGGAGGCA       CATC-3′,            
which include the AttB sites for Gateway recombination. The amplified PCR fragment was purified also using standard methods. The first step of the Gateway procedure, the BP reaction, was then performed, during which the PCR fragment recombines in vivo with the pDONR201 plasmid to produce, according to the Gateway terminology, an “entry clone”, p15972. Plasmid pDONR201 was purchased from Invitrogen, as part of the Gateway® technology.
 
     Example 41 
     Expression Vector Construction Using the Nucleic Acid Sequence as Represented by SEQ ID NO: 250 
     The entry clone comprising SEQ ID NO: 250 was subsequently used in an LR reaction with three different destination vectors used subsequently and individually for  Oryza sativa  transformation. The vectors contains as functional elements within the T-DNA borders: a plant selectable marker; a screenable marker expression cassette; and a Gateway cassette intended for LR in vivo recombination with the nucleic acid sequence of interest already cloned in the entry clone. The first destination vector comprises upstream of this Gateway cassette the rice GOS2 promoter (SEQ ID NO: 306) for strong constitutive expression, the second destination vector comprises the rice HMGB promoter for constitutive expression (SEQ ID NO: 307), and the third destination vector comprises the rice protochlorophyllide reductase promoter for specific expression in green tissue (SEQ ID NO: 308). 
     After the LR recombination step, the resulting expression vectors ( FIG. 16 ) were separately transformed into  Agrobacterium  strain LBA4044 according to methods well known in the art. 
     Example 42 
     Plant Transformation 
     See Example 9 above 
     Example 43 
     Phenotypic Evaluation Procedure 
     See Examples 10 and 22 above 
     Example 44 
     Results of the Phenotypic Evaluation of the Transgenic Plants Expressing SEQ ID NO: 250 Under the Control of a Strong Constitutive Promoter 
     The results of the evaluation of transgenic rice plants expressing the nucleic acid sequence useful in performing the methods of the invention, under the control of a strong constitutive GOS2 promoter (SEQ ID NO: 306), are presented in Table D5. The percentage difference between the transgenics and the corresponding nullizygotes is also shown, with a P value from the F test below 0.05. 
     The transgenic plants expressing the nucleic acid sequence useful in performing the methods of the invention, have increased early vigour and increased TKW compared to the control plants (in this case, the nullizygotes). 
     
       
         
           
               
             
               
                 TABLE D5 
               
             
            
               
                   
               
               
                 Results of the evaluation of transgenic rice plants 
               
               
                 expressing the nucleic acid sequence useful in performing 
               
               
                 the methods of the invention, under the control of a strong 
               
               
                 constitutive GOS2 promoter. 
               
            
           
           
               
               
               
               
            
               
                   
                   
                 % Increase in 
                 % Increase in 
               
               
                   
                 Trait 
                 T1 generation 
                 T2 generation 
               
               
                   
                   
               
               
                   
                 Increased early vigour 
                 8 
                 17 
               
               
                   
                 TKW 
                 7 
                 28 
               
               
                   
                   
               
            
           
         
       
     
     Example 45 
     Results of the Phenotypic Evaluation of the Transgenic Plants Expressing SEQ ID NO: 250 Under the Control of a Constitutive Promoter 
     The results of the evaluation of transgenic rice plants expressing the nucleic acid sequence useful in performing the methods of the invention, under the control of a constitutive HMGB promoter (SEQ ID NO: 307), are presented in Table D6. The percentage difference between the transgenics and the corresponding nullizygotes is also shown, with a P value from the F test below 0.05. 
     The transgenic plants expressing the nucleic acid sequence useful in performing the methods of the invention, have increased early vigour, increased aboveground biomass and increased number of filled seeds compared to the control plants (in this case, the nullizygotes). Transgenic plants flower earlier compared to the corresponding nullizygotes, by up to 3 days. 
     
       
         
           
               
             
               
                 TABLE D6 
               
             
            
               
                   
               
               
                 Results of the evaluation of transgenic rice plants 
               
               
                 expressing the nucleic acid sequence useful in performing 
               
               
                 the methods of the invention, under the control of a constitutive 
               
               
                 HMGB promoter. 
               
            
           
           
               
               
               
            
               
                   
                 % Increase in 
                 % Increase in 
               
               
                 Trait 
                 T1 generation 
                 T2 generation 
               
               
                   
               
               
                 Increased early vigour 
                 12 
                 8 
               
               
                 Increase in aboveground biomass 
                 11 
                 5 
               
               
                 Increase in number of (filled) seeds 
                 11 
                 9 
               
               
                   
               
            
           
         
       
     
     Example 46 
     Results of the Phenotypic Evaluation of the Transgenic Plants Expressing SEQ ID NO: 250 Under the Control of a Green Tissue-Specific Promoter 
     The results of the evaluation of transgenic rice plants expressing the nucleic acid sequence useful in performing the methods of the invention, under the control of a protochlorophyllide reductase (SEQ ID NO: 308) promoter, are presented in Table D7. The percentage difference between the transgenics and the corresponding nullizygotes is also shown, with a P value from the F test below 0.05. 
     The transgenic plants expressing the nucleic acid sequence useful in performing the methods of the invention, have increased early vigour compared to the control plants (in this case, the nullizygotes). Transgenic plants flower earlier compared to the corresponding nullizygotes, by up to 4 days. 
     
       
         
           
               
             
               
                 TABLE D7 
               
             
            
               
                   
               
               
                 Results of the evaluation of transgenic rice plants expressing  
               
               
                 the nucleic acid sequence useful in performing the methods of the 
               
               
                 invention, under the control of a protochlorophyllide reductase 
               
               
                 promoter. 
               
            
           
           
               
               
               
            
               
                   
                 % Increase in 
                 % Increase in 
               
               
                 Trait 
                 T1 generation 
                 T2 generation 
               
               
                   
               
               
                 Increased early vigour 
                 18 
                 8 
               
               
                   
               
            
           
         
       
     
     Example 47 
     Examples of Transformation of Other Crops 
     See Example 9 above 
     Example 48 
     Examples of Abiotic Stress Screens 
     See Example 22 above 
     Part V. SYPF1 
     Example 49 
     Identification of Sequences Related to SEQ ID NO: 321 and SEQ ID NO: 322 
     Sequences (full length cDNA, ESTs or genomic) related to SEQ ID NO: 321 and/or protein sequences related to SEQ ID NO: 322 were identified amongst those maintained in the Entrez Nucleotides database at the National Center for Biotechnology Information (NCBI) using database sequence search tools, such as the Basic Local Alignment Tool (BLAST) (Altschul et al. (1990) J. Mol. Biol. 215:403-410; and Altschul et al. (1997) Nucleic Acids Res. 25:3389-3402). The program was used to find regions of local similarity between sequences by comparing nucleic acid or polypeptide sequences to sequence databases and by calculating the statistical significance of matches. The polypeptide encoded by SEQ ID NO: 321 was used for the TBLASTN algorithm, with default settings and the filter to ignore low complexity sequences set off. The output of the analysis was viewed by pairwise comparison, and ranked according to the probability score (E-value), where the score reflects the probability that a particular alignment occurs by chance (the lower the E-value, the more significant the hit). In addition to E-values, comparisons were also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In some instances, the default parameters may be adjusted to modify the stringency of the search. 
     Table E1 provides a list of nucleic acid and protein sequences related to the nucleic acid sequence as represented by SEQ ID NO: 321 and the protein sequence represented by SEQ ID NO: 322. 
     
       
         
           
               
             
               
                 TABLE E1 
               
             
            
               
                   
               
               
                 Nucleic acid sequences encoding SYPF1 polypeptides 
               
               
                 and SYPF1 polypeptides. 
               
            
           
           
               
               
               
               
            
               
                   
                   
                 Nucleic acid 
                 Polypeptide 
               
               
                 Name 
                 Source organism 
                 SEQ ID NO: 
                 SEQ ID NO: 
               
               
                   
               
               
                 SEQ ID NO: 322 
                 
                   Arabidopsis 
                   thaliana 
                 
                 321 
                 322 
               
               
                 At4g18690 
                 
                   Arabidopsis 
                   thaliana 
                 
                 323 
                 324 
               
               
                 At4g18680 
                 
                   Arabidopsis 
                   thaliana 
                 
                 325 
                 326 
               
               
                 At4g18650 
                 
                   Arabidopsis 
                   thaliana 
                 
                 327 
                 328 
               
               
                 NP_564730.1 
                 
                   Arabidopsis 
                   thaliana 
                 
                 329 
                 330 
               
               
                 At5g10030 
                 
                   Arabidopsis 
                   thaliana 
                 
                 331 
                 332 
               
               
                 CAA40102.1 
                 
                   Triticum 
                   aestivum 
                 
                 333 
                 334 
               
               
                 Os01g0159000 
                 
                   Oryza 
                   sativa 
                 
                 335 
                 336 
               
               
                 Os01g0306400 
                 
                   Oryza 
                   sativa 
                 
                 337 
                 338 
               
               
                 BAA05470.1 
                   Nicotiana   glauca  × 
                 339 
                 330 
               
               
                   
                 
                   Nicotiana 
                   langsdorfii 
                 
                   
                   
               
               
                 AAT64037.1 
                 
                   Gossypium 
                   hirsutum 
                 
                 331 
                 332 
               
               
                 At4g18690 
                 
                   Arabidopsis 
                   thaliana 
                 
                 — 
                 333 
               
               
                 NP_193603.1 
                 
                   Arabidopsis 
                   thaliana 
                 
                 — 
                 334 
               
               
                 NP_193600.2 
                 
                   Arabidopsis 
                   thaliana 
                 
                 — 
                 335 
               
               
                 P_564730.1 
                 
                   Arabidopsis 
                   thaliana 
                 
                 — 
                 336 
               
               
                 At5g10030 
                 
                   Arabidopsis 
                   thaliana 
                 
                 — 
                 337 
               
               
                 CAA40102.1 
                 
                   Triticum 
                   aestivum 
                 
                 — 
                 338 
               
               
                 OS01g0159000 
                 
                   Oryza 
                   sativa 
                 
                 — 
                 339 
               
               
                 Os01g0306400 
                 
                   Oryza 
                   sativa 
                 
                 — 
                 340 
               
               
                 BAA05470.1 
                   Nicotiana   glauca  × 
                 — 
                 341 
               
               
                   
                 
                   Nicotiana 
                   langsdorfii 
                 
                   
                   
               
               
                 AAT64037.1 
                 
                   Gossypium 
                   hirsutum 
                 
                 — 
                 342 
               
               
                   
               
            
           
         
       
     
     Example 50 
     Alignment of SYPF1 Polypeptide Sequences 
     Alignment of polypeptide sequences was performed using the AlignX programme from the Vector NTI (Invitrogen) which is based on the popular Clustal algorithm of progressive alignment (Thompson et al. (1997) Nucleic Acids Res 25:4876-4882; Chema et al. (2003). Nucleic Acids Res 31:3497-3500). Default values are for the gap open penalty of 10, for the gap extension penalty of 0.1 and the selected weight matrix is Blosum 62 (if polypeptides are aligned). Results in  FIG. 19  show that SYPF1 polypeptides share regions of high sequence conservation. Motif 1, Motif 2 and Motif 3 represent the regions with highest sequence homology. 
     A phylogenetic tree of SYPF1 polypeptides was constructed using a neighbour-joining clustering algorithm as provided in the AlignX programme from the Vector NTI (Invitrogen).  FIG. 20  shows how SYPF1 polypeptides cluster with SEQ ID NO: 322. 
     Example 51 
     Cloning of Nucleic Acid Sequence as Represented by SEQ ID NO: 321 
     Unless otherwise stated, recombinant DNA techniques are performed according to standard protocols described in (Sambrook (2001) Molecular Cloning: a laboratory manual, 3rd Edition Cold Spring Harbor Laboratory Press, CSH, New York) or in Volumes 1 and 2 of Ausubel et al. (1994), Current Protocols in Molecular Biology, Current Protocols. Standard materials and methods for plant molecular work are described in Plant Molecular Biology Labfax (1993) by R. D. D. Croy, published by BIOS Scientific Publications Ltd (UK) and Blackwell Scientific Publications (UK). 
     The  Arabidopsis thaliana  SYPF1 gene was amplified by PCR using as template an  Arabidopsis thaliana  cDNA library (Invitrogen, Paisley, UK). Primers (SEQ ID NO: 353; sense: 5′-ggggacaagtttgtacaaaaaagcaggcttaaacaatgccaaacactagcagctc t-3′) and SEQ ID NO: 354; reverse, complementary: 5′-ggggaccactttgtacaag aaagctgggtagaagcagagcaaagcaaatta-3′), which include the AttB sites for Gateway recombination, were used for PCR amplification. PCR was performed using Hifi Taq DNA polymerase in standard conditions. A PCR fragment of the expected length (including attB sites) was amplified and purified also using standard methods. The first step of the Gateway procedure, the BP reaction, was then performed, during which the PCR fragment recombined in vivo with the pDONR201 plasmid to produce, according to the Gateway terminology, an “entry clone”. Plasmid pDONR201 was purchased from Invitrogen, as part of the Gateway® technology. 
     Example 52 
     Expression Vector Construction Using the Nucleic Acid Sequence as Represented by SEQ ID NO: 321 
     The entry clone comprising SEQ ID NO: 321 was subsequently used in an LR reaction with a destination vector used for  Oryza sativa  transformation. This vector contained as functional elements within the T-DNA borders: a plant selectable marker; a screenable marker expression cassette; and a Gateway cassette intended for LR in vivo recombination with the nucleic acid sequence of interest already cloned in the entry clone. A rice HMG promoter (SEQ ID NO: 355) for root specific expression was located upstream of this Gateway cassette. 
     After the LR recombination step, the resulting expression vector pHMG::SYPF1 ( FIG. 21 ) was transformed into  Agrobacterium  strain LBA4044 according to methods well known in the art. 
     Example 53 
     Plant Transformation 
     See Example 9 above 
     Example 54 
     Phenotypic Evaluation Procedure 
     See Examples 10 and 22 above 
     Example 55 
     Results of the Phenotypic Evaluation of the Transgenic Plants 
     The results of the evaluation of transgenic rice plants expressing the SYPF1 nucleic acid are as follows. 
     There was a statistically significant increase in the fill rate of seeds, the number of filled seeds, the total seed weight and the harvest index compared to corresponding nullizygotes (controls). For the fill rate, the best 3 lines showed a 16% or more increase compared to control plants. In the case of the number of filled seeds, the best 4 lines gave a 19% or more increase compared to control plants. The total weight of seeds was increased in the best 4 lines by 19% or more and, for harvest index, the best 3 lines gave a greater than 20% increase compared to control plants.